Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Thyroid hormones biosynthesis"	"Hormone, Thyroid hormone"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	685	"thyroid gland: 9416.4"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 5.5;Cardiomyocytes: 3.0;Early spermatids: 2.3;Late spermatids: 2.2;Microglial cells: 1.9;Proximal tubular cells: 4.0"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HSkMC: 2.4;Karpas-707: 5.6;PC-3: 2.8;U-266/70: 2.0;U-266/84: 1.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.1"	"Low region specificity"	"Detected in some"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"	NA	NA		1600000			"CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	1.6	3.2	2.9	0.5	0.4	7.9	1.4	0.3	1.6	1.2	1.4	1.7	0.0	1.8	1.0	2.0	0.4	8.6	13.7	1.6	0.4	2.9	3.7	4.2	12.1	0.4	0.6	0.6	1.3	8.1	2.7	1.2	0.2	0.5	3.6	0.1	0.1	3.9	1.8	2.8	5.9	1.8	0.1	0.2	1.9	2.2	3.0	0.4	0.4	9416.4	0.0	0.6	0.6	1.7	0.5	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	1.7	0.6	0.0	0.5	0.0	0.7	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.2	0.1	1.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.0	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.1	2.9	0.4	0.3	1.6	1.6	0.4	0.4	0.6	0.6	0.5	0.2	0.4	0.5	0.3	0.0	0.6	0.3	0.2	0.0	5.5	0.1	0.0	0.0	0.1	0.1	3.0	0.0	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.3	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.2	0.4	0.4	0.3	0.0	0.7	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	1.9	0.7	0.3	0.0	0.5	0.1	0.1	0.0	0.4	0.1	0.5	0.0	4.0	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.0	0.6	0.0	0.2	1.1	0.0	1.2
TPO	TPX	ENSG00000115705	"Thyroid peroxidase"	P07202	2	1374066-1543711	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	70	"thyroid gland: 1601.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.5;Early spermatids: 4.2;Endothelial cells: 12.6;Late spermatids: 7.5;Peritubular cells: 3.8"	"Cancer enriched"	"Detected in some"	364	"thyroid cancer: 188.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.9;RPMI-8226: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007987, CAB009587"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB009587: , HPA007987: AB_1080270"	"unprognostic (1.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.98e-3)"	"unprognostic (7.10e-3)"	11.1	0.3	0.1	0.4	0.0	0.1	11.1	0.0	0.6	0.1	0.0	4.3	0.6	0.6	0.0	2.0	0.7	3.1	6.5	0.0	0.1	0.2	0.6	0.8	1.4	0.1	0.0	0.0	0.3	2.4	0.3	0.6	0.0	0.2	0.6	0.9	0.2	3.4	0.0	6.0	1.5	3.8	0.6	0.1	22.9	2.8	1.2	0.2	0.0	1601.2	5.7	0.4	2.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.4	24.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.0	0.2	12.6	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	1.1	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.8	0.3	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.1
TSHR	LGR3	ENSG00000165409	"Thyroid stimulating hormone receptor"	P16473	14	80954989-81146306	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"thyroid gland: 276.5"	"Group enriched"	"Detected in some"	4	"Astrocytes: 5.5;Excitatory neurons: 7.0;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 9.5;Plasma cells: 11.7;Skeletal myocytes: 4.1"	"Cancer enriched"	"Detected in some"	116	"thyroid cancer: 100.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"naive B-cell: 1.7;T-reg: 6.9"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 58.4;MOLT-4: 23.8;SCLC-21H: 23.0;U-266/70: 11.3"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	CAB000473	Approved				"Intracellular and membrane"	NA	NA					"CAB000473: AB_2303782"	"unprognostic (3.36e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.17e-6)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.11e-3)"	"unprognostic (5.08e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	0.5	0.6	1.4	0.8	1.7	1.2	0.8	4.4	2.6	0.2	0.2	0.5	0.3	0.6	0.5	0.2	0.8	0.5	0.3	1.5	0.6	0.3	0.5	0.2	1.9	1.3	0.4	1.2	0.3	0.4	0.3	0.2	0.4	1.9	0.5	0.3	2.3	0.6	0.2	0.8	1.1	0.4	0.2	0.1	0.8	0.5	0.7	0.9	21.0	276.5	0.2	0.8	0.4	0.1	2.9	0.4	0.2	0.7	0.4	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.4	0.5	0.7	0.2	0.1	0.5	0.3	0.3	0.0	0.1	0.3	0.1	0.3	0.8	0.4	0.0	0.2	0.4	0.3	0.1	0.1	0.3	0.1	0.0	58.4	0.3	0.7	0.1	0.4	23.8	0.5	0.4	0.1	0.2	0.8	0.2	0.9	0.0	0.5	23.0	0.4	0.2	0.2	0.3	0.5	0.3	0.1	0.2	0.7	0.5	0.6	0.3	11.3	6.3	0.6	0.3	0.3	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.3	0.1	1.7	0.2	0.1	0.9	0.1	0.2	0.5	6.9	0.1	1.4	1.7	4.4	2.6	1.5	0.6	1.3	0.4	1.2	1.9	0.1	0.9	2.9	0.2	0.0	0.5	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.1	0.2	0.3	1.8	0.0	7.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	6.5	0.0	0.1	0.0	6.6	9.5	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.6	0.0	4.1	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823824-118826968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 221.3;endometrium 1: 102.3;fallopian tube: 133.3;smooth muscle: 142.7"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 4.6;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Group enriched"	"Detected in all"	4	"hypothalamus: 221.3;thalamus: 114.6"	"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 10.1;NTERA-2: 3.2;SH-SY5Y: 2.5;SuSa: 2.0"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (1.18e-1)"	0.2	7.8	39.0	0.8	26.3	0.0	0.5	22.1	24.0	25.0	1.2	0.9	0.3	102.3	8.7	0.0	133.3	0.4	0.1	24.5	221.3	0.1	0.1	0.5	0.6	26.6	34.5	30.2	3.1	0.1	0.0	27.1	0.0	27.8	0.4	0.4	4.2	0.0	0.5	0.0	0.0	0.9	142.7	10.1	0.2	0.9	0.6	114.6	0.6	3.1	0.0	0.7	0.0	6.1	32.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.0	3.9	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.5	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	39.0	26.3	22.1	24.0	24.5	221.3	26.6	34.5	30.2	27.8	10.1	114.6	32.7	0.2	0.0	0.0	0.7	0.6	0.0	0.1	0.0	0.6	0.9	0.2	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.2	0.2	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	4.6	0.5	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.5	1.4	1.2	5.6	0.1	0.1	0.0	0.7	0.5	0.1	0.0
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.7;epididymis: 2.0;lung: 3.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 7.1;Macrophages: 6.5"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Region enhanced"	"Detected in some"		"amygdala: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	0.5	0.0	4.7	0.1	2.2	0.2	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.9	0.1	0.0	0.4	3.8	0.2	0.6	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	2.2	0.0	0.7	0.9	0.1	0.6	0.1	0.7	0.7	0.0	0.7	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lung: 53.5;thyroid gland: 173.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.8;thalamus: 10.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SCLC-21H: 78.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 10.2"	"Group enriched"	"Detected in some"	13	"basal ganglia: 4.3;hypothalamus: 10.4"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.0	0.1	3.7	0.0	1.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.0	53.5	0.0	0.5	0.2	0.5	0.1	0.1	0.0	12.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	10.6	0.0	173.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	78.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.9	0.0	3.2	0.0	19.8	0.5	0.2	0.5	1.5	0.0	10.6	0.1	0.0	137.8	124.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428832-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"thyroid gland: 15.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Breast myoepithelial cells: 1.1;Endometrial stromal cells: 1.4;Oligodendrocyte precursor cells: 1.0"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;white matter: 11.4"	"Not detected"	"Not detected"			HPA050788	Uncertain					NA	NA					"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.5	0.2	0.9	0.1	0.6	0.1	0.5	0.2	0.7	1.3	1.2	0.6	0.1	0.9	0.1	0.1	0.9	0.2	0.1	0.9	0.7	0.2	0.0	0.1	0.6	0.2	0.1	0.5	0.7	0.2	1.3	1.2	0.3	0.2	0.7	0.0	0.2	0.2	3.3	0.0	0.0	0.3	0.1	0.1	1.0	0.2	0.1	0.1	0.1	15.6	0.0	0.0	1.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.6	0.2	0.7	0.9	0.7	0.2	0.1	0.5	0.2	0.1	0.1	0.2	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111768011-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 46.3;Inhibitory neurons: 78.5;Oligodendrocytes: 38.3"	"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.1	1.1	0.0	2.1	0.1	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.1	0.8	0.0	0.0	1.9	3.7	1.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	0.9	1.3	1.2	1.8	1.9	3.7	1.4	1.9	0.3	1.8	3.3	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	78.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"adrenal gland: 106.4;brain: 90.5;pituitary gland: 178.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	106.4	23.3	0.0	3.4	0.0	1.4	0.8	6.2	1.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	12.0	90.5	0.0	0.0	0.0	0.0	33.8	46.1	2.2	0.0	0.0	0.0	178.3	0.1	90.3	0.2	0.1	0.0	0.2	0.0	6.6	0.0	0.0	0.0	6.1	0.0	0.1	0.8	37.1	0.4	0.1	1.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	3.4	0.8	6.2	12.0	90.5	33.8	46.1	2.2	90.3	6.1	37.1	28.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
RAG2		ENSG00000175097	"Recombination activating 2"	P55895	11	36575574-36598279	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA recombination"	"Chromatin regulator"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 153.8"	"Group enriched"	"Detected in some"	19	"Astrocytes: 1.3;Early spermatids: 2.3;Excitatory neurons: 2.9;Inhibitory neurons: 1.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.3;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in single"	21	"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 40.0;MOLT-4: 46.8;REH: 183.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065704			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065704: AB_2732737"				"unprognostic (4.30e-2)"					"unprognostic (9.09e-2)"	"unprognostic (1.21e-1)"		"unprognostic (1.77e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.68e-3)"		0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	153.8	24.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	46.8	0.0	0.1	0.0	0.0	183.8	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DPRX		ENSG00000204595	"Divergent-paired related homeobox"	A6NFQ7	19	53632056-53637009	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.2;skeletal muscle: 1.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.6;Cytotrophoblasts: 1.2;Early spermatids: 1.1;Late spermatids: 2.0;Oligodendrocyte precursor cells: 1.0;Syncytiotrophoblasts: 5.6"	"Cancer enriched"	"Detected in single"	20	"thyroid cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA043682	Uncertain					NA	NA					"HPA043682: AB_10963073"												"unprognostic (2.47e-1)"			"unprognostic (1.89e-1)"			0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0
GABRB2		ENSG00000145864	"Gamma-aminobutyric acid type A receptor subunit beta2"	P47870	5	161288429-161549044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 69.7"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 570.3;Inhibitory neurons: 780.2"	"Cancer enriched"	"Detected in some"	20	"thyroid cancer: 10.2"	"Group enriched"	"Detected in many"	4	"cerebellum: 67.3;cerebral cortex: 69.7;hypothalamus: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001964, HPA067632"	Enhanced					NA	NA					"CAB001964: , HPA067632: AB_2685874"	"unprognostic (5.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.26e-6)"	"unprognostic (2.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.04e-2)"	0.5	2.3	3.2	0.0	5.6	0.0	0.1	67.3	69.7	0.5	0.0	0.6	1.2	0.1	3.5	0.0	0.4	0.0	0.1	12.7	20.0	1.8	0.0	0.9	0.0	0.0	3.2	10.6	0.1	0.1	0.1	0.5	0.2	12.2	0.1	1.1	6.6	0.5	0.6	0.1	0.1	0.6	0.1	0.0	2.4	0.5	0.6	10.0	0.1	0.5	0.4	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	5.6	67.3	69.7	12.7	20.0	0.0	3.2	10.6	12.2	0.0	10.0	9.1	0.0	0.0	0.0	21.5	0.0	0.3	0.0	0.1	0.0	19.8	0.1	0.0	1.9	0.0	0.0	0.0	27.1	0.0	0.0	1.0	5.9	0.0	1.6	0.0	0.3	0.3	1.2	0.0	570.3	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	780.2	1.8	4.1	0.0	0.4	1.4	0.0	1.3	0.0	20.6	0.0	2.3	0.0	33.7	17.9	0.0	0.5	0.4	0.0	0.1	0.0	3.2	0.0	10.6	0.0	0.3	3.5	3.1	1.8	0.1	0.4	0.0	0.0	1.9	4.2	0.1
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 477.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.5	0.6	0.4	0.3	0.5	0.8	0.7	0.1	0.2	6.5	18.3	0.2	0.6	0.0	0.0	8.9	0.5	0.5	0.3	26.9	33.9	0.7	0.5	0.6	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.8	0.2	6.6	0.2	0.1	0.0	0.0	0.2	19.8	0.2	0.0	0.1	2.0	0.2	0.7	0.0	477.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.5	0.4	0.8	0.7	0.5	0.3	0.6	0.5	0.5	0.8	0.0	0.7	0.7	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.7;pituitary gland: 3.2;testis: 4.8;thyroid gland: 6.3"	"Group enriched"	"Detected in some"	8	"Astrocytes: 876.3;Excitatory neurons: 988.4;Inhibitory neurons: 1438.9"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 6.0;SCLC-21H: 2.5;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	0.2	0.9	1.4	0.0	2.1	0.1	0.0	0.3	1.4	0.1	0.0	0.3	0.0	0.0	3.7	0.0	0.1	0.1	1.6	1.1	1.6	0.0	0.1	0.1	0.0	1.0	2.4	1.3	0.0	0.1	0.0	3.2	0.0	1.3	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.8	0.0	0.1	4.8	1.7	0.0	6.3	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.1	0.3	1.4	1.1	1.6	1.0	2.4	1.3	1.3	0.8	1.7	1.3	0.1	6.4	1.1	876.3	0.0	0.1	0.2	1.5	0.0	11.2	0.0	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	123.9	0.1	0.1	4.2	0.0	0.0	988.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1438.9	0.0	4.1	0.0	0.0	98.9	16.1	0.3	0.0	34.7	0.2	0.5	0.0	32.2	17.2	0.4	0.0	4.1	0.0	0.3	0.0	0.1	0.0	1.8	0.0	0.4	0.2	3.8	1.5	0.0	0.1	0.0	0.5	6.2	0.0	0.3
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"epididymis: 168.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Region enhanced"	"Detected in some"		"pons: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"TIME: 2.1"														"Secreted in other tissues"	NA	NA																					"unprognostic (2.11e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	15.1	0.0	168.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	1.1	0.2	0.1	1.9	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362461-109537207	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"thyroid gland: 69.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.4;Endometrial ciliated cells: 47.0;Endothelial cells: 14.0;Glandular and luminal cells: 49.9;Plasma cells: 28.2"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HHSteC: 1.4;TIME: 1.6;U-266/70: 3.9"	"Not detected"	"Not detected"							HPA044458	Uncertain					NA	NA		13000000			"HPA044458: AB_2678949"	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	12.8	2.7	0.2	0.5	0.1	0.4	2.6	0.1	0.3	13.9	1.4	2.4	1.1	6.0	0.3	1.7	14.2	0.4	5.3	0.1	0.4	1.9	0.6	7.0	1.2	0.2	0.1	0.1	2.6	0.5	0.0	0.8	0.0	0.1	0.7	1.6	0.0	0.7	0.2	0.2	1.7	4.3	0.4	0.2	0.5	1.6	0.5	0.1	0.1	69.4	0.6	1.1	1.2	1.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.4	0.2	0.1	0.1	0.1	0.2	0.1	0.4	1.3	0.0	2.8	0.7	24.4	0.3	0.0	0.0	0.6	0.0	0.1	0.0	1.9	1.5	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	47.0	3.4	14.0	1.8	0.4	0.2	0.0	0.1	6.6	1.1	49.9	1.3	0.0	10.4	0.6	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.5	0.6	0.3	1.8	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.1	0.0
PSG8		ENSG00000124467	"Pregnancy specific beta-1-glycoprotein 8"	Q9UQ74	19	42752686-42855691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"placenta: 6.6"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 34.3"	"Cancer enriched"	"Detected in single"	17	"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		55000000			"HPA046327: AB_2679624"																"unprognostic (1.85e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.3	0.0	0.0	0.0	0.0
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 64.2"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA					"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.3	64.2	2.2	0.4	1.5	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.0	0.1	0.1	0.1	0.2	0.3	9.8	0.0	1.0	0.3	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CNTN6	NB-3	ENSG00000134115	"Contactin 6"	Q9UQ52	3	1092658-1404217	"Predicted membrane proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;thyroid gland: 9.8"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 35.3;Excitatory neurons: 127.6;Inhibitory neurons: 75.9;Oligodendrocyte precursor cells: 52.8"	"Group enriched"	"Detected in some"	15	"renal cancer: 2.7;thyroid cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.1;SH-SY5Y: 2.3;SuSa: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016645	Uncertain					NA	NA		4700000			"HPA016645: AB_1847149"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"		"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-2)"	0.0	3.2	1.2	0.0	2.2	0.0	0.1	10.9	2.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	1.8	0.1	0.0	3.2	0.0	2.0	3.0	1.9	0.0	0.0	0.0	0.3	2.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	3.1	0.0	9.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.2	10.9	2.4	1.1	1.8	2.0	3.0	1.9	3.7	1.3	3.1	2.2	0.0	35.3	3.6	15.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.5	0.0	3.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	127.6	0.0	0.2	3.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	75.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	52.8	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.0	0.0
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 50.6;thyroid gland: 42.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 213.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	12.6	2.2	6.6	2.7	8.1	16.1	8.9	6.5	7.8	5.3	5.3	9.9	20.8	1.7	0.2	3.3	1.7	1.5	23.2	6.2	6.7	3.2	2.0	20.2	3.1	7.4	7.6	5.8	0.9	2.7	0.9	1.6	0.4	8.1	5.2	6.7	0.4	7.6	3.6	50.6	7.4	21.5	1.7	6.7	7.9	10.0	3.1	7.1	1.6	42.3	19.8	2.6	2.4	9.6	10.4	3.1	2.3	6.1	1.5	10.6	0.5	0.0	2.1	6.7	1.1	1.2	1.0	1.6	0.2	0.7	6.7	3.7	9.2	3.8	0.1	0.6	0.2	0.2	1.3	4.5	0.1	0.1	0.1	18.3	1.1	7.9	0.4	0.2	7.0	0.7	0.1	0.4	0.1	0.7	9.7	0.0	0.4	0.7	3.1	2.2	2.9	0.0	0.3	0.0	3.2	0.4	0.3	0.4	1.2	0.0	1.5	5.2	0.4	0.4	0.9	1.0	1.4	1.8	0.6	0.2	0.0	0.0	3.0	0.3	94.3	0.2	213.0	2.1	0.1	0.9	1.3	0.6	2.2	0.2	0.4	0.0	1.4	65.9	2.7	0.1	8.6	0.1	1.3	6.6	8.1	6.5	7.8	6.2	6.7	7.4	7.6	5.8	8.1	6.7	7.1	10.4	24.9	86.6	22.3	5.2	4.8	11.6	7.0	8.7	0.6	0.1	9.4	7.4	46.2	1.5	14.6	0.0	0.0	0.1	22.6	45.2	1.9	9.1	25.3	3.0	1.6	6.4	8.4	0.8	15.9	35.6	0.2	8.7	16.3	7.8	15.2	1.3	5.7	1.3	0.4	5.0	2.1	17.0	6.1	1.3	0.8	112.5	3.1	3.2	0.0	15.0	0.3	2.1	2.1	11.1	99.9	9.4	30.6	5.7	0.4	12.0	64.0	0.3	2.8	0.3	13.1	7.6	4.5	2.6	4.9	0.5	4.1	0.1	14.9	1.9	19.6	14.0
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 109.3;thyroid gland: 231.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 268.1;Club cells: 70.4;Distal tubular cells: 113.5;Fibroblasts: 43.8"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Hep G2: 2.5;HHSteC: 1.3;NTERA-2: 1.7;U-2197: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	NA	NA		1400000			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	17.9	4.2	17.3	6.1	17.1	0.2	12.9	15.9	28.5	20.4	14.3	6.3	17.8	3.5	87.9	6.8	12.5	45.4	13.2	16.5	19.1	17.0	0.3	109.3	0.9	17.0	15.9	14.4	2.8	5.5	0.1	5.7	0.9	16.9	4.2	5.0	0.5	35.3	1.1	0.2	0.5	7.9	4.9	16.9	0.6	83.1	1.2	18.5	2.8	231.0	4.0	2.2	14.5	3.2	19.9	0.0	0.1	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	2.5	1.3	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.7	0.3	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.0	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	17.3	17.1	15.9	28.5	16.5	19.1	17.0	15.9	14.4	16.9	16.9	18.5	19.9	0.9	44.8	268.1	23.2	0.0	0.4	1.8	0.3	0.6	0.5	23.6	18.0	2.8	0.0	70.4	0.0	0.0	0.1	0.1	0.1	113.5	0.0	1.7	3.7	0.4	1.3	0.0	0.0	0.9	7.8	0.1	43.8	17.3	0.3	5.1	0.0	0.0	0.0	6.0	0.0	0.7	0.6	6.1	0.0	0.4	2.7	9.3	0.7	0.0	11.2	0.0	0.3	0.0	1.0	1.6	0.7	0.4	14.7	0.0	5.0	0.0	1.5	16.9	0.2	0.0	1.9	1.9	0.8	0.1	0.6	0.3	0.3	0.6	0.0	0.7	5.0
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.7;retina: 6.2;thyroid gland: 15.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 69.9;Horizontal cells: 102.6"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030816			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030816: AB_10601721"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.0	0.9	1.2	0.0	3.9	0.0	0.1	0.6	5.7	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	2.3	2.2	0.0	0.0	0.0	0.0	2.4	1.4	3.2	3.1	0.3	0.5	1.3	0.0	1.2	0.6	0.0	6.2	0.0	0.6	0.0	0.5	0.0	0.0	1.2	0.2	0.0	1.6	1.8	0.6	15.1	0.0	0.1	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.9	0.6	5.7	2.3	2.2	2.4	1.4	3.2	1.2	1.2	1.8	2.6	0.0	0.0	0.0	0.7	0.0	0.6	0.2	0.0	2.2	5.9	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	69.9	0.0	0.7	0.9	0.5	0.1	0.0	0.1	0.0	0.0	0.0	102.6	14.5	0.0	0.0	0.0	0.0	0.1	4.7	0.2	10.6	1.0	0.0	0.9	0.0	3.0	2.3	0.1	0.0	4.5	0.0	0.7	0.0	0.0	0.0	4.3	0.0	0.3	0.2	0.4	3.7	2.8	0.6	0.1	0.1	2.5	0.0	0.1
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783540-32789201	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;retina: 18.4;testis: 4.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 572.0;Early spermatids: 129.9;Late spermatids: 302.1"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Region enhanced"	"Detected in some"		"thalamus: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.0	0.0	1.3	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.5	1.7	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	4.0	4.7	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.5	0.6	1.0	0.5	1.7	0.5	0.3	0.2	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	572.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	129.9	0.0	1.2	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	302.1	2.8	0.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.1	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS6	"FLJ30744, MT2"	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109713	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 129.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 61.0;Hepatocytes: 99.9;Late spermatids: 143.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 5.0;SCLC-21H: 8.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.3"							NA	NA						"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.1	0.2	0.2	3.6	0.2	0.4	0.1	0.6	0.1	0.0	0.6	2.2	0.1	0.8	0.3	0.5	0.9	0.0	0.2	0.3	0.1	129.4	0.7	0.3	1.9	0.3	0.0	0.1	1.3	0.0	13.1	0.7	0.7	0.2	0.5	0.1	0.0	0.0	0.0	2.3	1.1	0.0	0.1	0.3	3.6	7.8	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.2	0.1	5.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.0	8.1	0.3	0.1	0.6	0.0	0.1	0.1	0.0	0.4	0.3	1.0	0.1	0.0	1.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.1	0.6	0.2	0.3	1.9	0.3	0.0	0.7	0.1	0.9	0.1	0.0	0.0	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.3	0.5	2.8	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.2	61.0	0.0	0.0	0.3	5.3	8.0	0.1	0.0	2.6	0.0	2.6	0.0	0.0	0.0	2.5	99.9	0.1	0.0	0.1	1.5	0.0	3.2	0.0	143.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.1	0.3	0.3	0.1	0.6	0.0
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 385.9;skeletal muscle: 677.1;tongue: 586.5"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 177.3;Cardiomyocytes: 144.7;Muller glia cells: 198.7"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-266/70: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA025064	Uncertain				"Secreted in other tissues"	NA	NA		190000000			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	1.0	3.4	11.5	0.3	14.8	0.0	3.4	21.5	9.5	0.6	17.1	0.5	0.0	0.5	385.9	6.9	2.3	1.1	184.5	8.0	20.7	2.5	0.9	116.1	0.8	18.3	18.5	6.0	1.7	34.8	83.4	13.3	0.4	19.1	46.2	0.2	13.0	21.3	2.8	677.1	1.2	0.6	0.4	7.8	0.8	9.2	6.6	25.6	1.2	57.2	586.5	1.6	0.3	0.5	15.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	11.5	14.8	21.5	9.5	8.0	20.7	18.3	18.5	6.0	19.1	7.8	25.6	15.2	1.5	109.0	177.3	15.3	2.2	1.9	1.0	0.1	0.0	10.2	5.7	4.7	144.7	0.0	7.4	1.8	2.1	0.8	1.4	0.3	3.9	0.0	34.8	1.7	2.0	2.4	0.0	0.0	10.0	9.3	0.2	10.1	2.0	7.0	7.6	0.4	3.9	0.7	1.2	10.1	9.6	0.3	2.0	0.0	0.8	28.4	3.4	1.4	1.8	6.5	0.1	198.7	5.2	6.6	0.9	0.3	0.1	10.9	1.5	23.8	0.5	5.9	2.9	8.6	0.0	25.2	2.1	14.8	1.2	0.0	0.9	0.0	1.6	1.1	0.3	1.0
RGS8	"MGC119067, MGC119068, MGC119069"	ENSG00000135824	"Regulator of G protein signaling 8"	P57771	1	182641816-182684576	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 58.5;retina: 34.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 65.6;Early spermatids: 11.7;Inhibitory neurons: 18.0;Late spermatids: 22.1;Theca cells: 14.0"	"Group enriched"	"Detected in some"	13	"glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;Daudi: 2.1;SCLC-21H: 15.9;U-698: 3.3"	"Region enhanced"	"Detected in all"		"cerebellum: 425.5"	"Low region specificity"	"Detected in many"			HPA076764	Enhanced					NA	NA					"HPA076764: AB_2732321"	"unprognostic (6.75e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"		"unprognostic (9.29e-3)"		"unprognostic (1.16e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.02e-1)"	0.0	1.1	15.7	0.0	40.6	0.0	0.0	13.4	12.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	19.1	0.0	0.0	0.0	0.1	23.6	30.3	7.1	0.4	0.0	0.0	1.4	0.0	27.7	0.0	0.0	34.7	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	3.0	58.5	0.0	6.7	0.0	0.3	0.0	0.0	36.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	40.6	13.4	12.8	3.6	19.1	23.6	30.3	7.1	27.7	1.0	58.5	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	18.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;pituitary gland: 30.1;retina: 24.5;skeletal muscle: 50.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	1.7	3.2	12.9	0.4	14.1	0.0	1.0	10.0	14.4	3.0	9.4	3.2	0.7	1.1	0.7	1.0	2.8	0.6	5.3	10.9	16.3	0.2	0.3	2.8	0.3	20.4	11.2	10.7	1.0	2.1	0.1	30.1	0.7	21.1	1.1	2.0	24.5	1.2	1.4	50.2	2.3	1.6	1.2	11.2	0.4	1.4	1.0	21.6	0.1	0.7	7.7	0.0	1.6	2.1	13.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	14.1	10.0	14.4	10.9	16.3	20.4	11.2	10.7	21.1	11.2	21.6	13.7	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 197.3;thyroid gland: 570.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.1	1.9	0.6	1.4	0.5	1.7	0.1	1.2	14.7	1.6	1.8	0.6	8.9	33.2	2.2	37.8	3.6	2.1	1.1	1.9	197.3	1.2	1.6	1.7	4.5	1.4	0.4	1.7	1.0	1.4	1.4	1.9	2.9	1.1	0.9	1.5	1.9	26.4	0.5	1.8	2.4	0.8	3.2	0.8	1.4	2.5	2.0	0.5	570.1	0.3	1.1	2.1	1.0	2.2	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.9	1.4	0.1	1.2	1.1	1.9	4.5	1.4	0.4	2.9	3.2	2.0	2.2	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134412242	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 195.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 27.4;Bipolar cells: 37.0;Excitatory neurons: 37.2;Inhibitory neurons: 30.4;Muller glia cells: 116.2;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 77.8"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.1;HMC-1: 25.3;NTERA-2: 22.1;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	0.2	4.2	147.5	0.4	129.4	1.0	3.9	112.4	195.4	0.3	38.4	0.7	0.5	1.4	0.2	0.2	0.4	0.3	0.2	184.7	98.8	1.8	5.9	0.6	2.1	132.8	147.9	122.8	0.2	0.4	0.0	4.5	0.1	128.7	2.8	0.1	24.0	1.2	0.4	0.1	0.4	0.6	0.1	132.3	1.4	35.2	0.9	117.4	0.4	6.3	0.2	0.4	0.7	0.3	177.1	0.0	0.0	23.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.9	0.0	0.9	1.2	1.6	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.1	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.1	22.1	1.1	0.0	0.4	0.0	1.7	0.0	0.1	3.1	8.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	147.5	129.4	112.4	195.4	184.7	98.8	132.8	147.9	122.8	128.7	132.3	117.4	177.1	0.1	0.0	0.0	27.4	0.1	0.0	0.0	0.0	0.0	37.0	1.2	0.8	1.1	2.8	0.0	0.0	4.2	0.0	14.4	0.1	0.0	0.0	1.8	0.1	0.1	0.4	1.8	0.4	37.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	4.7	0.1	23.5	30.4	0.0	0.0	0.3	0.0	3.9	0.0	0.2	0.0	3.7	0.0	116.2	15.5	33.2	77.8	0.0	0.0	0.4	7.5	0.9	0.0	1.9	0.0	8.6	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.1	3.8	0.0	0.0	0.3
ECRG4	"augurin, C2orf40"	ENSG00000119147	"ECRG4 augurin precursor"	Q9H1Z8	2	106063246-106078155	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 185.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 87.6;Fibroblasts: 25.3;Smooth muscle cells: 19.1"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 72.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 8.5;naive CD8 T-cell: 7.2"	"Lineage enriched"	"Detected in single"	83	"T-cells: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008546	Uncertain				"Secreted to blood"	NA	NA		330000			"HPA008546: AB_2066524"	"prognostic favorable (4.58e-4)"	"unprognostic (3.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.30e-4)"	61.6	27.9	7.3	1.1	5.8	0.0	50.1	8.9	7.3	67.8	185.4	38.5	5.3	24.8	28.7	20.3	48.0	9.5	17.5	12.1	43.5	46.3	3.3	27.8	1.8	12.1	17.8	2.2	13.3	5.9	0.7	96.9	8.6	14.6	55.6	5.7	0.1	20.6	102.7	10.4	12.8	19.3	9.1	19.8	26.1	167.2	27.2	13.2	2.8	101.9	7.0	0.3	80.2	58.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	2.0	1.3	0.0	0.0	8.5	7.2	0.0	0.0	0.0	0.0	0.8	1.4	7.3	5.8	8.9	7.3	12.1	43.5	12.1	17.8	2.2	14.6	19.8	13.2	12.7	87.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	25.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 98.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 39.2;Distal tubular cells: 11.7;Excitatory neurons: 16.4;Inhibitory neurons: 20.0"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 3.0;naive CD4 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7;SH-SY5Y: 9.1;SK-MEL-30: 2.9;U-2 OS: 1.9;U-266/70: 2.4;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol		NA	NA			Cytosol		"HPA053808: AB_2682270"	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	0.0	10.2	62.2	0.8	98.0	0.4	0.0	44.5	79.9	0.0	3.8	0.2	0.2	0.0	0.3	5.2	0.0	0.2	0.8	86.3	52.1	4.8	0.0	0.6	1.0	26.2	35.0	91.5	2.9	4.9	0.2	2.1	0.0	34.9	0.3	0.1	11.0	0.1	0.1	3.2	0.1	0.4	0.0	21.3	0.3	0.6	4.6	50.9	0.2	0.1	1.3	0.8	0.1	0.1	60.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	1.4	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.8	9.1	0.2	0.0	2.9	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	2.4	3.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.0	0.5	0.1	0.0	2.6	0.9	0.0	0.0	0.0	0.0	2.2	0.9	62.2	98.0	44.5	79.9	86.3	52.1	26.2	35.0	91.5	34.9	21.3	50.9	60.1	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	39.2	0.1	0.1	1.5	0.0	0.6	1.8	0.0	0.0	0.0	0.0	11.7	0.0	3.4	0.1	0.0	0.1	0.0	0.0	16.4	0.8	0.0	0.6	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.7	20.0	0.0	0.0	0.0	0.0	1.2	1.2	0.1	0.0	1.0	0.0	4.9	0.0	1.5	1.3	0.2	0.0	1.5	0.3	0.0	0.0	0.1	0.0	1.4	0.0	0.3	0.1	2.8	0.7	0.0	0.0	0.0	0.9	0.1	0.0	0.0
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559032-26572263	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"epididymis: 1966.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Respiratory ciliated cells: 168.3;Syncytiotrophoblasts: 665.9"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.6;pons: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;K-562: 11.7;SK-BR-3: 18.0;SuSa: 12.0;U-266/70: 7.8;U-266/84: 21.1"	"Group enriched"	"Detected in some"	4	"cerebellum: 1.2;thalamus: 1.4"	"Low region specificity"	"Detected in many"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.0	0.3	0.4	0.0	3.6	0.0	15.5	0.0	0.6	3.2	1.0	0.0	0.0	0.4	1966.7	17.6	6.7	0.1	0.0	0.4	0.4	24.3	0.1	12.4	0.1	0.5	0.0	0.4	0.0	7.9	0.0	1.5	14.9	2.0	0.9	0.0	0.0	52.6	6.9	0.0	29.7	0.0	0.0	0.0	0.0	1.0	0.3	0.4	3.7	76.3	0.0	7.7	2.5	11.7	0.5	0.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.6	0.0	18.0	0.0	12.0	0.2	0.0	0.0	0.0	3.1	0.0	0.0	7.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.6	0.4	0.4	0.5	0.0	0.4	2.0	0.0	0.4	0.5	0.2	109.0	32.5	0.0	0.1	3.4	12.5	7.5	4.6	0.0	43.0	6.9	0.0	0.0	55.1	49.7	0.0	68.7	0.0	0.0	31.3	4.6	0.6	39.8	5.4	0.7	0.0	0.0	0.2	0.0	19.2	1.3	0.0	53.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	8.2	0.0	0.6	0.2	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	168.3	0.0	0.0	0.0	2.2	0.2	0.2	26.5	29.7	665.9	0.4	0.0	0.0	12.6
OR4D10	"OR4D10P, OST711"	ENSG00000254466	"Olfactory receptor family 4 subfamily D member 10"	Q8NGI6	11	59473315-59479361	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																					"unprognostic (2.59e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC26A7	SUT2	ENSG00000147606	"Solute carrier family 26 member 7"	Q8TE54	8	91209494-91398155	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 333.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Endometrial ciliated cells: 31.6;Endometrial stromal cells: 23.9;Enteroendocrine cells: 45.2;Glandular and luminal cells: 52.0;Hepatic stellate cells: 24.7"	"Group enriched"	"Detected in some"	11	"renal cancer: 8.7;thyroid cancer: 32.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.83e-3)"	1.5	0.1	0.1	0.0	0.2	0.0	0.3	0.2	0.1	1.4	0.2	0.2	0.1	2.7	0.1	0.0	0.5	0.6	0.8	0.0	0.6	24.0	0.0	0.1	3.7	0.1	0.2	0.0	0.1	1.2	0.2	0.3	0.3	0.2	0.1	0.4	0.0	0.4	0.2	0.1	0.1	0.1	0.2	0.2	0.1	6.1	0.5	0.2	0.0	333.5	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.1	0.2	0.0	0.2	0.2	0.2	0.4	3.9	0.0	1.5	5.9	0.1	0.3	0.4	0.2	0.0	0.0	1.9	0.6	1.1	0.0	0.3	23.9	0.0	0.0	0.0	0.3	13.7	0.1	11.9	31.6	23.9	1.5	45.2	0.0	0.5	0.2	0.0	1.5	1.5	52.0	0.0	0.1	24.7	0.1	0.1	0.0	0.7	0.7	2.0	0.6	0.3	2.9	3.7	0.2	3.6	0.0	0.0	0.1	0.0	0.0	3.8	1.4	0.2	0.0	0.0	0.3	0.0	0.3	1.9	0.2	0.0	0.0	4.4	0.6	1.1	0.0	0.1	0.0	0.4	0.5	0.3	0.1
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 62.0;retina: 42.4;thyroid gland: 26.9"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 168.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-266/70: 8.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5"	"Low region specificity"	"Detected in many"			HPA036621	Uncertain					NA	NA					"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.3	0.7	3.7	1.2	5.4	2.4	1.5	12.3	4.4	1.3	62.0	1.0	0.8	1.4	2.3	0.9	2.1	1.0	1.4	6.6	3.0	1.0	1.0	2.6	1.8	6.0	5.2	2.3	1.6	1.5	12.5	2.4	0.6	7.2	1.2	0.7	42.4	1.7	1.3	1.9	5.0	1.0	1.5	2.7	1.3	0.9	16.3	4.6	1.0	26.9	1.6	0.8	1.1	1.1	8.8	0.3	0.5	0.9	0.9	0.9	1.6	0.9	0.2	0.9	0.5	0.7	0.3	0.7	1.5	0.2	0.0	0.3	0.1	1.0	0.1	0.2	1.2	0.6	2.2	0.7	0.5	0.1	0.5	1.3	0.4	1.3	0.0	0.2	0.5	0.3	1.0	0.5	1.5	0.2	3.5	0.3	1.5	0.4	0.5	0.3	0.8	0.7	0.0	0.2	0.6	0.6	1.2	0.3	1.1	1.6	0.7	0.8	1.5	0.0	0.9	1.6	0.9	0.3	8.8	1.4	1.0	0.6	0.8	0.2	4.3	0.3	0.3	0.6	0.3	0.4	0.7	1.0	0.9	0.3	0.9	0.8	1.0	1.9	0.7	0.1	2.5	1.2	0.2	3.7	5.4	12.3	4.4	6.6	3.0	6.0	5.2	2.3	7.2	2.7	4.6	8.8	1.1	3.2	10.8	16.0	0.5	0.6	0.6	0.3	0.0	13.9	0.6	0.5	0.4	1.5	2.6	0.0	35.5	0.1	3.3	0.3	0.0	0.4	0.6	1.0	0.7	0.9	0.0	0.4	7.3	0.6	0.0	0.8	0.0	0.8	0.0	1.1	0.7	0.0	0.1	168.2	10.6	0.5	0.0	0.0	0.4	0.6	1.2	0.4	1.8	4.7	0.1	3.3	2.1	4.0	31.1	0.5	0.3	0.4	0.1	0.6	0.3	0.1	4.1	40.4	0.0	2.5	1.1	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.2	0.7
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288109-98708935	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 90.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 386.5;Inhibitory neurons: 395.1"	"Group enriched"	"Detected in many"	10	"glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.6;fHDF/TERT166: 7.3;HUVEC TERT2: 29.5;U-138 MG: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved				NA	NA					"CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993"	"unprognostic (2.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.09e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	0.0	3.6	16.3	0.2	39.7	0.0	0.0	10.1	90.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	33.0	17.8	0.0	0.0	0.3	0.0	12.1	19.6	42.1	0.0	0.1	0.2	0.6	0.1	20.2	0.0	0.0	8.6	0.0	0.1	2.9	0.1	0.0	0.1	0.4	0.0	0.2	0.6	40.7	0.0	1.4	0.5	0.2	0.5	0.0	36.2	0.0	0.0	0.0	0.0	0.1	0.1	1.2	14.6	2.9	3.0	5.5	0.1	0.1	0.0	0.9	7.3	0.6	0.0	0.1	0.2	1.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.9	0.2	0.0	29.5	0.0	0.3	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	1.2	11.5	0.7	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	16.3	39.7	10.1	90.5	33.0	17.8	12.1	19.6	42.1	20.2	0.4	40.7	36.2	0.1	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	86.4	0.5	0.1	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	90.3	0.1	0.0	0.6	0.0	0.0	386.5	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	395.1	0.0	0.0	0.0	0.0	34.5	0.3	0.1	1.8	11.2	0.0	1.8	0.0	26.2	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.4	0.0	0.3	1.3	0.7	0.9	0.0	0.1	0.4	0.0	0.3	0.1	0.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 197.9;parathyroid gland: 271.5;thyroid gland: 140.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	11.4	0.4	14.4	0.6	3.9	23.1	20.6	0.1	2.7	0.6	0.7	0.5	16.0	0.3	5.1	19.0	0.6	7.2	37.5	197.9	1.3	0.9	0.8	35.0	31.9	6.3	0.2	44.6	271.5	1.0	0.9	26.4	0.2	0.2	1.2	11.9	21.9	0.3	0.8	2.5	0.0	27.6	1.6	23.6	1.7	23.0	0.2	140.7	0.0	0.1	0.0	0.0	21.5	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	11.4	14.4	23.1	20.6	7.2	37.5	35.0	31.9	6.3	26.4	27.6	23.0	21.5	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.8;thyroid gland: 13.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.4	0.2	0.2	1.9	0.3	2.5	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.3	0.3	4.0	0.0	0.3	7.2	1.4	1.0	0.2	0.3	0.0	7.0	0.3	0.9	0.6	1.4	0.2	4.7	0.4	12.8	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.7	0.3	13.9	0.0	5.4	0.6	0.5	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.3	0.3	1.4	1.0	0.2	0.6	0.8	0.7	0.2	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
LCN6		ENSG00000267206	"Lipocalin 6"	P62502	9	136744017-136748525	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"epididymis: 1595.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 20.2;Endothelial cells: 80.6"	"Cancer enriched"	"Detected in some"	10	"thyroid cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 3.3;REH: 10.7"														"Secreted in male reproductive system"	NA	NA						"unprognostic (4.05e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.83e-4)"	"unprognostic (3.41e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-1)"	9.9	0.3	2.0	1.4	1.6	4.4	9.9	1.5	2.8	9.8	1.9	4.7	0.4	19.2	1595.5	3.3	12.8	2.0	17.9	1.5	1.6	0.4	0.3	3.4	0.9	1.7	1.8	1.3	5.7	3.2	0.9	0.5	0.0	1.9	7.6	0.8	0.0	4.6	4.3	2.8	2.2	7.7	5.3	1.5	3.2	7.3	3.9	2.6	0.4	5.2	6.6	0.4	8.4	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.6	1.5	2.8	1.5	1.6	1.7	1.8	1.3	1.9	1.5	2.6	1.7	20.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	80.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	5.6	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.0	0.1	6.6	0.1	1.6	0.4	0.5	0.0	0.0	0.0	5.3	0.0	0.0	1.5
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 701.9;vagina: 246.5"	"Group enriched"	"Detected in some"	5	"Club cells: 11.8;Squamous epithelial cells: 37.7;Urothelial cells: 32.0"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA052028	Enhanced					NA	NA					"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	64.9	0.0	0.1	0.0	0.1	0.0	701.9	0.2	0.0	0.1	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	107.7	0.0	0.3	0.2	0.1	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.1	0.0	13.6	0.2	246.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.3	0.1	0.0	32.0
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187126-210225447	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.3;pancreas: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.9;Early spermatids: 85.6;Late spermatids: 69.4;Leydig cells: 46.9;Peritubular cells: 46.6;Proximal tubular cells: 31.5"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;RPTEC TERT1: 2.6;SuSa: 2.3;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported				NA	NA					"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	12.0	1.1	0.7	0.1	0.6	0.0	8.1	0.6	1.1	3.4	0.8	0.5	0.0	0.7	1.1	0.5	4.0	0.6	2.1	0.6	1.1	20.0	28.3	10.1	0.0	0.7	0.6	0.6	12.8	28.6	4.5	2.9	1.0	0.6	20.8	0.1	0.0	6.8	4.9	9.6	2.6	0.4	0.1	0.6	0.0	5.6	3.1	0.6	1.5	23.9	5.1	0.0	1.0	3.8	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.6	0.5	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.6	1.1	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.2	28.9	70.9	1.0	0.0	0.6	1.4	1.1	1.2	0.2	1.3	0.5	1.1	8.6	7.6	22.0	2.1	8.8	0.0	0.0	15.6	4.0	85.6	7.1	0.4	0.2	0.0	0.0	0.2	11.9	0.3	4.9	3.6	5.9	2.5	0.8	0.7	23.0	0.5	0.0	13.3	0.0	0.0	0.3	0.4	69.4	46.9	0.4	0.0	4.7	0.0	0.2	0.0	7.5	0.3	3.9	0.0	46.6	0.0	8.2	0.0	31.5	2.4	0.2	0.0	7.6	13.7	0.7	0.7	0.7	1.0	6.3	0.4	0.1	0.0	0.7
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"kidney: 146.2;liver: 186.8;thyroid gland: 262.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 61.5;Proximal tubular cells: 115.7"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"Hep G2: 33.9;SK-BR-3: 79.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.2	0.2	0.1	0.2	0.2	0.7	0.2	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.2	4.7	1.0	0.6	0.1	0.1	146.2	186.8	0.4	0.8	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.2	0.0	262.5	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	1.0	0.3	0.0	33.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.1	0.1	0.2	0.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	79.0	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.9	0.1	15.2	11.5	0.4	0.0	0.0	0.5	0.1	0.0	11.7	0.0	3.6	0.3	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	61.5	0.5	0.0	0.5	0.0	0.0	2.2	0.0	5.3	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	115.7	10.2	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	2.3	0.3	0.1	0.0	0.0
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 50.9;pituitary gland: 169.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 3.9;Bipolar cells: 14.0;Breast glandular cells: 5.0;Horizontal cells: 3.3;Melanocytes: 3.6;Skeletal myocytes: 7.2"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 47.6;SH-SY5Y: 31.2"	"Region enhanced"	"Detected in all"		"hypothalamus: 144.0"	"Low region specificity"	"Detected in all"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		100000	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	1.9	12.6	14.5	0.8	10.1	0.1	2.8	10.4	9.8	3.4	4.9	0.7	0.4	1.2	2.4	1.6	2.5	1.2	8.0	8.0	50.9	0.7	1.5	0.3	0.4	11.4	17.0	4.6	1.1	2.6	0.8	169.1	0.7	18.7	4.0	0.4	6.4	2.4	5.7	2.0	1.4	0.6	3.1	7.4	0.3	1.1	12.3	23.6	0.6	4.6	5.1	0.9	0.4	0.9	10.3	0.4	0.6	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.1	1.8	0.0	0.0	6.0	0.4	0.0	3.0	47.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	4.1	2.8	0.0	0.0	0.0	0.1	0.1	0.2	3.4	31.2	0.0	0.2	0.0	4.1	0.6	0.0	0.0	0.5	0.8	0.0	4.1	1.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	10.1	10.4	9.8	8.0	50.9	11.4	17.0	4.6	18.7	7.4	23.6	10.3	0.2	3.2	0.6	3.9	0.2	0.0	0.5	0.0	1.2	14.0	5.0	1.7	2.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.3	1.5	0.0	0.1	0.0	0.7	0.7	0.3	0.0	3.3	0.4	0.0	0.0	0.0	0.8	1.1	0.0	0.2	3.6	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.3	0.0	0.8	0.0	0.7	0.0	7.2	0.3	0.1	0.4	0.0	0.4	0.3	0.1	0.0	0.0	0.3
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 32.6"	"Cell type enriched"	"Detected in single"	32	"B-cells: 6.4"	"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"memory B-cell: 6.5;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055919	Approved				"Secreted in male reproductive system"	NA	NA					"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	3.0	0.1	1.4	1.1	1.3	0.8	2.8	1.2	1.9	5.6	1.3	1.5	0.1	7.8	32.6	1.2	7.9	0.4	5.5	1.3	1.3	0.1	0.1	0.9	1.4	1.3	1.3	1.1	2.1	1.0	0.3	0.1	0.0	1.3	2.7	0.7	0.0	1.6	1.0	0.8	0.7	2.7	3.1	1.3	1.6	2.2	1.2	1.5	0.3	2.1	2.0	1.1	3.2	2.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.4	1.3	1.2	1.9	1.3	1.3	1.3	1.3	1.1	1.3	1.3	1.5	1.6	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	1.1	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660828-107717809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"thyroid gland: 266.2"	"Cell type enhanced"	"Detected in many"		"Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.8"	HPA042860	Approved					NA	NA					"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.4	0.1	2.2	0.1	9.8	0.0	0.8	0.0	4.9	1.4	0.0	0.2	0.1	0.5	0.1	0.1	0.3	0.4	0.6	7.7	2.4	6.5	0.1	0.5	0.4	3.5	0.2	11.4	0.3	0.3	3.9	0.3	0.3	1.0	3.8	0.2	0.1	0.4	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.7	0.6	0.0	0.2	266.2	0.1	0.2	1.5	0.3	0.3	0.3	0.1	0.2	0.0	0.3	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.0	3.7	0.0	0.3	0.0	0.1	2.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.1	1.3	0.3	0.3	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	9.8	0.0	4.9	7.7	2.4	3.5	0.2	11.4	1.0	0.0	0.0	0.3	1.8	3.2	7.7	2.6	0.2	1.7	0.7	6.5	0.0	6.6	3.2	1.8	0.6	0.0	19.0	0.0	2.1	0.3	0.4	0.4	0.0	0.2	3.9	0.3	0.5	4.9	7.3	0.0	29.3	0.0	0.1	1.5	0.0	1.8	5.1	0.2	1.1	0.2	0.3	1.7	53.9	0.0	54.9	0.6	2.0	2.7	0.9	0.7	7.2	3.7	0.7	1.2	1.0	1.5	1.6	0.1	0.1	1.2	0.0	17.3	0.0	0.1	15.2	1.8	0.0	2.9	1.6	2.0	0.4	0.1	1.4	0.0	1.7	0.2	0.5	19.9
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.6;brain: 26.5;fallopian tube: 21.4;heart muscle: 23.7"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 26.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.6	3.7	0.3	2.3	0.1	3.0	3.7	2.4	4.0	0.6	0.9	0.4	4.3	0.2	4.3	21.4	2.8	23.7	1.2	26.5	0.0	0.1	0.8	0.2	8.2	4.5	0.8	9.8	0.1	0.0	6.1	6.8	7.1	3.7	1.7	7.5	3.5	0.3	0.4	1.3	1.1	0.8	6.5	0.1	0.5	13.1	4.6	9.7	1.8	0.9	5.7	1.1	2.9	7.9	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.3	3.7	2.4	1.2	26.5	8.2	4.5	0.8	7.1	6.5	4.6	7.9	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.7;parathyroid gland: 49.3"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 271.5"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 7.4"									HPA057717	Approved					NA	NA					"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.6	2.9	0.3	0.0	0.3	0.0	0.9	2.1	0.4	0.5	3.9	0.4	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.7	0.6	96.7	0.2	0.3	0.0	0.4	0.6	0.3	0.9	3.5	49.3	18.4	0.0	0.9	0.8	0.0	2.3	7.0	0.2	0.5	0.7	0.1	0.2	0.3	0.1	3.9	4.5	0.4	0.0	21.8	0.3	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.1	0.4	0.7	0.6	0.4	0.6	0.3	0.9	0.3	0.4	0.3	0.0	3.2	0.5	0.3	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.1	3.8	0.0	0.7	25.8	0.0	0.4	0.0	0.1	25.4	0.3	40.2	0.1	0.0	0.1	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	13.5	0.2	0.1	67.1	0.0	0.0	271.5	0.3	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	1.9	1.2	0.0	0.0	0.7	0.1	0.0	0.3	0.2
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"	A0A1B0GTU2	15	80195481-80252213	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;liver: 9.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 6.3;Proximal tubular cells: 14.0"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.6;WM-115: 4.7"	"Region enriched"	"Detected in all"	4	"hippocampal formation: 35.0"											NA	NA						"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.2	3.7	11.1	0.2	7.5	0.0	0.2	5.3	14.4	0.3	2.8	0.7	0.4	0.1	5.4	0.1	0.3	0.1	2.7	31.5	12.5	2.2	9.4	1.6	0.2	7.2	9.4	6.5	0.4	0.5	0.0	1.4	0.0	8.7	0.3	0.3	1.4	0.1	0.1	0.5	0.8	0.5	0.0	5.1	1.4	2.6	0.4	12.2	0.0	0.4	0.1	0.2	0.5	0.3	6.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	7.5	5.3	14.4	31.5	12.5	7.2	9.4	6.5	8.7	5.1	12.2	6.7	0.0	0.0	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.9	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599185	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 150.6;thyroid gland: 244.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Extravillous trophoblasts: 67.9;Glandular and luminal cells: 49.0;Hepatocytes: 78.2"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 122.6;HaCaT: 189.8;RPTEC TERT1: 122.4;TIME: 247.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	810000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	4.6	0.2	0.6	16.4	0.5	0.3	1.0	4.0	2.6	0.9	1.6	5.9	6.5	1.4	2.9	1.3	0.5	14.1	1.0	2.9	1.8	6.4	35.0	7.2	1.8	2.7	1.8	0.5	0.2	1.9	0.2	0.4	150.6	1.6	1.5	7.3	5.0	0.5	21.1	2.5	1.2	7.2	7.7	1.4	0.4	1.7	7.0	2.2	1.9	244.6	0.1	1.8	14.5	0.6	1.8	2.2	0.3	53.6	122.6	0.5	0.1	0.9	0.6	5.8	0.0	0.1	54.5	19.6	0.2	29.7	0.0	37.2	189.8	8.1	39.0	0.0	0.6	0.3	0.1	0.2	0.3	8.1	0.1	0.8	5.4	43.0	19.1	36.8	0.3	28.0	0.2	0.3	0.3	0.0	0.0	0.0	0.2	8.1	1.4	0.5	0.1	0.0	3.0	122.4	14.8	0.8	0.1	1.0	1.4	0.1	6.9	0.2	0.2	247.4	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.5	4.0	2.6	2.9	1.8	2.7	1.8	0.5	1.6	1.4	2.2	1.8	0.3	0.0	1.1	0.7	0.3	1.8	5.6	3.3	0.0	0.6	2.8	1.9	1.8	24.3	3.5	14.7	60.5	5.5	0.1	9.3	0.0	3.3	8.4	19.1	8.3	7.9	13.8	0.0	0.2	1.4	67.9	6.0	2.6	49.0	0.0	11.5	5.3	78.2	1.8	0.0	0.3	5.3	2.0	1.9	0.0	8.1	0.3	0.8	1.8	2.8	0.7	1.1	0.0	1.0	0.2	12.8	2.7	0.0	0.3	10.6	10.1	1.3	0.5	2.9	0.0	1.0	2.0	1.4	0.9	0.4	2.6	19.4	1.1	0.1	11.2	11.4
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.4;thyroid gland: 19.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9"	"Lineage enriched"	"Detected in single"	70	"T-cells: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.3	23.4	10.4	1.2	13.6	0.6	1.8	11.1	15.3	2.5	5.2	0.9	0.4	0.5	2.3	1.3	0.7	1.0	8.0	12.0	11.3	0.4	2.2	7.6	3.0	7.3	9.5	12.1	6.4	0.9	0.2	3.1	5.8	9.0	2.6	1.0	6.4	1.2	5.0	4.1	0.3	1.4	0.4	7.3	1.4	0.4	15.1	11.5	10.6	19.8	0.5	3.6	0.8	0.9	11.1	0.0	0.1	24.7	3.1	11.2	4.8	0.1	14.7	31.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	15.6	0.1	1.5	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	0.1	0.0	0.1	0.1	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	43.9	0.0	0.0	0.0	13.6	24.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	2.7	2.0	0.0	0.1	32.5	30.9	0.2	0.0	0.1	0.0	0.4	6.1	10.4	13.6	11.1	15.3	12.0	11.3	7.3	9.5	12.1	9.0	7.3	11.5	11.1	0.8	0.0	4.3	47.0	0.8	0.0	0.0	0.0	0.0	29.2	0.6	0.8	24.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.1	0.3	0.5	1.2	1.8	0.0	81.2	0.0	0.5	13.3	1.5	0.5	1.3	0.0	1.1	0.0	0.8	3.3	46.5	0.0	0.0	0.0	0.4	4.4	56.2	0.2	1.8	7.5	0.8	11.0	1.0	61.3	7.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	1.6	1.7	1.1	0.4	0.0	0.1	0.4	10.3	0.5	0.0	0.2
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932429-72566530	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 11.5;Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	4.7	0.2	2.1	0.6	2.5	1.5	4.1	0.9	9.4	5.0	0.0	1.0	0.3	1.4	2.6	0.4	2.2	1.2	11.3	4.0	3.1	1.9	0.1	0.9	0.1	17.3	14.7	3.6	1.2	0.2	8.2	1.7	3.1	22.6	0.4	1.0	1.7	0.9	1.4	1.1	0.8	0.8	1.3	4.8	0.9	0.4	10.6	4.4	0.3	5.7	0.8	0.5	0.7	0.9	16.4	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	40.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.3	1.2	2.1	2.5	0.9	9.4	4.0	3.1	17.3	14.7	3.6	22.6	4.8	4.4	16.4	5.8	0.0	0.0	97.3	0.2	0.3	0.0	0.0	0.0	2.2	2.1	2.4	22.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	173.5	2.8	0.9	2.6	0.0	5.3	652.7	0.2	0.1	3.1	0.0	7.1	0.0	0.4	0.0	0.0	0.2	0.0	256.1	0.0	0.0	0.0	0.0	298.0	1.8	8.3	0.0	44.0	5.1	0.0	0.0	36.2	8.9	0.0	0.0	7.5	0.2	0.0	0.0	0.4	0.0	0.4	13.1	0.4	18.6	2.3	1.3	0.2	0.1	0.8	0.5	0.1	0.0	0.7
SNX22	FLJ13952	ENSG00000157734	"Sorting nexin 22"	Q96L94	15	64151715-64157481	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;thyroid gland: 39.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;B-cells: 33.4;Erythroid cells: 136.8;Oligodendrocyte precursor cells: 95.5"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.3;naive B-cell: 6.1"	"Lineage enriched"	"Detected in many"	6	"B-cells: 6.1"	"Cell line enriched"	"Detected in some"	5	"Daudi: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038470			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038470: AB_10673174"	"prognostic favorable (2.89e-5)"	"unprognostic (8.93e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.74e-2)"	0.4	0.4	11.6	3.8	12.6	6.6	0.5	12.2	11.8	0.4	5.5	0.3	0.6	0.2	1.9	0.3	0.2	0.3	6.5	11.6	11.6	0.7	3.0	5.8	7.3	17.9	13.7	9.2	0.1	1.7	0.0	3.2	0.2	14.6	4.2	0.2	0.0	1.4	4.5	0.1	0.2	3.4	0.2	14.5	5.4	2.3	0.4	12.9	2.6	39.1	0.0	8.7	0.5	0.3	17.2	0.0	0.4	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.4	17.5	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1	1.7	0.3	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.5	2.6	0.0	0.7	0.2	0.0	1.3	0.2	0.2	3.7	0.1	0.7	0.8	0.1	3.8	0.7	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.1	1.0	0.0	0.1	3.1	1.3	3.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.0	6.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	11.6	12.6	12.2	11.8	11.6	11.6	17.9	13.7	9.2	14.6	14.5	12.9	17.2	0.7	28.9	8.8	0.0	33.4	1.5	2.3	1.3	1.2	0.9	3.2	3.2	21.0	0.0	1.4	0.0	4.2	3.3	2.0	1.5	0.0	0.6	1.6	0.5	1.6	1.0	0.0	136.8	0.1	3.8	8.6	4.1	2.6	1.3	2.5	1.9	1.4	4.3	4.6	0.0	0.3	1.2	0.0	1.9	7.4	1.7	0.6	2.5	3.6	3.7	1.9	0.5	1.0	95.5	17.7	1.3	0.6	0.4	9.5	6.2	0.6	1.6	0.5	2.0	0.0	3.1	1.9	1.4	2.1	1.3	2.8	4.0	3.0	0.3	0.8	1.6
ST6GAL2	"KIAA1877, SIAT2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.4;thyroid gland: 29.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 58.8;Excitatory neurons: 78.7;Granulosa cells: 111.5;Inhibitory neurons: 44.8;Oligodendrocyte precursor cells: 94.0"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.3;hTERT-RPE1: 6.4;NTERA-2: 4.4;PC-3: 5.9;RPMI-8226: 9.6;SCLC-21H: 6.1;U-138 MG: 7.5;U-266/70: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	0.5	0.1	6.8	0.2	7.6	1.0	0.7	0.0	11.4	1.7	0.0	0.9	0.2	2.6	0.3	1.8	0.7	5.2	0.5	11.1	0.4	0.4	2.6	0.6	0.4	0.0	0.4	8.0	0.6	0.1	0.1	0.1	1.6	5.4	0.8	2.3	1.9	0.8	0.8	0.1	0.7	0.4	2.0	0.0	0.1	0.6	5.3	3.5	0.1	29.0	0.0	0.3	0.6	1.0	3.8	0.0	5.3	2.8	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.4	0.0	5.9	0.0	0.0	9.6	0.2	0.0	6.1	3.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.5	0.1	0.2	0.0	9.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.8	7.6	0.0	11.4	11.1	0.4	0.0	0.4	8.0	5.4	0.0	3.5	3.8	0.0	0.0	0.0	58.8	0.0	0.9	0.2	0.0	18.8	6.6	0.2	3.4	1.4	0.0	0.6	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.4	0.8	12.2	0.3	1.2	6.3	78.7	0.0	0.0	1.7	0.0	0.5	0.0	111.5	2.2	0.0	0.2	0.0	44.8	3.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	2.8	0.0	0.9	0.0	94.0	1.9	0.0	1.0	0.7	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.2	2.9	0.1	1.1	4.3	0.0	0.3	0.1	0.1	3.2	0.0
TSGA10IP	"FAM161C, FLJ32880"	ENSG00000175513	"Testis specific 10 interacting protein"	Q3SY00	11	65945445-65959963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 10.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 54.6;Late spermatids: 59.8"	"Group enriched"	"Detected in some"	7	"testis cancer: 1.5;thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.69e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.84e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.66e-2)"	"unprognostic (8.53e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.61e-1)"	"unprognostic (1.62e-4)"	"unprognostic (8.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.66e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.0	59.8	0.9	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252261-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;lymphoid tissue: 3.8;ovary: 6.4;skeletal muscle: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 157.0;Excitatory neurons: 54.4;Inhibitory neurons: 70.0;Oligodendrocyte precursor cells: 108.0;Skeletal myocytes: 28.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.8;hTERT-HME1: 14.1;U-2 OS: 19.4;U-251 MG: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"		NA	NA		19000	"Plasma membrane"		"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	0.1	1.3	7.6	0.0	4.1	0.1	0.2	0.0	3.4	0.5	0.0	0.2	0.0	0.2	0.0	0.2	0.6	0.1	0.1	3.2	3.4	0.3	0.2	0.3	0.0	1.7	2.0	3.4	6.4	0.5	0.1	0.5	0.0	1.6	0.3	0.0	0.8	0.3	0.8	3.8	0.7	0.2	0.0	0.0	3.8	0.2	0.9	7.4	0.2	0.3	0.0	0.0	0.2	0.2	1.3	0.1	1.2	10.8	0.0	0.2	0.7	0.2	3.1	0.0	5.6	0.6	0.3	0.0	0.0	0.3	3.7	3.6	4.1	0.0	6.2	2.2	0.3	0.0	0.0	0.1	0.1	7.1	0.0	0.1	1.1	1.4	1.1	14.1	3.0	1.2	0.4	0.0	0.1	2.1	0.4	0.1	0.1	1.3	0.0	0.1	0.0	0.0	1.6	3.2	0.0	1.0	2.7	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	19.4	0.1	35.2	6.3	0.1	0.1	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.6	4.1	0.0	3.4	3.2	3.4	1.7	2.0	3.4	1.6	0.0	7.4	1.3	0.0	3.2	0.0	157.0	0.0	0.3	0.4	0.0	0.0	1.8	0.4	0.9	1.6	0.0	0.7	0.0	2.1	0.0	0.1	0.1	0.0	1.3	0.9	0.1	0.3	0.2	0.0	0.0	54.4	0.0	0.0	1.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	16.8	70.0	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.0	10.3	0.0	19.9	0.0	108.0	24.9	0.2	0.0	0.4	0.0	0.6	0.0	0.1	0.0	1.6	0.0	28.7	0.4	0.1	2.2	0.0	0.3	0.0	0.1	0.4	0.0	0.3
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"epididymis: 1486.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 244.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (6.10e-4)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.99e-2)"	1.7	5.1	12.4	0.3	6.9	0.2	23.3	5.1	10.8	4.1	3.5	0.8	0.7	3.6	1486.5	0.3	1.5	0.0	0.6	6.5	42.8	5.1	0.4	0.6	0.3	8.5	9.7	6.7	1.5	1.6	0.0	211.5	0.0	17.1	11.3	0.2	4.6	0.8	3.0	0.4	0.6	1.0	8.1	4.2	0.4	1.0	201.5	23.7	0.2	8.0	0.4	0.1	0.5	1.0	10.7	0.4	0.3	2.2	57.1	2.5	0.0	2.1	0.0	0.5	0.4	0.3	0.1	0.6	0.0	0.2	0.0	0.6	0.0	20.5	1.4	0.1	6.1	8.0	0.9	0.4	0.0	0.0	0.2	10.4	1.1	0.8	0.5	1.0	0.2	0.2	0.2	2.5	0.0	0.4	0.8	0.2	4.4	3.3	0.0	3.6	0.1	3.6	3.2	0.1	0.4	25.8	12.5	0.4	5.1	244.4	0.2	1.4	1.0	0.0	0.2	1.9	0.4	0.8	0.2	0.5	0.2	0.5	0.4	5.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	6.9	5.1	10.8	6.5	42.8	8.5	9.7	6.7	17.1	4.2	23.7	10.7	2.2	0.0	0.0	0.0	0.0	0.1	1.0	0.4	0.0	5.6	87.4	47.6	0.4	1.5	0.1	3.7	6.2	0.1	0.3	0.3	0.0	0.1	20.4	0.5	0.8	1.0	1.2	0.0	0.7	0.8	0.1	0.7	0.0	0.3	0.0	31.0	0.4	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.7	58.4	7.5	0.8	3.6	1.9	0.1	1.7	0.0	0.0	0.1	0.4	33.8	3.0	0.0	19.3	0.7	0.3	0.0	3.8	13.1	1.2	3.2	12.6	6.8	0.0	0.0	0.0	0.1	0.5	0.5	1.0
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164624-227314792	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 53.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Bipolar cells: 62.1;Cone photoreceptor cells: 398.2;Muller glia cells: 143.1;Oligodendrocyte precursor cells: 84.9"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 18.8;hTERT-RPE1: 14.5;Karpas-707: 9.9;RPTEC TERT1: 11.0;U-266/70: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.5	11.6	2.1	2.1	2.3	0.3	1.0	1.7	1.8	0.3	18.4	0.7	0.7	1.3	16.5	1.0	2.2	3.3	7.0	1.5	2.9	30.2	0.7	15.2	2.9	3.1	3.1	0.4	3.9	5.0	0.2	16.3	0.2	3.1	6.0	1.0	53.4	1.2	10.0	22.4	0.4	6.8	0.8	1.6	7.2	1.8	1.7	7.1	0.5	20.7	15.3	5.7	1.4	1.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.3	1.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	1.2	0.0	9.9	0.0	0.4	0.0	0.1	1.4	0.0	0.0	0.1	0.0	3.2	11.0	2.3	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	9.0	3.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	1.7	1.8	1.5	2.9	3.1	3.1	0.4	3.1	1.6	7.1	2.3	0.5	169.9	31.7	3.9	14.0	0.1	0.1	0.1	0.6	62.1	0.1	0.9	2.6	1.5	9.3	42.3	398.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	2.4	0.0	0.0	5.5	1.0	0.0	4.6	0.5	0.3	1.3	22.8	0.4	0.2	0.0	1.7	14.1	0.0	0.0	0.0	0.3	0.3	8.4	0.3	1.8	13.1	0.0	143.1	0.0	84.9	3.6	1.0	0.0	12.0	8.0	0.1	0.0	1.9	0.1	11.9	13.1	11.7	3.6	0.4	0.0	0.3	0.3	0.0	1.2	0.1	0.0	0.0
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.3;liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.4"	"Group enriched"	"Detected in some"	7	"MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	2.5	0.2	5.0	6.8	8.0	28.3	0.2	2.0	10.4	1.8	5.4	0.4	0.1	3.7	1.0	0.5	3.0	1.7	0.5	6.7	8.5	0.8	27.8	2.9	0.3	3.2	3.3	6.9	0.2	0.9	0.6	1.4	0.7	5.4	0.8	0.3	5.7	0.2	1.5	9.1	1.0	0.3	3.1	0.8	12.8	0.3	15.7	3.9	0.9	1.7	9.7	0.4	1.4	0.5	7.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.5	3.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	36.4	0.0	2.0	2.3	0.0	1.6	5.0	8.0	2.0	10.4	6.7	8.5	3.2	3.3	6.9	5.4	0.8	3.9	7.4	0.0	0.0	0.0	1.6	0.4	0.9	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.0	4.7	0.0	0.0	0.1	14.6	0.6	2.3	0.1	0.0	0.0	37.6	0.0	0.0	0.4	0.0	4.8	0.0	0.1	1.1	10.4	1.4	0.0	30.2	0.0	0.0	8.5	0.0	41.7	0.3	9.4	1.8	6.5	12.4	10.4	1.0	34.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.3	0.0	0.2	0.2	4.0	0.6	0.0	0.3	0.1	0.2	0.0	0.0	0.0
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134697	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 124.2;thyroid gland: 205.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 35.0;Distal enterocytes: 24.0;Inhibitory neurons: 19.5;Muller glia cells: 25.2;Proximal enterocytes: 62.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 19.6;SK-BR-3: 41.1;T-47d: 25.7;U-698: 18.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 131.0"	"Low region specificity"	"Detected in all"			HPA034539			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	2.1	2.9	0.8	4.5	0.1	9.0	15.7	12.8	3.1	1.6	7.7	16.4	3.1	0.6	2.4	2.4	1.2	22.5	11.2	13.0	32.2	0.4	2.3	0.5	5.1	5.0	3.3	1.2	15.8	124.2	10.1	0.1	7.4	9.3	3.7	5.4	33.4	12.2	2.9	4.1	26.4	1.5	1.0	0.3	13.7	4.4	9.4	0.2	205.8	2.6	0.4	2.7	2.4	5.5	2.1	2.0	1.2	2.3	0.3	0.2	1.1	0.8	0.8	4.1	4.0	1.2	1.3	0.1	1.0	0.4	0.4	2.4	2.5	1.2	1.7	0.0	6.5	0.0	9.7	0.4	0.8	19.6	0.2	0.2	1.3	3.4	0.4	2.7	0.3	0.1	1.8	2.8	0.1	6.4	0.1	0.1	2.3	2.8	0.4	0.0	0.4	4.5	1.7	2.5	9.9	7.5	1.6	41.1	0.5	1.1	25.7	1.6	0.0	0.2	7.3	0.8	0.5	0.1	3.5	18.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	4.5	15.7	12.8	11.2	13.0	5.1	5.0	3.3	7.4	1.0	9.4	5.5	0.7	0.0	4.1	3.3	0.0	0.9	2.3	0.3	1.2	9.5	15.8	7.5	6.1	0.0	1.1	35.0	0.0	0.0	0.2	24.0	11.7	1.4	0.4	1.9	0.4	0.5	0.0	0.0	5.5	2.2	0.2	0.6	4.6	2.7	0.0	0.8	0.0	0.0	0.1	5.0	19.5	6.4	0.0	0.0	1.9	0.6	0.0	0.3	0.0	1.0	0.6	25.2	0.0	2.0	1.0	0.8	12.3	0.0	0.1	2.5	62.3	0.5	0.5	3.1	0.0	0.5	1.3	2.4	1.2	1.1	1.3	0.1	0.4	0.4	8.8	1.6
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 51.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.9;Late spermatids: 8.8;Macrophages: 15.8;Proximal tubular cells: 4.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.2"	"Group enriched"	"Detected in some"	19	"basophil: 5.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 167.8;HEL: 163.4;RPTEC TERT1: 109.8;U-87 MG: 78.3;WM-115: 255.9"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		38000000	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	7.4	0.6	0.3	9.6	0.8	6.2	5.4	0.7	1.3	3.4	1.6	13.9	3.5	13.3	2.6	4.3	7.6	3.5	4.8	0.3	7.2	13.2	3.4	5.7	0.9	2.2	1.1	0.2	1.6	0.8	1.2	1.2	4.5	1.6	4.9	7.1	0.9	2.6	16.3	1.5	2.4	5.8	23.2	1.0	2.9	3.8	2.5	1.0	0.3	51.9	2.5	1.2	9.7	2.6	0.9	0.1	1.5	0.7	0.1	8.6	3.8	0.1	4.7	23.1	9.6	8.6	0.3	0.1	0.6	167.8	1.2	13.4	0.0	0.1	0.0	12.6	3.4	0.0	163.4	0.5	0.0	7.8	0.0	0.2	3.4	0.0	54.6	1.4	6.7	43.6	2.5	0.5	0.3	2.1	0.0	1.0	0.1	0.1	0.0	0.8	0.0	4.2	0.0	109.8	0.2	0.0	0.5	5.6	0.0	33.2	8.8	0.1	0.2	47.1	2.1	2.4	1.3	11.7	0.2	0.1	1.1	78.3	0.0	255.9	5.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.0	6.8	0.3	0.8	0.7	1.3	0.3	7.2	2.2	1.1	0.2	1.6	1.0	1.0	0.9	1.3	0.0	0.0	0.0	0.5	0.1	0.2	0.9	0.0	0.0	0.1	0.3	0.8	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	3.9	0.8	0.9	3.1	0.0	0.0	0.4	0.4	0.0	2.1	0.0	0.9	0.0	0.6	1.8	0.7	0.8	0.0	0.6	0.0	0.0	0.3	0.7	8.8	0.3	15.8	0.0	1.0	0.4	0.0	0.0	0.0	0.4	1.5	0.0	1.2	0.0	0.3	0.0	4.6	0.2	0.0	6.6	0.3	2.1	0.0	2.0	0.1	0.4	1.2	0.3	0.4	0.0	0.2
LIPI	"CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5"	ENSG00000188992	"Lipase I"	Q6XZB0	21	14108813-14210955	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	166	"epididymis: 424.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1.7;Excitatory neurons: 1.5;Inhibitory neurons: 2.0;Microglial cells: 1.9;Oligodendrocyte precursor cells: 2.0"	"Cancer enriched"	"Detected in single"	6	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049665			Supported	"Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"		"HPA049665: "	"unprognostic (2.60e-2)"	"unprognostic (3.49e-1)"		"unprognostic (1.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.64e-13)"	"unprognostic (2.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.5	424.7	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.6	0.1	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.9;brain: 100.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.9	0.7	55.2	0.1	44.1	0.0	1.7	46.1	100.2	0.0	0.4	0.2	0.1	0.3	1.3	0.1	1.0	0.1	0.8	45.9	29.0	5.3	0.0	0.0	0.2	55.6	45.5	32.7	0.2	2.4	0.9	1.8	0.1	62.2	1.0	0.1	3.8	2.3	1.6	5.8	1.0	0.2	0.2	27.4	0.3	0.4	9.0	86.7	0.2	0.3	2.6	0.0	0.0	0.0	39.5	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	55.2	44.1	46.1	100.2	45.9	29.0	55.6	45.5	32.7	62.2	27.4	86.7	39.5	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	19.6	4.9	26.2	1.0	26.9	0.4	14.1	7.4	26.6	16.2	0.8	4.5	2.0	26.6	6.3	2.1	29.0	4.3	14.5	28.0	36.4	5.8	2.3	5.2	1.2	23.5	18.2	28.1	4.2	7.9	0.8	12.6	24.0	18.9	19.2	1.2	22.7	10.6	12.1	0.8	1.8	3.3	17.9	11.3	0.8	5.6	3.0	29.4	0.3	125.8	0.8	1.0	4.0	5.0	22.6	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	26.2	26.9	7.4	26.6	28.0	36.4	23.5	18.2	28.1	18.9	11.3	29.4	22.6	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.4	0.1	0.3	0.0	0.6	0.0	0.3	0.0	1.4	0.6	0.1	0.2	0.1	0.4	0.6	0.3	0.5	0.2	0.4	0.8	0.4	0.4	0.3	0.5	0.0	0.2	0.9	0.2	0.2	0.2	0.0	0.9	0.3	0.2	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.9	0.1	0.0	0.3	0.3	0.6	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	1.4	0.8	0.4	0.2	0.9	0.2	0.2	0.1	0.2	0.6	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798796	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 158.2;brain: 350.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 69.2;RPTEC TERT1: 90.1"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA					"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	5.4	158.2	242.0	3.7	278.4	2.9	5.7	310.9	262.5	10.7	101.9	9.9	4.5	12.6	98.5	5.9	18.9	9.4	6.0	227.7	282.0	33.4	2.5	15.1	3.1	350.7	275.3	215.7	94.6	41.2	18.9	31.6	7.6	298.1	12.8	4.1	70.8	18.2	24.5	1.3	8.3	6.0	12.1	317.6	4.5	10.7	33.6	268.2	10.7	35.8	4.3	4.5	7.8	8.7	331.4	11.2	7.1	36.0	18.6	19.7	12.5	0.6	69.2	33.9	29.7	22.8	0.5	1.7	22.5	23.5	14.5	8.0	19.9	10.6	7.6	37.0	4.4	4.7	1.0	8.1	0.7	2.9	10.0	6.9	10.0	30.6	5.9	5.2	30.5	48.4	25.8	1.3	2.2	15.6	4.4	42.6	2.1	2.6	0.2	5.0	35.6	21.5	17.9	90.1	11.2	20.1	11.5	11.4	0.5	6.8	3.5	1.3	5.0	59.5	31.5	18.1	11.9	18.9	6.0	2.5	2.2	15.3	10.5	9.0	1.9	0.6	0.1	3.9	0.2	2.5	0.2	0.8	2.3	0.3	0.4	0.7	2.6	0.7	1.1	0.4	0.7	0.2	1.2	242.0	278.4	310.9	262.5	227.7	282.0	350.7	275.3	215.7	298.1	317.6	268.2	331.4	1.4	44.8	3.9	248.4	0.8	10.7	16.5	16.3	5.7	101.4	6.8	4.8	2.9	27.1	25.7	27.6	25.0	1.9	3.9	0.4	13.7	79.7	115.0	13.5	9.3	7.7	7.7	0.0	84.3	46.9	0.2	16.8	2.6	14.8	0.0	10.5	10.4	0.2	1.1	101.0	107.0	0.3	10.2	1.3	3.3	100.3	55.0	1.8	3.6	23.4	1.9	145.3	4.1	892.7	513.6	8.9	0.0	58.3	0.7	11.3	0.2	20.4	13.0	14.6	6.6	3.6	11.5	2.9	3.7	2.7	7.2	0.1	3.2	137.4	2.0	9.3
SCX	"bHLHa41, bHLHa48, SCXA, SCXB"	ENSG00000260428	"Scleraxis bHLH transcription factor"	Q7RTU7	8	144266453-144268481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.7;thyroid gland: 38.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 14.2;Horizontal cells: 16.8"	"Group enriched"	"Detected in all"	6	"endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HaCaT: 5.3"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Low region specificity"	"Detected in some"			HPA043183	Uncertain					NA	NA					"HPA043183: AB_2678357"	"unprognostic (5.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.89e-3)"	1.2	3.4	2.9	0.9	2.1	0.6	1.4	7.7	6.9	6.7	2.5	7.0	0.9	2.9	0.5	3.4	3.9	0.1	8.2	2.5	2.5	6.0	2.1	3.5	0.4	5.3	2.4	2.3	2.6	3.8	0.8	19.7	0.2	5.3	4.5	0.2	0.1	2.7	0.1	14.0	3.1	5.0	0.2	0.7	4.6	5.9	5.2	2.4	0.7	38.4	1.2	0.1	2.7	3.3	3.8	2.0	0.4	0.1	0.5	0.0	0.0	4.8	0.1	0.0	0.1	0.0	0.1	1.4	1.3	1.4	0.2	0.2	5.3	0.0	0.0	0.0	0.9	0.8	0.3	1.9	0.2	0.2	0.1	2.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.2	0.6	0.1	3.0	0.5	1.1	1.1	0.4	2.3	1.6	0.2	0.8	0.1	2.0	0.2	0.9	0.5	1.8	2.2	0.1	2.3	0.9	0.3	0.4	3.5	1.6	0.3	1.8	0.6	0.3	0.8	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.1	7.7	6.9	2.5	2.5	5.3	2.4	2.3	5.3	0.7	2.4	3.8	3.4	0.0	2.7	8.5	2.5	0.0	1.2	0.0	0.6	14.2	6.7	8.3	6.2	1.5	1.3	3.7	0.0	1.5	7.5	2.2	1.9	0.6	0.2	5.7	1.4	1.2	2.4	0.0	5.9	1.4	0.6	1.2	8.2	7.1	0.0	3.2	0.4	0.4	0.4	16.8	8.5	2.3	0.0	0.6	0.0	0.9	0.3	0.9	0.0	1.0	0.0	8.2	1.0	2.5	0.3	1.5	2.1	0.7	0.7	2.7	1.5	0.2	0.0	1.5	0.0	4.2	6.4	2.5	9.0	0.6	0.0	1.1	3.1	0.3	1.8	1.0
TMEM233	"DSPB2, IFITMD2"	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593774-119643075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 67.1;tongue: 21.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 79.1;Skeletal myocytes: 77.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 22.2;hTERT-RPE1: 9.0;RH-30: 11.8;U-2197: 17.9;U-87 MG: 70.3"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.7	0.6	3.3	0.1	6.7	0.0	0.4	1.1	9.1	0.4	1.6	0.2	0.2	0.3	0.2	0.3	0.2	0.5	1.1	4.1	2.3	1.2	0.6	0.9	0.2	1.8	1.4	4.2	1.0	0.2	1.4	0.8	0.2	1.8	0.6	0.2	0.2	0.5	0.3	67.1	0.1	0.3	0.4	1.4	0.2	0.3	0.2	2.9	0.9	14.5	21.3	0.2	1.0	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.7	0.0	22.2	0.0	9.0	0.1	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.7	1.1	9.1	4.1	2.3	1.8	1.4	4.2	1.8	1.4	2.9	4.0	12.0	3.2	1.1	0.7	0.0	0.0	0.4	0.0	0.0	2.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.9	9.5	0.3	0.1	13.3	0.0	0.0	5.4	8.5	0.0	3.6	0.0	0.4	79.1	5.5	15.4	0.1	0.1	8.4	3.7	0.0	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.5	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	77.8	2.2	3.1	1.0	0.2	0.1	0.1	0.9	9.2	0.0	0.2
ADCY8	"AC8, ADCY3, HBAC1"	ENSG00000155897	"Adenylate cyclase 8"	P40145	8	130780301-131040909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 30.3;epididymis: 23.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 151.8;Inhibitory neurons: 250.9;Oligodendrocyte precursor cells: 138.7"	"Group enriched"	"Detected in some"	5	"glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;GAMG: 8.2;U-138 MG: 17.6;U-87 MG: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018652, HPA024291"	Supported					NA	NA					"CAB018652: AB_633654, HPA024291: AB_1844597"	"unprognostic (5.59e-3)"				"unprognostic (3.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.22e-3)"	"unprognostic (4.91e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.67e-2)"		0.0	0.0	15.5	0.0	13.6	0.0	0.5	22.3	9.8	0.4	1.6	0.0	0.0	0.0	23.0	0.0	3.9	0.0	0.0	11.3	13.0	0.2	0.0	1.2	0.0	17.1	19.6	8.1	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	3.1	1.1	1.4	0.1	2.0	0.0	0.5	23.4	0.0	0.1	0.5	30.3	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.1	1.3	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.6	0.4	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	13.6	22.3	9.8	11.3	13.0	17.1	19.6	8.1	16.8	23.4	30.3	24.2	0.0	0.0	1.5	151.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.1	0.0	138.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.8"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 31.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	0.3	0.6	2.2	0.2	2.2	0.0	0.1	0.7	2.8	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	10.8	0.0	0.0	0.1	0.0	3.8	5.2	1.6	0.0	0.0	0.0	1.3	0.0	7.2	0.0	0.2	0.7	0.1	0.1	0.0	0.1	0.3	0.1	2.2	0.0	0.1	1.2	2.2	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.4	31.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.2	0.7	2.8	1.3	10.8	3.8	5.2	1.6	7.2	2.2	2.2	2.3	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.5	0.1	0.2	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	274.2	0.0	0.0	0.0	0.0	41.2	0.0	0.5	0.0	7.5	0.0	0.6	0.0	433.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85791383	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 55.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 123.8;Endothelial cells: 41.7;Hepatocytes: 39.1;Muller glia cells: 32.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;fHDF/TERT166: 6.8;hTERT-RPE1: 5.0;RH-30: 9.5;RT4: 5.6;TIME: 7.9;U-2197: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028406: AB_2672587"	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	30.6	1.8	1.9	0.3	2.2	0.0	30.1	2.6	1.9	20.3	1.1	8.8	0.2	26.1	0.2	5.6	19.5	0.4	25.9	1.5	7.2	7.3	25.3	25.8	0.8	5.1	2.9	0.8	15.1	4.2	0.2	5.4	0.3	7.1	17.5	0.4	0.6	5.3	1.9	55.1	17.6	9.0	1.3	1.8	12.3	9.5	2.1	3.1	0.2	48.9	2.0	0.1	21.9	20.8	3.2	0.0	1.1	4.1	6.2	3.0	0.4	0.0	3.4	0.5	0.8	0.3	0.0	0.0	0.0	1.1	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.1	1.6	0.0	0.0	2.1	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	9.5	0.0	0.0	5.6	3.0	1.4	0.6	0.0	0.6	0.0	0.0	0.0	7.9	1.2	0.0	5.5	0.0	0.0	0.0	0.0	0.8	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	2.6	1.9	1.5	7.2	5.1	2.9	0.8	7.1	1.8	3.1	3.2	123.8	9.6	18.3	10.7	0.3	2.5	8.5	11.8	0.6	0.4	0.5	0.8	13.2	5.7	17.5	1.8	0.0	0.1	0.1	1.1	0.0	11.9	13.6	5.9	5.7	41.7	4.2	0.0	0.3	2.3	0.6	11.4	1.1	20.5	1.3	5.3	5.7	39.1	3.2	0.0	0.3	2.2	6.1	3.1	4.0	25.9	3.4	4.3	1.8	5.6	0.6	32.3	0.0	14.6	3.1	1.0	5.5	0.4	0.0	4.5	0.0	0.6	2.4	1.3	0.0	12.2	11.6	3.0	2.7	0.2	1.4	0.3	0.5	0.1	1.0	2.3
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193398967-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 65.1;parathyroid gland: 58.9;thyroid gland: 52.3"	"Group enriched"	"Detected in many"	4	"Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.1	0.3	18.9	0.2	19.6	0.2	23.0	19.5	23.2	1.4	24.8	2.0	0.3	0.1	65.1	20.3	2.4	4.6	0.1	18.8	25.8	0.4	0.6	27.5	0.4	24.1	18.2	14.8	0.3	5.3	58.9	4.8	0.1	24.4	0.1	3.5	2.6	7.2	2.4	0.5	17.0	0.3	0.1	13.3	0.3	9.6	0.5	18.9	0.3	52.3	0.0	4.8	0.1	6.8	15.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.9	19.6	19.5	23.2	18.8	25.8	24.1	18.2	14.8	24.4	13.3	18.9	15.5	0.2	64.1	30.5	409.4	1.1	0.1	0.0	1.7	0.0	1.6	6.1	3.6	0.4	11.5	15.3	0.0	0.0	1.2	0.5	1.6	0.0	3.3	0.4	4.0	0.7	0.1	0.0	0.0	5.8	0.2	0.1	0.2	17.3	6.4	1.3	0.3	1.4	0.1	0.2	1.7	10.9	1.9	0.0	0.3	0.5	1.0	0.0	0.5	1.8	13.1	0.0	0.5	0.0	163.3	20.6	1.3	1.7	0.4	0.2	0.0	0.0	0.4	8.5	1.0	0.0	0.1	0.2	0.7	1.5	2.2	1.6	0.7	0.9	0.1	2.2	0.1
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689735	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.1;thyroid gland: 5.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.9;Excitatory neurons: 16.8;Inhibitory neurons: 12.3"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 1.9;T-47d: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066992			Uncertain	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA066992: "	"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.2	3.4	2.9	0.8	4.4	0.6	0.1	1.5	10.1	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.0	9.4	2.3	0.1	0.0	0.5	1.9	7.3	1.8	3.3	0.1	0.1	0.0	0.3	0.0	8.7	0.1	0.0	2.6	0.1	0.0	0.0	0.1	3.3	0.0	0.2	1.6	0.6	0.8	1.9	0.2	5.3	0.0	0.5	0.4	0.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	4.4	1.5	10.1	9.4	2.3	7.3	1.8	3.3	8.7	0.2	1.9	5.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.4	16.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	3.3	12.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	1.0	2.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.1
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 18.7;thyroid gland: 20.9"	"Group enriched"	"Detected in some"	4	"Melanocytes: 5.4;Spermatogonia: 5.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9"	"Region enhanced"	"Detected in many"		"pons: 18.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in many"	5	"amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7"	HPA059886		Supported			"Secreted to blood"	NA	NA					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.2	0.0	0.9	0.3	0.8	0.1	0.2	0.5	2.5	0.1	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.3	9.8	0.3	0.8	0.1	0.1	7.3	7.6	0.0	0.1	1.5	0.3	2.2	0.1	18.7	0.1	0.2	0.1	0.3	0.0	0.8	0.1	0.4	0.1	2.1	0.1	0.1	0.3	1.4	0.0	20.9	0.1	0.1	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.4	0.1	0.0	10.4	0.0	0.0	0.0	0.6	2.9	0.1	0.1	0.4	0.0	0.2	0.0	0.0	1.1	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.6	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.8	0.5	2.5	0.3	9.8	7.3	7.6	0.0	18.7	2.1	1.4	4.7	0.0	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.4	0.2	0.9	0.5	0.2	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	5.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1
CARNS1	"ATPGD1, KIAA1394"	ENSG00000172508	"Carnosine synthase 1"	A5YM72	11	67414968-67425607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 295.2;skeletal muscle: 76.3"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 447.9"	"Group enriched"	"Detected in many"	5	"glioma: 4.1;thyroid cancer: 10.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"RPMI-8226: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA038569	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038569: AB_2676089"	"unprognostic (1.07e-4)"	"unprognostic (4.33e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.33e-2)"	5.7	0.3	81.2	0.4	155.2	0.5	0.7	139.2	116.3	0.6	39.9	0.7	0.4	0.5	1.4	0.9	1.3	0.5	8.6	78.7	109.4	0.8	0.5	0.9	1.2	215.4	158.7	59.8	0.9	1.3	0.9	0.6	0.0	208.2	0.7	0.2	0.0	1.3	0.2	76.3	0.5	0.9	0.2	134.6	2.1	7.6	0.2	128.8	0.4	5.6	30.3	0.5	0.5	0.6	295.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.5	0.3	1.0	0.0	0.6	0.4	1.0	0.0	0.5	0.0	0.0	0.2	0.3	81.2	155.2	139.2	116.3	78.7	109.4	215.4	158.7	59.8	208.2	134.6	128.8	295.2	0.6	3.2	0.5	1.0	3.5	0.3	0.2	0.2	0.0	0.0	0.3	0.4	13.5	7.2	0.7	0.0	0.0	0.1	6.1	0.6	0.0	0.5	0.0	0.3	0.2	1.0	3.0	0.0	1.2	0.0	0.1	1.5	23.0	0.5	0.0	0.1	0.4	0.4	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	4.1	2.5	447.9	0.1	0.1	0.4	4.0	0.2	0.2	0.3	0.9	0.5	0.0	3.5	3.0	0.0	0.3	0.1	0.9	0.0	2.3	0.3	0.2	0.1
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739820	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.8;retina: 8.4;salivary gland: 6.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	35	"NTERA-2: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010510	Uncertain				"Secreted to extracellular matrix"	NA	NA		9500			"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.0	0.0	1.7	0.0	4.8	0.0	0.0	2.1	2.5	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	2.3	0.0	0.0	1.6	0.0	2.3	2.2	1.7	0.0	0.3	0.0	1.0	0.1	2.5	0.5	0.0	8.4	6.8	0.0	0.1	0.0	0.1	0.0	2.5	0.3	0.0	1.8	2.3	0.1	3.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	4.8	2.1	2.5	1.8	2.3	2.3	2.2	1.7	2.5	2.5	2.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66012008-66013505	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"skin 1: 599.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0"	"Group enriched"	"Detected in many"	5	"thyroid cancer: 171.0;urothelial cancer: 43.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 130.2;CAPAN-2: 364.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		82000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	1.7	0.3	0.1	0.3	0.2	0.2	28.8	0.8	0.4	4.1	0.9	0.4	0.0	0.3	0.6	34.9	15.0	0.5	1.9	0.1	0.7	2.3	0.3	18.5	0.0	0.2	0.2	0.0	0.7	0.7	2.1	1.6	8.2	0.5	0.9	0.0	0.0	7.5	4.9	2.0	599.0	0.3	0.1	0.1	0.2	0.6	1.9	0.3	2.7	21.6	0.0	2.3	1.2	22.7	0.2	130.2	0.0	0.0	0.6	0.0	0.0	37.6	1.4	0.0	0.3	0.2	1.0	364.6	0.0	1.8	5.1	0.1	4.5	0.0	32.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.8	0.2	0.7	0.0	0.0	35.8	0.4	0.1	0.8	0.1	0.0	0.2	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.8	0.4	0.1	0.7	0.2	0.2	0.0	0.5	0.1	0.3	0.2	0.1	93.0	6.1	0.0	0.6	1.1	1.7	41.4	0.6	0.0	5.3	7.1	1.2	0.0	115.2	58.8	0.0	33.3	0.0	0.1	0.0	57.4	0.2	7.7	0.1	0.9	0.0	0.0	0.0	21.6	24.4	2.0	0.0	0.6	21.6	0.1	0.4	0.1	41.1	0.0	0.0	0.0	24.4	1.4	10.0	0.8	0.0	5.3	5.4	0.0	1.1	1.3	0.0	0.0	0.0	368.1	1.1	0.4	9.8	1.9	0.0	0.5	404.0	0.1	0.0	0.3	16.0	5.2	17.6	1.0	27.6	64.2	0.7	0.0	0.4	6.1
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	427.7	307.0	57.8	403.2	60.0	87.7	251.1	60.8	94.1	479.1	93.5	295.6	121.9	382.3	117.9	425.0	371.7	232.6	391.4	57.8	188.8	413.7	501.3	432.6	292.0	94.7	70.5	51.3	170.5	136.5	80.2	158.0	255.3	85.2	257.6	160.9	33.9	440.9	158.0	239.3	183.2	262.4	319.1	94.3	525.3	196.0	33.4	172.2	61.5	1160.1	100.2	104.9	435.9	481.8	161.9	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	57.8	60.0	60.8	94.1	57.8	188.8	94.7	70.5	51.3	85.2	94.3	172.2	161.9	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197526-80387757	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 165.3;thyroid gland: 359.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 150.7;Endometrial stromal cells: 158.3;Extravillous trophoblasts: 523.3;Muller glia cells: 246.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.8;fHDF/TERT166: 41.8;HeLa: 95.4;HHSteC: 44.2;SiHa: 168.1;SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048002			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.67e-4)"	"prognostic favorable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.5	3.0	19.4	0.6	15.0	0.1	15.5	16.6	26.0	165.3	8.7	1.4	1.3	40.6	0.5	59.4	0.7	5.1	12.0	19.0	27.8	5.0	0.1	1.6	0.8	15.4	17.0	15.0	0.2	1.8	6.6	31.8	14.6	17.6	9.1	1.7	7.5	33.6	30.7	6.5	7.1	1.5	4.5	6.8	0.6	5.4	4.7	14.2	1.2	359.0	71.3	33.4	6.0	25.2	17.6	0.2	9.5	0.0	0.0	0.5	1.4	0.3	80.8	16.6	6.2	0.9	0.0	0.3	0.2	0.2	41.8	0.3	1.7	2.9	0.0	6.1	0.0	0.2	0.0	95.4	0.0	44.2	0.0	0.2	5.1	0.0	1.2	0.0	3.9	1.4	0.0	0.0	0.8	0.5	1.9	0.1	0.1	1.7	0.0	0.5	0.8	3.9	0.1	0.0	0.8	0.0	0.2	168.1	35.3	0.3	7.1	0.1	0.0	0.8	0.3	7.0	17.4	20.1	2.8	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	15.0	16.6	26.0	19.0	27.8	15.4	17.0	15.0	17.6	6.8	14.2	17.6	0.1	0.0	0.5	52.9	0.3	2.9	0.1	0.0	2.2	3.3	150.7	34.4	1.9	0.0	0.0	0.0	0.0	4.8	0.5	0.2	0.0	0.0	29.5	14.2	158.3	2.3	0.0	0.0	1.0	0.0	523.3	24.6	0.0	15.6	0.0	0.1	0.7	0.2	9.2	1.7	1.0	0.5	0.0	1.3	5.7	12.5	3.4	1.3	5.4	4.7	0.0	246.4	0.0	8.5	1.4	1.0	0.0	4.1	0.3	0.3	0.0	0.0	0.0	7.8	0.0	69.1	6.5	9.7	0.7	8.9	3.0	28.2	1.7	0.9	0.1	0.1
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976655-991732	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.1;parathyroid gland: 27.1;testis: 10.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.8;Smooth muscle cells: 2.3;Spermatocytes: 13.9;Spermatogonia: 5.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;HEK 293: 1.4;hTERT-RPE1: 2.1;THP-1: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	HPA077685	Approved					NA	NA					"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	2.0	0.0	0.8	0.0	0.2	0.0	1.7	0.0	1.0	0.0	8.1	0.1	0.0	0.1	0.0	0.3	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.3	0.2	0.2	0.0	0.0	27.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.7	0.5	0.0	0.2	0.2	0.0	0.0	10.2	0.1	0.1	5.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.0	1.4	0.0	0.3	0.2	0.2	0.2	0.2	0.1	1.2	1.5	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.3	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	13.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.8;skeletal muscle: 82.0;tongue: 75.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	8.3	7.4	7.9	2.0	5.8	5.4	6.7	4.7	6.8	3.0	10.7	5.6	3.0	2.7	15.9	2.5	2.2	2.5	85.8	6.6	7.6	15.0	0.7	4.1	1.3	10.5	7.0	5.2	1.4	1.6	20.8	4.3	15.0	6.8	2.8	6.7	21.8	2.9	7.9	82.0	1.8	6.8	3.6	8.0	7.3	2.8	10.0	8.7	1.1	7.2	75.4	0.5	4.6	2.6	5.8	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	7.9	5.8	4.7	6.8	6.6	7.6	10.5	7.0	5.2	6.8	8.0	8.7	5.8	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
GAL3ST3	GAL3ST2	ENSG00000175229	"Galactose-3-O-sulfotransferase 3"	Q96A11	11	66040765-66049161	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 17.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.9;Cardiomyocytes: 3.6;Cone photoreceptor cells: 10.4;Excitatory neurons: 3.7;Horizontal cells: 5.0;Inhibitory neurons: 4.7;Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 15.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;ovarian cancer: 5.5;thyroid cancer: 10.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 6.5;SH-SY5Y: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA									"prognostic unfavorable (6.53e-6)"	"unprognostic (1.24e-1)"			"unprognostic (3.30e-1)"		"unprognostic (1.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.29e-1)"	0.0	0.0	3.3	0.0	5.4	0.0	0.0	4.6	5.1	2.5	0.0	0.0	0.0	3.9	0.1	0.0	2.6	0.0	4.3	4.6	2.0	2.3	0.0	0.0	0.0	2.1	2.3	4.7	0.2	0.6	0.3	4.1	0.0	3.2	0.8	0.0	5.7	0.0	1.6	0.3	0.1	0.0	2.8	0.6	0.0	0.0	2.1	2.1	0.0	17.2	0.3	0.0	0.0	0.3	3.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.4	4.6	5.1	4.6	2.0	2.1	2.3	4.7	3.2	0.6	2.1	3.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	7.5	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT9	GALNAC-T9	ENSG00000182870	"Polypeptide N-acetylgalactosaminyltransferase 9"	Q9HCQ5	12	132196372-132329589	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.9;thyroid gland: 13.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.7;Collecting duct cells: 27.6;Excitatory neurons: 37.1;Inhibitory neurons: 13.1;Proximal tubular cells: 8.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.9;ovarian cancer: 0.5;renal cancer: 1.6;thyroid cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-87 MG: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075016			Approved	Vesicles		NA	NA			Vesicles		"HPA075016: AB_2686729"	"unprognostic (1.13e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.69e-2)"	4.3	1.2	6.6	0.1	11.5	0.0	0.1	18.3	21.9	3.5	0.0	1.2	0.2	0.8	2.3	0.1	1.9	0.0	0.4	10.9	3.7	7.7	0.2	0.5	0.3	6.1	5.6	10.1	1.3	0.1	0.2	8.5	0.0	8.7	1.0	0.0	0.6	0.2	0.3	0.1	0.1	0.5	0.0	0.5	0.9	0.6	0.7	10.0	0.1	13.1	0.0	0.0	0.5	0.8	10.7	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.5	18.3	21.9	10.9	3.7	6.1	5.6	10.1	8.7	0.5	10.0	10.7	0.0	0.0	0.6	2.6	0.0	0.0	0.5	0.0	0.0	7.7	0.1	0.0	1.6	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	1.3	0.0	0.0	37.1	0.0	0.0	2.7	0.0	0.8	1.3	0.0	0.0	0.0	0.2	3.3	13.1	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	5.6	0.0	1.7	0.0	2.0	2.9	0.1	0.0	1.9	0.0	0.6	0.0	8.2	0.0	3.3	0.0	0.9	0.6	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.8
GFRA2	"GDNFRB, NTNRA, RETL2, TRNR2"	ENSG00000168546	"GDNF family receptor alpha 2"	O00451	8	21690398-21812357	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.5;thyroid gland: 8.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 91.9;Horizontal cells: 220.4;Late spermatids: 238.1"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 6.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.6"	"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 9.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.5;monocytes: 9.2"	"Cell line enhanced"	"Detected in some"		"HEL: 9.1;HMC-1: 21.4;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024704, CAB032791"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA		9000000	Vesicles		"CAB032791: AB_2110428, HPA024704: AB_1849629"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.48e-4)"	"unprognostic (2.87e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.63e-3)"	2.4	1.8	0.7	2.0	1.1	0.6	0.6	0.0	5.6	2.6	0.0	2.1	1.9	0.5	0.2	1.5	1.3	0.6	1.0	1.4	2.1	0.2	1.0	1.2	1.6	0.0	0.3	0.1	0.3	0.3	0.1	0.4	7.2	1.4	0.4	1.1	2.7	0.9	1.5	0.1	0.5	1.8	2.1	0.0	7.6	1.0	9.5	1.6	1.1	8.8	0.6	0.8	1.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.9	0.8	0.0	9.2	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.4	0.0	1.3	0.0	0.0	0.9	0.7	1.1	0.0	5.6	1.4	2.1	0.0	0.3	0.1	1.4	0.0	1.6	0.1	0.3	0.0	1.8	1.3	0.1	1.8	0.2	0.0	0.0	4.3	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	91.9	0.0	1.2	0.3	0.0	0.0	39.5	0.0	0.1	1.8	0.0	0.1	1.3	0.0	0.7	0.2	0.6	220.4	6.5	0.0	0.0	30.6	25.2	238.1	0.6	11.8	0.0	3.7	0.5	1.9	0.0	2.5	1.1	0.0	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.1	6.6	0.7	1.8	1.2	7.0	0.0	0.9	0.3	0.2	0.1	0.0	0.1
GRID1	"GluD1, KIAA1220"	ENSG00000182771	"Glutamate ionotropic receptor delta type subunit 1"	Q9ULK0	10	85599552-86366795	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.5"	"Group enriched"	"Detected in some"	19	"Astrocytes: 149.8;Excitatory neurons: 284.5;Inhibitory neurons: 301.2;Oligodendrocyte precursor cells: 316.2;Oligodendrocytes: 534.1"	"Group enriched"	"Detected in many"	5	"glioma: 3.6;thyroid cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;HEL: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.60e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.31e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.30e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.58e-9)"	"unprognostic (3.15e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.65e-3)"	0.6	1.0	5.3	0.1	5.6	0.0	0.8	3.9	7.0	1.4	0.2	0.3	0.3	1.0	0.7	0.2	1.2	0.2	0.2	5.5	4.5	0.1	0.1	0.4	0.3	5.4	5.4	5.2	0.4	0.2	0.2	0.2	0.7	5.8	0.4	0.1	0.7	0.1	1.0	0.2	0.4	0.3	0.4	4.1	0.0	0.4	0.9	5.3	0.1	2.0	0.0	0.2	0.1	0.6	7.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	2.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.6	3.9	7.0	5.5	4.5	5.4	5.4	5.2	5.8	4.1	5.3	7.5	1.1	3.2	0.5	149.8	0.0	0.5	0.1	0.1	2.2	10.5	0.0	0.1	1.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.3	0.3	0.0	0.0	284.5	0.2	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	301.2	0.0	0.0	0.0	0.4	3.0	2.1	0.2	5.4	15.9	0.0	0.8	0.0	316.2	534.1	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.5	13.1	0.2	5.7	0.1	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;testis: 33.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2"	"Group enriched"	"Detected in many"	5	"glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.3	4.0	19.3	1.7	15.8	3.0	1.3	5.3	26.9	4.5	0.0	11.8	0.8	7.3	1.8	1.6	6.9	1.9	3.3	36.5	10.1	5.6	0.3	0.6	0.7	5.0	5.1	18.3	3.6	2.7	14.9	18.4	0.0	7.1	6.3	1.0	12.6	0.7	6.6	0.5	0.9	3.4	5.2	1.0	1.3	5.4	33.2	9.0	0.9	11.4	0.7	0.6	5.0	2.7	6.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	13.7	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	21.2	0.0	0.6	0.1	0.6	0.0	0.2	0.2	0.0	13.1	0.1	0.0	37.5	0.0	0.1	5.8	0.1	10.3	22.7	0.1	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	15.8	5.3	26.9	36.5	10.1	5.0	5.1	18.3	7.1	1.0	9.0	6.3	0.2	0.0	0.0	17.9	0.1	0.4	0.1	0.0	0.0	23.0	0.2	0.8	3.1	0.0	0.0	1.8	2.1	0.0	0.0	0.1	0.0	0.8	1.6	0.2	0.2	0.4	0.0	0.0	32.4	0.0	0.0	0.6	0.0	0.3	4.5	7.2	0.0	0.0	0.0	18.5	31.1	0.0	0.0	0.0	0.0	2.3	0.9	0.1	0.0	2.8	0.0	9.1	0.0	31.7	0.9	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	21.2	0.0	4.9	1.7	4.2	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667219-113737736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"retina: 42.9"	"Group enriched"	"Detected in some"	16	"Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 84.9"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced					NA	NA					"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;liver: 92.0;thyroid gland: 102.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	14.6	18.7	5.0	22.4	4.8	85.5	11.3	5.2	8.9	6.4	5.5	7.4	6.5	6.4	3.5	4.2	6.2	27.6	5.3	4.5	5.1	6.2	92.0	17.1	39.4	5.6	5.1	3.5	3.0	38.5	1.9	2.3	14.7	5.9	4.8	6.5	0.3	3.5	4.0	3.0	4.7	19.1	5.8	5.9	40.2	5.3	2.4	7.0	4.5	102.9	6.3	30.7	12.8	5.1	6.2	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	4.8	5.2	8.9	4.5	5.1	5.6	5.1	3.5	5.9	5.9	7.0	6.2	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 124.7;lung: 163.4;placenta: 201.5"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	16.8	30.5	7.1	3.1	8.2	0.7	14.8	7.2	11.0	3.7	10.8	4.1	1.7	2.5	0.6	4.4	2.6	14.8	21.8	7.5	7.0	124.7	16.1	163.4	0.7	7.8	7.3	5.7	1.1	4.9	0.8	5.7	201.5	8.6	5.0	3.4	2.9	1.8	4.7	2.5	3.9	8.0	3.8	7.5	1.4	25.3	0.5	8.3	1.3	4.1	0.7	0.8	6.6	4.0	8.6	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.1	8.2	7.2	11.0	7.5	7.0	7.8	7.3	5.7	8.6	7.5	8.3	8.6	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823507	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 23.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		500000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.9	15.6	1.5	4.6	1.6	8.6	5.9	0.0	6.2	22.0	5.1	7.4	6.3	10.7	4.0	15.6	5.4	9.5	20.3	6.9	4.7	4.0	14.9	9.0	4.1	0.6	1.6	1.7	5.0	1.8	2.6	1.7	9.9	1.2	12.6	6.9	0.7	4.2	10.9	2.8	3.0	9.1	15.9	0.2	22.8	7.6	7.0	2.4	1.8	20.9	9.9	2.4	6.6	4.5	1.5	0.2	0.0	4.3	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	10.1	0.0	3.2	1.4	0.0	0.1	0.2	3.8	0.0	0.0	0.1	0.6	8.1	0.1	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.4	0.3	0.0	0.2	0.5	11.8	0.1	0.5	0.7	16.9	0.0	3.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	6.2	6.9	4.7	0.6	1.6	1.7	1.2	0.2	2.4	1.5	20.8	0.0	14.7	16.0	0.1	2.5	1.1	0.1	1.2	1.2	1.1	2.9	12.9	2.8	3.1	1.8	0.0	0.2	0.0	0.0	0.0	0.1	1.5	1.4	4.9	21.6	0.0	3.0	82.0	0.0	0.5	7.5	0.0	0.9	6.3	36.2	54.3	1.3	2.8	0.0	61.0	0.1	0.0	31.9	2.2	4.2	41.3	5.7	3.6	53.4	0.1	0.6	0.0	93.5	6.2	0.0	0.0	74.9	0.4	0.2	0.0	0.1	0.0	0.0	0.0	3.2	3.3	0.6	0.9	0.0	1.7	0.3	1.8	25.9	0.4	0.3
KLHDC8A	FLJ10748	ENSG00000162873	"Kelch domain containing 8A"	Q8IYD2	1	205336061-205357090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"ovary: 286.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 50.8;Granulosa cells: 97.0;Muller glia cells: 19.8;Peritubular cells: 21.1;Theca cells: 44.6"	"Group enriched"	"Detected in many"	5	"glioma: 45.7;thyroid cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HAP1: 8.7;NTERA-2: 2.1;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.92e-1)"	"unprognostic (8.37e-3)"	"unprognostic (7.39e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.84e-7)"	"unprognostic (4.53e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.20e-2)"	0.1	26.7	9.5	0.4	7.3	6.5	0.5	15.3	15.2	1.8	3.9	2.1	0.8	1.6	0.7	4.6	14.0	0.6	0.4	12.9	44.0	0.2	0.2	0.2	0.2	14.9	11.2	7.0	286.3	2.1	0.6	18.1	0.0	17.9	0.4	0.6	26.7	1.4	0.2	0.1	0.5	0.8	2.5	11.6	0.3	6.9	6.4	15.0	0.3	3.4	0.0	1.2	0.4	2.5	16.1	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	7.3	15.3	15.2	12.9	44.0	14.9	11.2	7.0	17.9	11.6	15.0	16.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	50.8	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	2.1	7.1	11.6	1.2	0.0	0.0	7.6	0.0	0.2	0.0	97.0	0.4	0.0	0.0	5.0	8.9	0.0	0.0	0.0	0.0	0.2	5.3	0.2	0.0	0.0	0.0	19.8	0.0	3.0	0.2	0.3	0.0	21.1	0.5	0.0	0.0	0.2	0.1	4.8	0.0	0.0	8.1	0.8	5.0	0.0	0.0	0.0	0.0	44.6	0.0	0.0
LCN12	MGC48935	ENSG00000184925	"Lipocalin 12"	Q6JVE5	9	136949551-136955497	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"epididymis: 80.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.6;Collecting duct cells: 49.7;Distal tubular cells: 19.6;Endometrial ciliated cells: 29.8;Glandular and luminal cells: 57.2;Muller glia cells: 27.1"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 44.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"	NA	NA						"unprognostic (7.27e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.33e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.06e-1)"	"unprognostic (5.00e-2)"	"unprognostic (7.91e-4)"	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.3	0.8	2.9	0.5	0.1	0.3	0.2	80.2	0.0	3.4	0.0	0.1	0.4	0.8	0.6	1.2	0.0	0.0	0.9	0.5	0.3	0.0	0.5	0.7	0.6	0.0	0.4	0.0	0.1	0.1	0.1	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.3	0.2	6.1	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.3	0.8	0.4	0.8	0.9	0.5	0.3	0.4	0.5	0.3	0.4	0.1	0.0	2.2	19.6	0.3	0.0	0.4	0.9	0.0	0.3	2.8	1.3	8.0	2.8	2.3	49.7	2.1	0.1	1.7	2.9	19.6	1.2	1.5	29.8	4.3	0.4	16.4	0.0	1.0	1.2	0.0	0.8	0.0	57.2	0.0	6.7	0.0	13.8	0.2	0.0	0.7	4.0	4.1	0.6	0.0	1.0	14.9	0.5	0.0	3.7	0.0	27.1	2.1	1.0	0.2	0.5	1.2	10.9	0.5	0.7	4.4	6.1	1.3	0.9	0.0	0.0	0.2	1.1	0.5	0.0	0.0	0.3	0.5	7.8	5.7	0.3
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146830-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 107.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA			Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	0.3	3.4	50.0	0.2	70.8	0.1	0.2	72.3	82.7	2.2	2.5	0.7	0.4	1.2	0.3	6.5	1.6	0.1	1.4	43.7	62.1	0.4	0.1	16.1	0.0	79.2	69.7	37.5	0.2	0.8	0.3	2.8	0.0	84.3	1.3	0.1	3.9	1.7	2.8	0.2	15.1	0.5	0.6	60.7	0.1	0.9	0.8	70.7	0.3	13.1	0.1	0.3	0.2	2.5	107.9	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.0	70.8	72.3	82.7	43.7	62.1	79.2	69.7	37.5	84.3	60.7	70.7	107.9	0.0	0.0	22.2	2.0	0.0	2.3	0.0	0.0	0.0	2.7	0.1	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.8	0.0	17.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.4	0.0	0.3	0.1	40.9	2.8	0.0	1.2	0.0	6.6	58.4	0.1	0.0	7.2	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.6	0.1	0.1	1.4	0.6	0.0	0.0	0.9	0.0	0.0
LMO3	"DAT1, RBTNL2, Rhom-3"	ENSG00000048540	"LIM domain only 3"	Q8TAP4	12	16548372-16610594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Alveolar cells type 2: 210.2;Astrocytes: 293.8;Excitatory neurons: 226.2;Oligodendrocyte precursor cells: 112.6"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 32.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"ASC diff: 189.3;LHCN-M2: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (3.62e-2)"	"unprognostic (5.44e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-5)"	"unprognostic (4.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.83e-2)"	25.0	8.1	67.8	2.3	97.4	0.0	13.5	38.3	94.5	33.4	29.2	58.3	1.0	18.6	2.7	2.6	7.3	5.2	4.7	86.5	53.9	3.0	0.4	34.1	0.2	46.9	64.2	85.7	8.7	39.6	0.7	20.4	1.1	53.4	13.2	9.8	2.7	3.2	28.9	1.6	1.8	14.1	11.4	41.9	0.5	7.2	0.9	58.1	15.4	51.0	1.8	0.0	55.4	18.7	64.4	0.0	0.0	0.2	0.1	189.3	7.4	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.2	0.0	0.0	0.8	0.6	2.5	0.0	0.0	4.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	91.9	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.1	3.6	1.3	14.3	0.0	0.0	0.0	0.2	0.8	0.0	0.7	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.8	97.4	38.3	94.5	86.5	53.9	46.9	64.2	85.7	53.4	41.9	58.1	64.4	8.3	173.1	210.2	293.8	0.1	0.3	0.2	5.8	0.0	0.3	2.8	1.4	1.1	0.0	62.8	53.3	18.8	0.2	0.1	0.0	3.9	0.0	5.7	1.8	0.4	0.3	0.0	0.0	226.2	3.6	0.0	23.5	0.0	0.1	5.1	2.5	0.0	0.0	0.2	0.0	46.8	0.0	8.2	0.0	0.5	0.8	0.9	0.7	3.6	18.7	0.0	0.8	0.0	112.6	7.0	0.5	0.0	0.4	0.1	0.2	0.0	0.1	63.7	0.6	0.0	6.3	10.4	1.7	0.8	0.2	0.1	0.3	0.6	0.0	0.0	0.2
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100271875-100322501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.2;fallopian tube: 46.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.6;Excitatory neurons: 166.8;Horizontal cells: 111.0;Inhibitory neurons: 126.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;GAMG: 7.3;HAP1: 5.8;HEK 293: 6.2;HMC-1: 5.1;PC-3: 5.3;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034595, HPA057366"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034595: , HPA057366: AB_2683420"	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	2.2	32.2	16.3	0.5	20.6	0.1	3.2	8.5	22.3	9.8	4.7	3.9	0.6	26.6	42.5	2.6	46.0	2.3	6.4	23.1	73.2	1.8	1.0	1.8	0.5	3.3	8.4	21.7	24.5	6.3	9.7	18.1	0.7	7.6	4.2	0.7	11.3	2.4	4.0	7.1	0.9	1.6	28.5	0.0	0.8	4.6	2.2	19.9	0.4	5.0	4.1	0.3	4.2	3.7	18.1	0.0	6.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	1.1	0.0	1.0	0.0	7.3	0.0	5.8	0.0	0.0	0.5	6.2	0.0	0.4	0.0	0.2	0.1	5.1	0.0	0.0	0.2	0.0	0.4	0.0	1.6	3.5	0.1	0.0	4.0	0.0	0.3	0.3	1.1	5.3	0.0	0.0	0.0	1.4	0.2	12.5	3.4	0.0	0.0	0.8	1.9	3.2	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	16.3	20.6	8.5	22.3	23.1	73.2	3.3	8.4	21.7	7.6	0.0	19.9	18.1	0.5	0.0	11.7	52.5	0.5	0.8	1.4	0.0	1.2	72.6	5.1	2.3	37.4	8.6	3.1	5.5	31.3	2.3	0.1	0.3	5.9	3.7	0.6	22.5	43.6	1.8	11.4	2.7	166.8	2.2	0.2	12.7	4.1	37.1	5.7	25.8	0.0	0.6	0.4	111.0	126.2	0.5	0.0	0.0	1.2	2.3	3.4	0.6	1.8	7.5	0.0	8.4	0.0	58.3	38.7	1.5	0.1	11.7	0.1	4.9	0.0	0.3	3.4	20.6	6.6	3.3	5.3	0.8	0.6	0.8	0.1	2.9	1.6	0.9	0.4	0.4
MRGPRE	"GPR167, mrgE"	ENSG00000184350	"MAS related GPR family member E"	Q86SM8	11	3225030-3232417	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	34	"brain: 26.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 1.0;RPMI-8226: 2.7;SCLC-21H: 3.9"	"Low region specificity"	"Detected in all"							HPA046556	Uncertain					NA	NA					"HPA046556: AB_10961404"	"unprognostic (1.18e-1)"			"unprognostic (7.52e-4)"	"unprognostic (1.04e-1)"			"unprognostic (9.09e-2)"		"unprognostic (6.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.22e-2)"		"unprognostic (1.19e-1)"		0.0	0.3	1.9	0.0	2.3	0.6	0.1	4.0	5.5	0.7	0.0	0.2	0.0	0.5	0.3	0.1	0.6	0.1	0.4	0.3	6.3	0.0	0.0	0.0	0.0	22.5	5.9	0.2	0.0	0.1	0.0	0.1	0.1	26.4	0.2	0.0	0.6	0.2	0.3	0.0	0.1	0.1	0.2	2.5	0.4	0.0	0.0	3.9	0.0	0.2	0.1	0.0	0.1	0.4	16.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.3	4.0	5.5	0.3	6.3	22.5	5.9	0.2	26.4	2.5	3.9	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"heart muscle: 3302.6"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.0	0.5	0.3	0.4	0.3	135.7	2.8	0.2	0.4	0.3	0.4	0.7	0.8	0.8	0.0	0.6	0.5	1.1	3302.6	0.3	0.3	1.3	1.4	9.5	0.9	0.3	1.1	0.2	0.8	8.7	0.3	0.5	9.2	0.4	1.1	0.3	42.5	3.0	0.2	3.6	1.1	1.3	0.8	0.3	3.1	3.5	15.6	0.3	2.4	11.1	6.5	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.3	0.3	0.2	0.4	0.3	0.3	0.3	1.1	0.2	0.4	0.3	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"epididymis: 16929.9"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1619.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		53000000			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	262.0	299.9	131.0	263.7	148.2	308.0	223.5	160.1	192.2	286.9	395.4	262.1	203.5	198.6	16929.9	186.7	171.5	359.2	217.1	123.6	225.9	325.4	204.1	793.0	363.3	190.3	145.8	114.3	285.6	221.8	243.5	199.1	265.3	179.8	165.7	223.0	49.0	223.7	263.8	59.3	175.9	194.9	182.1	165.9	308.3	208.7	158.2	159.9	135.6	448.6	115.7	243.9	350.7	189.5	194.1	297.2	199.3	124.8	179.4	1619.3	498.6	404.8	194.1	707.1	200.9	398.9	351.7	420.3	78.6	141.6	181.9	372.6	595.9	170.0	405.5	188.6	120.4	126.3	29.6	96.7	296.2	348.6	51.0	548.4	467.7	388.9	173.7	336.9	930.2	298.1	87.0	32.9	601.4	224.0	106.9	70.1	75.9	52.9	489.0	307.9	39.5	219.1	281.6	511.1	735.0	5.5	91.3	296.3	120.3	298.0	359.6	205.2	225.7	268.9	291.9	342.0	396.1	188.2	253.7	452.5	24.2	292.1	168.4	163.4	668.7	1300.7	274.1	92.2	1772.7	87.9	295.2	126.5	92.3	587.8	241.8	120.9	100.5	674.2	99.5	1252.1	2113.2	187.8	1304.5	131.0	148.2	160.1	192.2	123.6	225.9	190.3	145.8	114.3	179.8	165.9	159.9	194.1	154.9	381.4	2034.2	11.1	160.2	374.9	557.8	1074.2	170.2	9.9	138.6	220.5	55.4	163.0	626.9	331.1	22.9	228.3	664.0	301.0	305.2	500.4	90.9	123.8	168.5	276.5	119.7	65.4	2.1	279.4	803.3	318.1	61.7	161.0	341.4	104.2	447.3	195.6	2898.5	8.4	3.8	264.8	832.1	2035.4	750.9	69.6	566.7	1462.6	602.9	6.5	790.5	167.4	117.4	7.5	24.4	368.3	405.1	291.9	287.4	357.9	298.1	969.0	393.3	25.1	131.5	118.3	155.9	268.1	166.7	182.6	320.7	210.4	109.9	330.0	298.5	521.6
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027054	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 200.2;thyroid gland: 118.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1144.3;Excitatory neurons: 750.1;Inhibitory neurons: 877.7;Oligodendrocyte precursor cells: 557.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;HaCaT: 3.0;RPTEC TERT1: 9.7;SH-SY5Y: 11.2;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Supported	"Plasma membrane"		NA	NA		20000000	"Plasma membrane"		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	40.8	2.8	199.6	1.7	175.9	0.1	62.8	147.1	192.4	9.1	62.5	6.0	0.4	3.9	4.0	8.3	5.7	33.6	9.3	178.1	200.2	20.6	1.8	10.1	3.1	145.1	199.2	133.8	9.7	34.6	2.5	10.2	1.8	167.4	4.7	3.6	41.6	14.5	19.3	2.9	11.7	1.6	3.4	87.1	11.0	1.9	2.4	199.4	4.0	118.0	13.9	4.3	5.0	12.1	140.7	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	9.7	0.7	0.7	11.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	199.6	175.9	147.1	192.4	178.1	200.2	145.1	199.2	133.8	167.4	87.1	199.4	140.7	17.4	0.0	0.5	1144.3	0.7	56.6	1.0	1.8	93.9	30.3	144.1	116.8	11.4	0.0	0.2	9.2	6.2	0.0	1.0	8.7	27.4	36.1	1.8	1.2	0.4	8.0	0.0	0.0	750.1	0.7	0.1	76.6	0.0	2.3	0.0	0.1	5.0	0.0	0.2	242.3	877.7	0.7	0.0	0.0	14.2	3.6	104.1	1.4	17.8	65.6	0.6	241.0	0.0	557.9	109.5	0.5	7.0	48.2	0.3	0.9	0.0	7.1	1.7	12.2	124.9	9.9	114.4	0.8	2.3	5.2	24.6	0.0	3.3	0.2	7.2	0.9
RSPH6A	"RSHL1, RSP4, RSP6, RSPH4B"	ENSG00000104941	"Radial spoke head 6 homolog A"	Q9H0K4	19	45795713-45815308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 29.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 80.7;Spermatocytes: 49.0"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA045382	Enhanced					NA	NA					"HPA045382: AB_10959735"	"unprognostic (1.99e-1)"	"unprognostic (3.23e-1)"		"unprognostic (6.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"		"unprognostic (4.16e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.72e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.99e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	49.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3105.8;skeletal muscle: 3089.2;tongue: 4955.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	181.3	8.3	724.3	6.5	774.6	2.3	78.0	766.5	960.2	2.4	564.9	11.2	11.2	4.2	1.0	81.7	42.1	4.9	3105.8	695.3	710.4	192.2	4.5	4.0	5.1	844.2	800.4	660.0	2.0	16.9	162.4	55.1	18.2	802.7	29.2	1.2	36.8	627.5	9.4	3089.2	22.5	7.0	1.7	813.2	4.3	23.3	6.0	811.0	9.5	169.4	4955.1	4.0	4.4	3.0	920.4	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	724.3	774.6	766.5	960.2	695.3	710.4	844.2	800.4	660.0	802.7	813.2	811.0	920.4	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 134.1;pituitary gland: 405.8"	"Cell type enriched"	"Detected in many"	4	"Enteroendocrine cells: 470.8"	"Group enriched"	"Detected in many"	5	"glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		100000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.1	61.7	59.7	3.3	69.5	0.3	3.7	61.3	90.1	0.9	80.9	7.9	18.1	5.4	42.9	0.5	3.5	5.6	0.9	69.7	74.9	0.9	3.7	3.9	1.3	68.7	63.7	67.8	3.3	134.1	74.2	405.8	0.3	68.3	5.0	9.9	27.0	0.2	0.9	0.2	1.3	5.7	6.7	59.6	0.5	38.1	5.3	62.1	0.3	5.8	0.1	0.3	2.6	2.7	92.8	0.5	0.2	0.1	0.2	0.6	4.5	0.1	4.2	0.4	0.4	0.4	0.1	0.0	0.5	1.9	0.4	1.7	1.2	0.5	0.2	1.2	0.7	0.3	0.6	0.0	0.1	26.9	0.2	0.7	33.5	0.1	0.8	0.4	0.9	0.7	1.0	0.3	0.6	0.8	0.0	0.3	0.3	15.3	0.1	0.8	0.1	0.4	0.6	0.4	0.0	31.5	36.4	0.2	0.0	0.2	0.4	0.1	0.4	0.0	5.2	3.8	0.3	0.5	0.6	2.3	0.4	47.2	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	69.5	61.3	90.1	69.7	74.9	68.7	63.7	67.8	68.3	59.6	62.1	92.8	0.2	0.0	0.5	20.2	0.3	0.6	0.2	6.2	0.0	51.0	0.5	16.5	0.4	0.0	3.9	0.0	2.1	0.2	0.1	1.1	0.0	0.6	52.1	3.7	19.3	1.1	470.8	0.0	82.8	78.3	0.3	17.9	23.0	0.6	2.5	51.4	0.4	11.9	6.0	50.5	97.8	14.5	97.6	0.6	0.8	80.0	2.1	1.6	3.6	20.6	0.6	15.6	0.0	52.3	79.7	22.9	1.1	7.9	0.3	1.4	0.5	0.0	0.5	32.6	0.0	0.3	34.2	39.2	2.9	0.1	0.3	0.3	0.3	51.8	2.4	1.0
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5356.9"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.2	1.1	0.2	13.6	1.4	0.1	0.7	0.7	1.5	2.8	1.9	0.3	5356.9	0.2	0.3	0.1	3.8	0.2	0.3	0.2	0.2	0.2	4.8	0.3	0.4	0.2	0.4	0.1	0.0	4.2	0.0	0.3	3.6	2.1	0.0	2.0	242.9	1.8	0.5	3.1	0.3	0.2	1.8	3.1	348.8	0.3	3.9	0.6	2.3	4.9	0.5	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.2	0.2	0.1	0.7	0.2	0.3	0.3	0.4	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
SRL	SAR	ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"heart muscle: 243.4;skeletal muscle: 515.1;tongue: 385.7"	"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 247.3"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HSkMC: 4.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	NA	NA		230000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.0	0.4	1.1	1.2	1.0	0.2	1.7	1.0	1.4	2.6	1.0	1.2	0.4	3.0	2.3	9.7	3.1	1.8	243.4	0.8	1.2	1.4	0.4	1.2	0.7	1.2	1.4	0.8	1.3	0.6	0.2	0.5	1.3	1.1	5.6	1.1	8.6	6.5	2.6	515.1	0.8	1.7	3.4	1.1	2.2	1.1	1.1	1.2	1.7	2.3	385.7	1.1	1.4	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.1	1.0	1.0	1.4	0.8	1.2	1.2	1.4	0.8	1.1	1.1	1.2	1.1	0.5	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.0	247.3	0.0	0.0	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.4	0.0	0.0	8.5	0.0	0.1	0.0	0.2	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.3	0.0	1.8	0.1	0.0	1.0	0.0	1.2	0.0	1.0	0.3	0.1	0.0	3.8	0.0	0.3	0.0	0.2	0.0	12.1	6.6	5.5	15.4	0.1	0.2	0.0	0.4	0.0	0.1	0.4	0.0	0.1
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387855	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1"	"Cell type enriched"	"Detected in many"	19	"Oligodendrocyte precursor cells: 306.6"	"Group enriched"	"Detected in many"	5	"glioma: 4.3;melanoma: 11.9;thyroid cancer: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 13.6;SK-MEL-30: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040236			Approved	Centrosome		NA	NA			Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	1.1	11.3	6.0	0.6	8.3	0.0	1.3	13.0	3.7	1.0	0.9	1.7	0.5	0.5	2.6	0.3	0.8	1.5	0.8	3.4	37.1	3.4	0.1	1.2	0.0	11.7	17.2	2.2	2.6	2.7	0.1	8.1	0.1	14.6	1.0	0.3	2.6	0.9	0.8	0.2	3.4	0.7	0.4	10.3	0.3	1.2	1.0	13.1	0.1	8.8	0.5	0.0	1.7	1.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.2	4.4	13.6	1.2	0.5	0.0	0.0	48.6	0.2	0.0	0.0	0.1	0.0	0.5	0.7	0.4	1.0	0.2	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.3	13.0	3.7	3.4	37.1	11.7	17.2	2.2	14.6	10.3	13.1	17.5	0.2	0.0	2.6	8.5	0.0	1.5	0.2	1.4	0.0	1.8	1.3	0.5	0.5	0.0	1.0	1.8	0.0	0.0	0.0	0.1	1.9	1.8	6.9	0.2	0.5	0.1	0.0	0.0	4.6	2.7	0.0	2.7	0.0	0.7	0.0	4.2	0.0	0.0	0.1	0.0	5.2	0.0	2.0	0.0	1.0	10.5	0.9	0.2	16.0	0.0	0.0	4.0	0.0	306.6	0.7	5.5	0.0	4.1	0.0	0.3	0.0	4.1	0.2	1.0	0.0	5.4	0.5	0.0	0.1	0.0	0.3	0.1	0.1	1.4	0.0	0.6
UTS2R	GPR14	ENSG00000181408	"Urotensin 2 receptor"	Q9UKP6	17	82371400-82375586	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;testis: 3.2;thyroid gland: 1.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.2;U-266/70: 15.2;U-266/84: 2.7"															NA	NA						"unprognostic (1.55e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.26e-2)"		"unprognostic (2.30e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.73e-2)"		"unprognostic (1.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.84e-2)"		0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.0	1.6	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.2	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.6	0.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014236-49115522	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	18.8	41.9	7.1	3.3	8.5	0.3	9.9	8.0	6.9	22.5	8.0	6.8	2.5	12.4	7.4	7.9	8.6	10.6	12.3	6.3	7.6	12.5	3.9	10.9	3.5	8.8	9.2	5.8	35.5	1.6	27.0	5.1	10.5	9.3	13.6	5.6	2.3	3.5	11.8	5.6	5.0	5.0	11.5	8.8	2.3	5.7	9.4	8.0	6.6	28.1	6.0	4.6	12.1	7.6	9.4	0.0	0.0	3.1	0.1	1.3	0.7	0.1	2.6	4.1	0.9	0.2	0.0	0.1	0.1	0.1	6.1	3.4	0.1	0.2	0.0	0.4	3.2	1.4	0.2	0.1	0.1	0.1	0.1	0.0	4.7	0.0	4.2	0.0	0.0	0.0	0.8	8.6	0.1	0.8	0.1	0.0	0.2	0.6	0.0	0.0	0.0	9.3	5.0	0.0	0.1	0.1	7.9	0.1	0.0	0.0	0.4	0.1	0.3	0.0	10.6	1.2	24.0	0.1	0.0	6.8	0.0	11.6	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.3	0.1	0.1	0.0	0.0	7.1	8.5	8.0	6.9	6.3	7.6	8.8	9.2	5.8	9.3	8.8	8.0	9.4	9.4	3.2	17.5	17.3	1.3	6.5	1.6	0.1	0.6	5.4	1.2	1.1	16.7	0.0	9.4	0.0	2.1	0.4	3.7	0.2	1.9	0.1	88.5	0.8	10.7	6.2	0.0	0.0	11.1	0.0	0.3	29.7	0.0	0.7	12.6	96.9	5.3	5.0	0.7	5.0	7.0	0.0	0.0	2.2	11.1	140.6	9.6	2.9	7.2	4.7	1.0	9.1	2.1	20.1	33.3	0.2	0.1	14.7	0.7	0.8	0.0	9.4	3.8	2.9	59.2	20.6	37.7	1.3	4.4	0.4	4.3	0.4	2.0	44.7	0.0	0.7
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 48.0;thyroid gland: 71.7"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 44.8"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.0	1.8	0.5	0.3	0.2	0.0	0.1	2.6	0.1	0.1	0.1	0.1	0.2	12.9	20.1	0.3	0.1	0.0	0.0	0.2	0.0	10.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.1	0.0	2.8	0.4	0.0	1.7	0.5	0.0	0.0	0.3	0.5	0.0	0.0	48.0	71.7	0.0	13.0	0.4	10.0	0.0	15.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	54.8	0.5	37.4	0.0	0.0	53.1	0.0	119.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	10.8	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.2	0.1	0.0	2.1	0.6	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	44.8	1.1	0.0	0.6	4.5	0.3	3.1	4.6	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.8	0.0	4.5	0.0	0.1	0.2
BEX5	NGFRAP1L1	ENSG00000184515	"Brain expressed X-linked 5"	Q5H9J7	X	102153708-102155977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 127.6;pituitary gland: 78.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 171.6;Distal tubular cells: 137.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 45.7;thyroid cancer: 14.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 6.2;MAIT T-cell: 15.5;memory CD4 T-cell: 11.6;memory CD8 T-cell: 8.1;naive CD4 T-cell: 16.4;naive CD8 T-cell: 10.1;NK-cell: 10.1;T-reg: 11.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 10.1;T-cells: 16.4"	"Group enriched"	"Detected in some"	4	"HAP1: 16.4;Karpas-707: 61.9"					"Low region specificity"	"Detected in all"			HPA059058	Enhanced					NA	NA					"HPA059058: AB_2683894"	"unprognostic (1.88e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.79e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-2)"	3.2	15.7	72.1	3.7	77.3	2.1	7.8	58.9	127.6	4.1	51.0	5.2	4.0	6.3	33.6	1.9	5.0	13.1	3.8	80.8	101.0	20.1	3.5	13.8	4.9	77.6	80.6	76.9	13.8	26.5	33.9	78.1	0.0	77.6	6.6	6.1	31.0	7.6	3.7	0.5	3.4	3.4	3.4	62.9	4.4	8.3	13.2	81.9	1.1	26.0	0.5	7.8	2.1	3.4	113.5	0.0	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.3	1.4	16.4	0.3	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	2.4	0.4	0.1	6.0	2.5	61.9	0.3	7.1	0.4	0.1	7.3	0.0	2.6	0.0	0.0	0.2	5.8	0.0	8.9	0.9	0.1	0.1	0.0	1.2	1.6	0.0	6.0	0.4	4.2	0.5	0.0	7.1	4.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	6.2	0.0	15.5	2.1	11.6	8.1	0.1	0.9	16.4	10.1	0.0	10.1	0.0	0.8	11.9	2.9	72.1	77.3	58.9	127.6	80.8	101.0	77.6	80.6	76.9	77.6	62.9	81.9	113.5	9.0	3.2	5.6	4.2	12.2	14.9	24.2	0.1	10.2	53.2	25.9	32.1	19.4	171.6	7.4	38.6	0.0	0.0	13.4	2.1	137.0	16.5	1.3	6.7	0.7	16.3	35.9	1.7	18.1	22.8	0.1	5.8	2.6	8.4	22.8	25.1	26.7	18.2	0.3	57.2	14.0	31.9	0.0	0.8	6.2	7.0	2.5	1.3	30.2	6.5	6.0	55.5	7.2	6.6	3.5	8.5	2.5	0.4	24.5	16.4	0.5	23.2	6.8	25.4	0.0	8.8	2.3	2.1	1.2	4.3	11.2	0.0	13.4	21.5	6.2	11.0
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase acidic"	Q9BZP6	1	111290851-111320566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"stomach 1: 330.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 34.6"	"Group enriched"	"Detected in some"	4	"lung cancer: 1.8;stomach cancer: 2.0;thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.5	1.6	0.3	0.0	0.0	0.1	0.2	0.1	0.2	10.7	0.3	0.1	0.1	0.1	0.1	0.2	2.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	330.2	0.5	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0
COL23A1	DKFZp434K0621	ENSG00000050767	"Collagen type XXIII alpha 1 chain"	Q86Y22	5	178237476-178590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.2;Cardiomyocytes: 11.3;Excitatory neurons: 21.8;Muller glia cells: 62.6"	"Group enriched"	"Detected in many"	4	"renal cancer: 41.3;testis cancer: 16.0;thyroid cancer: 14.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 8.4;NB-4: 9.6;THP-1: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067824	Uncertain					NA	NA					"HPA067824: AB_2685907"	"unprognostic (5.24e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (3.04e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.37e-1)"	1.1	1.2	0.6	0.0	0.8	1.8	2.4	1.3	1.1	3.1	0.0	2.2	1.0	1.5	0.0	1.3	2.0	0.1	14.1	0.2	0.2	4.5	1.6	2.5	0.1	1.2	0.4	0.3	0.3	0.4	0.8	1.6	0.0	1.0	8.9	0.1	2.1	2.0	1.4	2.1	7.6	5.6	0.0	0.1	2.1	2.8	5.2	0.8	0.0	79.2	0.0	0.1	0.7	3.1	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.3	1.1	0.2	0.2	1.2	0.4	0.3	1.0	0.1	0.8	0.3	1.8	0.0	0.0	20.2	0.0	2.2	4.2	0.4	1.2	1.0	0.2	3.2	11.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	6.3	2.2	0.0	0.0	21.8	0.0	0.4	3.7	0.0	0.7	0.0	0.6	2.2	0.1	0.5	0.0	9.1	0.0	0.0	2.1	5.0	0.4	0.3	1.8	0.0	4.7	0.1	62.6	0.0	1.0	2.2	0.1	0.0	2.6	0.0	1.9	0.0	0.6	0.0	3.4	6.6	0.1	4.8	1.4	2.5	0.1	4.7	0.1	0.5	0.1	0.0	0.2
CRLF1	"CISS, CISS1, CLF, CLF-1"	ENSG00000006016	"Cytokine receptor like factor 1"	O75462	19	18572220-18607741	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 61.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Basal keratinocytes: 9.7;Fibroblasts: 16.0;Respiratory ciliated cells: 11.9;Skeletal myocytes: 19.9;Smooth muscle cells: 10.5"	"Group enriched"	"Detected in all"	4	"lung cancer: 27.4;thyroid cancer: 36.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"ASC diff: 1048.7;Hep G2: 458.8"	"Region enriched"	"Detected in many"	7	"hippocampal formation: 21.1"	"Group enriched"	"Detected in some"	6	"cerebellum: 2.3;spinal cord: 8.6"	"HPA041493, HPA041793"	Approved				"Secreted in other tissues"	NA	NA					"HPA041493: AB_10795637, HPA041793: AB_10804117"	"unprognostic (1.97e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.95e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.27e-3)"	31.4	14.6	19.6	0.9	19.5	0.0	18.9	21.4	52.1	20.5	7.7	7.9	0.5	12.9	0.9	17.6	11.4	1.4	61.3	16.3	31.7	7.7	1.5	16.2	0.4	19.5	14.2	18.1	4.6	9.0	0.5	9.0	11.4	11.3	8.9	0.4	0.1	15.0	6.2	21.6	23.7	5.0	1.5	13.3	2.4	7.6	1.3	7.3	0.3	50.7	0.9	0.2	9.4	15.6	21.5	0.0	0.0	0.0	10.7	1048.7	15.3	5.2	5.4	0.0	0.0	0.0	0.1	0.0	0.0	66.5	33.2	1.9	0.4	10.8	0.2	0.0	0.0	1.4	0.0	18.1	458.8	7.5	0.1	0.5	12.0	1.0	0.2	0.3	1.6	0.3	0.0	0.1	0.2	0.3	16.6	0.0	0.0	1.2	0.1	0.3	0.0	9.1	0.1	0.0	0.5	0.0	0.1	14.2	0.0	0.0	2.0	13.0	0.6	1.3	0.1	11.1	0.8	0.4	0.1	0.0	0.5	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	19.5	21.4	52.1	16.3	31.7	19.5	14.2	18.1	11.3	13.3	7.3	21.5	0.4	0.0	0.0	15.3	0.3	9.7	0.6	6.8	0.0	0.2	0.7	4.2	2.5	0.0	2.6	0.0	0.0	0.1	0.3	0.1	5.9	0.3	6.9	2.6	1.9	0.5	0.0	0.0	7.8	0.2	1.3	16.0	0.5	0.5	0.0	0.2	0.4	0.1	0.3	0.0	1.0	0.0	2.0	0.0	1.0	0.4	0.0	0.4	0.0	0.0	0.1	0.9	1.0	0.5	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.3	11.9	1.3	0.0	19.9	10.5	0.2	2.2	0.6	4.5	0.3	0.6	0.2	0.1	0.3
DGKI	DGK-IOTA	ENSG00000157680	"Diacylglycerol kinase iota"	O75912	7	137381037-137847092	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.4;choroid plexus: 6.6;retina: 6.6;thyroid gland: 15.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 606.4;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 329.2"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;melanoma: 0.6;renal cancer: 1.0;thyroid cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 3.0;GAMG: 3.6;hTEC/SVTERT24-B: 3.2;SCLC-21H: 5.0;U-2197: 14.1;U-87 MG: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.01e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.98e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.73e-3)"	0.5	0.3	2.2	0.2	13.4	0.0	0.2	0.9	10.9	0.1	6.6	0.2	0.0	0.3	0.1	0.1	0.1	0.6	2.8	5.4	3.2	0.5	0.0	0.0	0.0	3.5	4.5	3.5	0.0	0.0	0.2	1.3	0.0	3.3	0.1	0.1	6.6	0.3	0.1	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.6	6.1	0.0	15.7	0.0	0.0	0.2	0.0	7.0	0.0	0.0	0.4	0.0	0.8	0.6	0.0	3.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.2	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.3	0.0	0.0	0.5	0.2	0.0	0.0	0.1	1.3	0.5	14.1	0.6	0.1	0.0	0.0	5.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	13.4	0.9	10.9	5.4	3.2	3.5	4.5	3.5	3.3	0.0	6.1	7.0	0.3	0.0	0.0	7.5	0.3	1.1	0.2	1.4	0.6	53.1	1.0	0.1	11.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.4	1.3	1.1	0.0	0.0	606.4	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.4	0.0	0.6	45.4	414.6	0.0	44.7	0.0	0.7	3.6	0.9	0.2	0.0	60.9	0.0	2.1	1.0	329.2	84.4	0.0	0.0	1.5	0.0	0.2	0.0	0.3	0.2	3.3	0.0	0.8	2.2	0.2	0.5	0.2	0.6	0.0	0.1	0.5	0.0	0.0
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045886-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.5;ovary: 60.7;pituitary gland: 53.0"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 64.6;Theca cells: 206.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.3	20.3	30.5	0.5	19.1	0.1	5.1	2.6	10.3	4.7	3.0	2.6	7.5	2.6	10.7	1.7	3.4	10.3	11.4	7.1	97.5	7.0	9.6	5.2	0.2	36.5	47.1	6.1	60.7	20.1	7.6	53.0	0.6	17.2	3.0	0.8	4.0	2.4	2.6	1.1	2.1	1.4	1.2	8.0	2.6	4.3	5.5	69.1	1.6	3.8	1.9	0.3	3.1	6.5	11.2	0.0	1.5	1.6	0.0	5.2	3.9	0.6	4.6	1.6	0.3	1.2	0.0	0.8	0.0	0.2	4.8	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.6	0.0	8.2	0.0	0.0	17.2	0.1	0.7	0.0	0.0	1.0	0.2	0.3	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	11.2	0.0	0.5	0.2	9.1	2.7	0.0	0.0	16.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	30.5	19.1	2.6	10.3	7.1	97.5	36.5	47.1	6.1	17.2	8.0	69.1	11.2	0.3	0.0	1.8	5.2	0.0	3.2	25.0	0.6	0.6	1.1	5.4	6.5	5.9	7.2	2.5	3.7	10.4	1.1	0.0	0.4	64.6	3.7	0.1	0.7	0.7	1.7	16.2	0.0	2.2	18.7	0.1	10.3	4.1	1.8	0.0	0.8	3.3	3.9	0.1	0.0	8.8	2.3	0.0	0.0	4.8	0.8	6.8	0.3	5.4	0.0	0.0	0.7	1.0	5.0	0.2	2.9	0.1	1.5	0.0	5.3	0.1	11.1	0.9	6.1	0.0	16.9	1.7	0.0	1.4	1.7	2.8	0.4	0.7	206.2	0.7	2.4
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50674927-51384198	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 12.3"	"Group enriched"	"Detected in some"	11	"Astrocytes: 223.6;Excitatory neurons: 777.2;Inhibitory neurons: 837.1;Oligodendrocyte precursor cells: 445.4;Oligodendrocytes: 814.7"	"Group enriched"	"Detected in many"	4	"glioma: 2.7;thyroid cancer: 7.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.1;GAMG: 5.9;HMC-1: 4.9;JURKAT: 5.8;U-87 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	0.7	3.3	5.4	0.2	11.8	0.2	0.3	0.8	19.4	0.8	0.0	2.2	0.2	0.7	0.7	2.1	0.9	0.3	2.9	10.6	5.3	0.7	0.1	0.5	0.3	2.3	1.9	12.1	0.4	0.4	5.3	6.4	0.1	4.8	2.0	0.3	10.2	1.5	1.9	1.9	2.0	0.8	1.0	0.0	0.5	1.4	6.0	0.9	0.0	12.3	1.8	0.3	2.0	0.6	15.9	0.1	0.2	0.2	6.1	0.0	0.0	2.6	0.1	0.1	0.3	0.2	0.1	0.4	0.0	0.5	1.9	5.9	0.4	4.1	0.0	0.1	3.7	4.3	0.1	1.2	0.1	0.0	0.1	4.9	0.0	0.1	0.2	0.0	0.3	0.0	5.8	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.3	1.9	0.0	0.6	0.0	0.3	0.6	3.7	0.0	0.3	3.4	0.0	4.1	0.1	0.0	0.4	0.2	1.6	0.2	2.2	0.3	0.0	0.0	7.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	5.4	11.8	0.8	19.4	10.6	5.3	2.3	1.9	12.1	4.8	0.0	0.9	15.9	0.0	0.0	0.6	223.6	0.0	0.0	0.2	0.0	0.0	22.0	0.3	0.4	7.5	0.0	0.7	0.0	2.1	0.1	0.4	0.1	1.9	0.0	11.4	0.3	0.2	0.4	0.0	0.0	777.2	0.0	0.2	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.5	33.7	837.1	0.0	0.0	0.0	0.0	6.0	0.0	0.4	0.0	52.5	0.0	3.1	1.0	445.4	814.7	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.1	5.1	0.0	1.1	1.2	6.0	4.1	0.4	0.1	0.0	1.1	0.1	0.0	0.1
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205896-29259597	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;lymphoid tissue: 55.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HEL: 28.8;NB-4: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"	NA	NA					"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	29.3	31.2	4.3	31.6	14.9	2.5	24.6	49.9	5.9	21.5	5.8	5.1	10.1	1.7	1.3	10.5	4.8	1.7	33.5	26.2	14.8	3.4	13.1	7.6	27.3	27.9	31.5	7.1	14.1	12.5	2.1	4.9	26.0	6.1	3.5	0.3	3.7	3.9	0.9	5.4	8.4	2.3	23.4	55.2	7.8	2.3	24.6	4.8	13.3	0.3	2.4	5.0	2.2	29.8	0.0	0.2	4.9	10.5	0.0	0.0	0.7	0.0	0.0	0.4	0.3	5.7	0.7	0.0	4.7	0.1	0.0	0.0	2.5	0.1	0.0	11.5	8.6	28.8	0.1	1.1	0.7	4.1	2.2	0.3	0.2	0.2	0.0	0.0	0.0	6.4	2.5	0.0	0.0	8.0	0.2	102.0	1.1	0.1	0.4	0.0	0.2	11.3	0.0	0.1	13.2	6.3	0.4	0.1	0.2	0.8	4.2	5.4	0.0	0.0	8.0	0.0	0.1	0.5	0.0	0.0	0.0	14.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.2	31.6	24.6	49.9	33.5	26.2	27.3	27.9	31.5	26.0	23.4	24.6	29.8	0.4	0.0	2.5	92.1	0.1	2.8	1.0	0.1	0.0	1.7	5.3	3.9	0.7	4.3	0.6	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.2	10.8	22.6	6.2	0.0	18.5	5.6	1.3	0.1	11.8	0.5	20.0	11.4	32.7	11.4	2.1	0.3	0.0	6.2	0.4	0.0	0.3	5.2	0.5	3.1	0.6	0.0	10.3	0.6	1.1	0.0	51.8	1.0	0.4	0.0	1.9	1.0	1.9	0.1	1.9	0.0	0.4	0.0	17.5	4.0	0.1	1.5	0.0	2.0	0.3	1.1	151.0	0.3	0.4
FOXE1	"FKHL15, FOXE2, HFKH4, TITF2, TTF-2"	ENSG00000178919	"Forkhead box E1"	O00358	9	97853226-97856717	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"thyroid gland: 196.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 7.9;Basal squamous epithelial cells: 9.1;Cardiomyocytes: 2.7;Club cells: 2.1;Spermatogonia: 2.8;Squamous epithelial cells: 6.1;Urothelial cells: 3.2"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 84.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.9;BJ hTERT+: 8.4;HaCaT: 7.9;HeLa: 20.9;RPTEC TERT1: 19.5;SiHa: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (8.78e-3)"	"unprognostic (9.18e-3)"		"unprognostic (3.79e-5)"	"unprognostic (2.19e-4)"	"unprognostic (8.29e-3)"		"unprognostic (1.04e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.05e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.3	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.1	196.1	0.0	24.3	0.0	3.3	0.0	13.9	4.5	0.0	0.0	0.0	0.0	0.0	1.3	8.4	1.0	1.4	0.0	1.1	0.0	0.6	0.0	0.0	7.9	0.9	0.1	4.0	0.0	0.7	0.0	20.9	0.0	0.0	0.0	1.4	0.0	0.9	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	19.5	1.3	0.0	0.0	14.7	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	7.9	9.1	0.0	0.0	0.1	2.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.2	1.3	2.8	6.1	0.3	0.0	0.0	0.0	0.0	3.2
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin like and fibronectin type III domain containing 1"	Q86VF2	1	201190824-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 188.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 103.8"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HeLa: 76.6"	"Group enriched"	"Detected in many"	7	"amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9"	"Low region specificity"	"Detected in some"			HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA			"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.3	0.8	0.6	0.1	0.0	10.5	15.2	0.0	0.9	0.2	0.3	1.0	0.5	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.2	7.0	0.0	0.1	0.0	0.3	0.7	0.2	0.0	0.0	0.3	188.1	0.2	0.0	0.8	0.0	0.0	0.1	2.6	0.4	0.0	14.7	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	76.6	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	0.5	0.1	0.2	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	22.1	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	103.8	0.7	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LGALS13	"PLAC8, PP13"	ENSG00000105198	"Galectin 13"	Q9UHV8	19	39602501-39607474	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis	Hemagglutinin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"placenta: 11.9"	"Cell type enriched"	"Detected in some"	17	"Syncytiotrophoblasts: 319.9"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SuSa: 2.1"									HPA046803			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046803: AB_10965990"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	11.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.7	0.2	0.4	0.1	0.5	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	319.9	0.0	0.0	0.0	0.0
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.0;skin 1: 31.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	20.7	1.0	28.8	0.0	1.6	20.8	21.1	2.3	0.0	4.8	3.4	1.7	0.9	1.9	1.4	2.0	7.0	22.0	15.8	0.7	0.2	2.9	0.1	44.0	21.9	13.0	4.6	2.2	5.7	2.6	2.6	24.8	2.1	3.5	7.9	1.7	2.3	4.5	31.8	4.9	1.5	19.9	3.9	7.9	1.1	29.6	1.5	2.4	7.7	0.3	0.9	1.4	25.1	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	28.8	20.8	21.1	22.0	15.8	44.0	21.9	13.0	24.8	19.9	29.6	25.1	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 243.5;retina: 414.6"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5"	"Group enriched"	"Detected in many"	4	"glioma: 30.4;thyroid cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	5.6	11.7	80.9	1.2	110.0	0.3	5.6	2.3	243.5	4.4	0.0	2.5	0.9	2.3	4.0	6.6	2.5	7.7	8.5	120.9	136.4	3.7	3.9	13.6	1.8	36.5	76.5	113.4	7.5	10.7	15.6	34.1	0.9	48.8	7.7	1.7	414.6	7.8	4.9	1.7	17.1	1.6	2.8	4.5	1.7	3.3	6.6	77.3	3.5	16.9	4.7	2.4	1.6	5.3	172.3	2.6	0.6	296.9	0.0	3.9	2.2	0.1	1.9	2.1	0.7	2.2	0.0	16.1	0.0	1.7	3.8	14.0	4.1	23.4	1.8	1.0	0.1	1.4	1.2	8.9	0.1	36.7	0.3	0.2	3.1	9.6	0.1	5.8	17.3	7.8	0.1	0.0	3.1	0.3	1.1	0.1	0.0	106.7	0.5	0.5	0.0	0.6	0.3	3.8	0.1	148.6	82.7	6.3	0.9	3.7	34.8	8.2	0.0	0.2	0.3	1.7	0.1	4.1	1.9	0.0	0.0	15.5	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	80.9	110.0	2.3	243.5	120.9	136.4	36.5	76.5	113.4	48.8	4.5	77.3	172.3	16.8	96.1	3.2	127.3	1.8	5.9	3.3	12.0	4.6	144.7	6.2	8.0	4.9	27.1	3.7	5.5	875.7	0.4	0.1	0.0	3.9	26.8	22.1	2.2	1.1	15.7	32.4	2.7	883.3	11.0	0.1	5.3	3.6	4.4	1.3	1.6	18.5	0.4	0.5	33.7	823.6	0.2	6.1	1.4	1.5	10.7	28.6	1.4	19.6	74.0	0.0	129.7	0.0	688.6	53.8	10.0	0.0	15.4	0.1	12.3	0.0	0.4	3.4	514.5	32.9	5.1	26.1	6.6	22.7	2.3	6.5	0.3	0.3	6.6	0.0	0.7
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1"	P21941	1	30711277-30723585	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 5.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.1;Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 1.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028580	Supported				"Secreted to extracellular matrix"	NA	NA					"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"	0.0	0.1	0.3	0.3	0.4	0.7	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.4	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.6	0.4	0.1	0.7	0.2	0.0	0.2	0.3	0.7	0.1	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.1	0.2	0.3	0.0	0.3	0.0	0.0	0.1	0.2	1.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.3	0.3	0.2	0.2	0.6	0.4	0.1	0.7	0.2	0.3	1.1	0.3	0.0	0.5	0.0	4.1	0.1	0.6	0.1	0.0	0.0	0.4	1.0	0.5	0.0	0.6	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.1	0.4	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.5	0.2	0.8	0.5	0.5	0.1	0.3	0.5	0.3	0.0	0.1
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3506.9;liver: 7016.2;thyroid gland: 2912.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	124.7	21.7	342.2	106.7	413.9	2.9	28.3	393.5	919.5	12.4	301.5	828.7	518.4	8.4	2.4	257.4	76.2	12.1	6.8	338.0	346.5	3506.9	7016.2	50.3	5.6	403.6	361.9	358.6	3.2	1822.1	0.3	21.8	2.1	372.5	428.9	521.1	43.0	44.5	5.9	8.5	56.7	1105.7	77.0	331.0	3.9	1272.7	4.0	363.1	0.9	2912.8	1.0	2.6	14.3	26.1	402.5	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	342.2	413.9	393.5	919.5	338.0	346.5	403.6	361.9	358.6	372.5	331.0	363.1	402.5	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"pituitary gland: 103.9;thyroid gland: 44.2"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 1.3"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 28.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.6"	"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.0	0.0	8.4	0.0	8.4	0.0	0.1	10.3	11.6	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	11.5	0.3	0.2	0.0	0.0	8.4	9.2	7.2	0.0	0.0	0.0	103.9	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	9.1	0.0	44.2	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	8.4	10.3	11.6	9.3	11.5	8.4	9.2	7.2	9.7	7.7	9.1	10.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 28.7;brain: 31.7;retina: 36.1;thyroid gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.3;Excitatory neurons: 322.8;Horizontal cells: 132.9;Inhibitory neurons: 148.8;Melanocytes: 209.9;Muller glia cells: 452.7"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 65.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 60.0;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		18000	Vesicles		"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	0.8	28.7	9.8	0.8	14.1	0.5	0.4	1.0	31.7	1.7	0.0	5.3	4.8	0.2	0.3	1.1	1.0	0.5	2.9	14.4	7.9	0.2	0.2	2.5	0.0	3.5	5.6	20.2	9.1	20.0	0.8	2.1	0.6	6.0	1.4	1.7	36.1	1.7	1.2	0.1	14.2	2.2	0.4	0.3	0.1	8.2	4.9	21.0	0.0	57.4	0.1	0.1	3.0	2.4	13.5	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	14.1	1.0	31.7	14.4	7.9	3.5	5.6	20.2	6.0	0.3	21.0	13.5	0.1	0.0	7.3	7.8	0.0	8.2	0.0	0.0	1.2	28.1	0.0	0.0	1.2	0.0	0.6	0.0	6.2	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	1.3	0.0	0.0	322.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	132.9	148.8	0.6	0.0	0.0	1.3	6.3	2.8	0.2	209.9	8.4	0.0	452.7	0.0	44.7	6.4	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.5	1.2	1.0	0.3	0.2	1.4	0.0	0.1	0.6	0.0	0.1
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	14.2	11.4	1.1	11.0	3.4	2.1	9.7	5.0	4.3	33.0	13.1	27.6	15.6	14.6	41.9	41.7	23.1	10.5	12.9	1.6	2.3	5.9	1.6	22.3	6.4	4.9	8.2	1.3	5.4	12.5	8.4	3.6	13.3	5.5	60.3	26.2	9.6	9.9	50.2	7.0	4.3	19.0	11.5	0.1	5.8	9.7	9.5	3.3	3.7	17.0	5.7	3.5	14.8	15.9	2.2	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	1.1	3.4	5.0	4.3	1.6	2.3	4.9	8.2	1.3	5.5	0.1	3.3	2.2	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032325-22251310	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 45.3;Granulosa cells: 161.7"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	37	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.7;HUVEC TERT2: 2.8;PC-3: 3.0;TIME: 3.1;U-87 MG: 6.5;WM-115: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (7.68e-2)"	0.0	0.0	1.1	0.5	1.0	0.0	0.7	1.8	0.8	0.8	0.4	0.2	0.5	2.0	0.1	0.2	0.1	0.9	0.0	0.9	2.0	0.1	0.0	2.8	1.5	1.6	1.6	0.7	1.6	0.0	0.0	0.2	0.1	1.7	0.6	0.0	0.3	0.2	0.4	0.0	0.1	0.6	1.5	1.8	0.4	0.1	0.1	1.3	0.3	1.0	0.3	0.9	0.2	0.3	2.2	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	3.7	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.3	0.7	0.7	2.1	0.1	2.8	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.6	0.0	0.4	0.1	0.1	0.1	0.2	1.5	0.5	0.4	1.8	0.0	3.1	0.6	0.1	0.4	0.5	0.0	0.0	0.0	6.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	1.1	1.0	1.8	0.8	0.9	2.0	1.6	1.6	0.7	1.7	1.8	1.3	2.2	0.0	0.0	0.0	3.9	0.8	0.0	5.8	2.3	0.0	0.4	3.0	1.8	0.5	0.0	1.6	0.0	0.0	0.2	45.3	0.7	0.0	0.9	0.4	1.3	1.4	0.2	0.0	0.0	2.2	1.2	0.1	2.9	0.0	1.8	0.0	161.7	0.0	0.0	0.0	16.8	1.9	0.5	4.1	0.0	0.4	0.3	1.8	1.2	1.8	0.0	0.0	0.6	0.0	1.5	0.5	0.8	0.0	0.0	0.3	1.8	8.2	0.9	4.5	0.5	0.0	2.1	2.6	0.1	0.4	0.1	0.1	0.8	0.4	18.9	0.4	3.3
PNPLA5	"dJ388M5.4, GS2L"	ENSG00000100341	"Patatin like phospholipase domain containing 5"	Q7Z6Z6	22	43879678-43892013	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9;epididymis: 1.7;skin 1: 2.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.2;Inhibitory neurons: 2.1;Late spermatids: 2.1"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;RPMI-8226: 2.7"	"Not detected"	"Not detected"							"HPA050409, HPA054211"	Uncertain					NA	NA					"HPA050409: AB_2681118, HPA054211: AB_2682418"				"unprognostic (6.69e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.27e-2)"		"unprognostic (3.33e-3)"				"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		0.0	0.0	0.5	0.1	2.9	0.3	0.3	0.1	2.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.1	0.0	1.3	0.4	0.0	1.0	0.0	0.0	1.2	0.5	0.6	0.0	0.0	0.0	0.9	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.5	2.9	0.1	2.3	1.3	0.4	1.2	0.5	0.6	0.7	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.5;esophagus: 15.2"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3"									"HPA062673, HPA066741"			Supported	"Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Vesicles, Plasma membrane"		"HPA062673: , HPA066741: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	1.5	8.5	0.6	0.4	0.6	0.0	0.6	0.1	0.7	2.3	0.0	0.2	0.1	0.3	0.7	15.2	0.6	0.7	0.4	0.5	0.3	0.5	0.1	0.5	0.1	1.0	0.6	0.4	0.7	0.1	0.2	0.3	0.1	0.6	0.7	0.1	0.1	3.7	1.0	0.2	2.7	0.2	0.6	0.1	0.1	0.4	0.3	0.6	0.0	0.5	0.1	1.1	1.8	6.1	0.3	1.0	1.4	0.0	1.7	2.3	1.7	0.0	0.8	3.0	1.3	1.9	0.0	1.5	0.0	0.6	1.7	1.4	2.7	0.9	5.3	1.1	0.3	1.6	0.5	29.5	0.0	0.7	0.0	0.0	3.3	22.6	3.5	1.7	1.5	0.3	0.7	0.3	0.2	0.6	1.3	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	1.0	3.2	0.3	0.3	11.9	0.5	0.0	0.1	0.4	0.4	1.6	0.6	0.5	1.6	0.8	0.0	0.0	0.0	9.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.7	0.5	0.3	1.0	0.6	0.4	0.6	0.1	0.6	0.3	1.4	0.0	0.0	0.0	0.0	3.1	5.1	42.9	2.8	0.0	0.4	0.4	0.1	1.5	14.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.4	0.1	1.3	0.0	0.0	0.0	1.3	0.0	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.7	0.1	0.9	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.2	1.1	0.0	0.3	8.9	1.7	0.1	0.3	0.5	0.0	8.1
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669049-7670455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 249.4"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 118.2;Kupffer cells: 47.0;Macrophages: 90.4;monocytes: 58.2"	"Group enriched"	"Detected in many"	4	"lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Group enriched"	"Detected in many"	8	"classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 118.7;monocytes: 170.4"	"Group enriched"	"Detected in some"	11	"NB-4: 524.3;U-937: 243.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	5120000	1200000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	3.1	1.0	0.1	5.2	0.2	249.4	1.4	0.0	1.0	0.5	0.0	0.7	6.1	0.7	0.0	0.5	2.4	0.3	2.0	0.4	0.0	1.7	3.3	34.3	0.1	0.1	0.1	0.1	0.4	0.9	0.1	0.5	1.2	0.2	1.0	0.2	0.0	1.1	0.0	0.6	0.6	0.7	4.3	0.0	53.7	1.0	0.2	0.2	4.0	0.8	0.0	0.0	0.6	0.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.9	524.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	243.2	0.0	0.1	170.4	0.1	0.4	91.7	1.2	0.0	1.9	1.5	118.7	0.1	4.4	9.0	13.6	0.3	47.4	4.5	0.0	64.3	0.1	0.2	0.0	1.0	0.4	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.3	0.0	12.8	9.9	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	1.1	0.6	0.0	0.0	3.8	0.0	0.4	0.1	118.2	0.0	0.0	0.0	0.0	47.0	8.7	0.2	0.0	90.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	2.2	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 759.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.3	0.8	0.0	0.3	0.0	0.0	19.3	2.1	0.2	67.1	5.5	0.0	16.6	34.9	0.1	1.5	70.5	9.1	0.1	0.1	0.6	16.8	1.2	759.7	0.1	0.0	0.2	0.0	1.4	7.3	0.0	2.1	4.8	0.2	1.0	0.0	0.5	91.0	16.9	0.1	2.3	4.4	0.2	0.0	0.7	2.5	2.7	0.2	2.1	33.9	0.0	7.5	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.6	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210238	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Symport, Transport"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 20.4;kidney: 5.6;thyroid gland: 15.7"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.1;Early spermatids: 7.9;Enteroendocrine cells: 31.5;Excitatory neurons: 14.6;Horizontal cells: 10.1;Inhibitory neurons: 17.3;Proximal tubular cells: 21.4"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.7;renal cancer: 7.6;thyroid cancer: 5.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"SK-BR-3: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.5	0.4	0.0	0.4	0.0	0.0	0.2	1.1	20.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	5.6	0.0	0.9	0.0	0.8	0.2	0.3	1.1	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.2	1.0	0.2	15.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	1.1	0.4	0.4	0.8	0.2	0.3	0.5	0.3	1.0	0.7	0.0	0.0	5.3	1.3	0.0	0.0	0.0	4.6	0.0	3.9	0.1	0.1	0.6	0.0	9.1	1.8	0.0	0.0	0.0	0.3	1.9	0.0	7.9	0.0	0.1	0.0	31.5	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	17.3	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.2	21.4	2.1	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.9
SLIT1	"MEGF4, SLIL1, Slit-1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185959	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 32.2;pituitary gland: 13.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.0;Excitatory neurons: 96.2;Inhibitory neurons: 34.6;Late spermatids: 25.5;Oligodendrocyte precursor cells: 25.1"	"Group enriched"	"Detected in many"	4	"glioma: 9.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 23.2;MOLT-4: 81.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"	NA	NA			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	0.4	0.1	18.3	0.2	30.7	0.2	0.1	0.0	20.4	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.1	32.2	6.6	0.1	0.1	0.2	0.1	6.7	2.5	31.6	0.1	0.6	0.1	13.6	0.0	8.9	0.3	0.1	0.8	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.3	0.3	1.8	9.5	2.4	2.5	0.0	0.1	0.1	0.1	15.0	0.0	0.1	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	23.2	0.0	0.6	0.0	0.2	81.0	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	4.9	2.1	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.3	30.7	0.0	20.4	32.2	6.6	6.7	2.5	31.6	8.9	0.2	9.5	15.0	0.2	0.0	0.0	6.5	0.5	0.0	0.1	0.0	0.0	3.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	27.0	0.5	0.1	0.1	1.8	0.0	96.2	0.0	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.5	0.0	34.6	0.0	0.0	0.3	0.0	25.5	0.0	0.3	0.0	2.8	0.2	0.1	0.0	25.1	3.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.1	0.2	3.4	2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 165.2;liver: 249.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.9	15.9	4.9	3.1	3.7	2.9	54.3	8.3	8.5	165.2	1.7	5.4	7.6	4.3	6.9	10.3	6.8	8.3	5.7	5.0	3.4	50.8	249.0	3.2	2.6	4.5	3.7	2.9	2.4	5.7	4.5	3.2	2.5	4.3	88.6	7.8	4.9	5.4	27.3	2.2	16.7	7.3	3.5	3.9	2.4	9.3	12.3	3.8	3.8	90.2	2.8	3.5	9.2	7.0	6.1	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.7	8.3	8.5	5.0	3.4	4.5	3.7	2.9	4.3	3.9	3.8	6.1	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
TEPP		ENSG00000159648	"Testis, prostate and placenta expressed"	Q6URK8	16	57976435-57988116	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 14.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 317.5;Late spermatids: 440.1"	"Group enriched"	"Detected in some"	4	"thyroid cancer: 3.2;urothelial cancer: 1.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062092	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA062092: AB_2684679"	"unprognostic (4.86e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.59e-1)"	0.0	0.4	0.2	0.0	0.3	0.0	0.2	0.1	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.4	0.3	0.0	0.2	0.2	0.3	0.1	0.0	0.5	0.0	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.0	0.2	0.4	0.0	0.2	0.3	0.4	0.0	0.2	0.1	0.0	0.1	0.1	0.0	14.3	0.3	0.1	2.2	0.0	0.1	0.9	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.9	0.0	1.1	0.8	0.0	0.2	1.1	1.7	0.0	0.1	0.0	0.1	0.6	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.1	0.5	12.8	5.9	0.0	0.2	0.1	8.2	24.4	2.2	0.1	1.0	8.6	30.4	1.5	8.7	1.8	0.0	2.7	0.5	0.0	0.0	0.0	317.5	0.4	0.1	1.4	0.0	0.0	0.2	0.6	4.1	1.4	0.0	0.2	2.5	0.2	2.5	0.0	0.5	0.0	0.1	0.0	4.1	0.0	0.6	440.1	3.7	0.3	1.8	0.0	0.0	0.8	0.0	0.5	0.1	0.1	0.0	0.4	0.0	1.6	0.0	0.0	3.0	1.1	0.0	0.2	3.1	2.7	3.3	0.3	0.0	1.1	1.7	2.9	0.0	3.6
UNC5C		ENSG00000182168	"Unc-5 netrin receptor C"	O95185	4	95162504-95549206	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 2078.8"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000				"unprognostic (1.55e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.70e-5)"	"unprognostic (1.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.62e-4)"	1.1	9.1	8.0	1.0	15.9	0.0	1.3	5.0	17.9	1.8	0.0	2.9	1.4	2.4	1.8	0.6	1.9	2.0	2.3	6.7	10.1	1.1	1.0	2.6	0.5	17.1	13.5	5.9	2.8	0.3	0.1	1.2	1.8	19.9	3.4	3.4	6.5	6.3	3.9	0.1	0.2	1.9	2.0	7.1	4.3	2.1	2.7	10.2	1.9	12.0	0.4	0.3	2.6	1.6	39.8	0.0	0.5	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	4.2	0.0	0.2	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	0.0	0.2	4.8	0.3	12.3	0.0	0.1	1.2	0.0	7.9	0.0	0.0	0.0	0.1	9.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	15.9	5.0	17.9	6.7	10.1	17.1	13.5	5.9	19.9	7.1	10.2	39.8	0.7	0.0	0.0	105.4	0.0	0.1	0.1	0.1	0.0	1.9	0.7	1.5	1.7	0.0	0.2	1.8	0.0	0.5	0.0	2.6	0.0	0.0	0.7	0.5	3.4	0.7	1.2	0.0	326.1	0.0	0.1	4.6	0.0	1.2	0.0	20.2	0.4	0.0	1.8	0.0	448.3	0.5	0.0	0.8	0.0	0.8	21.1	0.4	1.8	57.1	0.0	1.3	0.0	308.1	2078.8	0.0	26.9	11.7	0.0	0.3	0.0	0.1	0.0	12.5	6.6	0.3	4.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0
ZNF208	"PMIDP, ZNF95"	ENSG00000160321	"Zinc finger protein 208"	O43345	19	21932958-22010949	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2"									HPA077100			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA077100: "	"unprognostic (4.06e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-3)"	4.2	1.1	4.5	2.0	7.0	1.5	3.4	3.2	4.9	4.1	3.1	3.6	1.4	6.7	4.7	2.3	4.9	3.5	11.5	6.5	7.4	3.4	0.7	1.4	2.8	9.4	7.0	3.6	3.4	2.6	13.4	7.1	2.7	8.6	3.6	1.5	2.4	2.8	3.3	1.0	4.1	2.2	6.0	3.7	2.7	1.7	8.7	6.1	0.5	8.0	1.3	1.7	3.2	2.7	7.5	0.4	0.3	0.5	1.1	0.0	0.2	1.5	0.3	0.1	0.2	0.1	1.8	0.6	0.6	0.3	0.3	9.3	0.7	1.2	0.2	0.4	0.2	0.2	0.6	1.5	0.8	0.0	0.4	0.2	1.0	0.3	0.0	0.2	0.7	0.4	0.4	0.5	1.6	0.0	0.5	0.4	0.6	33.1	0.0	1.1	0.2	0.0	1.9	1.1	1.8	0.8	1.6	0.2	0.8	0.3	6.9	0.9	0.8	0.0	0.5	0.3	1.9	0.1	1.0	11.2	0.2	0.1	0.4	0.7	2.4	0.6	0.7	0.8	0.4	0.4	1.3	1.5	0.5	0.3	1.6	0.6	0.9	2.6	1.0	0.3	1.6	1.5	0.3	4.5	7.0	3.2	4.9	6.5	7.4	9.4	7.0	3.6	8.6	3.7	6.1	7.5	6.7	0.0	0.0	11.4	4.3	0.0	1.0	0.0	0.6	6.6	4.2	2.5	11.4	0.0	1.3	5.5	0.0	6.8	0.5	0.0	3.9	6.6	15.4	0.2	3.7	3.4	0.0	1.3	11.5	0.2	3.1	5.9	0.5	0.1	0.0	2.7	1.1	0.5	0.7	3.3	1.7	0.0	0.0	0.0	0.7	14.1	1.5	0.2	0.0	9.4	0.0	0.8	1.0	11.1	26.3	0.7	0.0	1.2	0.4	1.2	0.0	2.6	0.0	0.4	0.0	2.5	1.7	8.7	6.2	0.9	0.3	5.3	2.2	0.3	0.0	2.0
ADIG	"MGC39724, RP5-1100H13.2, SMAF1"	ENSG00000182035	Adipogenin	Q0VDE8	20	38581195-38588463	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"testis: 53.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 1714.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041124	Uncertain					NA	NA					"HPA041124: AB_10795534"					"unprognostic (2.97e-2)"		"unprognostic (7.69e-3)"					"unprognostic (2.27e-1)"	"unprognostic (4.52e-3)"			"unprognostic (1.34e-2)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.9	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	409.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1714.0	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.0	6.6	0.0	0.0	5.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 65.0;parathyroid gland: 69.2;thyroid gland: 82.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7"	"Low region specificity"	"Detected in all"							HPA037843	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	6.9	2.4	17.3	4.3	11.6	0.1	10.3	21.2	13.5	20.6	6.9	10.7	3.9	24.1	13.3	9.4	23.2	4.6	4.8	12.2	11.9	14.6	1.7	5.3	4.4	13.4	12.2	10.9	15.2	12.0	69.2	2.4	18.6	13.6	13.2	5.1	3.8	6.9	24.1	3.1	9.9	6.5	19.1	14.0	65.0	5.9	1.4	12.1	13.6	82.9	4.5	7.6	6.0	14.8	13.1	74.4	10.8	10.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.1	77.4	0.1	56.4	0.6	1.1	98.7	0.2	27.2	0.2	1.5	0.1	0.0	0.7	0.0	3.0	0.0	2.7	0.0	28.9	8.1	7.1	0.3	0.3	2.8	0.0	0.2	0.0	3.1	1.9	0.1	0.5	2.0	0.5	0.9	0.8	51.3	59.7	0.6	0.3	0.5	2.3	1.7	2.9	16.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.6	1.1	1.2	0.0	1.6	0.3	0.9	0.1	0.4	0.0	0.1	1.8	0.6	17.3	11.6	21.2	13.5	12.2	11.9	13.4	12.2	10.9	13.6	14.0	12.1	13.1	14.6	0.0	0.0	0.7	1.2	12.4	7.3	3.1	5.2	0.8	1.8	5.3	2.2	0.0	1.8	40.5	0.0	1.5	2.4	8.1	0.0	0.6	1.0	5.3	7.4	14.5	0.0	0.8	6.5	14.3	1.2	10.7	3.1	9.5	0.0	0.3	13.2	0.0	0.5	1.7	10.1	1.8	0.0	0.0	3.7	3.0	3.1	0.5	5.4	34.7	0.6	3.2	0.0	122.6	0.6	23.2	1.7	1.9	0.1	3.7	2.2	0.4	1.5	0.6	19.7	21.4	24.7	0.0	0.8	2.3	6.8	0.3	3.4	2.4	2.2	4.3
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 734.6"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	1.8	1.8	0.1	1.1	0.1	0.5	1.7	0.2	0.4	4.2	0.2	3.2	0.6	2.5	2.0	2.1	4.5	0.1	2.4	0.1	0.1	5.5	2.7	734.6	0.6	0.2	0.1	0.1	4.8	1.8	0.0	5.1	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	1.8	3.2	0.1	0.0	7.0	2.1	2.2	0.1	0.8	39.5	0.1	0.5	2.9	3.3	0.1	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565430	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 2.4;thyroid gland: 2.4;urinary bladder: 1.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 5.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"	NA	NA					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	1.2	0.0	0.8	0.6	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.7	0.2	0.0	0.4	0.1	0.1	0.0	2.4	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.2	0.0	0.5	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 156.1"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	14.5	46.6	28.5	11.6	30.2	0.5	17.7	23.6	29.2	33.0	27.3	20.4	5.4	30.9	156.1	9.3	29.1	20.8	33.5	29.2	31.4	23.0	3.2	17.0	8.6	26.3	26.4	29.8	48.3	19.1	71.8	78.9	26.5	28.0	28.5	8.0	15.4	44.9	68.6	6.3	6.4	13.1	32.5	24.0	21.5	16.5	5.8	28.2	7.8	60.3	7.6	6.5	27.2	20.3	28.8	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.5	30.2	23.6	29.2	29.2	31.4	26.3	26.4	29.8	28.0	24.0	28.2	28.8	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	35.2	59.5	34.1	24.6	36.2	14.9	32.5	38.7	38.3	45.4	31.5	28.3	20.4	41.3	106.2	18.3	28.0	34.3	51.5	36.7	40.9	37.6	24.8	29.8	21.9	37.8	37.0	30.9	38.7	57.9	104.4	48.0	45.8	38.0	44.9	22.1	19.2	60.1	47.2	31.0	11.5	21.7	36.6	40.2	41.6	30.0	13.0	37.0	20.3	50.4	64.2	21.7	32.2	22.7	40.7	26.4	18.8	48.8	23.9	109.4	118.3	10.0	56.5	54.3	23.2	68.3	20.7	21.5	9.5	31.7	64.7	50.8	5.0	34.9	20.2	28.7	21.6	23.2	18.7	64.9	30.2	85.2	18.2	41.5	67.0	27.4	30.9	30.3	65.1	47.6	11.6	15.2	78.9	67.4	10.9	15.0	0.8	24.4	49.5	4.3	19.1	62.2	8.9	36.0	10.1	22.1	18.9	28.3	1.5	63.9	67.7	19.2	19.0	67.5	29.8	18.9	70.8	11.2	69.7	20.9	0.1	50.4	14.5	25.5	43.6	15.3	13.6	14.6	15.8	18.3	15.0	14.0	12.4	15.8	9.8	15.2	10.6	5.6	13.7	16.8	25.8	9.0	14.4	34.1	36.2	38.7	38.3	36.7	40.9	37.8	37.0	30.9	38.0	40.2	37.0	40.7	67.4	44.8	36.1	16.3	61.1	37.9	81.2	40.6	42.7	63.1	70.9	42.3	114.6	50.1	48.4	75.4	58.4	55.3	61.1	20.4	37.2	53.9	0.6	42.2	80.9	69.2	82.4	25.6	35.9	30.6	27.4	85.8	33.1	78.8	79.1	45.5	58.2	48.6	50.7	62.2	41.8	67.6	40.7	52.5	84.9	2.8	64.7	72.3	97.8	18.7	27.2	86.6	34.0	28.6	31.0	30.6	22.1	72.6	122.6	75.2	20.1	43.1	25.1	13.3	32.9	57.1	73.2	2.5	0.4	24.6	21.5	114.9	58.0	70.2	32.1	81.2
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 63.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: AB_2681282"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	14.8	13.4	3.2	5.2	5.1	7.4	14.2	5.0	8.4	10.1	2.8	11.7	5.3	11.6	1.7	10.6	11.6	4.1	9.5	5.0	2.6	7.3	19.6	15.2	5.9	2.0	2.8	3.8	19.9	10.4	1.5	12.4	4.5	2.5	8.6	4.1	23.6	12.8	3.4	27.2	17.4	12.5	5.6	1.7	11.7	10.9	11.0	4.4	14.3	19.1	8.2	6.5	9.4	11.6	7.4	8.2	9.0	7.5	4.0	15.0	9.0	5.7	9.5	8.1	8.6	9.7	3.7	10.9	0.1	2.6	5.2	10.4	3.4	5.3	10.3	7.7	13.6	6.3	3.9	6.6	1.8	23.7	1.8	16.2	10.1	21.3	3.7	14.1	5.9	6.2	12.6	2.5	14.9	6.9	4.7	4.7	0.9	1.6	5.4	4.3	5.1	11.4	3.4	5.7	1.8	1.2	12.2	6.1	0.7	7.6	7.1	5.7	7.0	11.5	6.2	6.8	20.3	5.5	4.1	12.0	0.0	6.4	4.1	8.3	4.3	8.3	17.9	18.1	9.0	25.2	2.6	16.8	15.6	8.4	3.1	9.4	11.1	24.5	14.1	8.9	1.1	11.1	10.7	3.2	5.1	5.0	8.4	5.0	2.6	2.0	2.8	3.8	2.5	1.7	4.4	7.4	4.9	25.6	21.0	49.9	9.0	30.8	13.4	7.3	10.2	28.3	6.1	5.0	8.8	10.0	11.1	1.8	16.7	17.6	34.8	8.6	17.6	6.8	1.5	6.1	14.2	6.6	1.2	3.0	63.6	6.4	2.2	10.3	11.7	12.9	2.5	6.9	10.8	22.9	8.2	30.3	30.5	4.6	4.1	14.0	12.3	4.2	12.8	11.9	3.6	18.7	13.1	18.8	32.0	34.2	11.9	8.3	9.3	19.9	11.5	8.0	13.5	11.3	5.3	30.9	13.1	6.6	10.7	4.7	5.4	9.4	32.4	6.3	33.0	4.7	4.5	12.0
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 82.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	9.0	2.5	9.6	26.9	23.7	3.7	5.9	23.9	2.2	0.0	12.9	4.3	2.4	12.3	2.3	2.4	2.5	8.5	13.5	17.7	3.8	1.7	12.0	15.1	8.4	8.3	4.9	16.4	7.1	36.3	2.2	2.4	13.2	8.3	11.8	19.5	4.4	5.3	10.1	1.7	8.9	2.8	8.1	9.1	12.6	2.1	11.3	10.0	40.1	15.7	11.9	2.5	1.5	82.3	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	2.5	26.9	5.9	23.9	13.5	17.7	8.4	8.3	4.9	13.2	8.1	11.3	82.3	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
BHLHE41	"BHLHB3, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120030-26125037	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 123.5;skeletal muscle: 93.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 347.5;Cone photoreceptor cells: 183.5;Horizontal cells: 250.7;Muller glia cells: 239.8;Rod photoreceptor cells: 309.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 78.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 92.4;RT4: 126.6;U-266/70: 52.6;U-87 MG: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	9.8	14.8	35.7	7.4	45.5	0.6	13.7	55.0	35.0	39.1	13.3	9.6	2.7	8.2	19.4	3.3	45.9	18.4	20.2	32.2	39.5	3.9	0.7	11.7	8.0	57.7	49.4	23.7	13.0	7.8	6.6	16.8	10.6	61.1	9.8	11.2	123.5	18.5	14.1	93.3	5.2	6.4	4.1	63.9	9.2	4.9	4.4	51.8	6.3	58.3	13.0	18.1	21.5	10.0	71.3	11.4	0.1	0.3	0.0	20.4	9.4	4.7	2.2	3.8	0.4	1.4	0.0	13.4	0.0	1.9	4.4	31.4	11.3	0.4	1.9	1.1	0.1	1.7	1.0	0.2	0.0	0.9	5.7	0.3	1.5	1.1	7.8	15.0	92.4	0.0	0.1	0.0	39.6	2.4	1.3	0.0	3.9	10.4	3.7	7.8	0.0	1.9	31.6	4.9	126.6	0.2	0.2	1.4	0.6	29.7	0.6	0.0	0.2	6.7	7.1	8.2	0.8	5.9	52.6	32.3	0.1	44.9	4.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	45.5	55.0	35.0	32.2	39.5	57.7	49.4	23.7	61.1	63.9	51.8	71.3	1.6	0.0	1.1	46.0	25.0	6.0	59.8	34.1	10.8	347.5	9.2	56.0	46.7	37.1	11.2	29.5	183.5	26.6	0.2	55.0	0.0	40.6	0.6	78.5	27.1	12.0	13.1	0.0	10.1	21.9	3.6	22.7	3.1	60.8	5.7	0.2	2.5	0.1	91.1	250.7	12.4	4.4	0.0	4.0	4.4	1.3	30.1	39.8	14.2	120.9	27.4	239.8	0.0	22.1	56.2	21.9	12.0	26.7	61.8	49.0	0.4	2.3	34.8	309.5	6.6	13.0	7.5	0.5	3.7	3.5	3.3	7.1	2.4	2.3	5.0	83.8
BMP8A	OP-2	ENSG00000183682	"Bone morphogenetic protein 8a"	Q7Z5Y6	1	39491636-39529869	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	9	"thyroid gland: 92.4"	"Group enriched"	"Detected in some"	7	"Early spermatids: 42.2;Late spermatids: 164.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 7.0;HL-60: 5.8;U-2197: 22.2;U-266/70: 8.6;U-266/84: 7.9"									HPA047254			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA047254: "	"unprognostic (9.62e-3)"	"unprognostic (2.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.95e-9)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	0.6	0.8	2.4	1.4	4.2	1.3	0.2	2.9	4.4	2.3	0.4	1.0	1.4	3.3	3.8	0.5	3.5	1.2	1.1	2.9	2.1	0.5	0.3	0.4	1.8	6.3	3.9	2.5	3.0	2.6	0.8	0.5	0.4	4.8	1.2	0.6	1.9	1.2	3.5	2.6	1.8	2.1	5.1	5.1	1.6	0.9	3.3	3.5	5.9	92.4	0.1	0.5	0.9	0.5	10.1	0.4	1.1	0.8	0.5	0.1	0.1	0.6	0.2	0.0	0.0	0.0	1.2	0.2	0.3	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.8	1.0	0.1	2.0	0.1	7.0	5.8	0.2	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.3	3.7	0.0	1.6	0.2	1.2	2.0	0.2	0.1	0.8	0.1	3.2	0.0	0.3	1.2	0.2	0.3	0.3	0.5	1.0	1.0	1.1	0.2	0.1	0.8	22.2	0.1	8.6	7.9	0.5	0.2	0.7	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	2.4	4.2	2.9	4.4	2.9	2.1	6.3	3.9	2.5	4.8	5.1	3.5	10.1	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.2	0.1	0.0	0.0	5.7	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	164.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 25.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 28.3;Cone photoreceptor cells: 8.4;Oligodendrocyte precursor cells: 37.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.6"	"Region enhanced"	"Detected in many"		"hippocampal formation: 22.7"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"	NA	NA					"HPA057934: AB_2683558"	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.0	0.0	16.3	0.0	7.8	0.0	0.2	2.1	17.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	10.6	0.0	0.0	0.0	0.1	5.9	5.1	7.1	0.1	0.0	0.0	0.5	0.0	6.1	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	2.7	0.0	0.0	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	7.8	2.1	17.2	25.1	10.6	5.9	5.1	7.1	6.1	2.7	12.9	6.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	28.3	1.3	0.8	0.5	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	37.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKII"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.4;skeletal muscle: 133.8"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.4	65.8	0.6	93.8	0.1	1.5	113.3	253.4	0.1	0.0	0.8	1.0	0.2	28.6	1.4	1.1	0.2	66.0	197.6	35.1	1.6	7.8	0.3	1.3	32.1	19.6	77.3	0.3	3.8	6.1	51.7	0.1	42.2	3.2	0.4	21.6	1.4	1.6	133.8	1.2	0.9	0.1	1.6	0.3	2.3	2.2	24.0	0.8	20.5	59.7	1.6	0.0	0.3	83.6	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	65.8	93.8	113.3	253.4	197.6	35.1	32.1	19.6	77.3	42.2	1.6	24.0	83.6	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281838	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 114.6;testis: 32.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 100.9;Late spermatids: 291.0;Spermatocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enhanced"	"Detected in all"		"cerebellum: 114.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"NTERA-2: 40.0;SCLC-21H: 126.0"	"Region enriched"	"Detected in all"	9	"cerebellum: 613.4"	"Region enriched"	"Detected in many"	13	"cerebellum: 369.4"						"Secreted in brain"	NA	NA		6000000				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.60e-2)"	11.9	1.1	9.1	0.2	3.4	0.0	3.8	114.6	6.4	2.1	1.1	0.7	1.0	5.8	0.4	1.0	1.3	7.5	4.6	2.3	13.5	0.2	1.0	0.1	0.8	11.7	17.8	3.4	1.3	2.8	0.2	4.3	0.0	31.1	0.5	0.7	3.6	0.6	0.6	0.9	0.7	1.3	1.8	4.8	0.1	0.7	32.1	21.7	0.2	2.3	1.8	2.8	1.5	0.5	8.4	0.0	0.0	0.6	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	2.7	2.6	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	126.0	3.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	3.4	114.6	6.4	2.3	13.5	11.7	17.8	3.4	31.1	4.8	21.7	8.4	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.3	2.2	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	100.9	0.1	2.4	6.7	13.2	0.0	0.6	0.4	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.7	4.7	0.5	0.0	0.0	0.0	291.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.2	0.0	0.4	0.0	0.1	0.3	0.0	0.0	1.8	26.3	0.1	19.2	61.7	5.8	0.0	0.1	0.0	0.0	8.8	0.2	0.0
CCDC187	MGC50722	ENSG00000260220	"Coiled-coil domain containing 187"	A0A096LP49	9	136249973-136306901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 11.1;pituitary gland: 7.2;testis: 29.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 446.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"RPMI-8226: 10.4;SCLC-21H: 3.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 3.2"							NA	NA						"unprognostic (1.11e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-2)"		"unprognostic (6.18e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.93e-4)"	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.1	2.8	0.0	11.1	0.0	0.0	0.0	0.5	0.2	0.0	2.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	29.9	0.3	0.0	4.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	10.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	107.8	49.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	446.1	3.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	0.1	22.6	0.0	0.0	0.0	0.0	2.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CCDC85A	KIAA1912	ENSG00000055813	"Coiled-coil domain containing 85A"	Q96PX6	2	56183990-56386172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.7;Excitatory neurons: 228.7;Inhibitory neurons: 160.5;Microglial cells: 60.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 45.9;fHDF/TERT166: 74.5;U-266/70: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043106, HPA057020"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA043106: AB_10794770, HPA057020: AB_2683311"	"unprognostic (2.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.55e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.83e-2)"	12.7	0.6	7.1	0.7	8.7	0.0	3.6	2.6	8.1	2.5	0.0	0.7	0.3	6.4	0.8	0.7	2.1	1.2	4.6	7.3	7.3	1.0	0.1	5.6	0.6	19.5	7.1	7.3	0.5	0.7	1.3	0.2	10.1	8.0	2.0	0.7	4.0	1.2	2.7	5.4	1.7	0.4	4.7	9.9	0.7	0.5	0.4	5.8	0.6	9.2	7.6	0.7	0.7	0.7	15.6	0.0	0.8	0.1	0.0	13.9	0.8	0.0	11.6	1.1	9.8	0.9	0.0	0.1	45.9	1.7	74.5	0.0	2.0	0.0	0.0	5.6	0.0	0.3	0.0	0.6	0.0	0.7	0.0	0.1	3.3	0.3	0.0	1.2	5.5	9.7	0.0	0.0	6.1	1.3	0.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	1.7	1.3	0.0	0.3	0.1	0.0	2.1	5.3	0.0	15.3	7.9	2.3	0.1	0.9	32.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	8.7	2.6	8.1	7.3	7.3	19.5	7.1	7.3	8.0	9.9	5.8	15.6	57.7	25.6	0.6	15.3	0.8	3.3	0.5	0.0	0.0	7.8	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.3	3.6	0.2	1.9	14.8	1.2	0.0	228.7	0.4	0.1	3.7	0.0	0.5	0.0	0.2	8.6	0.0	2.3	0.0	160.5	0.2	0.0	0.3	2.0	11.9	0.3	0.3	5.4	60.0	0.0	0.7	0.0	33.7	7.2	0.7	0.1	0.0	0.1	0.3	0.0	0.3	0.0	1.5	0.0	10.0	2.7	0.2	0.8	0.1	1.3	0.1	0.1	3.6	0.9	0.3
CIB4		ENSG00000157884	"Calcium and integrin binding family member 4"	A0PJX0	2	26581205-26641366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.5"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 181.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.7;thyroid cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036130, HPA036131"	Uncertain					NA	NA					"HPA036130: AB_10670709, HPA036131: AB_2674959"	"unprognostic (3.63e-3)"		"unprognostic (1.78e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.63e-1)"			"unprognostic (1.66e-1)"		"unprognostic (1.27e-1)"	"unprognostic (4.29e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.20e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.50e-1)"	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.0	0.1	0.2	0.0	0.8	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	17.5	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.2	0.1	0.2	0.5	0.2	0.1	0.8	0.1	0.3	0.6	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	14.6	0.0	0.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	181.0	0.0	0.3	0.3	1.8	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	24.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	11.9	0.7	0.0	0.0	0.8	0.0	0.5	0.0	0.0
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.3	7.2	7.1	16.8	7.2	9.8	16.8	6.7	14.9	20.2	10.1	11.0	8.7	22.8	7.9	9.5	12.7	19.2	14.7	8.4	7.9	5.9	12.9	30.8	30.4	7.5	6.9	5.9	21.8	3.5	4.6	4.5	9.4	7.3	4.6	13.8	2.5	6.3	6.4	4.5	5.9	10.4	17.9	7.6	50.5	8.6	3.3	8.4	14.6	32.1	14.5	25.8	16.1	10.8	7.7	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	7.1	7.2	6.7	14.9	8.4	7.9	7.5	6.9	5.9	7.3	7.6	8.4	7.7	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994608-136996568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 319.6;skin 1: 120.1;thyroid gland: 110.5;vagina: 133.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 2635.7"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 2635.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	4.6	0.6	0.9	1.4	0.7	4.1	2.6	1.3	1.8	37.0	2.2	1.4	0.4	1.9	4.6	319.6	1.7	0.8	6.9	0.6	2.1	1.0	1.0	38.9	4.2	1.3	0.8	0.4	0.6	0.6	0.2	2.4	41.9	0.9	3.0	0.2	0.0	38.0	1.1	1.0	120.1	1.7	0.3	0.7	6.9	7.5	0.7	1.1	7.7	110.5	1.2	20.7	2.1	133.3	1.1	28.8	0.0	0.0	0.0	0.5	1.4	350.3	2.7	1.5	1.0	0.4	3.7	14.0	0.1	22.5	24.3	0.1	12.5	0.0	1.2	0.0	0.0	0.2	0.0	20.7	4.5	3.9	0.0	0.0	1.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.1	0.1	0.2	0.1	58.4	5.8	0.0	0.5	0.0	0.0	0.0	0.8	0.0	45.9	65.0	0.0	0.0	147.2	0.0	118.4	0.0	4.1	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.0	2.9	0.8	2.6	232.3	2.1	99.3	2.6	32.0	143.8	9.4	5.5	6.9	120.4	10.3	283.2	2.3	2635.7	11.5	168.3	0.9	0.7	1.3	1.8	0.6	2.1	1.3	0.8	0.4	0.9	0.7	1.1	1.1	11.5	214.7	42.0	0.0	11.6	3.8	3.6	86.6	8.0	0.0	7.3	20.6	3.2	2.8	95.2	1.8	0.0	811.8	456.0	25.2	9.8	1.8	1.7	16.7	2.3	13.4	4.9	5.3	0.0	6.4	1219.2	27.0	22.4	14.4	1.3	1.8	3.6	1.1	91.6	0.0	0.0	5.6	4.1	2.2	5.9	7.8	125.6	8.5	10.6	1.9	4.9	0.0	541.7	0.0	0.0	84.6	10.4	41.8	23.7	4.5	0.7	0.4	12.0	0.0	0.0	0.2	4.4	0.0	1.0	70.2	19.5	2039.4	78.4	1.0	5.2	18.1
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002714-227164453	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Collecting duct cells: 46.0;Cone photoreceptor cells: 56.3;Granulosa cells: 62.6;Muller glia cells: 78.6;Oligodendrocyte precursor cells: 55.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 4.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 34.3;hTERT-RPE1: 27.2;Karpas-707: 8.9;RPTEC TERT1: 14.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	0.7	7.0	1.6	2.2	1.4	0.1	0.7	0.9	1.2	0.4	12.3	0.9	0.9	2.1	7.3	1.1	2.2	4.4	7.2	1.0	1.5	13.9	1.6	8.4	2.8	3.0	2.2	0.2	2.0	5.6	0.6	10.3	0.3	2.7	4.5	0.9	8.5	0.7	8.4	7.0	0.2	2.4	1.7	1.4	2.0	1.2	1.3	5.6	0.9	9.9	5.8	4.5	3.0	0.9	2.3	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.1	0.6	0.0	0.7	0.0	1.7	0.0	0.7	0.1	3.1	1.1	0.2	0.0	3.4	0.0	34.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	27.2	0.0	1.1	0.0	8.9	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	14.5	5.6	0.8	0.0	2.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	2.7	0.0	0.3	6.7	5.3	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	1.4	0.9	1.2	1.0	1.5	3.0	2.2	0.2	2.7	1.4	5.6	2.3	2.0	73.7	24.1	3.6	11.1	0.5	0.4	0.2	0.0	29.1	0.5	1.3	3.5	8.6	6.2	46.0	56.3	0.0	1.4	0.1	1.9	0.3	0.8	0.3	1.8	5.2	1.2	0.0	2.5	3.8	0.0	8.1	1.5	0.9	0.0	62.6	2.5	0.7	0.1	0.0	10.4	0.1	2.0	0.3	1.5	4.3	25.1	0.8	0.0	12.2	0.0	78.6	0.0	55.3	3.4	4.1	0.1	27.1	14.9	0.2	0.0	3.6	0.0	8.5	0.0	16.8	8.6	0.1	0.6	0.2	0.0	0.0	1.4	0.9	0.3	0.1
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 34.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 26.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	19.2	7.1	5.5	5.9	2.5	0.0	5.7	2.0	13.1	3.2	18.8	9.5	1.0	5.2	2.7	11.2	9.1	10.9	37.6	1.2	26.3	5.8	0.9	33.1	0.9	3.4	3.3	0.7	9.3	1.2	18.0	11.4	4.2	2.8	12.8	7.0	0.5	7.1	12.1	2.3	2.6	3.7	31.8	3.1	1.0	5.3	0.5	2.6	0.4	27.7	7.9	0.5	25.2	5.4	3.0	0.1	0.4	3.0	0.3	142.2	236.4	0.2	68.5	45.7	69.6	138.6	0.0	0.3	0.1	5.9	1098.3	1.9	0.1	0.4	88.2	157.8	0.1	0.2	0.1	7.9	0.0	26.8	0.0	0.1	142.8	3.2	52.6	82.9	431.9	129.4	0.0	0.1	0.2	313.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	144.3	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.1	0.2	471.5	31.0	24.1	1.6	34.2	0.1	0.0	0.1	58.4	0.0	241.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	2.5	2.0	13.1	1.2	26.3	3.4	3.3	0.7	2.8	3.1	2.6	3.0	4.4	246.8	22.1	0.0	0.4	0.8	0.5	2.8	14.8	0.4	1.8	5.2	4.9	4.3	3.9	9.2	0.0	0.1	0.9	0.0	0.0	0.1	1.3	0.2	2.6	14.1	0.0	0.0	1.9	0.0	0.3	53.3	2.0	0.3	5.1	0.2	102.8	0.8	0.1	0.0	0.7	0.0	0.0	1.9	2.3	1.0	2.1	0.8	1.8	4.7	0.2	0.7	2.1	9.0	0.6	0.1	0.0	9.4	0.5	0.2	0.0	1.6	1.0	0.6	0.0	1.9	51.6	0.3	0.3	1.0	0.6	0.4	0.9	0.1	0.0	0.5
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.2;choroid plexus: 26.6;salivary gland: 23.8;thyroid gland: 25.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8"					"Low region specificity"	"Detected in all"			"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	1.4	1.5	17.7	0.7	28.9	0.0	2.8	19.2	14.9	2.9	26.6	8.7	0.7	1.2	0.2	1.3	1.7	0.1	4.7	10.7	15.8	1.1	0.6	0.4	0.2	34.3	28.1	5.7	1.7	7.6	0.1	14.1	0.5	40.2	3.2	0.1	1.6	23.8	1.2	0.5	1.8	3.1	0.1	19.7	0.3	2.7	20.8	22.7	0.1	25.6	0.0	0.0	2.8	3.8	37.6	0.2	0.3	0.3	0.2	0.0	0.8	143.4	0.1	0.0	0.1	0.0	1.6	0.2	0.0	13.1	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.9	0.0	8.2	59.6	0.3	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.3	0.0	0.0	1.0	0.7	6.4	8.2	0.0	2.5	0.0	1.8	0.0	0.1	0.0	1.5	0.2	0.1	51.1	4.6	0.2	5.4	0.0	0.0	0.7	0.1	1.0	0.2	0.1	0.0	0.2	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	28.9	19.2	14.9	10.7	15.8	34.3	28.1	5.7	40.2	19.7	22.7	37.6	1.6	3.2	0.0	1.0	26.1	3.2	2.2	1.2	1.8	0.9	2.1	2.5	1.6	0.0	0.2	5.5	10.4	5.1	0.4	0.7	1.9	3.6	116.6	2.7	0.4	3.7	4.2	1.3	2.5	0.0	46.4	15.3	6.1	0.7	0.0	0.6	2.5	6.8	2.2	0.0	2.0	3.3	0.0	2.2	0.9	401.9	4.1	1.7	3.6	0.0	0.5	95.8	0.0	84.9	68.9	0.1	7.3	1.5	44.0	1.2	2.3	23.7	2.5	3.7	0.0	0.8	1.0	2.9	7.8	0.9	7.0	4.0	1.4	3.7	2.0	1.0
CORO6	FLJ14871	ENSG00000167549	"Coronin 6"	Q6QEF8	17	29614756-29622907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 604.9;tongue: 254.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 38.1;Excitatory neurons: 64.1;Extravillous trophoblasts: 32.7;Horizontal cells: 30.3;Inhibitory neurons: 73.8;Skeletal myocytes: 25.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 16.5;RH-30: 17.8;SH-SY5Y: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021556			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA021556: "	"unprognostic (7.12e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-4)"	"unprognostic (9.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.00e-4)"	"unprognostic (6.70e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.61e-7)"	"unprognostic (8.48e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.13e-2)"	10.7	3.2	6.4	1.2	9.4	0.5	10.4	2.0	25.4	6.3	0.0	18.9	1.4	14.5	2.0	15.4	16.0	4.1	71.3	7.9	7.6	1.9	0.7	9.8	0.7	12.2	6.6	11.2	4.8	1.5	16.1	4.3	28.1	12.8	14.7	2.3	2.0	16.2	4.4	604.9	5.7	11.8	12.0	1.1	1.4	9.0	1.9	8.0	1.8	100.2	254.8	0.8	21.9	8.6	16.3	10.2	4.4	3.8	0.0	5.9	3.2	6.0	3.3	1.2	2.1	0.8	0.3	0.0	0.1	0.8	5.3	0.3	10.5	2.9	0.6	1.0	0.2	4.9	0.0	9.8	1.3	9.4	0.0	0.6	11.5	0.9	1.1	0.0	5.4	2.2	0.0	0.7	0.2	7.1	0.0	6.8	0.3	1.2	0.0	0.2	16.5	17.8	0.4	0.5	0.0	0.1	21.9	0.9	3.0	0.0	2.8	0.0	1.4	0.6	1.4	0.0	1.7	1.4	8.3	4.7	1.2	3.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.4	2.0	25.4	7.9	7.6	12.2	6.6	11.2	12.8	1.1	8.0	16.3	1.1	0.0	0.0	4.6	0.4	1.5	2.5	0.6	1.8	3.5	0.8	1.9	38.1	0.0	0.6	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.2	0.1	2.4	1.8	0.0	0.0	64.1	0.0	32.7	7.7	0.5	0.2	0.0	1.0	2.2	0.1	1.3	30.3	73.8	0.0	2.0	1.2	0.8	0.6	7.2	0.7	0.0	7.5	0.0	0.2	2.1	5.0	6.6	0.0	0.0	4.1	0.7	1.0	0.0	0.3	0.2	1.5	6.6	25.6	6.0	2.4	3.9	0.2	0.4	2.5	1.3	1.1	0.0	0.2
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892951-17026815	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.3;prostate: 34.4;seminal vesicle: 36.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.5;Alveolar cells type 1: 22.4;Alveolar cells type 2: 29.8;Collecting duct cells: 27.6;Leydig cells: 31.4;Prostatic glandular cells: 19.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 19.5;EFO-21: 12.6;T-47d: 34.4"					"Region enriched"	"Detected in single"	8	"spinal cord: 5.6"	"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	NA	NA		2700000	"Focal adhesion sites"		"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	5.8	2.5	6.7	0.5	13.9	0.5	6.2	41.3	3.9	6.6	6.5	1.0	0.3	2.2	10.5	0.5	1.8	0.3	14.7	2.3	5.6	16.1	0.8	15.2	0.2	20.2	18.9	0.7	1.6	0.4	3.3	4.1	4.2	21.2	34.4	0.1	0.5	2.8	36.4	2.8	1.5	1.2	0.4	25.7	1.7	0.8	2.3	13.4	1.3	21.2	3.0	0.3	1.6	3.1	36.3	0.0	0.0	0.8	0.0	0.0	0.0	19.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	12.6	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	1.1	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	3.2	0.7	0.0	0.0	1.9	0.0	0.1	0.5	2.8	0.1	0.0	0.0	0.6	0.0	0.1	34.4	0.2	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	13.9	41.3	3.9	2.3	5.6	20.2	18.9	0.7	21.2	25.7	13.4	36.3	19.5	22.4	29.8	3.6	0.5	0.9	10.1	5.8	1.2	2.3	7.5	9.0	6.1	1.5	10.7	27.6	0.0	9.1	0.4	1.0	0.0	0.9	1.8	3.1	3.2	15.1	0.0	0.0	0.8	0.0	6.1	2.8	2.0	6.1	2.5	1.8	11.7	0.3	3.1	0.0	0.8	0.7	0.0	6.3	1.4	4.3	31.4	5.8	0.0	1.9	3.3	0.1	2.1	1.5	1.0	1.2	1.4	6.4	3.4	19.3	0.0	0.1	4.7	0.1	0.0	1.6	2.1	6.2	1.2	0.4	0.6	6.0	0.4	1.7	0.2	6.0
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 220.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.4	23.8	6.9	66.9	9.6	60.3	25.2	49.0	12.1	28.7	35.0	29.2	33.1	17.3	35.0	25.6	20.0	42.4	80.1	6.1	25.0	95.5	53.3	58.1	93.7	15.3	9.7	4.6	18.3	8.0	5.5	10.2	85.6	20.5	18.1	25.9	0.9	5.3	21.5	12.6	19.5	46.9	34.4	12.5	220.8	15.6	34.7	11.1	67.4	129.5	8.3	36.1	51.1	15.9	18.5	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	6.9	9.6	49.0	12.1	6.1	25.0	15.3	9.7	4.6	20.5	12.5	11.1	18.5	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212723	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;gallbladder: 1.3;lymphoid tissue: 1.5"	"Cell type enriched"	"Detected in some"	4	"monocytes: 100.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.2	0.0	0.0	1.5	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.5	0.8	0.1	0.3	2.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.9	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.3	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.8	0.0	1.0	100.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1
CYRIA	"CYRI-A, DKFZP566A1524, FAM49A, FLJ11080"	ENSG00000197872	"CYFIP related Rac1 interactor A"	Q9H0Q0	2	16549459-16666331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 46.4;Extravillous trophoblasts: 102.6;Hofbauer cells: 37.1;Macrophages: 24.0;Syncytiotrophoblasts: 150.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.1;HUVEC TERT2: 43.1;RH-30: 95.6;SK-BR-3: 28.2;TIME: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017847, HPA060398"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017847: , HPA060398: AB_2684275"	"unprognostic (3.45e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.46e-4)"	14.0	11.1	22.0	21.3	34.4	23.4	8.9	4.8	31.2	15.9	3.3	6.7	3.4	10.2	2.2	5.1	9.2	11.0	4.0	34.5	22.6	1.9	7.7	13.1	19.3	11.9	20.0	33.6	12.0	2.8	1.1	6.5	20.2	12.9	8.3	6.3	6.4	4.2	8.6	8.5	3.5	6.5	10.8	10.3	28.0	4.3	2.0	20.9	5.1	41.3	7.4	18.3	10.4	9.5	26.2	0.5	0.0	6.1	0.3	6.2	1.8	18.0	0.0	0.1	0.0	0.0	0.1	0.0	2.9	1.0	0.0	4.2	3.7	1.5	2.4	0.0	6.8	0.2	3.8	0.1	0.0	3.3	0.1	53.1	3.1	2.3	0.5	0.0	4.9	43.1	0.1	0.4	4.8	3.8	0.4	0.1	12.9	2.7	0.3	0.0	2.1	95.6	0.4	5.1	24.4	1.0	3.6	0.0	28.2	0.0	7.4	1.1	1.7	34.1	0.4	5.4	0.0	0.2	2.8	0.1	3.4	13.9	2.8	2.0	0.2	100.1	140.5	21.6	129.7	2.5	37.2	1.0	11.3	66.4	32.3	0.8	8.1	195.4	58.1	159.2	33.0	0.4	43.2	22.0	34.4	4.8	31.2	34.5	22.6	11.9	20.0	33.6	12.9	10.3	20.9	26.2	12.2	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	46.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	102.6	4.7	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	150.0	0.7	0.0	0.0	0.0
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 26.0;seminal vesicle: 17.7"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 9.3;Macrophages: 13.1;Melanocytes: 5.4;monocytes: 4.8;NK-cells: 5.2;Sertoli cells: 13.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"eosinophil: 100.6"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 100.6"	"Cell line enriched"	"Detected in some"	47	"HDLM-2: 89.9"									HPA046528	Approved					NA	NA					"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.5	7.3	4.0	3.1	3.2	1.1	1.1	2.8	4.2	0.8	2.3	1.2	2.4	1.5	1.3	0.8	3.8	1.8	10.1	3.2	9.8	1.9	1.3	1.8	4.7	3.9	3.4	2.4	1.8	0.5	0.6	1.3	26.0	3.8	0.8	1.2	1.0	0.3	17.7	0.4	1.3	2.9	0.8	2.5	8.3	1.3	0.9	3.5	1.8	1.3	0.0	1.8	0.9	0.5	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.8	2.5	100.6	0.6	8.0	0.0	0.0	1.1	0.2	2.5	0.0	1.1	0.4	0.3	1.1	5.8	0.0	0.9	1.0	4.0	3.2	2.8	4.2	3.2	9.8	3.9	3.4	2.4	3.8	2.5	3.5	3.6	0.3	0.0	1.1	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	3.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.0	0.1	2.0	0.0	0.8	0.0	0.0	1.5	3.8	0.0	0.1	1.3	0.3	9.3	0.0	0.6	0.0	0.0	0.0	0.0	4.7	0.8	0.4	0.3	13.1	5.4	0.0	4.8	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	13.1	0.0	3.7	0.0	0.2	0.0	0.0	2.9	2.9	0.1	0.0	0.0
DGCR6		ENSG00000183628	"DiGeorge syndrome critical region gene 6"	Q14129	22	18906028-18914238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 46.5;skeletal muscle: 185.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1045.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	8	"OE19: 46.5"															NA	NA						"unprognostic (9.80e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.28e-1)"	13.4	10.1	6.8	0.7	6.5	2.0	15.1	8.3	7.4	5.6	7.3	3.8	1.4	2.1	2.3	7.3	4.0	1.1	46.5	6.7	6.4	9.7	27.3	9.7	1.7	7.3	6.1	7.0	2.2	13.2	1.8	20.1	1.3	8.0	6.9	0.9	4.6	12.7	1.5	185.0	25.0	5.0	0.8	5.2	4.2	5.5	26.4	7.2	1.4	22.0	7.0	1.4	4.8	8.0	7.3	0.7	2.5	3.8	2.9	1.7	1.5	0.8	0.9	0.8	1.4	0.9	0.6	1.5	0.3	1.2	1.4	0.8	1.7	2.9	1.5	1.0	1.2	5.6	0.6	3.1	0.6	1.2	1.5	0.5	1.0	2.1	1.1	0.4	1.2	0.6	1.9	3.9	1.8	1.3	1.7	1.3	2.2	1.5	46.5	1.7	2.2	3.3	0.2	0.7	0.2	3.5	1.7	1.2	0.5	0.5	2.8	1.9	0.3	0.3	2.5	2.1	0.7	0.7	1.8	0.3	0.4	1.6	2.5	1.8	10.3	1.1	1.9	0.4	1.8	1.1	0.3	1.2	1.0	3.0	0.1	1.8	1.5	0.4	0.4	1.1	0.2	1.2	2.4	6.8	6.5	8.3	7.4	6.7	6.4	7.3	6.1	7.0	8.0	5.2	7.2	7.3	3.8	9.6	5.1	17.3	1.4	16.4	10.2	19.6	0.0	6.0	6.9	17.8	60.4	7.2	15.2	7.3	4.2	2.3	2.0	1.5	23.5	1.3	245.4	3.8	1.8	3.9	1.8	0.0	6.3	2.6	2.7	8.9	0.5	1.1	8.9	0.6	1.8	16.3	2.6	30.3	5.4	3.9	14.2	4.6	16.3	1045.2	4.4	2.3	80.0	3.7	2.5	11.3	0.0	10.6	5.4	1.9	0.1	8.2	1.1	2.9	10.5	4.9	46.4	2.7	6.6	11.0	11.6	5.1	3.2	0.0	31.7	2.3	2.9	0.9	1.6	8.5
DOCK9	"KIAA1058, ZIZ1"	ENSG00000088387	"Dedicator of cytokinesis 9"	Q9BZ29	13	98793429-99086625	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 158.7;Excitatory neurons: 150.6;Inhibitory neurons: 202.2;Microglial cells: 148.0;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 402.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 20.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 2.0;MAIT T-cell: 4.8;memory CD4 T-cell: 5.2;memory CD8 T-cell: 2.1;naive CD4 T-cell: 6.0;naive CD8 T-cell: 4.0;NK-cell: 7.3;T-reg: 2.4"	"Group enriched"	"Detected in many"	11	"NK-cells: 7.3;T-cells: 6.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 200.8;hTERT-HME1: 435.4;HUVEC TERT2: 180.9;TIME: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034061, CAB034065, HPA043940"	Uncertain					NA	NA					"CAB034061: AB_2277513, CAB034065: AB_2094798, HPA043940: AB_2678741"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.79e-1)"	"unprognostic (7.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.31e-2)"	78.3	22.6	86.0	21.6	128.5	6.0	71.7	92.2	93.8	32.8	47.6	40.5	15.9	31.5	35.8	93.8	30.6	36.9	48.1	70.3	92.9	22.1	15.9	93.8	34.1	114.8	113.6	56.0	27.7	20.1	42.1	21.2	99.0	125.6	23.2	21.0	39.8	51.7	21.9	26.2	77.5	35.5	37.2	96.6	17.0	24.9	16.4	115.9	48.3	63.2	64.8	40.7	29.2	50.0	217.1	61.6	19.4	10.6	14.2	10.6	8.3	200.8	17.2	14.2	12.1	10.7	127.4	47.7	51.3	39.8	16.6	21.8	59.5	27.4	54.3	21.8	52.2	15.2	0.0	37.6	2.1	14.0	0.1	2.9	9.0	37.2	12.4	435.4	27.9	180.9	33.0	10.6	11.6	52.1	20.2	35.5	0.3	4.9	84.6	14.2	2.1	39.3	2.7	38.3	50.8	22.4	24.3	26.4	63.4	15.7	85.9	16.9	0.4	179.7	9.7	11.4	6.5	28.5	17.6	14.8	8.6	15.6	0.0	16.0	0.0	0.0	0.0	2.0	0.0	4.8	0.6	5.2	2.1	0.0	0.2	6.0	4.0	0.1	7.3	0.0	0.0	2.4	1.5	86.0	128.5	92.2	93.8	70.3	92.9	114.8	113.6	56.0	125.6	96.6	115.9	217.1	158.7	16.0	39.5	37.5	3.4	15.3	7.1	14.7	10.2	37.9	15.4	6.5	9.4	11.5	12.5	9.2	50.1	35.6	7.0	11.9	1.9	5.4	1.7	10.5	5.3	90.2	6.7	3.6	150.6	6.6	8.3	17.2	2.6	21.4	2.5	18.0	47.8	8.4	5.0	25.2	202.2	6.0	10.2	1.9	7.4	3.3	7.8	1.7	1.8	148.0	0.4	12.9	4.1	238.8	402.2	14.7	5.6	14.7	2.8	10.1	10.6	3.8	7.1	23.9	0.0	122.6	12.4	7.2	5.4	25.6	32.0	17.2	11.0	2.4	5.9	10.5
DTX4	"KIAA0937, RNF155"	ENSG00000110042	"Deltex E3 ubiquitin ligase 4"	Q9Y2E6	11	59171430-59208588	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.6;Oligodendrocytes: 33.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 63.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 62.8;CACO-2: 34.5;CAPAN-2: 37.7;OE19: 35.4;RT4: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056760, HPA059294"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056760: AB_2683228, HPA059294: AB_2683969"	"unprognostic (3.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (5.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.57e-3)"	9.8	1.9	20.9	5.6	19.8	9.4	9.6	20.6	18.8	8.0	7.3	17.4	16.5	3.9	1.9	4.7	5.8	4.9	2.9	14.4	18.2	8.5	32.8	18.2	5.4	28.5	22.4	12.2	15.2	7.9	1.0	4.1	14.9	26.2	7.5	17.4	10.5	21.9	3.1	1.4	3.9	14.5	2.6	40.0	6.8	11.7	1.7	23.5	1.5	10.3	1.7	6.5	15.2	3.9	53.2	4.8	5.7	30.5	0.6	8.5	0.5	62.8	0.4	2.7	0.3	0.4	34.5	37.7	11.6	2.1	0.7	1.2	16.5	9.5	11.8	0.1	0.8	0.5	0.1	6.6	11.2	2.4	0.9	2.3	1.4	19.3	0.1	0.5	2.1	0.0	2.1	0.1	1.1	1.4	2.7	0.5	0.1	16.1	35.4	1.5	4.1	27.1	1.3	2.6	95.2	0.0	0.1	24.3	6.4	0.8	7.7	4.9	0.5	0.3	0.1	4.9	0.1	0.0	0.4	0.1	1.1	0.2	2.8	2.6	0.7	0.4	0.4	0.0	0.4	0.0	1.0	0.0	0.0	0.6	1.3	0.0	0.0	1.5	0.0	0.2	2.8	0.0	0.1	20.9	19.8	20.6	18.8	14.4	18.2	28.5	22.4	12.2	26.2	40.0	23.5	53.2	8.9	19.2	16.8	9.4	3.1	1.7	3.2	7.9	2.2	2.0	2.9	3.9	1.4	28.6	21.8	7.3	0.0	15.0	6.9	33.6	0.0	10.2	0.4	1.5	8.1	3.6	4.9	0.0	12.0	4.9	19.2	7.2	12.2	3.0	1.3	4.9	5.7	23.1	3.7	0.0	8.4	10.5	2.0	2.5	2.5	0.4	4.1	2.7	5.4	3.7	0.9	30.3	0.0	7.5	33.9	10.8	16.3	3.4	0.0	3.1	19.8	9.1	14.9	2.0	0.0	22.1	3.6	0.4	1.7	1.8	1.3	5.5	1.2	5.9	18.5	22.5
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 82.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Group enriched"	"Detected in many"	5	"cerebellum: 11.3;pons: 5.1;white matter: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.6"	HPA023544	Approved					NA	NA					"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	1.1	14.2	0.9	1.0	1.1	0.2	4.6	11.3	1.4	44.8	0.0	0.9	0.6	3.1	50.5	109.4	14.1	3.4	2.2	1.2	0.2	0.5	0.4	70.7	0.4	0.5	0.6	0.7	1.8	0.5	5.2	1.3	1.5	5.1	13.9	0.3	0.7	18.8	13.2	0.4	82.4	0.8	0.4	0.1	0.3	64.8	1.6	0.2	1.1	70.9	0.0	14.9	11.2	42.3	3.4	8.3	0.1	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	64.4	0.0	6.1	0.0	0.8	0.4	0.0	0.9	0.1	0.0	0.0	0.3	0.0	30.5	0.0	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.1	0.0	0.0	36.3	0.8	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.1	11.3	1.4	1.2	0.2	0.5	0.6	0.7	5.1	0.1	0.2	3.4	0.9	83.3	168.6	4.2	4.5	11.1	14.3	22.8	11.4	21.3	4.7	2.8	2.4	8.6	32.5	3.7	8.4	5.3	7.6	2.5	0.0	3.8	0.7	67.1	9.4	3.8	21.7	2.7	5.1	5.4	0.6	5.1	17.9	88.5	8.2	7.9	7.9	1.5	1.2	6.7	3.9	4.0	16.2	3.1	43.5	0.3	3.4	3.3	16.0	1.0	3.2	3.5	33.0	9.5	10.6	4.7	4.0	3.8	0.1	9.5	6.8	0.5	64.9	4.4	0.0	8.5	4.7	11.5	7.5	36.4	18.0	3.7	4.5	0.4	5.6	30.0
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114172	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 292.9;thyroid gland: 76.3;urinary bladder: 93.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 159.3;Ductal cells: 225.2;Exocrine glandular cells: 125.5;Gastric mucus-secreting cells: 85.1;Pancreatic endocrine cells: 411.7;Urothelial cells: 110.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HaCaT: 6.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.5	1.4	0.1	21.7	0.1	0.0	0.6	0.1	0.3	1.6	0.0	11.7	1.5	0.2	3.2	21.7	0.5	292.9	0.6	0.1	0.1	0.6	0.8	2.5	0.1	0.2	0.6	0.1	0.5	1.2	0.2	0.1	0.0	0.1	12.0	5.5	0.0	4.6	1.9	0.0	4.7	8.3	2.7	0.1	0.0	42.7	1.4	0.1	0.0	76.3	0.0	4.3	93.7	21.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.3	0.1	48.1	36.9	0.0	3.0	1.9	5.2	11.7	1.8	0.4	0.6	0.6	1.9	54.3	31.5	0.0	0.0	0.1	0.0	159.3	0.0	225.2	0.6	1.0	0.5	5.6	1.2	0.0	0.1	125.5	0.0	5.1	85.1	3.5	32.8	0.1	0.4	0.1	0.1	0.0	0.1	10.1	4.1	0.0	0.4	0.3	0.3	3.9	0.0	0.0	5.2	0.2	0.0	0.0	0.1	411.7	45.5	0.0	0.8	4.5	2.9	0.0	43.4	0.3	0.0	0.2	2.7	0.9	1.0	3.6	1.8	0.0	4.6	0.1	34.7	110.4
DUOXA1	"FLJ32334, mol, NIP, NUMBIP"	ENSG00000140254	"Dual oxidase maturation factor 1"	Q1HG43	15	45117367-45129938	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 190.5;skin 1: 92.3;thyroid gland: 112.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041578	Approved					NA	NA					"HPA041578: AB_10795691"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.36e-2)"	1.0	5.1	0.2	1.3	0.6	0.1	4.0	0.7	1.2	23.7	0.0	0.9	0.8	4.6	49.7	190.5	5.7	4.4	1.5	0.5	0.6	0.5	0.3	64.9	0.1	0.6	0.3	0.2	1.1	0.4	5.0	0.8	0.8	1.0	21.8	0.5	0.1	27.7	12.1	0.5	92.3	0.8	0.2	0.2	0.1	44.0	0.2	0.4	0.7	112.0	0.0	18.1	23.5	78.0	3.0	10.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	103.9	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	14.5	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.7	1.2	0.5	0.6	0.6	0.3	0.2	1.0	0.2	0.4	3.0	0.0	60.9	118.0	1.0	0.0	9.4	18.8	26.9	18.2	0.6	1.4	1.7	0.5	0.0	35.5	0.0	2.1	2.4	0.0	3.3	0.0	2.0	0.1	28.7	4.0	0.8	3.0	0.0	0.7	3.1	0.1	1.6	8.6	47.7	1.3	0.3	0.0	0.0	0.3	0.0	0.4	0.1	4.1	0.0	1.2	0.0	0.3	0.8	0.0	0.0	0.6	0.1	0.0	0.5	1.8	1.9	3.3	0.0	0.0	13.4	0.0	0.0	36.9	0.1	0.0	0.7	1.1	0.0	0.9	53.6	21.9	3.0	0.6	0.1	0.4	44.2
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 228.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	114.9	25.0	12.0	64.3	12.6	180.3	51.3	9.6	26.4	39.7	24.8	47.7	25.0	26.4	14.4	35.1	36.9	76.2	30.6	19.1	11.7	59.5	144.6	89.0	42.6	11.5	11.9	11.0	14.4	18.0	34.8	18.0	74.7	12.4	18.9	56.6	6.9	228.1	23.1	8.6	15.8	52.5	43.6	11.5	71.6	28.9	7.0	13.5	48.1	78.1	40.5	27.4	77.1	13.9	13.4	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.6	9.6	26.4	19.1	11.7	11.5	11.9	11.0	12.4	11.5	13.5	13.4	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 20.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 169.8;Late spermatids: 185.7;Spermatocytes: 64.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	3.2	2.6	1.7	3.2	1.8	3.9	4.2	3.4	3.7	3.4	2.1	2.7	4.8	6.1	4.1	1.6	3.5	3.0	2.1	0.8	2.9	5.4	3.5	3.1	4.6	2.7	1.8	0.2	3.9	1.8	3.2	2.6	3.6	2.8	2.8	3.4	4.0	2.3	2.0	0.8	2.2	3.4	2.5	1.9	4.4	3.6	20.6	2.2	1.8	14.3	0.4	3.3	2.7	2.4	7.2	0.9	3.7	1.5	0.2	1.8	6.4	2.8	2.1	0.4	0.6	1.0	1.7	5.2	0.3	5.8	0.7	0.0	1.0	0.0	0.4	3.5	0.1	0.5	4.9	3.4	0.5	1.8	3.8	0.5	1.2	1.7	2.4	0.0	4.4	4.1	3.8	1.5	9.0	2.2	0.1	1.7	2.1	0.8	2.6	2.9	4.5	1.1	1.8	8.3	3.0	1.1	0.5	1.1	0.1	2.5	1.1	6.0	4.5	1.5	0.2	1.1	0.3	1.0	9.4	6.9	0.9	5.5	7.3	3.8	2.8	1.0	0.3	0.5	0.6	0.4	2.2	0.4	0.3	0.5	2.6	1.2	0.7	0.0	0.5	0.4	0.3	0.1	0.3	1.7	1.8	3.4	3.7	0.8	2.9	2.7	1.8	0.2	2.8	1.9	2.2	7.2	5.3	9.6	2.2	7.2	7.9	0.8	1.8	0.9	0.6	2.5	2.3	2.4	6.2	1.5	1.3	0.0	0.0	0.3	1.3	0.4	0.0	1.0	169.8	1.9	2.5	6.0	3.0	1.3	8.0	0.9	0.1	4.1	2.6	5.4	6.3	1.3	4.6	0.5	1.9	3.3	10.1	0.4	2.0	2.9	2.0	185.7	1.8	2.6	0.0	32.8	2.7	1.0	0.0	13.0	19.5	1.1	0.3	3.8	1.4	1.1	1.2	1.6	3.3	2.9	0.0	3.2	4.0	64.1	24.5	0.0	0.6	0.0	2.3	1.2	0.7	1.3
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 60.4;thyroid gland: 137.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 20.0"	"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031165			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031165: AB_2673768"	"prognostic favorable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	13.8	10.7	0.3	9.9	1.0	8.2	8.7	1.2	10.2	18.7	1.8	3.3	2.0	6.0	60.4	8.8	4.6	32.2	11.4	4.2	20.0	8.0	5.5	15.3	14.5	0.3	0.3	0.1	9.5	4.2	7.1	8.7	3.0	0.5	17.7	3.8	1.4	3.0	1.9	0.9	11.1	4.6	16.9	0.2	4.6	2.3	4.1	0.4	26.7	137.7	9.2	7.2	15.8	1.7	1.5	0.0	0.2	2.5	1.0	1.8	2.4	0.4	0.5	0.2	0.6	0.8	0.0	0.3	0.6	0.0	0.6	0.7	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	3.8	0.3	0.6	1.3	0.2	0.8	0.1	0.3	0.2	0.8	0.1	1.2	0.0	1.8	0.2	0.1	1.1	0.1	0.3	0.4	0.0	0.2	0.1	0.3	0.2	0.5	4.2	0.5	0.0	0.5	0.1	0.5	0.4	0.2	0.3	1.3	0.7	0.3	22.5	0.5	0.4	0.0	0.5	0.2	0.1	2.5	0.0	0.4	0.0	0.1	0.5	0.4	0.0	0.1	0.7	0.2	2.3	0.0	0.0	0.4	0.3	1.0	1.2	10.2	4.2	20.0	0.3	0.3	0.1	0.5	0.2	0.4	1.5	15.9	0.0	12.6	0.0	14.0	21.3	30.1	36.0	33.0	1.4	55.5	68.1	7.8	0.0	9.4	0.0	0.0	1.1	9.9	9.5	0.0	1.4	8.9	13.9	14.0	16.7	73.1	0.0	1.7	0.6	1.6	30.4	13.3	26.1	20.8	2.3	5.3	2.4	25.2	0.0	0.5	29.4	14.2	28.1	39.5	4.3	1.8	40.5	8.8	0.0	0.8	4.1	0.0	0.0	0.1	1.0	4.4	7.2	6.4	5.5	7.7	0.0	7.1	0.7	6.6	20.7	12.0	0.1	2.0	14.8	12.5	1.1	13.6	5.1	25.8	3.1
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.9	8.4	5.5	24.9	5.4	27.8	10.9	4.5	6.5	17.6	5.7	12.3	9.4	28.2	19.5	19.4	14.1	27.9	8.6	4.9	5.2	6.6	5.5	16.2	20.4	6.6	5.7	4.3	5.6	2.8	3.4	4.0	11.5	7.3	11.3	12.9	6.9	6.1	18.3	4.1	6.3	11.8	50.1	5.3	21.7	7.4	4.6	6.5	6.8	20.2	8.8	25.8	30.9	11.1	6.1	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.5	5.4	4.5	6.5	4.9	5.2	6.6	5.7	4.3	7.3	5.3	6.5	6.1	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 32.0"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 317.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"basophil: 1.6;gdT-cell: 1.7;MAIT T-cell: 1.7;memory B-cell: 1.3;memory CD4 T-cell: 2.5;memory CD8 T-cell: 1.7;naive B-cell: 1.2;naive CD4 T-cell: 1.0;NK-cell: 3.5;T-reg: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 77.0;ASC diff: 33.9;CACO-2: 59.3;U-2197: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		9300000			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.9	1.6	1.5	1.9	4.8	3.7	4.0	0.0	22.6	4.6	32.0	4.0	1.0	6.4	2.8	4.8	4.9	3.1	17.5	18.0	15.5	4.9	0.8	3.7	2.7	0.0	2.1	4.9	11.2	1.1	1.9	0.6	1.6	2.8	5.4	4.5	4.3	2.6	6.1	2.8	13.0	2.8	8.0	0.0	3.4	2.4	11.8	2.4	3.9	9.6	4.0	3.2	3.6	3.5	0.6	2.6	2.4	77.0	0.0	33.9	20.9	0.1	18.2	8.3	16.9	6.2	59.3	0.9	0.0	0.1	26.7	0.0	7.0	12.3	0.1	7.0	9.7	6.4	0.0	0.9	0.0	0.9	0.0	1.4	8.5	4.2	5.3	0.1	10.3	14.9	0.0	0.0	0.0	4.4	9.5	0.2	0.0	5.6	5.9	1.7	0.1	8.5	0.0	25.8	4.3	13.2	0.0	6.2	1.3	1.3	6.2	2.9	0.0	0.0	1.7	3.2	38.4	1.0	0.0	0.1	0.0	6.9	0.0	3.6	1.6	0.0	0.0	1.7	0.0	1.7	1.3	2.5	1.7	0.0	1.2	1.0	0.2	0.1	3.5	0.0	0.1	1.2	0.4	1.5	4.8	0.0	22.6	18.0	15.5	0.0	2.1	4.9	2.8	0.0	2.4	0.6	36.3	0.0	6.4	51.9	8.2	6.1	0.7	9.7	2.8	9.8	4.3	6.0	31.6	7.2	13.7	9.2	0.0	0.1	12.2	4.7	7.9	0.2	3.9	1.9	5.7	26.3	3.5	0.0	317.9	0.2	0.0	5.1	4.6	5.2	1.3	9.0	20.0	0.4	0.3	1.7	68.8	12.8	8.2	0.0	1.5	5.8	1.2	0.9	7.2	70.3	0.2	7.2	3.1	8.0	7.9	30.9	3.6	8.6	2.1	1.4	0.1	1.7	4.5	3.2	0.0	3.6	10.2	10.0	1.9	4.1	12.5	0.0	5.4	11.3	6.6	2.4
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377207-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 114.7;Hepatic stellate cells: 66.8;Hofbauer cells: 42.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	NA	Yes			"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	5.6	17.6	6.3	1.4	6.5	22.6	5.0	6.8	8.3	6.1	7.7	2.5	1.4	3.3	13.7	1.4	6.7	2.3	9.3	6.5	6.4	21.2	10.8	6.5	2.2	6.3	6.3	6.1	3.2	11.9	23.4	8.3	8.1	6.5	4.6	1.8	3.4	3.3	7.4	2.4	1.6	2.3	1.8	6.3	12.0	7.9	1.8	6.4	1.8	30.5	1.5	1.6	3.2	3.7	6.6	3.7	1.2	3.6	4.2	5.3	3.4	2.1	2.2	7.0	3.6	4.5	1.3	1.4	2.5	4.0	4.1	5.0	0.9	2.8	1.4	4.1	2.1	1.6	14.3	1.3	2.1	3.8	2.9	5.5	2.4	0.5	4.8	3.3	8.5	8.5	5.3	12.5	12.0	4.1	3.3	2.7	3.5	1.9	2.0	9.6	7.2	6.3	5.6	3.4	1.9	1.4	11.0	1.5	2.0	6.4	3.7	3.6	4.9	3.5	1.9	2.6	6.6	2.1	6.0	4.7	2.8	10.5	2.9	2.1	9.3	3.7	3.0	1.7	4.6	3.6	2.0	3.4	2.5	2.1	1.2	3.7	2.2	10.2	0.8	7.3	0.1	3.3	2.4	6.3	6.5	6.8	8.3	6.5	6.4	6.3	6.3	6.1	6.5	6.3	6.4	6.6	6.1	19.2	18.8	24.8	11.5	2.3	4.0	2.0	2.8	3.8	3.6	6.1	6.5	5.7	3.1	20.2	0.0	2.2	5.2	1.3	3.9	2.2	0.8	9.9	6.8	13.5	8.4	114.7	2.2	3.3	12.2	9.8	15.3	13.9	26.6	1.2	66.8	3.5	42.4	1.7	3.0	3.5	2.0	17.0	4.0	0.6	2.8	15.4	8.8	7.5	4.6	7.9	11.3	1.0	1.6	3.1	0.4	4.1	3.8	1.8	0.2	1.0	2.9	2.5	19.7	3.8	18.5	5.1	7.7	1.6	1.0	3.0	9.6	2.6	1.8	1.2
ERFE	"C1QTNF15, CTRP15, FAM132B, FLJ37034"	ENSG00000178752	Erythroferrone	Q4G0M1	2	238158970-238168900	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 15.1;testis: 12.9;thyroid gland: 25.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 6.3;Club cells: 2.5;Collecting duct cells: 1.8;Distal tubular cells: 3.9;Glandular and luminal cells: 1.8;granulocytes: 5.1;Respiratory ciliated cells: 2.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 20.3;RH-30: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	277000					"unprognostic (1.66e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.64e-4)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.84e-1)"	"unprognostic (9.61e-4)"	"unprognostic (4.68e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.31e-4)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (4.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.33e-2)"	0.6	0.1	3.0	2.2	4.1	4.1	0.4	4.2	6.8	0.7	2.3	0.4	0.6	0.4	0.0	0.4	0.5	0.3	0.9	3.8	2.9	3.6	0.5	0.9	0.1	2.4	2.7	3.2	0.1	0.4	0.0	0.1	1.3	2.9	0.7	0.2	0.0	0.3	0.4	15.1	0.1	0.9	0.5	2.5	0.8	0.5	12.9	2.7	0.1	25.1	0.6	0.1	2.4	0.3	3.0	3.1	0.8	1.4	3.0	0.2	4.9	0.3	2.0	3.2	4.9	8.7	0.2	7.7	0.0	5.4	0.5	10.0	0.3	13.7	0.7	4.5	0.0	15.2	0.0	0.3	0.2	1.8	0.1	1.1	10.5	1.5	20.3	14.3	0.6	0.1	6.5	4.6	0.0	13.6	3.8	0.0	8.9	2.1	0.9	1.5	17.3	25.6	0.8	10.7	0.1	0.4	7.7	3.1	0.5	9.7	2.5	0.4	15.5	1.0	8.2	7.1	3.2	10.7	0.0	0.0	1.1	12.2	4.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	4.1	4.2	6.8	3.8	2.9	2.4	2.7	3.2	2.9	2.5	2.7	3.0	0.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.5	1.8	0.0	0.2	0.7	0.0	3.9	0.1	0.0	1.2	0.2	0.5	0.0	0.0	0.0	0.0	0.2	1.2	0.0	1.8	5.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;skin 1: 6.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 37.7;Excitatory neurons: 9.4;Inhibitory neurons: 9.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.4;NTERA-2: 3.3;SCLC-21H: 3.5;SK-MEL-30: 1.7;SuSa: 1.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.3"	"Low region specificity"	"Detected in all"			HPA039200	Approved					NA	NA					"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.1	0.1	2.0	0.0	2.2	0.0	0.8	5.1	2.4	0.7	0.4	2.6	0.0	2.2	0.0	0.4	0.2	0.3	0.4	2.3	7.6	0.6	0.0	4.8	0.0	2.2	2.4	2.1	0.5	1.0	0.8	1.9	0.3	2.9	0.2	0.2	0.1	0.3	0.0	0.4	6.7	0.3	1.5	1.4	0.0	1.7	0.5	2.1	0.0	4.8	0.0	0.4	1.0	0.7	2.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.8	0.8	0.1	0.2	1.3	0.0	0.0	0.2	0.0	0.1	0.4	0.5	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	1.2	0.1	1.7	1.4	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.2	5.1	2.4	2.3	7.6	2.2	2.4	2.1	2.9	1.4	2.1	2.3	0.1	38.5	37.7	4.2	0.1	0.8	0.8	0.5	1.2	1.9	0.9	1.3	2.5	1.5	4.5	1.8	4.2	0.8	0.0	0.1	0.0	1.0	0.2	1.5	0.8	0.7	0.0	0.0	9.4	0.9	0.4	0.9	3.6	2.2	0.0	0.5	0.4	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.4	0.2	0.3	0.2	1.8	1.0	0.0	0.3	0.0	2.0	0.5	0.7	0.1	0.0	0.0	1.1	0.0	0.3	0.8	3.9	0.0	1.4	0.3	1.5	1.7	0.5	1.6	0.7	0.1	0.7	0.2	0.1
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69504326-69532508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 33.2"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 23.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain					NA	NA					"HPA036093: AB_10673613"	"prognostic unfavorable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (1.83e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.1	0.8	2.4	0.0	2.2	0.0	0.3	3.1	2.6	0.2	0.6	0.2	0.1	0.3	0.4	0.1	0.7	0.2	33.2	2.2	2.6	0.9	0.2	0.1	0.1	2.6	3.2	2.1	0.1	1.8	3.1	2.4	0.0	3.2	0.9	0.2	0.4	1.1	4.9	0.1	0.0	0.2	0.1	1.8	0.7	1.1	1.6	3.2	0.1	8.0	0.0	0.1	0.2	0.1	2.5	0.0	2.7	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	5.2	0.0	0.0	0.0	16.2	0.6	0.0	0.0	5.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.2	0.0	0.0	24.3	6.5	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.8	0.1	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	3.1	2.6	2.2	2.6	2.6	3.2	2.1	3.2	1.8	3.2	2.5	0.2	0.0	0.0	1.3	0.0	0.0	0.3	1.6	0.0	0.4	0.6	0.1	23.7	0.0	0.8	1.8	0.0	0.0	0.0	0.5	0.0	0.5	0.0	2.0	0.5	0.7	1.2	0.0	0.8	1.2	0.0	0.4	0.0	4.4	0.0	0.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.8	0.2	0.0	0.0	1.2	0.0	0.5	0.3	0.8	0.0	0.1	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3
FAM167A	"C8orf13, DIORA-1"	ENSG00000154319	"Family with sequence similarity 167 member A"	Q96KS9	8	11421476-11475908	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1;thyroid gland: 53.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 28.4;Distal tubular cells: 13.7;Early spermatids: 24.8;Enteroendocrine cells: 19.1;Late spermatids: 41.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 57.6;RPMI-8226: 61.5;SH-SY5Y: 44.4;U-698: 44.8;U-87 MG: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023915, HPA030426"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023915: AB_1845768, HPA030426: AB_10601318"	"unprognostic (8.51e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (3.08e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-2)"	0.3	0.8	23.7	1.2	21.5	0.7	1.3	23.3	24.7	0.5	14.4	0.7	0.3	0.1	0.5	0.9	1.3	1.0	0.1	24.6	24.6	6.0	0.3	10.3	2.4	27.1	24.8	19.6	0.0	2.1	1.8	17.5	1.0	25.0	1.5	0.7	5.2	2.6	4.6	0.0	11.9	1.3	0.0	23.5	1.3	2.1	3.8	26.5	3.0	53.7	0.1	3.0	0.3	1.6	23.3	4.8	3.0	6.1	0.6	0.4	2.5	0.2	16.8	16.0	10.1	4.4	0.2	1.5	57.6	0.9	18.3	4.7	1.6	0.1	4.0	11.9	24.8	0.8	0.0	0.1	0.0	20.8	0.0	0.1	2.9	2.6	5.3	32.2	32.3	0.0	0.0	0.2	2.2	6.0	1.8	0.1	0.0	1.6	0.1	0.1	0.3	0.0	61.5	5.1	0.5	26.3	44.4	0.8	4.7	2.2	0.8	1.8	0.1	28.5	1.0	1.6	25.8	0.2	17.7	14.0	44.8	36.3	0.1	1.6	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.0	23.7	21.5	23.3	24.7	24.6	24.6	27.1	24.8	19.6	25.0	23.5	26.5	23.3	0.0	16.0	1.8	28.4	5.4	5.9	0.6	0.5	0.0	0.1	1.2	1.3	0.7	1.5	0.5	5.5	10.4	0.0	1.1	0.2	13.7	2.1	24.8	2.1	0.2	0.2	19.1	0.0	0.6	1.8	0.0	0.3	2.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.4	1.3	0.0	0.3	0.3	41.1	0.3	0.3	0.0	3.7	0.3	1.7	0.0	0.0	1.3	1.1	2.4	0.4	0.9	0.8	0.1	0.2	1.9	1.8	0.0	0.3	0.2	3.9	2.2	0.0	3.4	0.0	1.0	0.1	0.1	0.2
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.8;thyroid gland: 58.6"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 157.0;Astrocytes: 256.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NTERA-2: 5.1;RPTEC TERT1: 1.8;RT4: 2.3;SK-MEL-30: 5.0;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029411, HPA057207"	Approved					NA	NA					"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	4.8	4.8	12.0	0.4	13.1	0.0	13.8	16.0	12.3	26.2	7.4	5.4	1.2	6.8	1.7	5.2	6.9	1.7	12.2	11.4	16.6	3.2	0.2	22.5	0.6	18.6	13.7	7.8	24.8	7.4	6.0	7.6	1.5	15.5	11.2	1.1	4.5	6.3	3.4	48.8	11.9	4.1	5.0	14.4	0.4	13.8	1.3	19.6	5.6	58.6	9.1	0.9	7.9	4.6	14.3	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.7	0.7	0.0	0.0	0.6	1.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.1	0.3	0.0	0.0	0.1	0.0	1.8	2.3	0.0	0.0	0.0	0.0	5.0	1.9	0.1	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	13.1	16.0	12.3	11.4	16.6	18.6	13.7	7.8	15.5	14.4	19.6	14.3	12.1	157.0	23.3	256.3	0.4	3.3	4.9	1.9	7.4	2.1	18.4	39.6	14.6	0.0	26.9	1.8	0.0	1.2	0.4	1.5	0.0	0.9	0.1	19.9	2.8	8.0	0.0	0.0	0.7	0.6	0.1	1.7	11.7	33.0	0.0	2.0	2.2	0.0	0.3	0.0	3.9	0.4	0.0	0.3	1.3	0.0	0.0	0.4	19.6	20.6	0.0	35.1	0.0	7.1	2.1	3.5	1.2	0.0	0.2	3.7	0.2	0.2	2.3	1.0	0.0	3.8	3.8	0.1	0.6	1.9	2.4	0.3	1.0	0.7	0.7	1.8
FAM240C		ENSG00000216921	"Family with sequence similarity 240 member C"	A0A1B0GVR7	2	241893988-241902551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"tongue: 227.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;REH: 2.4;SCLC-21H: 1.6"									HPA073342			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	3.6	0.7	5.4	0.1	5.6	0.3	3.9	6.0	8.3	1.1	5.0	0.2	0.2	1.9	0.0	4.1	1.8	0.1	0.7	4.9	5.4	0.1	0.2	0.1	0.4	5.7	5.6	4.9	1.6	37.1	0.5	0.4	0.2	6.1	3.5	0.0	0.6	5.5	4.0	10.3	3.1	0.2	0.1	5.1	0.3	0.4	1.3	5.9	3.4	6.9	227.1	0.2	0.4	1.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.0	0.7	0.5	0.0	0.2	0.0	0.0	2.4	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.6	6.0	8.3	4.9	5.4	5.7	5.6	4.9	6.1	5.1	5.9	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1740.1;placenta: 2952.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	127.2	31.7	42.9	133.0	37.5	0.6	77.2	33.3	81.6	118.1	130.3	325.0	34.1	157.4	61.8	254.0	176.0	188.7	298.8	35.5	128.6	37.7	1740.1	792.7	37.6	34.7	36.2	22.0	110.9	26.2	19.4	26.4	2952.1	37.1	106.6	239.5	6.1	67.6	433.0	38.1	44.4	104.3	729.1	32.4	14.4	128.3	26.0	89.1	135.0	40.7	149.7	24.1	364.7	87.8	57.6	12.5	84.2	104.6	22.8	4456.5	34405.9	4.8	1799.2	1200.2	1765.3	1259.9	1059.2	43.7	1.2	9.7	6331.7	47.2	192.7	17.4	4220.9	946.9	1.0	7.4	0.8	24.7	3607.2	3192.2	1.2	6.6	16044.5	29.3	4136.5	9585.3	10587.1	2177.2	1.0	8.2	5.0	3673.9	17.0	2.9	1.5	52.7	2.4	15.2	1.0	2.4	8.0	47.4	13.7	6.0	25.0	213.7	116.4	1219.8	4649.5	19.4	3.2	4161.0	2553.1	269.9	2837.4	355.6	4.4	1.6	1.6	3161.2	1.0	694.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	37.5	33.3	81.6	35.5	128.6	34.7	36.2	22.0	37.1	32.4	89.1	57.6	138.9	67.3	67.8	13.4	2.3	55.1	4.1	227.0	2.2	6.4	4.2	5.2	36.3	30.0	34.0	16.5	0.0	216.6	2.3	3.4	0.0	6.5	1.8	6.5	265.8	215.4	21.0	16.8	9.5	9.8	2583.6	562.6	4.1	5.5	18.9	53.5	227.7	1012.4	365.2	1.7	8.1	10.2	12.2	38.0	73.7	4.6	186.4	85.9	110.3	101.2	1.2	1.9	0.0	11.6	10.7	12.5	1.4	88.4	1.7	17.8	0.0	0.6	23.1	8.7	72.3	401.5	450.2	1.6	7.8	5.0	37.4	205.8	11.3	8.5	23.7	1.7
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169400-159272108	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 14.3;thyroid gland: 20.5"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 28.7;Smooth muscle cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 5.8;hippocampal formation: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;fHDF/TERT166: 2.9;SuSa: 3.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		14000	"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.4	0.5	0.9	1.9	0.4	0.0	2.1	0.4	5.8	6.5	0.4	9.6	2.5	2.2	0.0	1.1	0.6	14.3	3.8	9.0	1.7	0.6	0.7	1.6	2.8	0.1	0.6	0.1	1.2	1.1	0.3	0.2	0.9	0.2	0.4	1.8	0.1	0.9	0.8	2.1	0.9	4.2	11.8	0.2	0.5	0.4	0.4	0.3	0.1	20.5	9.7	2.4	1.0	1.7	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.4	5.8	9.0	1.7	0.1	0.6	0.1	0.2	0.2	0.3	1.2	2.6	0.0	0.6	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.1	0.5	2.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.3	0.4	4.7	0.7	0.0	0.0	0.2	0.0	0.2	28.7	0.0	0.3	0.0	0.1	1.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	3.1	0.0	0.3	0.2	1.8	2.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	3.0	11.5	1.1	1.4	0.0	1.4	0.1	0.5	0.1	0.0	0.0
FSCN2	"RFSN, RP30"	ENSG00000186765	"Fascin actin-bundling protein 2, retinal"	O14926	17	81528377-81537130	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 4.6;retina: 8.8;thyroid gland: 4.2"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 25.0;Exocrine glandular cells: 12.0;Rod photoreceptor cells: 25.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;T-47d: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079270	Enhanced					NA	NA					"HPA079270: "	"unprognostic (3.50e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.73e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.11e-1)"	0.2	0.2	0.4	0.2	0.8	0.1	0.5	1.3	0.6	0.9	0.1	0.4	0.2	1.3	0.5	0.6	0.8	0.1	0.2	0.4	0.2	0.6	0.1	0.5	0.2	1.0	0.3	0.3	0.9	4.6	2.0	1.0	0.1	0.7	0.8	0.1	8.8	1.8	0.4	0.1	0.5	0.5	0.1	0.6	0.6	0.8	0.5	0.3	0.1	4.2	0.1	0.2	0.3	0.5	0.7	0.7	0.4	0.3	0.5	0.1	0.0	0.5	0.3	0.5	0.0	0.0	0.4	0.5	0.5	1.9	0.5	0.3	0.5	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.2	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.6	0.3	2.0	0.0	0.6	0.6	0.1	0.1	0.2	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.3	0.6	0.4	0.2	1.0	0.3	0.3	0.7	0.6	0.3	0.7	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.2	0.0	3.8	0.6	0.4	0.9	0.0	0.0	0.0	25.0	0.1	0.0	0.1	1.9	0.4	0.5	0.1	0.1	0.2	0.0	0.0	0.7	12.0	0.5	0.1	1.1	0.1	0.0	0.5	0.0	0.0	0.1	3.3	0.9	0.0	0.0	0.0	0.0	3.2	0.3	0.3	0.0	0.0	1.0	4.9	0.0	3.5	0.3	3.0	0.1	0.0	0.2	0.1	0.3	0.1	0.0	25.7	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.8	0.1	0.1	0.2	0.0
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142333-96160806	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 11.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8;thyroid cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.2"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	0.9	0.1	0.3	0.9	0.3	0.0	0.4	0.4	0.7	0.2	0.0	0.6	0.3	1.4	0.4	0.4	0.5	2.4	1.7	0.3	1.6	0.2	0.4	0.2	0.1	0.6	0.3	0.2	0.1	0.7	0.1	0.1	11.0	0.9	0.3	0.3	0.0	0.0	1.5	0.0	0.0	0.9	1.1	0.3	0.0	0.7	0.6	0.6	0.1	0.6	0.1	0.0	0.8	0.9	0.4	0.0	0.0	0.2	0.0	1.1	0.6	3.9	2.6	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	3.2	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	3.0	0.0	20.4	0.2	0.0	0.0	0.0	33.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.7	0.3	1.6	0.6	0.3	0.2	0.9	0.3	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.8	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 8.7;thyroid gland: 8.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Early spermatids: 5.6;Late spermatids: 18.7;Proximal tubular cells: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HeLa: 3.5;Karpas-707: 1.3;U-2197: 8.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.7	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.1	0.0	0.1	1.5	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	1.0	0.1	0.0	8.6	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.3	0.3	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.1	0.2	0.0	3.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 230.3"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 14.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.79e-4)"	14.5	29.1	12.9	7.2	13.0	18.6	21.0	15.8	14.5	24.7	12.8	16.0	0.9	17.0	12.1	10.1	28.2	7.0	14.7	13.0	13.2	41.3	42.2	24.0	19.8	13.2	13.3	12.9	56.1	230.3	0.7	61.0	3.0	13.6	38.1	1.5	8.0	18.3	10.7	10.2	12.6	25.4	2.0	13.0	38.8	28.9	43.5	13.0	2.9	114.8	1.3	7.5	19.9	13.5	13.1	2.6	2.8	0.3	5.3	2.8	5.4	7.3	2.3	0.7	2.5	4.0	2.8	3.5	0.0	4.7	2.5	0.3	2.1	0.9	2.4	1.9	3.6	8.4	0.4	20.4	16.2	3.9	2.3	2.5	7.8	3.3	1.5	4.5	2.7	2.6	4.0	0.9	0.2	2.3	1.2	1.2	24.5	3.2	5.0	4.6	0.1	0.0	0.4	2.2	4.9	3.8	5.8	1.3	0.4	3.2	3.9	2.2	4.8	0.0	3.7	8.8	1.1	4.0	1.8	1.7	3.9	1.2	1.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	13.0	15.8	14.5	13.0	13.2	13.2	13.3	12.9	13.6	13.0	13.0	13.1	19.0	192.3	66.5	95.0	34.8	21.9	8.8	10.9	33.0	53.6	30.9	34.3	37.4	20.0	74.7	31.3	73.0	7.6	30.6	2.8	1.9	9.2	53.8	17.3	27.1	11.0	7.2	13.0	133.4	13.0	5.4	12.7	20.4	24.5	9.5	36.4	11.0	28.7	1.5	45.4	126.1	10.1	12.2	6.6	9.9	10.8	39.4	5.0	21.4	12.2	6.4	9.3	32.0	112.1	24.2	16.8	4.9	37.6	45.1	7.6	7.1	5.8	39.9	67.8	13.1	13.5	13.8	48.9	28.4	10.0	14.8	2.9	49.8	22.0	9.4	6.6
GOLGA8M		ENSG00000188626	"Golgin A8 family member M"	H3BSY2	15	28701954-28738384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.4;thyroid gland: 14.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.8;Early spermatids: 24.7;NK-cells: 7.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 2.6;U-937: 6.4"															NA	NA						"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"			"unprognostic (2.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.16e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.66e-4)"	"unprognostic (8.24e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.60e-1)"	3.0	0.7	0.3	0.0	0.4	0.6	2.6	0.1	0.5	1.4	0.1	0.3	0.0	0.7	0.5	0.2	1.2	0.3	0.8	0.2	1.2	1.4	3.4	0.7	0.1	0.8	0.4	0.1	4.2	0.7	0.0	1.9	1.8	0.5	0.6	0.0	0.0	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.4	0.3	6.4	0.2	0.0	14.0	0.0	0.0	0.6	1.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.2	1.2	0.8	0.4	0.1	0.5	0.2	0.2	0.7	1.7	3.2	2.2	8.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.0	3.0	0.0	1.9	0.0	24.7	0.3	0.2	0.5	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.1	3.3	1.5	0.0	0.0	0.0	0.3	2.9	0.0	0.4	0.0	1.9	0.5	0.2	7.2	3.0	2.9	0.0	0.0	0.7	0.3	0.0	0.0	0.8	0.7	0.1	0.0	0.8	0.3	3.9	0.8	0.0	0.0	0.1	1.4	0.2	0.0	0.1
GOLGA8N		ENSG00000232653	"Golgin A8 family member N"	F8WBI6	15	32593456-32607310	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 92.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"gdT-cell: 1.1;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.3;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.6;THP-1: 38.1;U-937: 33.2"															NA	NA						"unprognostic (2.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	10.5	6.7	1.9	1.9	2.7	6.4	9.8	1.9	3.4	12.8	3.2	8.9	1.2	10.3	5.0	6.0	12.7	0.7	10.9	1.6	2.0	8.0	12.1	8.6	1.9	3.3	3.1	1.0	19.5	31.6	3.1	23.1	0.5	3.4	8.8	0.5	2.4	8.0	2.4	6.8	7.0	8.6	1.3	1.6	9.7	8.3	16.3	2.2	0.9	34.5	1.9	1.2	10.1	10.3	3.0	0.0	0.0	0.1	0.5	2.2	3.0	0.1	1.0	0.5	0.2	0.3	0.0	0.8	0.8	0.3	0.7	0.2	0.0	0.4	0.1	0.4	0.1	0.5	61.6	0.0	0.0	0.6	1.0	0.1	0.9	1.2	0.0	0.8	3.1	0.0	0.0	0.2	0.0	0.3	1.0	0.0	10.9	0.1	0.1	0.0	0.1	1.5	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.0	38.1	1.5	1.2	0.2	0.0	0.0	3.1	3.2	0.5	0.3	33.2	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	2.3	0.0	0.2	0.0	0.1	1.9	2.7	1.9	3.4	1.6	2.0	3.3	3.1	1.0	3.4	1.6	2.2	3.0	7.4	19.2	18.6	6.2	1.6	0.0	0.4	0.0	0.0	1.8	0.9	1.4	10.9	1.5	6.2	1.8	0.0	0.2	8.3	1.3	0.0	0.4	92.7	15.9	3.7	3.6	3.5	4.2	2.9	2.0	0.0	4.9	3.6	6.5	6.3	3.3	2.2	5.3	0.6	13.5	3.3	1.1	0.0	1.3	0.0	10.1	5.6	6.2	0.0	1.9	3.2	1.8	15.5	4.5	5.4	0.6	0.8	2.2	2.5	0.3	1.4	0.8	6.6	1.9	0.0	3.4	5.6	11.5	0.9	2.0	0.0	0.1	5.4	1.4	1.3	0.2
GPR83	GPR72	ENSG00000123901	"G protein-coupled receptor 83"	Q9NYM4	11	94377316-94401419	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 10.6;thyroid gland: 3.0"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 2.7;Excitatory neurons: 2.6;Inhibitory neurons: 4.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 67.5"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (6.74e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.36e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.47e-12)"	"unprognostic (3.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.28e-3)"	0.1	0.7	1.2	0.1	3.2	0.4	0.0	10.6	3.7	0.2	0.7	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.3	3.9	4.5	0.3	0.2	0.0	0.2	1.1	5.3	2.3	0.1	0.1	0.0	0.3	0.0	2.5	0.1	0.1	0.7	0.1	0.0	0.3	0.2	0.1	0.1	0.5	0.2	0.1	0.4	2.2	0.1	3.0	0.0	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.2	3.2	10.6	3.7	3.9	4.5	1.1	5.3	2.3	2.5	0.5	2.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	2.7	0.1	0.0	0.0	0.0	2.6	0.4	0.0	0.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651092-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.6;Cardiomyocytes: 28.6;Cone photoreceptor cells: 37.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.5;REH: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA000161: AB_2247872, HPA031061: AB_2673718"	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.23e-2)"	8.0	22.8	24.7	5.5	27.7	3.8	10.0	23.4	34.6	30.9	7.2	18.1	2.5	25.8	10.8	4.4	26.9	7.6	15.6	24.9	31.2	8.9	2.9	7.3	9.5	19.7	18.8	25.1	53.8	5.7	17.4	43.8	2.9	23.9	20.6	4.5	30.1	8.8	17.9	6.1	5.0	12.5	15.5	12.6	11.4	9.7	5.3	23.3	6.9	26.3	4.2	7.7	18.7	17.1	23.5	0.2	0.5	1.7	1.1	1.7	1.7	1.0	1.8	0.1	2.7	4.5	0.2	0.3	0.0	0.4	3.8	0.3	0.5	0.5	0.1	3.9	0.0	0.2	0.1	0.6	0.5	1.4	0.2	0.2	2.2	0.7	3.3	0.3	0.4	0.2	1.8	0.3	0.1	4.3	0.4	3.7	0.1	1.2	0.3	0.6	5.6	1.7	0.0	0.2	0.4	1.7	2.7	0.6	0.2	0.5	1.4	0.2	0.9	0.5	0.8	1.0	0.5	0.3	0.3	0.5	0.0	0.4	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.3	0.2	1.1	0.4	0.0	0.7	2.3	2.3	0.0	0.1	0.0	0.3	0.8	0.5	24.7	27.7	23.4	34.6	24.9	31.2	19.7	18.8	25.1	23.9	12.6	23.3	23.5	5.1	0.0	3.6	0.0	4.4	3.6	4.1	0.8	1.8	42.6	1.8	3.0	28.6	1.5	3.5	5.5	37.5	0.4	3.5	0.1	0.0	0.2	0.3	0.6	6.5	7.3	6.0	0.4	0.0	0.2	0.2	9.9	1.1	0.7	2.5	13.9	7.1	0.7	0.3	6.7	0.0	0.7	0.0	0.3	2.0	1.7	15.2	1.3	1.8	0.0	0.5	12.9	3.1	0.0	0.0	0.6	0.1	15.4	2.2	3.8	0.4	1.7	1.2	18.8	6.6	16.9	8.5	7.0	2.4	0.4	0.9	0.1	7.3	6.5	0.8	1.6
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 11782.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 20125.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 605.6;thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 20.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.7"	"Cell line enriched"	"Detected in many"	12	"ASC diff: 7677.4"	"Region enhanced"	"Detected in all"		"hypothalamus: 239.5"	"Low region specificity"	"Detected in all"			CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	6200000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	4266.6	447.5	63.5	76.1	66.1	8.0	3215.4	61.2	74.4	820.7	500.4	713.7	89.1	419.5	91.5	573.2	1047.5	137.6	1882.5	67.6	307.8	11782.1	994.4	2493.3	134.4	333.5	98.9	53.6	522.2	259.1	113.4	799.9	597.1	107.0	562.2	94.3	4241.6	485.3	141.3	854.8	569.4	726.7	61.6	68.9	560.1	646.5	81.0	120.1	27.0	3657.3	463.0	45.3	1206.7	899.3	74.9	2.2	10.0	8.5	2.7	7677.4	6.7	9.2	3.5	0.8	7.9	2.4	177.5	3.9	1.1	214.1	5.6	3.2	2.8	39.6	433.2	6.0	6.1	2.5	1.9	4.3	195.0	294.7	0.5	4.3	649.1	41.2	0.2	1.0	10.6	11.3	1.2	1.2	0.3	11.0	31.4	0.5	1.2	13.8	0.8	0.2	1.0	5.2	1.7	74.1	4.3	11.3	11.4	1.2	31.6	1.9	33.6	43.5	2.1	2.5	2.3	19.6	3.7	1.0	2.7	15.6	2.5	7.0	3.0	0.6	0.0	4.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	0.0	1.6	63.5	66.1	61.2	74.4	67.6	307.8	333.5	98.9	53.6	107.0	68.9	120.1	74.9	353.6	9.6	33.7	1.0	106.8	18.5	86.9	94.8	1.2	26.3	31.7	5.5	639.8	18.6	58.3	649.2	43.8	713.8	2.2	2.3	1772.6	5.5	2.9	48.1	71.1	144.6	45.6	24.0	4.0	48.2	1191.3	514.0	50.0	627.9	11.4	274.9	735.3	228.4	151.5	16.8	0.4	5.9	91.6	47.9	86.7	17.5	446.7	160.2	23.2	3.7	0.7	5019.8	0.0	0.0	0.3	9.9	13.8	41.0	2.2	141.8	0.5	20125.9	39.1	86.8	683.7	131.6	264.6	7.1	10.3	13.9	21.6	1767.7	68.3	1.0	1.3	34.3
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 53.6;thyroid gland: 16.8"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 138.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 43.2"							NA	NA						"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	0.6	2.4	24.4	0.2	23.5	0.6	0.2	53.6	27.2	0.4	7.8	0.5	0.2	0.2	0.2	0.2	0.2	0.2	9.7	21.5	15.2	0.1	0.2	0.1	0.1	29.0	20.6	17.5	0.3	0.2	0.1	0.7	1.8	34.4	0.2	0.1	3.3	10.6	0.2	0.4	0.2	0.4	0.2	12.3	0.2	0.3	3.8	24.6	0.0	16.8	0.2	0.0	0.3	0.3	25.0	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	2.3	0.0	0.1	2.8	0.2	1.2	0.1	0.4	0.4	0.4	0.0	0.1	0.2	1.1	0.2	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	23.5	53.6	27.2	21.5	15.2	29.0	20.6	17.5	34.4	12.3	24.6	25.0	0.5	0.0	0.0	138.7	0.0	0.1	0.1	0.0	0.0	6.9	0.2	0.0	16.6	1.5	0.2	1.8	0.0	0.2	0.7	0.0	0.0	0.1	1.1	0.7	0.4	0.4	0.0	0.0	0.4	0.2	0.2	0.9	0.0	3.4	0.0	21.5	0.7	0.1	12.5	1.7	1.3	0.4	0.0	0.6	0.3	6.5	0.0	0.5	1.8	11.2	0.1	20.7	2.1	4.5	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.9	2.8	5.8	3.4	0.0	0.0	0.7	0.6	8.5	0.1	0.1
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 243.3;heart muscle: 526.1;skeletal muscle: 285.0;tongue: 155.6"	"Group enriched"	"Detected in some"	8	"Astrocytes: 59.1;Bipolar cells: 119.6;Cardiomyocytes: 65.2;Muller glia cells: 49.9;Oligodendrocytes: 168.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.2;thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA018174	Enhanced					NA	NA					"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	0.4	0.7	82.3	0.0	157.6	0.0	1.4	128.5	115.7	0.4	41.5	0.2	0.0	0.9	0.4	4.0	1.9	0.4	526.1	79.4	112.9	0.2	0.3	0.7	0.3	140.6	158.1	61.6	0.1	1.3	2.9	3.8	0.1	171.5	1.7	0.1	38.1	10.8	0.2	285.0	1.1	0.2	0.2	131.6	0.2	0.2	1.1	127.1	2.2	21.6	155.6	0.1	0.1	0.3	243.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.3	157.6	128.5	115.7	79.4	112.9	140.6	158.1	61.6	171.5	131.6	127.1	243.3	0.0	0.0	0.0	59.1	0.0	0.4	0.0	0.0	0.0	119.6	0.0	0.0	65.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.1	1.2	0.0	0.0	4.8	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	11.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	5.4	2.8	0.0	49.9	0.0	1.5	168.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.2	0.0	5.5	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289952-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 36.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 33.9;Erythroid cells: 8.2;Excitatory neurons: 17.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	6	"amygdala: 14.1;basal ganglia: 18.4;cerebral cortex: 19.5;hippocampal formation: 36.4;olfactory bulb: 24.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 16.3;K-562: 13.2;RPMI-8226: 14.7;U-266/70: 17.5;U-87 MG: 9.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	14	"amygdala: 40.8;basal ganglia: 45.1;cerebral cortex: 50.7;hippocampal formation: 76.2;olfactory bulb: 27.4"	"HPA008943, HPA009083, CAB025178"	Enhanced					NA	NA		3300000			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.1	0.0	14.1	0.0	18.4	0.6	0.2	0.0	19.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.7	36.4	2.8	0.3	0.0	6.2	0.2	2.9	0.2	24.6	2.1	0.0	0.1	0.2	0.1	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.0	0.6	0.0	0.0	0.2	0.5	3.9	3.5	0.0	0.0	7.4	0.0	0.0	0.3	5.0	0.8	0.2	0.5	0.0	0.1	5.6	2.3	0.0	0.0	6.5	0.2	0.0	0.0	0.2	1.0	16.3	6.1	0.5	0.1	0.0	3.1	0.0	0.6	0.1	0.0	0.0	0.0	2.0	13.2	0.1	0.0	0.8	0.0	2.3	0.0	0.3	4.9	0.1	0.0	14.7	0.2	0.0	0.9	0.1	2.3	0.2	0.5	0.0	2.7	0.0	0.0	1.5	0.0	0.9	0.0	17.5	3.1	3.5	9.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	18.4	0.0	19.5	36.4	2.8	2.9	0.2	24.6	2.8	0.0	0.5	3.9	3.2	6.4	2.8	1.6	0.4	0.3	0.2	0.3	1.8	0.7	1.6	5.2	33.9	0.0	1.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.5	0.6	0.5	2.8	0.0	8.2	17.7	0.0	0.1	1.1	1.1	1.3	2.5	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.3	1.7	0.0	0.0	2.1	0.0	2.8	0.3	0.0	0.0	1.5	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.4	0.5	0.0	0.0	0.7	1.7	1.7	1.3	0.4	0.1	0.1	0.7	0.1	0.2	0.2
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837370-19842197	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 277.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 246.6;Endometrial ciliated cells: 438.4;Endometrial stromal cells: 362.6;Glandular and luminal cells: 335.3;Muller glia cells: 391.8;Smooth muscle cells: 368.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 111.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.0;AN3-CA: 50.7;EFO-21: 105.1;HEK 293: 66.0;SCLC-21H: 117.0;SuSa: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	61.7	5.1	51.9	7.5	46.3	0.2	42.1	41.4	55.9	39.0	26.5	9.5	7.3	30.3	9.5	21.9	70.9	10.3	41.3	51.0	69.0	19.7	4.4	28.0	5.0	46.8	57.1	36.9	48.8	19.2	2.5	36.7	22.4	49.6	30.0	6.7	19.6	27.4	44.4	3.6	106.4	12.0	21.1	43.3	20.4	20.0	23.1	52.5	2.0	277.3	3.1	2.1	31.6	33.3	43.2	0.0	0.6	45.0	50.7	1.2	0.1	0.1	5.8	0.1	0.4	0.0	0.0	0.0	0.0	105.1	14.1	0.2	20.3	0.0	0.0	0.4	0.0	66.0	0.0	0.0	0.5	0.3	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	8.1	6.3	0.0	0.0	0.0	0.2	7.6	14.2	117.0	1.5	0.0	1.8	7.2	37.6	3.2	0.0	0.0	0.2	5.6	0.1	1.6	0.0	0.1	1.1	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.9	46.3	41.4	55.9	51.0	69.0	46.8	57.1	36.9	49.6	43.3	52.5	43.2	31.8	96.1	53.0	229.9	1.9	83.1	190.8	16.7	232.8	11.2	143.8	246.6	42.5	7.2	19.6	68.0	2.1	9.9	2.9	15.6	50.9	18.0	2.1	438.4	362.6	19.9	91.6	0.0	1.8	3.3	9.5	83.9	118.3	335.3	0.0	17.6	23.9	0.0	2.7	3.3	1.2	23.4	22.4	0.6	24.8	7.9	8.1	5.3	88.9	2.8	0.0	391.8	0.0	0.5	0.3	1.4	27.1	0.0	1.4	93.6	8.2	76.0	8.4	13.7	0.0	76.3	368.8	1.2	44.9	119.6	78.6	5.9	6.1	0.7	7.8	42.4
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Region enriched"	"Detected in all"	5	"hypothalamus: 263.0"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.2	91.1	28.9	9.3	30.6	0.4	151.8	32.0	51.6	271.3	87.2	68.2	21.0	118.2	130.7	76.5	239.4	37.1	73.1	28.0	263.0	30.2	7.8	40.7	8.8	32.2	30.1	28.1	137.9	16.1	4.8	107.2	15.8	33.4	130.4	28.3	6.6	36.2	123.4	38.9	35.9	53.0	39.3	36.5	45.6	68.2	22.4	39.1	6.9	58.9	103.1	9.2	128.2	215.9	32.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.9	30.6	32.0	51.6	28.0	263.0	32.2	30.1	28.1	33.4	36.5	39.1	32.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
INHBB		ENSG00000163083	"Inhibin subunit beta B"	P09529	2	120346136-120351803	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 45.2;breast: 43.7"	"Group enriched"	"Detected in many"	7	"Adipocytes: 200.5;Granulosa cells: 653.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 44.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 47.6;ASC diff: 63.1;BJ hTERT+ SV40 Large T+ RasG12V: 38.5;MCF7: 58.4;PC-3: 91.7;SK-BR-3: 163.4;T-47d: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		130000				"unprognostic (7.80e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.57e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.76e-2)"	45.2	3.8	5.3	1.0	5.1	0.2	43.7	8.3	4.2	6.7	3.1	3.1	1.3	7.5	2.6	2.5	6.3	2.6	5.4	3.5	4.3	3.9	20.4	4.4	1.2	9.8	7.1	3.2	2.5	4.2	6.4	8.1	1.3	5.9	8.3	0.3	1.1	16.5	0.8	10.5	15.6	2.4	2.2	5.8	0.5	3.7	17.3	7.8	0.4	21.1	2.4	0.7	8.3	6.5	5.3	24.5	47.6	0.2	0.0	63.1	4.9	0.0	3.3	3.8	20.7	38.5	1.0	0.0	0.0	8.3	1.2	0.1	0.1	3.7	0.0	28.9	0.1	0.8	0.0	0.0	1.2	1.0	0.0	0.1	2.6	3.5	0.7	0.0	0.3	0.4	0.0	0.0	0.0	0.1	58.4	0.0	0.1	0.0	4.7	91.7	0.0	0.0	1.2	5.6	0.0	5.4	0.0	0.2	163.4	0.0	0.0	39.2	0.5	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	5.1	8.3	4.2	3.5	4.3	9.8	7.1	3.2	5.9	5.8	7.8	5.3	200.5	3.2	2.2	8.1	0.2	4.0	2.2	5.5	0.0	0.1	53.7	24.4	0.7	8.6	9.2	1.8	25.0	0.1	0.7	0.1	0.0	0.4	0.6	9.2	1.6	24.3	0.0	2.7	0.1	0.0	0.2	9.8	0.0	12.5	0.0	653.3	24.7	19.4	0.1	0.0	1.3	0.0	8.2	1.3	6.6	3.6	11.8	1.3	1.8	1.0	0.0	0.2	0.0	2.5	0.0	0.2	0.0	6.8	0.3	8.9	0.0	0.0	30.0	0.6	0.0	37.3	3.1	0.8	6.0	0.6	3.0	0.1	0.6	0.2	0.0	3.2
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 207.6"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 150.4;Hepatic stellate cells: 268.4;Leydig cells: 285.2;Peritubular cells: 455.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 16.7;HHSteC: 6.7"									HPA061343			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favorable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	36.1	51.7	3.1	2.7	5.8	0.7	10.3	8.2	13.4	6.0	11.5	8.6	2.9	16.1	25.7	15.2	44.2	8.3	55.4	6.6	13.3	19.7	23.5	207.6	7.7	9.8	6.5	2.2	17.8	11.4	5.8	7.8	33.9	5.0	29.9	4.7	0.5	9.2	48.4	14.5	4.0	8.5	26.0	2.2	13.1	12.8	15.9	4.0	1.7	21.5	13.4	4.0	11.2	7.3	17.2	0.0	0.1	0.0	0.1	1.5	2.1	0.3	0.2	2.1	0.0	0.0	16.7	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	6.7	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.1	0.6	0.0	0.6	0.1	0.0	1.0	0.0	0.6	0.2	0.0	0.7	0.3	0.0	0.2	0.1	0.3	1.6	0.2	0.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.5	0.1	0.3	0.1	0.2	3.1	5.8	8.2	13.4	6.6	13.3	9.8	6.5	2.2	5.0	2.2	4.0	17.2	39.4	0.0	3.6	0.0	1.0	2.2	0.1	0.0	1.2	0.0	0.4	0.6	10.0	7.2	2.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	2.3	0.1	0.8	150.4	1.2	8.0	0.0	0.0	0.4	38.2	0.0	0.0	0.0	0.9	268.4	5.1	0.8	0.0	0.0	0.2	0.0	16.6	4.4	16.0	285.2	0.7	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	455.5	1.5	0.2	0.0	0.1	0.7	0.0	32.9	5.0	19.6	1.3	1.3	0.4	2.3	1.8	1.3	0.2	0.0	0.4
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 17.9;brain: 13.8;lymphoid tissue: 13.6;thyroid gland: 39.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 71.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HMC-1: 19.8;THP-1: 10.5;U-937: 11.0"	"Low region specificity"	"Detected in all"							"HPA028708, HPA028710"	Supported		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	0.7	0.2	5.3	7.9	5.1	17.9	1.5	4.5	13.8	2.7	0.0	1.3	0.7	1.2	1.4	1.4	2.1	2.9	0.6	4.7	7.6	2.8	2.1	1.5	13.6	0.0	8.8	3.7	0.6	0.7	0.1	0.6	1.6	3.4	0.8	1.2	0.2	1.2	0.4	0.2	0.5	2.3	0.9	0.7	6.9	2.4	1.0	11.5	10.7	39.5	0.2	12.9	2.1	0.5	10.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	19.8	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.1	1.2	0.8	0.0	0.5	0.1	0.1	0.3	0.7	2.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	3.2	14.5	71.6	13.0	6.5	27.6	0.0	16.3	12.5	16.2	0.1	27.9	16.8	42.7	14.3	8.5	0.4	22.6	12.6	5.3	5.1	4.5	13.8	4.7	7.6	0.0	8.8	3.7	3.4	0.7	11.5	10.3	1.1	0.0	1.7	7.8	3.5	0.6	0.5	0.4	12.0	0.6	1.8	1.0	1.1	1.5	1.7	1.8	0.0	1.7	46.1	0.0	7.9	2.1	1.3	2.0	1.2	2.3	0.0	3.2	120.0	0.0	0.1	1.0	3.1	2.5	0.0	0.1	3.3	1.1	2.8	3.3	9.8	0.5	2.0	23.4	15.2	0.3	0.3	15.2	0.0	252.9	17.9	0.2	27.8	9.0	14.6	0.0	0.1	0.4	20.7	0.6	0.1	2.0	1.3	0.2	0.0	3.4	0.4	0.2	1.1	4.0	0.6	2.7	65.5	2.0	0.3	1.3
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507535	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.4;choroid plexus: 21.7;thyroid gland: 19.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 180.9;Endometrial ciliated cells: 54.7;Respiratory ciliated cells: 115.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;HBEC3-KT: 3.3;HeLa: 3.8;hTERT-RPE1: 6.9;SuSa: 4.4;U-2 OS: 12.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 7.2"	HPA057320			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	1.1	1.2	24.5	0.4	25.7	0.0	1.8	20.5	46.4	1.2	21.7	0.2	0.1	1.7	5.4	0.7	11.1	1.7	0.4	22.3	19.9	3.8	0.1	2.7	0.4	21.8	24.4	18.2	2.4	1.3	1.4	10.4	0.2	21.1	1.5	0.1	2.2	1.2	1.3	0.0	0.2	0.3	0.5	14.6	3.1	0.5	4.6	19.6	2.9	19.4	0.0	0.6	1.7	1.0	17.2	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.3	0.1	0.0	0.0	3.2	0.0	1.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	0.2	1.7	0.0	0.0	6.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.2	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	24.5	25.7	20.5	46.4	22.3	19.9	21.8	24.4	18.2	21.1	14.6	19.6	17.2	2.8	16.0	12.6	180.9	0.4	0.5	7.8	26.9	1.8	26.2	1.7	14.1	1.3	11.5	26.7	3.7	16.7	0.5	0.0	0.0	0.0	10.8	24.0	54.7	5.2	10.4	0.0	0.0	26.0	1.5	5.6	3.3	0.5	9.8	1.3	6.7	2.2	0.0	0.3	0.0	11.6	0.0	16.2	0.0	0.0	14.5	2.1	0.4	0.0	9.4	0.0	0.5	1.0	4.5	2.4	1.2	0.0	6.0	0.3	1.7	0.0	11.7	115.7	2.3	0.0	0.8	2.2	31.0	28.3	0.8	0.3	0.3	0.8	1.9	0.0	3.1
ISM1	"bA149I18.1, C20orf82"	ENSG00000101230	"Isthmin 1"	B1AKI9	20	13221274-13300651	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 44.8"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 19.2;Fibroblasts: 18.4;Microglial cells: 8.4;Proximal tubular cells: 5.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 48.9;Hep G2: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA		17000				"unprognostic (7.13e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.27e-3)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.32e-6)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.81e-2)"	10.2	2.6	1.3	0.3	1.0	0.0	16.7	0.9	1.3	3.0	0.8	1.6	0.4	3.1	0.3	6.6	4.4	4.8	2.3	1.0	3.0	2.0	6.4	4.5	0.3	1.4	1.4	0.6	0.5	3.8	0.4	2.1	14.5	1.6	1.6	0.2	0.1	15.3	0.7	1.5	17.0	2.6	1.9	1.0	8.2	3.3	0.1	3.2	4.9	44.8	2.1	0.7	1.3	5.6	0.9	0.0	0.5	0.2	0.7	48.9	6.8	0.3	0.4	4.2	0.0	0.0	2.9	0.4	0.0	0.2	0.0	0.4	0.2	0.0	0.1	0.0	0.0	4.1	0.0	0.0	20.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.4	0.0	0.5	0.5	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.1	4.2	0.0	0.0	1.4	0.2	0.9	0.0	0.0	0.0	2.9	0.4	0.1	0.3	0.0	4.7	0.9	0.0	2.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.3	1.0	0.9	1.3	1.0	3.0	1.4	1.4	0.6	1.6	1.0	3.2	0.9	1.9	0.0	0.5	0.0	0.0	4.6	0.4	0.4	0.6	0.8	0.5	19.2	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.1	0.2	2.0	2.0	0.0	0.0	0.6	0.0	0.3	18.4	0.0	0.2	0.0	3.4	0.0	2.3	0.5	0.0	4.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	1.8	8.4	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.4	0.1	0.5	0.0	5.2	0.0	0.0	0.0	0.4	1.4	0.0	0.3	0.3	2.8	0.7	0.9	0.0	0.0	0.1
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	16.0	6.4	11.9	1.2	42.7	1.6	7.4	17.2	17.0	6.7	6.6	3.8	1.7	5.5	12.9	2.2	4.3	3.0	5.5	24.4	12.2	1.8	2.6	3.4	0.9	11.4	11.5	12.7	2.9	4.1	2.0	1.8	1.3	16.3	22.6	1.9	12.9	3.9	19.4	2.0	1.7	2.8	2.7	9.4	5.2	1.6	3.1	13.6	1.8	29.0	5.1	0.3	3.0	5.0	17.1	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	11.9	42.7	17.2	17.0	24.4	12.2	11.4	11.5	12.7	16.3	9.4	13.6	17.1	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 243.8;thyroid gland: 130.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.8	0.5	1.0	20.9	0.7	14.2	2.8	1.0	6.0	12.8	1.5	0.9	1.5	0.5	11.1	8.6	1.2	30.6	0.8	0.8	1.3	243.8	2.8	42.6	1.2	0.9	0.8	0.4	0.3	58.3	0.7	0.4	4.7	1.9	2.6	0.4	0.5	25.7	14.8	0.5	3.0	0.7	2.4	0.4	11.8	40.9	1.8	4.4	1.9	130.7	3.0	1.9	25.3	8.2	1.4	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	1.0	0.7	1.0	6.0	0.8	1.3	0.9	0.8	0.4	1.9	0.4	4.4	1.4	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6;parathyroid gland: 36.3"	"Group enriched"	"Detected in many"	4	"Horizontal cells: 240.6;Oligodendrocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.9;HUVEC TERT2: 6.3;REH: 7.5;RH-30: 29.2;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA					"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	2.0	0.8	7.9	5.2	18.4	1.9	5.0	12.2	13.6	0.6	0.7	3.9	0.9	0.9	0.6	2.9	6.7	1.4	9.9	5.1	12.1	1.0	1.3	2.1	1.3	15.7	15.7	3.9	0.7	0.4	36.3	0.6	6.4	20.1	1.8	3.2	7.7	1.3	1.9	9.8	4.7	1.4	1.0	14.4	7.4	0.8	0.3	14.5	1.8	1.2	8.4	1.5	1.9	1.8	42.6	0.0	0.9	1.8	0.0	1.9	0.5	0.0	0.6	4.5	0.1	0.1	0.0	0.0	0.0	0.4	0.5	1.2	0.5	0.1	0.3	0.1	0.0	0.2	0.0	0.6	0.0	5.4	0.0	0.0	2.0	0.1	2.8	0.3	8.9	6.3	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.2	0.8	0.2	7.5	29.2	0.0	0.7	0.0	0.4	0.8	0.5	0.1	0.0	3.5	0.3	0.5	0.1	10.6	0.1	0.1	2.4	0.0	0.0	0.1	2.3	0.0	1.5	4.2	3.5	5.6	0.0	6.9	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	30.4	0.0	7.3	0.2	0.0	0.8	7.9	18.4	12.2	13.6	5.1	12.1	15.7	15.7	3.9	20.1	14.4	14.5	42.6	12.0	0.0	3.2	0.0	0.6	8.2	4.1	4.9	16.5	43.5	5.8	9.3	19.3	0.0	1.9	1.8	0.0	0.5	0.1	13.5	0.0	0.1	0.3	2.3	0.2	16.0	10.7	0.4	3.8	0.0	0.4	1.7	4.1	1.6	0.0	0.1	3.3	0.1	6.8	240.6	16.2	2.7	0.0	36.9	7.4	0.0	1.5	7.8	3.6	2.8	8.2	5.8	0.0	1.5	164.7	0.0	12.3	1.2	0.0	2.2	0.9	0.1	4.9	5.2	0.0	3.9	2.6	0.1	0.9	6.9	3.3	1.4	0.8	0.2	8.5	0.3
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120859-132481095	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 501.5;Inhibitory neurons: 485.6;Microglial cells: 502.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 6.6;JURKAT: 3.8;RPMI-8226: 2.8;U-2 OS: 4.3;U-87 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.2	1.4	6.4	0.5	15.9	0.0	0.9	0.0	22.3	0.3	0.0	0.3	0.2	0.2	0.1	0.1	0.3	0.3	0.7	9.4	4.4	0.6	0.0	1.9	0.1	6.1	8.2	12.2	0.1	0.9	0.2	2.0	0.2	7.1	0.4	0.2	2.6	0.4	0.6	0.0	0.4	0.6	0.6	0.0	0.5	0.1	0.2	19.1	0.5	0.5	0.0	0.2	0.4	0.4	12.2	0.2	0.1	0.0	0.0	0.3	1.0	0.0	0.3	1.1	0.0	0.0	0.0	1.0	0.0	1.2	1.5	2.5	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	6.6	0.1	0.0	3.8	0.0	0.1	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	2.8	1.6	0.0	1.3	1.2	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	15.9	0.0	22.3	9.4	4.4	6.1	8.2	12.2	7.1	0.0	19.1	12.2	0.4	0.0	14.0	84.5	0.2	0.3	0.0	0.0	0.0	6.7	1.3	0.6	4.6	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.6	0.3	4.2	2.7	0.0	0.0	501.5	6.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	485.6	0.7	0.0	0.3	1.6	2.9	0.0	2.1	0.0	502.2	0.6	0.4	0.0	117.1	31.2	1.8	0.0	0.0	0.0	0.1	4.6	1.6	0.8	0.6	0.0	0.0	2.7	0.0	0.5	0.1	0.1	0.0	0.4	0.1	1.2	0.1
KCTD8		ENSG00000183783	"Potassium channel tetramerization domain containing 8"	Q6ZWB6	4	44173903-44448809	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.6;retina: 6.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 169.4;Excitatory neurons: 223.7;Inhibitory neurons: 445.3;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 610.8"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.2;NTERA-2: 1.5;SCLC-21H: 5.7;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031562	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA031562: AB_10602609"	"unprognostic (1.49e-2)"	"unprognostic (7.70e-3)"		"unprognostic (1.53e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.77e-2)"		"unprognostic (1.48e-1)"		"unprognostic (7.85e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.44e-1)"	0.7	0.2	5.9	0.0	11.6	0.0	0.0	26.6	8.2	1.0	3.2	0.7	0.0	1.4	0.2	0.1	0.2	0.3	0.2	6.9	11.9	0.8	0.0	0.1	0.0	10.4	13.9	4.2	1.5	0.6	1.0	0.0	0.0	10.5	0.4	0.1	6.9	0.4	0.9	1.5	0.1	0.1	0.6	11.2	0.0	1.6	1.3	9.9	0.0	3.1	1.1	0.0	0.1	0.3	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	11.6	26.6	8.2	6.9	11.9	10.4	13.9	4.2	10.5	11.2	9.9	16.0	0.1	0.0	0.0	169.4	0.0	0.0	0.6	0.0	1.8	2.6	1.3	0.3	0.3	4.3	0.0	3.7	4.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	3.5	1.0	0.0	0.0	223.7	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.4	0.0	0.1	0.0	445.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	71.2	0.0	4.4	0.0	322.7	610.8	0.2	0.0	0.0	0.0	1.2	0.0	1.9	0.0	17.1	0.0	1.7	0.2	0.1	1.6	1.0	0.0	0.1	0.0	10.0	0.0	0.1
KHDRBS2	"MGC26664, SLM-1, SLM1"	ENSG00000112232	"KH RNA binding domain containing, signal transduction associated 2"	Q5VWX1	6	61679961-62286225	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;retina: 4.1;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 1423.1;Inhibitory neurons: 720.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 6.4"	"Group enriched"	"Detected in some"	13	"memory B-cell: 5.9;naive B-cell: 6.9;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.9;dendritic cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 4.7;NTERA-2: 1.6;THP-1: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000500, HPA029392"	Supported					NA	NA					"HPA000500: AB_1079184, HPA029392: AB_10600816"	"unprognostic (6.98e-2)"			"unprognostic (1.21e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-5)"	"unprognostic (5.52e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.15e-1)"	0.1	0.9	0.8	0.3	2.3	0.1	0.0	0.0	6.4	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.3	0.0	2.3	0.4	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.4	0.7	0.1	0.1	4.1	0.0	0.1	0.2	0.0	0.7	0.0	0.0	1.0	0.1	0.1	0.4	0.6	4.1	0.0	0.5	0.2	0.0	2.6	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.3	1.9	0.0	0.3	0.8	2.3	0.0	6.4	1.3	0.7	0.0	0.0	2.1	0.7	0.0	0.4	2.6	0.0	38.5	3.3	17.6	24.3	0.0	0.0	0.0	0.6	41.4	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.7	1423.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.4	0.0	0.1	35.3	720.1	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	117.1	0.3	30.5	0.0	238.8	99.4	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.0	3.1	0.0	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782550	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"skin 1: 44.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9;thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"hippocampal formation: 80.6"	HPA055114	Enhanced					NA	NA					"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	8.8	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0
KRT83	"Hb-3, KRTHB3"	ENSG00000170523	"Keratin 83"	P78385	12	52314301-52321398	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"skin 1: 40.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 13.3"									HPA049778	Supported					NA	NA		130000000			"HPA049778: AB_2680877"	"unprognostic (7.03e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.30e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-2)"		"unprognostic (2.43e-1)"	"unprognostic (1.12e-3)"	"unprognostic (7.49e-3)"		"unprognostic (2.16e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	0.6	0.0	0.4	0.0	0.7	0.0	0.3	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	40.1	0.0	0.0	0.8	0.0	0.0	0.2	0.6	0.2	1.0	0.0	0.0	0.0	0.0	1.9	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.3	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.7	0.5	0.7	0.4	0.7	0.6	0.3	0.9	0.8	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134599923-134651636	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 16.4;skin 1: 9.6;tongue: 27.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.1	2.7	2.7	0.2	1.8	0.3	0.8	1.5	2.9	0.6	0.1	0.6	0.4	2.0	0.8	2.0	2.0	0.5	1.8	1.9	1.5	0.3	0.0	0.1	0.0	1.9	2.0	1.4	0.9	0.0	2.2	3.3	0.0	2.7	2.2	0.2	1.7	0.8	1.8	16.4	9.6	0.2	4.2	2.1	0.1	0.7	0.3	2.0	0.9	3.1	27.9	0.0	0.6	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.1	0.7	0.0	5.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	1.5	2.9	1.9	1.5	1.9	2.0	1.4	2.7	2.1	2.0	1.8	0.0	0.0	0.0	15.0	0.0	0.6	0.1	0.0	0.0	0.4	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.0	0.0	2.5	0.0	24.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	96	"epididymis: 84.4"	"Group enriched"	"Detected in some"	11	"B-cells: 17.9;Plasma cells: 5.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 4.1;naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	79	"B-cells: 8.1"	"Cell line enriched"	"Detected in single"	6	"REH: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA									"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	84.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6635960	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 18.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 83.8;T-cells: 66.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA013170	Approved					NA	NA					"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favorable (6.56e-5)"	"unprognostic (7.43e-2)"	1.4	2.6	5.1	5.3	5.5	1.0	1.3	5.9	6.0	3.2	3.7	9.0	9.8	0.5	2.7	21.1	1.6	1.7	2.6	4.9	9.7	0.7	1.3	1.9	9.0	9.3	6.7	3.3	0.7	0.5	0.8	1.0	5.5	8.6	1.0	8.4	0.2	5.5	1.3	0.2	6.6	8.9	1.0	9.6	9.4	7.3	1.6	9.0	2.6	1.6	0.1	12.5	2.1	9.7	13.5	5.8	0.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	10.5	4.3	1.3	0.0	0.1	7.0	0.0	3.2	0.0	0.0	0.0	19.6	0.6	0.4	0.0	0.0	26.0	0.0	3.5	0.1	1.5	0.0	0.0	4.0	14.8	0.0	0.0	0.5	0.6	6.1	0.1	9.4	1.0	4.8	0.0	0.0	0.0	3.3	0.1	0.1	3.0	0.0	0.0	1.1	0.0	2.2	0.1	0.0	3.9	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	10.4	0.3	0.1	66.8	3.4	51.2	83.8	11.2	40.2	17.3	82.7	10.8	24.6	0.8	4.6	6.1	1.1	18.0	20.1	5.1	5.5	5.9	6.0	4.9	9.7	9.3	6.7	3.3	8.6	9.6	9.0	13.5	0.2	0.0	0.0	0.0	26.5	1.5	0.4	3.9	1.8	0.0	0.6	0.5	2.8	1.5	4.4	1.8	0.0	0.3	2.8	16.9	0.0	0.3	4.9	0.4	0.1	1.5	1.2	0.8	0.2	0.9	0.2	0.6	3.6	0.7	16.5	0.0	1.1	0.2	38.0	0.0	0.3	11.1	2.0	15.6	7.0	14.5	0.0	13.9	0.0	33.7	4.6	0.1	17.5	0.5	0.1	9.4	16.8	0.0	2.7	0.7	18.4	0.1	0.6	0.1	0.0	0.1	0.2	0.6	1.4	10.3	1.3	0.5	6.9	0.0	13.0	2.2
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55509072-55586666	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.2;thyroid gland: 87.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 173.3;Microglial cells: 224.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 151.4;eosinophil: 199.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 199.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 115.9;HaCaT: 89.2;HL-60: 103.0;HMC-1: 161.7;hTERT-RPE1: 162.9;WM-115: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	8.7	9.1	5.6	14.5	8.0	89.2	12.3	11.2	6.1	14.1	12.4	9.1	7.4	18.6	37.0	7.9	8.9	10.5	5.7	5.2	9.7	11.0	4.0	10.5	5.1	14.2	9.3	3.4	15.9	5.5	13.7	1.0	16.1	15.3	7.1	9.4	7.8	8.5	28.9	2.2	12.1	9.2	15.2	15.4	11.9	9.1	4.2	9.1	3.6	87.1	5.9	4.1	9.6	7.6	20.2	33.5	4.2	3.5	0.3	10.8	4.1	5.6	14.1	13.5	6.8	6.9	7.5	115.9	0.0	46.6	19.9	5.5	89.2	2.2	19.4	10.9	9.1	9.6	34.2	10.2	17.3	4.1	103.0	161.7	2.1	19.2	7.5	6.3	162.9	53.5	1.8	1.5	0.4	11.6	2.1	0.0	41.8	5.1	9.5	0.4	10.4	3.8	5.1	6.8	12.9	2.2	25.3	27.1	10.8	19.9	15.8	4.6	25.8	60.3	0.3	0.1	6.9	9.6	0.6	0.2	0.2	0.5	49.4	117.8	151.4	17.5	199.2	0.0	27.4	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	47.0	0.0	39.1	0.7	0.0	6.5	5.6	8.0	11.2	6.1	5.2	9.7	14.2	9.3	3.4	15.3	15.4	9.1	20.2	68.6	6.4	25.7	2.9	1.1	15.4	37.2	68.3	17.1	5.5	8.8	33.9	2.2	4.3	22.3	68.0	10.4	0.7	3.3	7.0	1.9	8.3	1.7	6.4	4.8	41.0	1.2	9.7	8.1	9.7	7.5	20.7	10.2	13.9	173.3	0.4	12.1	2.0	36.5	0.0	11.7	12.2	18.3	71.9	57.7	3.1	16.4	74.4	17.8	224.9	40.6	24.0	0.0	4.5	66.5	32.8	23.0	12.8	1.0	9.0	3.4	3.5	8.1	5.3	0.0	20.0	4.2	49.6	24.0	14.2	15.3	1.9	5.6	7.0	11.6	17.6
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515385-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 45.7;skeletal muscle: 166.6;tongue: 94.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 198.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	2.4	0.7	1.2	0.7	4.0	0.8	2.0	1.2	2.8	3.4	0.3	1.6	0.7	4.8	2.4	1.5	2.4	3.0	45.7	2.7	1.5	4.5	5.6	1.2	0.6	0.7	0.6	2.7	5.2	1.1	0.9	1.3	1.0	0.8	2.1	1.6	0.3	2.2	0.3	166.6	1.8	0.8	4.1	0.8	2.8	1.8	0.8	0.3	3.2	22.3	94.9	0.7	2.3	2.1	1.6	0.1	0.0	0.1	0.1	0.6	1.4	0.1	0.5	1.0	0.3	0.5	0.0	0.1	0.2	0.1	7.2	0.0	0.1	2.5	0.0	0.9	0.3	0.0	4.2	0.3	0.0	0.1	0.1	0.0	0.1	0.0	2.8	0.0	2.3	0.1	0.5	0.0	0.2	4.1	0.0	0.5	0.1	1.0	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.8	0.5	0.1	1.0	0.7	0.1	0.5	3.2	0.1	0.3	1.6	1.1	0.2	0.2	1.9	0.1	0.1	0.9	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.5	0.1	1.2	4.0	1.2	2.8	2.7	1.5	0.7	0.6	2.7	0.8	0.8	0.3	1.6	1.6	9.6	1.1	2.0	0.2	1.9	1.1	0.6	0.6	0.1	0.8	1.3	198.4	7.2	0.0	1.8	0.0	0.1	0.0	0.2	9.8	0.6	2.3	0.3	1.6	4.0	3.0	0.0	12.5	1.0	0.0	11.9	3.1	0.4	10.2	2.5	5.0	10.2	2.0	0.0	11.2	1.8	0.0	0.8	5.7	2.9	0.6	0.6	10.6	3.7	0.0	0.4	0.0	3.5	0.7	1.0	0.4	0.0	3.0	0.6	0.0	0.8	0.7	0.2	0.0	32.7	2.6	0.6	0.7	0.0	2.4	0.1	2.1	7.9	1.9	0.4
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 52.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 17.1;thyroid cancer: 22.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.1"	"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	4.8	3.1	0.9	10.2	1.7	9.1	2.6	0.9	2.5	5.1	1.4	3.4	0.6	4.8	2.0	7.1	4.1	6.3	3.3	1.3	8.1	11.0	5.6	52.9	6.9	1.8	1.2	0.9	5.5	3.7	8.5	2.1	1.2	1.3	2.6	1.8	1.5	3.6	2.1	5.5	2.1	3.6	4.0	1.2	10.9	2.1	0.8	1.3	2.6	2.9	8.0	5.4	4.5	5.5	1.6	0.0	4.6	0.0	0.0	2.3	5.6	0.0	1.3	3.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.4	0.0	2.1	0.4	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.5	2.7	0.1	3.1	1.5	1.0	0.4	0.5	0.6	0.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	7.2	2.2	0.0	5.2	0.0	1.8	0.0	0.0	2.1	1.7	0.0	0.0	58.2	0.0	6.9	0.3	0.0	1.3	0.9	1.7	0.9	2.5	1.3	8.1	1.8	1.2	0.9	1.3	1.2	1.3	1.6	7.4	32.1	502.2	17.3	29.9	2.4	1.8	0.4	2.8	8.6	1.3	1.4	7.8	5.7	17.3	27.6	0.0	0.0	1.9	0.0	1.9	1.3	0.5	0.4	2.6	7.0	0.0	2.1	92.0	2.7	0.1	16.1	0.5	0.4	13.9	2.7	13.2	8.2	4.6	47.1	28.0	0.0	0.0	55.8	8.7	1.2	19.0	52.2	12.4	73.1	133.1	8.6	3.1	256.9	3.1	0.8	1.1	12.0	2.8	0.6	0.0	22.5	3.4	1.0	0.0	22.5	4.8	0.3	1.0	12.6	3.1	0.4	3.4	11.2	0.0	0.7
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298564-36320637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 30.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	16.4	19.6	19.6	12.2	19.7	35.5	25.1	22.3	22.2	28.1	19.2	17.1	17.1	26.8	21.5	16.7	16.6	16.6	14.3	18.0	25.3	26.5	29.2	77.4	17.6	17.5	19.1	18.2	32.5	17.8	19.8	22.6	19.2	18.0	18.7	22.4	22.5	16.1	16.4	7.3	28.7	17.4	20.4	17.7	15.7	31.5	18.3	20.3	18.0	82.4	9.4	16.2	15.3	13.6	23.0	29.6	15.4	31.7	32.1	31.3	30.0	24.1	24.8	30.7	32.2	33.6	31.2	28.9	28.0	36.8	32.1	16.8	22.1	33.7	22.9	39.3	40.5	25.5	16.4	14.7	55.0	33.9	33.8	17.5	30.8	35.1	21.1	27.2	33.2	20.4	38.3	28.4	33.8	24.2	28.8	32.5	27.7	26.9	25.2	44.6	15.4	27.7	19.5	37.2	22.7	47.3	18.8	20.4	19.5	33.4	27.3	31.9	21.6	16.0	35.6	23.2	26.3	26.0	27.8	34.5	44.0	13.6	17.3	25.3	2.0	12.6	3.0	14.6	9.9	18.5	16.4	17.6	18.0	12.8	12.3	22.6	18.5	7.0	12.9	8.1	14.5	23.6	13.3	19.6	19.7	22.3	22.2	18.0	25.3	17.5	19.1	18.2	18.0	17.7	20.3	23.0	16.0	218.0	316.0	18.3	14.9	90.2	30.7	41.5	22.2	24.9	15.3	23.0	10.7	10.0	106.7	25.8	2.1	24.7	12.2	16.1	58.7	21.2	4.2	20.9	28.2	18.3	31.5	9.7	21.2	19.0	21.1	29.7	13.3	35.6	13.3	30.2	16.1	25.2	18.7	92.5	24.8	15.5	20.3	9.5	15.4	4.2	32.0	14.5	21.4	9.4	11.5	29.0	12.3	31.7	27.0	17.8	18.6	27.1	18.9	29.0	18.9	49.6	34.9	24.1	13.1	18.0	27.8	50.1	35.5	17.9	65.5	19.8	20.6	25.5	21.1	21.4
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797110-8799365	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.4;testis: 25.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 8.3"	"Not detected"	"Not detected"							HPA023164	Uncertain					NA	NA					"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.0	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.1	1.8	0.1	2.7	2.4	0.1	1.3	0.6	2.0	0.8	0.1	0.1	0.2	1.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	9.4	4.2	4.9	0.4	0.1	0.4	3.1	0.0	6.8	2.1	0.0	0.3	1.5	0.0	0.2	0.2	4.0	25.7	0.2	0.2	3.4	0.0	0.2	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.7	0.8	0.2	4.3	1.1	1.8	0.0	2.9	0.0	1.7	0.0	7.2	125.7	1.2	0.1	0.1	1.2	0.0	0.0	7.6	0.3	0.0	3.6	2.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.9	28.5	0.6	0.0	46.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	1.2	0.1	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.2	45.0	0.3	0.6	0.0	1.5	0.0	0.0	4.5	1.0
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657731-56660698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 590.1;kidney: 579.1;liver: 566.6;thyroid gland: 1194.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 10399.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 55.6;classical monocyte: 30.2;gdT-cell: 47.0;MAIT T-cell: 41.8;memory B-cell: 25.7;memory CD4 T-cell: 48.9;memory CD8 T-cell: 80.3;naive CD4 T-cell: 49.4;naive CD8 T-cell: 85.5;T-reg: 89.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.4;NB-4: 238.9;NTERA-2: 137.1;RPTEC TERT1: 754.6;THP-1: 131.9;U-937: 126.2"															NA	NA		160000				"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	28.7	60.9	318.7	30.2	324.1	10.3	16.6	374.2	590.1	8.1	283.4	159.8	82.9	8.7	2.7	10.7	20.0	19.3	7.9	307.5	310.0	579.1	566.6	11.6	23.6	362.4	332.2	300.1	2.8	315.0	5.1	23.4	4.0	339.8	71.1	124.1	52.9	18.5	14.1	2.9	8.3	224.0	16.7	318.6	20.7	89.1	4.5	349.8	6.4	1194.1	1.8	14.7	14.9	6.1	326.4	4.9	7.4	0.0	0.2	0.4	0.3	10.0	6.1	15.6	5.6	9.5	2.0	29.5	0.1	19.3	1.3	8.8	26.5	51.5	6.0	5.8	143.4	7.1	8.9	1.4	2.6	3.7	0.2	100.9	1.5	1.7	6.1	1.7	2.5	0.8	2.1	0.4	0.1	0.3	14.7	0.4	238.9	137.1	1.2	12.9	0.0	0.6	4.4	754.6	5.3	75.1	8.3	6.1	2.4	2.6	19.8	3.5	131.9	0.0	0.0	1.7	0.9	0.7	0.4	0.0	0.0	87.5	126.2	1.1	55.6	30.2	8.9	47.0	2.8	41.8	25.7	48.9	80.3	8.2	10.7	49.4	85.5	4.8	8.1	1.4	3.3	89.2	64.1	318.7	324.1	374.2	590.1	307.5	310.0	362.4	332.2	300.1	339.8	318.6	349.8	326.4	25.9	0.0	9.3	18.6	55.4	8.5	28.1	18.6	18.2	0.0	42.0	77.1	9.5	181.6	15.1	327.4	0.0	6.7	27.5	652.8	1119.2	194.4	0.6	376.6	79.5	16.8	170.9	95.6	0.1	123.2	379.6	22.5	57.1	946.3	11.4	77.8	48.9	1365.5	29.6	0.0	0.0	631.0	4.1	70.3	9.4	1.9	31.4	115.6	92.5	2.8	53.4	0.0	27.8	1.0	0.3	126.5	1252.2	5.3	65.9	107.0	2028.8	10399.1	22.6	0.0	6.6	26.4	41.6	3.2	1.5	3.9	8.0	19.4	68.6	6.9	851.3	19.2
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 115.4;fallopian tube: 60.6;retina: 85.9"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 652.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1"	"Lineage enriched"	"Detected in many"	10	"T-cells: 111.1"	"Cell line enhanced"	"Detected in some"		"AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		6400000	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.5	17.1	30.7	11.0	63.7	7.4	1.9	3.1	115.4	23.3	53.3	2.0	26.5	2.2	0.4	1.2	60.6	1.9	0.4	95.8	47.1	1.2	1.0	5.1	20.9	2.3	2.6	60.5	0.8	0.9	0.2	34.8	0.3	10.5	27.5	2.2	85.9	1.4	2.0	0.3	9.4	15.4	2.8	0.0	6.2	2.9	3.0	3.7	8.8	6.6	0.6	15.9	4.1	4.2	46.8	0.3	0.1	104.6	3.5	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	8.3	12.4	0.0	0.0	0.2	25.3	0.2	0.0	0.0	27.5	0.4	8.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	1.6	0.2	0.4	0.0	0.4	0.2	0.4	41.2	0.0	14.0	0.2	12.7	0.2	0.0	0.0	75.6	1.8	0.0	0.4	0.0	1.3	0.1	0.7	0.0	0.4	3.8	0.1	2.1	27.5	29.5	40.3	0.2	0.2	0.4	0.2	0.2	0.0	5.0	0.1	24.9	0.2	30.3	52.9	0.1	0.1	70.4	111.1	0.5	11.0	0.1	0.1	0.4	26.7	30.7	63.7	3.1	115.4	95.8	47.1	2.3	2.6	60.5	10.5	0.0	3.7	46.8	0.3	0.0	1.3	48.0	1.0	1.1	0.0	0.0	5.7	35.4	0.4	0.6	0.5	2.8	6.2	0.0	33.3	0.1	2.5	5.8	0.0	0.0	0.4	0.7	0.8	0.7	0.0	0.0	652.4	0.2	0.3	3.7	0.0	0.3	0.0	49.4	0.0	0.0	0.1	1.7	108.4	0.9	0.0	0.0	1.5	1.0	0.0	0.4	0.0	18.7	1.3	7.9	1.0	74.4	16.5	0.4	0.4	0.4	0.5	0.3	18.5	0.2	21.9	58.3	0.0	4.1	4.6	1.9	4.2	0.2	1.1	0.1	23.4	0.1	2.9	0.1
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.0;Endothelial cells: 19.7;Fibroblasts: 46.0;Microglial cells: 19.7;Smooth muscle cells: 22.6;Theca cells: 19.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 285.4;ASC TERT1: 113.0;BJ: 152.1;BJ hTERT+: 131.8;HHSteC: 158.1;HSkMC: 591.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		6300000	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.78e-4)"	28.5	5.3	0.7	9.2	0.8	0.7	9.7	0.5	2.4	7.4	37.5	7.4	2.3	17.5	5.9	5.4	6.7	19.1	15.7	1.3	0.5	4.9	6.0	6.2	3.6	1.8	0.9	0.2	19.1	3.5	13.3	2.5	61.3	0.5	8.5	6.9	0.1	3.7	10.5	4.4	1.6	3.6	11.5	1.0	1.9	6.9	1.4	0.7	2.1	31.9	5.6	1.4	15.5	5.4	1.7	0.0	3.4	76.6	0.0	285.4	113.0	0.2	152.1	131.8	14.5	15.0	0.4	0.0	0.0	22.2	17.3	0.0	10.7	9.9	0.1	3.9	0.1	2.0	0.0	3.0	0.0	158.1	0.0	0.0	591.5	0.0	59.6	0.1	82.5	8.1	0.1	0.0	0.0	8.6	0.0	0.0	0.4	3.3	0.0	5.1	23.5	0.2	0.1	19.9	0.0	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.0	0.9	54.4	0.6	33.0	0.0	0.0	0.0	0.1	17.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	2.4	1.3	0.5	1.8	0.9	0.2	0.5	1.0	0.7	1.7	31.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	1.4	0.2	0.3	2.1	0.0	0.0	1.8	0.0	0.7	0.7	3.7	0.0	0.1	14.0	1.5	11.3	19.7	0.0	0.0	0.8	0.0	1.1	46.0	1.1	0.4	1.3	0.4	8.6	0.0	1.6	0.0	1.7	2.0	0.0	0.3	1.2	4.4	6.2	0.3	3.6	19.7	1.0	0.0	0.0	2.0	4.8	0.2	1.3	8.6	0.1	0.2	1.7	0.4	0.0	0.8	6.6	6.1	22.6	0.2	0.1	0.1	1.0	0.8	0.4	19.1	3.0	0.2
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580004-36582614	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;esophagus: 2.6;testis: 8.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;PC-3: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.0	0.0	0.9	0.0	1.0	0.0	0.0	1.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.0	1.9	1.2	0.1	0.0	0.0	0.1	1.1	0.0	2.2	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	8.0	1.9	0.0	1.4	0.0	0.0	0.0	0.0	4.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.2	0.6	0.2	2.1	1.9	1.2	0.1	2.2	2.8	1.9	4.9	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.9	6.8	0.0	1.0	1.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	3.4	0.4	0.0	0.0	0.0	0.0	0.4
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Microglial cells: 26.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074367			Approved	Mitochondria		NA	NA			Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	10.6	2.9	3.2	8.9	2.9	6.9	9.6	2.5	2.8	4.9	5.6	5.1	2.2	6.2	2.6	4.8	6.5	5.5	7.3	2.2	7.3	3.9	2.2	12.0	6.1	7.6	3.5	1.7	10.4	1.8	2.8	2.9	12.3	4.7	4.1	4.4	0.6	6.2	3.2	4.0	5.5	5.5	7.4	3.0	11.2	4.9	2.0	4.6	3.5	10.9	4.0	5.0	7.3	5.0	4.5	4.8	2.5	3.5	10.5	2.2	10.3	5.3	3.3	2.3	5.5	7.0	2.2	5.7	6.9	3.8	4.2	6.1	11.2	3.5	5.8	3.7	3.6	3.0	9.7	7.7	2.2	2.8	4.3	7.0	9.6	2.5	3.5	3.0	4.9	18.3	10.1	5.2	2.4	5.0	2.8	6.2	7.7	4.1	5.3	4.5	7.4	4.0	6.3	1.8	3.8	0.6	12.4	4.2	10.7	3.7	4.8	3.6	9.6	7.7	4.8	7.6	6.0	4.5	2.2	8.0	0.3	3.5	15.1	5.1	13.7	3.7	13.5	8.1	5.0	8.9	7.5	5.5	5.3	3.3	10.9	4.9	4.0	2.8	8.5	6.6	8.0	4.8	2.6	3.2	2.9	2.5	2.8	2.2	7.3	7.6	3.5	1.7	4.7	3.0	4.6	4.5	19.3	3.2	15.1	7.2	6.6	0.8	0.5	1.0	5.2	2.4	2.9	2.9	4.9	1.5	5.0	5.5	0.0	5.0	6.7	4.5	0.0	1.3	0.2	4.4	1.7	12.0	0.0	3.4	5.3	2.1	2.3	8.2	1.1	4.6	2.5	7.8	13.6	1.3	4.6	0.0	1.4	5.5	2.0	3.1	3.7	0.0	0.6	4.3	5.4	26.2	4.0	0.6	6.2	2.5	1.1	1.7	1.7	1.9	3.1	0.2	1.6	0.5	2.9	0.2	0.0	2.5	5.6	0.0	0.6	5.4	1.8	1.5	5.3	1.0	5.6	0.8
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.1;parathyroid gland: 39.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.4	18.5	9.0	0.1	19.4	1.2	2.1	9.4	45.1	4.5	3.3	1.0	2.2	5.1	0.9	1.0	3.2	1.9	1.7	14.4	11.2	6.7	1.6	1.8	0.6	9.6	10.9	18.6	1.5	11.1	39.5	18.6	0.5	11.7	6.7	1.1	5.7	2.8	1.4	0.3	1.8	1.2	3.6	1.3	12.6	1.9	5.2	7.9	3.0	25.5	0.3	0.4	2.1	2.3	16.9	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	9.0	19.4	9.4	45.1	14.4	11.2	9.6	10.9	18.6	11.7	1.3	7.9	16.9	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 138.2;thyroid gland: 236.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	19.5	6.4	9.9	5.6	7.7	0.2	27.2	4.7	7.7	30.9	6.8	23.9	56.6	21.0	22.4	11.0	22.6	30.8	5.3	7.5	13.6	104.2	4.0	138.2	4.5	5.7	26.1	8.5	11.0	40.4	1.0	47.8	3.4	6.6	83.6	25.5	2.4	9.0	18.9	5.0	7.6	74.7	14.2	4.1	14.9	15.0	3.2	10.9	14.3	236.4	11.6	5.4	9.7	22.3	6.1	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	7.7	4.7	7.7	7.5	13.6	5.7	26.1	8.5	6.6	4.1	10.9	6.1	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.1;brain: 4.7;thyroid gland: 6.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.5;K-562: 4.1;PC-3: 13.2;U-2 OS: 8.4;U-937: 6.3;WM-115: 9.4"					"Not detected"	"Not detected"			HPA045594	Uncertain					NA	NA					"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.3	0.6	0.9	0.4	1.2	13.1	0.2	0.0	1.3	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.8	0.1	0.1	1.4	4.0	0.1	0.1	0.5	0.1	2.8	2.6	1.6	0.0	0.3	0.0	0.2	1.4	3.3	0.5	0.6	0.3	0.1	0.2	0.0	0.4	0.2	0.5	0.5	1.0	0.2	1.2	4.7	0.1	6.3	0.9	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.3	13.5	0.0	0.0	0.0	1.7	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	13.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	8.4	0.0	0.0	1.4	0.0	0.0	0.0	6.3	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.2	0.0	1.3	1.4	4.0	2.8	2.6	1.6	3.3	0.5	4.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.5	52.3	3.7	27.9	6.4	0.4	29.6	0.0	20.9	43.7	2.5	92.2	7.0	35.0	14.1	13.6	23.5	28.9	104.6	10.2	24.9	56.4	1.3	34.0	18.3	2.0	10.7	7.1	19.8	34.4	73.7	41.4	41.1	14.7	84.5	114.5	6.1	39.7	65.1	21.2	11.0	15.8	48.6	0.0	15.4	13.5	12.1	4.2	17.5	124.8	18.2	21.0	45.2	25.2	7.2	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	3.7	6.4	0.0	20.9	10.2	24.9	2.0	10.7	7.1	14.7	0.0	4.2	7.2	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 154.2"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.8	56.5	11.1	13.0	15.7	6.9	10.1	17.5	11.7	23.6	8.5	34.6	6.9	9.9	20.2	11.9	14.4	22.7	38.3	7.5	15.5	6.9	18.3	13.1	8.0	19.2	18.6	7.4	58.7	18.9	154.2	12.7	6.8	18.3	31.1	13.8	28.2	11.9	28.3	8.6	19.5	14.4	22.8	19.6	12.9	21.7	8.3	16.0	16.8	35.4	5.8	7.0	20.9	22.0	22.9	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	11.1	15.7	17.5	11.7	7.5	15.5	19.2	18.6	7.4	18.3	19.6	16.0	22.9	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867438-39929397	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 609.6;seminal vesicle: 1292.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 600.9;Distal tubular cells: 645.6;Horizontal cells: 1398.2;Proximal tubular cells: 941.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 41.7;thyroid cancer: 48.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 215.9;T-47d: 64.7"					"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	5.3	53.4	196.0	2.0	501.1	0.0	8.5	161.8	168.6	173.9	429.8	81.3	5.2	128.0	368.8	230.4	10.3	4.2	4.5	126.1	185.8	52.7	0.5	0.6	0.2	163.0	321.1	66.0	3.6	6.2	19.8	8.9	2.0	145.7	326.3	32.6	388.7	21.5	1292.4	0.6	13.6	6.0	55.1	59.0	2.7	7.1	0.9	609.6	8.0	229.9	0.0	1.0	471.9	129.7	89.2	0.0	0.0	3.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	2.3	1.9	0.0	0.0	0.0	0.0	215.9	0.5	0.0	0.3	0.3	0.0	34.8	0.0	0.2	64.7	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	196.0	501.1	161.8	168.6	126.1	185.8	163.0	321.1	66.0	145.7	59.0	609.6	89.2	0.0	0.0	1.5	15.3	2.9	3.1	0.4	0.0	0.0	600.9	0.4	0.4	8.8	2.8	0.0	77.3	62.6	0.3	0.0	0.1	645.6	0.4	1.3	0.0	0.2	5.0	1.2	0.0	71.3	0.2	0.3	1.5	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1398.2	21.5	0.2	0.0	0.0	7.5	0.4	9.6	7.0	21.4	8.4	0.0	68.4	0.0	7.5	11.9	0.8	0.2	0.4	0.0	4.4	0.0	941.2	0.0	200.0	0.0	0.0	77.4	3.4	9.5	0.0	6.0	2.9	2.2	0.5	0.5	1.0
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.1;thyroid gland: 46.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 396.3;Excitatory neurons: 764.9;Late spermatids: 592.1;Oligodendrocytes: 1178.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 37.2;HHSteC: 22.0;HSkMC: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	9.7	4.4	14.7	4.6	20.9	0.0	5.0	38.1	23.4	15.5	5.4	9.0	3.0	8.8	8.1	5.6	10.4	24.0	15.7	27.3	12.0	47.1	3.9	3.6	2.1	8.2	9.5	18.6	11.0	2.1	2.2	2.7	1.2	12.9	3.6	6.7	1.4	2.1	5.5	2.8	1.8	5.8	13.0	5.4	3.2	5.6	35.9	15.9	8.4	46.2	5.0	0.9	9.8	9.9	19.3	0.0	0.2	3.9	0.0	37.2	3.1	0.1	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	4.7	0.0	5.1	0.0	22.0	0.0	0.0	47.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.5	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.7	0.0	5.4	0.1	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.7	20.9	38.1	23.4	27.3	12.0	8.2	9.5	18.6	12.9	5.4	15.9	19.3	6.7	0.0	2.6	15.3	0.0	1.3	2.0	0.1	8.0	20.0	0.3	0.3	5.9	1.5	1.4	27.6	0.0	0.1	0.0	0.1	185.9	0.5	396.3	0.3	0.4	8.9	0.0	0.0	764.9	0.4	0.0	18.6	0.0	0.8	0.0	0.1	5.0	0.0	0.1	0.0	185.8	1.0	0.0	0.0	1.8	592.1	14.9	0.4	0.0	30.0	0.0	0.3	0.0	18.1	1178.0	0.2	0.1	8.2	0.2	2.6	0.1	1.5	0.0	1.2	52.6	21.0	45.1	9.1	4.9	1.0	1.3	0.0	0.2	7.6	0.1	0.7
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	34.4	4.2	2.5	3.9	3.4	0.2	52.4	2.8	3.0	28.0	2.1	6.8	0.9	15.9	10.4	3.0	23.5	13.5	9.4	2.3	6.7	1.3	0.7	4.7	1.2	2.7	2.6	2.1	43.3	6.9	9.1	7.5	9.1	2.6	5.5	3.2	0.6	13.2	6.8	18.6	10.2	2.7	26.3	2.4	0.8	6.2	6.5	2.7	3.8	33.3	38.3	2.0	6.5	12.1	3.3	0.0	17.7	1.0	189.4	5.6	2.5	13.8	4.6	159.1	7.5	31.3	1.0	0.2	0.0	0.9	2.5	24.7	0.0	11.6	0.9	3.7	0.2	14.5	0.0	5.3	4.1	14.6	0.0	0.0	86.9	0.1	9.2	0.1	0.0	13.0	1.6	0.0	2.4	1.1	12.5	0.2	0.4	9.9	0.7	3.6	0.0	0.2	0.4	1.0	11.4	0.6	1.2	1.4	1.7	3.3	11.4	0.6	0.0	2.6	0.2	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.4	2.8	3.0	2.3	6.7	2.7	2.6	2.1	2.6	2.4	2.7	3.3	15.5	0.0	3.6	2.3	0.3	13.3	0.5	4.3	0.6	0.6	2.9	3.3	4.5	1.5	2.8	0.0	0.0	14.9	0.7	0.4	0.0	4.1	36.0	2.4	5.4	4.1	1.2	0.0	1.1	7.1	19.9	186.2	0.5	4.7	0.0	0.3	1.4	0.2	3.5	0.0	3.5	1.3	2.0	0.0	14.6	6.7	74.6	1.6	10.6	1.9	1.6	1.4	0.0	3.0	1.3	3.1	0.1	70.7	0.2	1.9	0.4	0.1	0.2	0.4	0.0	8.0	10.7	0.8	1.9	0.6	9.9	9.7	1.7	1.5	0.4	0.5
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596516	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2318.9;tongue: 1227.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 681.3;Cardiomyocytes: 764.5;Kupffer cells: 464.0;Proximal enterocytes: 654.2;Smooth muscle cells: 489.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8;thyroid cancer: 89.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 32.5;eosinophil: 38.1;intermediate monocyte: 63.5;myeloid DC: 16.8;non-classical monocyte: 39.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 16.8;granulocytes: 38.1;monocytes: 63.5"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 482.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA					"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	455.2	218.3	32.4	33.7	47.4	2.5	392.0	32.9	43.4	73.7	188.5	223.9	72.9	89.7	10.5	152.8	154.8	81.3	371.8	40.7	161.7	129.0	225.3	121.5	24.2	46.9	42.6	25.3	243.0	554.0	18.4	40.2	105.7	45.2	92.0	43.0	2.0	60.7	534.4	2318.9	80.8	164.7	62.7	35.7	99.8	174.6	13.4	38.2	13.9	72.7	1227.3	13.6	189.1	96.0	61.0	0.0	37.7	1.5	9.5	482.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	12.8	0.0	5.3	1.7	1.6	0.0	0.1	0.0	0.0	0.0	1.3	0.2	66.8	0.0	4.5	0.0	0.0	5.3	0.0	0.0	0.0	0.2	2.4	0.0	1.7	0.0	0.2	0.9	0.0	0.4	0.1	0.0	2.1	0.0	0.0	0.3	23.5	2.6	0.5	2.7	0.0	3.0	8.6	2.4	1.3	1.1	0.0	0.0	0.8	2.1	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.3	32.5	38.1	0.0	63.5	0.1	0.4	0.0	0.0	16.8	1.5	0.0	0.0	2.5	3.3	39.8	0.5	0.0	14.2	32.4	47.4	32.9	43.4	40.7	161.7	46.9	42.6	25.3	45.2	35.7	38.2	61.0	681.3	32.1	16.0	154.4	6.0	10.5	279.2	9.2	19.9	0.1	95.9	40.6	764.5	30.0	36.1	378.9	0.0	5.9	3.9	67.7	13.7	7.2	14.9	151.0	52.1	108.0	55.4	9.3	0.4	5.5	0.7	326.9	158.5	347.5	5.1	19.9	199.2	130.5	49.8	0.0	1.2	96.0	6.1	464.0	21.5	6.7	134.2	204.8	90.7	19.7	19.8	8.4	1.0	7.1	26.2	6.2	46.3	44.8	6.4	110.0	654.2	74.2	66.3	0.4	164.3	293.2	489.7	1.8	1.0	12.3	9.2	10.9	5.3	18.7	60.5	157.4
PDZRN4	"DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4"	ENSG00000165966	"PDZ domain containing ring finger 4"	Q6ZMN7	12	41188320-41574745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 18.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 371.6;Inhibitory neurons: 125.6;Oligodendrocyte precursor cells: 561.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"U-266/70: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042101	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042101: AB_2732496"	"unprognostic (6.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.41e-3)"	1.2	0.9	1.1	1.1	2.2	0.0	2.0	0.3	2.2	2.2	0.2	7.9	0.8	0.9	2.2	3.9	2.2	1.7	0.4	1.5	1.0	0.5	0.6	0.3	0.0	1.7	2.8	1.2	1.9	0.4	0.2	0.4	4.0	1.6	6.6	3.1	1.0	0.3	18.0	0.3	0.5	2.9	2.5	1.1	0.2	3.3	2.4	1.5	0.0	0.3	1.9	0.3	3.9	2.6	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.3	2.2	1.5	1.0	1.7	2.8	1.2	1.6	1.1	1.5	2.0	0.1	0.0	0.0	37.5	0.3	0.8	0.0	0.0	2.8	9.8	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.3	0.0	0.0	371.6	0.0	0.2	17.3	1.1	0.0	0.0	19.8	1.4	0.0	0.4	0.0	125.6	0.0	0.0	0.0	0.3	1.6	28.0	0.2	0.0	5.6	0.0	0.4	0.0	561.9	13.7	0.0	0.0	56.4	1.2	0.1	0.0	0.0	0.7	1.1	0.0	0.1	5.7	0.1	0.2	0.8	0.6	0.4	0.0	34.1	0.0	0.1
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 229.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	8.2	33.4	115.5	1.5	165.5	0.0	9.4	116.4	229.2	10.8	0.0	10.5	1.3	14.6	2.8	9.9	25.8	6.8	3.9	225.3	67.1	9.2	0.7	2.5	0.2	82.5	32.3	163.6	7.1	1.6	0.2	36.0	2.5	94.2	12.0	0.6	2.2	1.8	6.0	0.9	52.4	5.1	8.1	2.2	11.6	3.7	10.8	38.5	0.2	3.9	0.3	0.2	12.2	15.3	150.5	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.5	165.5	116.4	229.2	225.3	67.1	82.5	32.3	163.6	94.2	2.2	38.5	150.5	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	156.2	53.4	90.6	33.9	85.3	13.2	141.0	86.4	106.9	297.1	47.8	56.4	24.2	108.1	56.7	51.8	123.6	66.9	79.7	86.1	86.1	92.2	183.5	87.7	22.6	98.8	95.4	72.2	82.6	37.1	131.3	23.3	227.4	103.3	103.7	42.2	19.2	76.8	171.3	51.3	76.2	46.2	66.1	77.3	23.5	66.6	37.6	107.9	30.1	330.7	63.5	20.1	140.4	144.0	83.3	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	90.6	85.3	86.4	106.9	86.1	86.1	98.8	95.4	72.2	103.3	77.3	107.9	83.3	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143044-150250392	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 76.2;skeletal muscle: 67.1;skin 1: 92.9;thyroid gland: 59.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 53.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044667, HPA047907"	Approved					NA	NA					"CAB044667: , HPA047907: "	"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.3	0.2	5.4	1.4	6.4	0.2	6.1	6.9	8.6	5.1	5.7	12.7	10.5	1.4	0.9	18.5	16.1	0.1	76.2	8.1	4.9	9.6	0.0	12.4	0.3	6.2	5.3	5.9	0.1	0.7	5.1	1.7	3.4	6.4	1.3	8.7	0.6	3.2	0.2	67.1	92.9	2.7	0.9	5.0	0.1	0.8	6.8	5.0	0.5	59.3	8.5	5.9	0.5	22.2	7.8	27.9	0.1	11.7	0.1	0.1	0.6	0.0	3.7	0.0	0.0	0.1	1.3	3.8	0.7	8.0	5.3	1.8	40.7	6.1	86.1	0.0	0.0	36.2	0.3	0.0	0.0	0.0	0.0	1.1	0.0	103.0	0.2	41.1	0.0	0.0	0.5	23.6	0.0	0.0	3.8	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	35.5	1.5	6.2	0.0	0.6	37.7	2.2	0.7	0.2	1.9	0.0	0.1	20.4	32.5	9.5	0.0	0.0	0.0	14.2	16.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.4	6.9	8.6	8.1	4.9	6.2	5.3	5.9	6.4	5.0	5.0	7.8	0.3	19.2	41.1	1.3	0.5	280.2	17.9	19.6	12.0	1.1	6.5	4.3	79.5	0.0	17.1	14.7	0.0	0.1	0.4	24.5	1.9	3.8	0.2	37.9	0.6	3.0	28.2	0.0	28.0	0.2	0.1	6.7	0.0	5.1	1.3	4.1	0.0	0.0	3.0	1.7	13.3	3.1	14.2	0.0	19.7	1.6	0.0	0.6	30.2	2.8	1.1	0.0	0.0	37.2	2.5	12.8	41.5	0.4	0.0	16.6	5.0	38.6	61.5	0.5	0.0	80.9	4.3	0.5	1.8	14.7	336.6	1.9	1.4	0.5	8.7	1.9
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	4	"B-cells: 11.5"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 1015.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	5.6	3.0	2.1	5.2	4.6	1.7	5.0	0.0	6.6	12.6	0.0	3.3	2.7	12.2	1.6	2.4	6.4	10.1	14.0	4.1	2.6	5.0	1.7	9.6	4.6	0.2	1.6	3.7	12.6	2.0	1.4	2.0	5.4	1.5	5.1	2.3	4.3	7.9	5.6	4.0	4.5	2.4	12.8	0.0	15.0	2.9	6.1	4.0	1.7	7.9	4.7	3.5	5.5	6.3	4.4	7.7	4.4	17.0	0.5	12.4	13.1	0.5	11.0	5.2	3.0	5.1	0.5	16.0	0.5	31.4	1.6	0.0	2.9	12.5	1015.4	3.5	0.6	6.4	17.5	0.9	0.4	1.7	0.3	0.2	19.3	7.5	12.7	1.7	1.8	39.7	0.3	1.8	3.1	2.9	0.3	0.1	0.5	56.1	0.1	18.0	0.2	0.7	0.1	21.1	0.7	4.4	3.0	0.3	0.7	0.7	13.7	0.3	35.1	2.9	0.9	13.4	14.0	14.2	0.9	0.6	6.1	0.2	10.7	0.6	2.6	1.8	0.4	0.2	1.0	0.7	7.6	0.2	0.2	1.0	11.5	0.4	0.2	2.4	0.5	0.6	1.6	0.2	0.9	2.1	4.6	0.0	6.6	4.1	2.6	0.2	1.6	3.7	1.5	0.0	4.0	4.4	6.9	16.0	8.2	8.8	13.2	2.7	5.3	7.3	4.0	13.5	4.0	2.2	5.7	14.3	2.6	1.8	2.1	0.6	0.2	0.0	0.0	3.8	72.8	5.2	43.0	8.1	0.0	0.4	307.7	2.6	0.2	19.2	3.6	8.6	1.3	59.1	14.6	0.1	0.6	8.4	122.2	0.0	2.0	0.9	2.3	25.4	9.9	1.2	7.2	64.6	1.1	2.7	0.0	114.6	5.3	3.9	0.1	24.8	3.1	1.0	0.0	3.3	0.3	4.5	0.0	3.8	7.9	5.1	4.8	1.9	1.4	0.7	1.1	18.6	0.0	0.8
PRMT8	"HRMT1L3, HRMT1L4"	ENSG00000111218	"Protein arginine methyltransferase 8"	Q9NR22	12	3381349-3593973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.7;retina: 3.9;testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.7;Cone photoreceptor cells: 16.7;Early spermatids: 22.8;Excitatory neurons: 60.5;Inhibitory neurons: 63.8;Late spermatids: 15.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"hTERT-HME1: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039747, HPA069769"	Enhanced					NA	NA					"HPA039747: AB_2732482, HPA069769: AB_2686193"	"unprognostic (3.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (5.59e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.80e-3)"	"unprognostic (9.41e-2)"		"unprognostic (3.41e-5)"	"unprognostic (5.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.49e-2)"	0.0	0.0	2.4	0.0	7.1	0.0	0.0	4.2	7.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.9	5.0	4.9	0.3	0.0	0.8	0.0	2.3	3.5	4.9	0.0	0.6	0.0	0.1	0.0	2.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	4.0	1.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	7.1	4.2	7.7	5.0	4.9	2.3	3.5	4.9	2.8	0.4	4.0	3.8	0.0	6.4	1.7	1.6	0.1	0.0	0.0	0.0	0.0	21.7	0.1	0.0	1.3	0.0	5.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	22.8	2.2	0.1	0.3	0.0	0.0	60.5	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.0	63.8	0.0	4.1	0.0	4.2	15.4	0.6	0.4	0.0	1.0	0.0	0.7	0.0	3.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	7.5	1.6	0.0	0.0	0.2	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.2
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 91.5;heart muscle: 117.8;liver: 285.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 83.1;Hepatocytes: 307.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 64.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 112.3;ASC TERT1: 100.1;HSkMC: 78.2;SK-MEL-30: 157.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	5000000000			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	33.9	8.8	1.9	8.2	1.3	0.3	24.9	1.5	3.0	14.8	91.5	17.4	13.7	16.5	2.0	16.8	19.5	34.0	117.8	3.2	5.0	38.0	285.5	39.5	4.7	2.1	2.5	0.8	32.9	5.7	13.6	8.6	32.3	2.2	8.5	21.8	4.6	12.4	10.4	4.9	18.3	20.7	19.4	1.8	11.3	10.6	5.1	2.3	1.5	17.2	17.1	3.7	18.7	15.2	1.5	0.4	2.7	3.0	27.1	112.3	100.1	1.6	4.6	9.4	1.0	6.6	12.7	1.4	0.0	30.0	3.0	18.8	0.0	1.4	0.9	1.8	0.1	7.3	51.4	1.4	29.8	8.7	1.5	1.2	78.2	0.4	4.0	0.6	63.0	7.2	3.7	32.8	0.1	49.2	0.0	0.1	0.0	3.1	2.7	6.5	0.3	1.2	0.0	27.7	0.0	7.6	19.8	5.0	0.0	157.0	0.6	0.0	19.9	9.4	14.8	2.8	8.2	1.7	0.0	0.0	0.0	60.4	30.4	27.8	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	3.2	1.9	1.3	1.5	3.0	3.2	5.0	2.1	2.5	0.8	2.2	1.8	2.3	1.5	55.9	64.1	33.8	17.9	1.9	14.8	3.6	2.1	4.0	0.5	1.7	14.0	44.6	14.3	7.5	1.8	10.4	0.6	0.5	7.5	3.9	9.8	3.2	2.1	30.7	47.1	15.7	16.4	28.4	4.4	0.7	83.1	2.0	1.1	30.9	5.0	65.7	307.1	12.8	1.7	19.7	11.6	0.0	31.5	20.6	6.3	28.6	14.6	19.6	27.2	1.3	22.8	0.0	10.6	4.6	5.6	19.3	36.9	0.3	4.5	1.9	42.2	56.6	8.1	13.1	32.4	28.4	0.4	0.7	11.8	33.2	1.6	2.1	10.8	12.6	2.3
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004305	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 58.8"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;REH: 3.7;TIME: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051264			Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	2.0	0.3	7.3	0.5	3.2	0.3	2.2	4.7	2.4	3.7	10.8	0.4	0.2	0.6	0.3	0.2	58.8	0.7	1.1	3.1	6.0	1.1	0.2	10.5	0.4	10.3	10.4	1.0	0.6	0.3	0.9	10.8	0.3	7.0	0.7	0.0	0.0	0.6	0.6	0.6	0.4	0.7	0.2	9.7	5.8	0.4	14.0	4.9	0.2	4.8	0.0	0.3	0.8	0.6	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.7	0.1	3.7	0.0	1.5	0.3	0.0	0.2	1.0	0.0	0.1	0.2	0.5	0.5	0.0	2.8	0.1	1.1	0.4	0.1	0.4	0.1	0.2	0.4	0.1	0.0	0.9	0.2	0.0	0.4	0.5	0.1	0.1	0.4	0.2	0.1	0.2	0.7	0.4	0.2	0.2	0.4	0.0	0.2	0.3	7.3	3.2	4.7	2.4	3.1	6.0	10.3	10.4	1.0	7.0	9.7	4.9	4.0	3.3	0.0	2.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	1.5	9.9	3.7	0.0	0.0	0.7	0.0	0.0	0.1	12.4	57.4	0.5	2.1	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	0.0	1.6	1.8	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	10.5	0.0	0.9	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.1	89.6	0.0	0.0	0.3	0.3	18.1	1.4	0.0	0.0	0.3	0.7	3.5	0.0	0.1
PSG1	"CD66f, PBG1, PSBG1, PSGGA"	ENSG00000231924	"Pregnancy specific beta-1-glycoprotein 1"	P11464	19	42866464-42879822	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	193	"placenta: 262.1"	"Cell type enriched"	"Detected in some"	98	"Syncytiotrophoblasts: 207.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"U-2197: 412.3"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		75000000			"HPA046327: AB_2679624"					"unprognostic (2.02e-1)"	"unprognostic (3.54e-1)"							"unprognostic (2.44e-7)"			"unprognostic (2.28e-2)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	262.1	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.1	18.1	6.0	1.5	2.3	0.0	0.4	0.0	0.0	21.1	4.3	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	21.9	0.2	0.0	0.7	0.0	0.0	412.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.3	0.7	0.4	0.0	0.2	0.0	0.2	0.7	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	207.0	0.0	0.0	0.0	0.0
RAPGEF3	"bcm910, cAMP-GEFI, EPAC"	ENSG00000079337	"Rap guanine nucleotide exchange factor 3"	O95398	12	47734363-47771040	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004386, HPA040365, HPA043518"	Approved		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524"	"unprognostic (2.12e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (6.67e-7)"	"unprognostic (9.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.61e-3)"	"unprognostic (3.38e-2)"	41.9	2.8	27.2	2.6	32.2	1.4	44.4	28.9	29.4	25.5	12.0	9.2	4.1	16.5	6.9	13.3	24.3	13.3	16.7	27.9	21.4	40.0	1.9	12.0	4.5	32.5	28.3	20.3	38.5	4.8	5.9	6.5	9.0	33.6	13.6	2.5	0.9	21.4	11.1	11.5	9.5	8.9	5.2	21.9	16.3	11.6	3.6	28.5	1.6	32.6	9.0	2.1	15.1	21.4	39.1	2.3	0.6	0.7	2.4	0.3	2.3	0.9	1.7	1.5	0.7	0.4	0.3	6.1	0.1	26.9	3.0	1.1	2.4	0.8	4.5	0.3	3.0	0.4	0.2	2.6	0.2	0.2	0.4	0.3	0.9	0.3	1.3	0.8	3.4	12.1	0.6	0.1	2.9	0.5	1.5	0.0	14.3	0.6	1.0	3.7	0.4	0.1	1.0	13.3	2.5	0.2	0.3	0.2	1.7	0.4	0.8	6.7	0.6	12.0	6.6	1.1	1.5	0.6	1.0	0.4	0.2	4.1	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	32.2	28.9	29.4	27.9	21.4	32.5	28.3	20.3	33.6	21.9	28.5	39.1	130.6	0.0	11.7	143.0	0.7	2.7	5.8	2.6	13.1	0.5	4.5	4.8	15.7	2.8	3.6	69.9	0.0	0.2	1.4	1.7	7.9	1.1	1.6	11.8	2.4	53.0	0.0	0.0	1.5	0.7	0.4	6.3	18.3	21.2	3.8	1.5	20.7	0.2	0.9	0.0	2.9	6.6	4.1	0.6	2.6	3.7	24.2	1.5	5.4	12.2	0.0	1.5	2.1	10.6	45.7	5.8	6.3	8.6	4.4	11.6	0.8	41.3	1.9	0.5	6.6	2.7	5.1	1.2	1.6	1.4	3.3	0.3	1.3	6.6	0.8	17.2
RBMS3		ENSG00000144642	"RNA binding motif single stranded interacting protein 3"	Q6XE24	3	28574791-30010391	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 331.1;Inhibitory neurons: 655.9;Microglial cells: 1013.7;Oligodendrocyte precursor cells: 229.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.7;WM-115: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034719	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034719: AB_10670172"	"unprognostic (8.39e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.25e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.24e-4)"	15.8	8.7	6.8	2.1	6.2	0.1	12.3	9.6	6.4	9.5	16.1	6.5	1.4	6.2	6.7	3.1	9.9	6.8	10.9	2.1	19.2	5.1	3.7	12.7	2.7	11.3	7.0	1.4	11.7	2.0	5.0	3.3	10.5	9.2	6.5	2.7	0.4	4.7	8.8	6.5	3.5	4.1	4.5	5.6	6.6	4.3	2.2	10.4	5.5	15.5	10.9	1.7	8.2	7.4	10.7	2.2	0.2	10.2	0.1	19.6	12.5	0.0	5.7	3.6	5.9	6.8	0.0	0.4	0.0	6.1	20.7	1.8	0.2	0.5	3.8	10.9	0.0	1.1	5.9	8.7	0.0	19.9	0.1	0.0	11.8	2.6	10.5	12.3	8.4	7.9	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.3	0.0	0.4	0.4	7.5	0.0	2.2	0.0	0.0	19.4	13.7	0.0	0.7	4.6	0.0	0.0	17.1	11.1	11.6	13.5	11.7	0.0	0.0	0.8	1.5	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.9	0.3	0.0	6.8	6.2	9.6	6.4	2.1	19.2	11.3	7.0	1.4	9.2	5.6	10.4	10.7	100.9	118.6	18.8	331.1	0.6	8.3	25.5	23.0	2.2	0.4	2.7	19.8	16.2	31.5	21.3	9.2	0.0	16.4	5.9	0.0	0.0	5.3	35.1	2.8	7.0	54.4	0.0	0.0	20.7	1.2	3.0	96.8	2.0	4.6	5.1	19.8	129.9	1.9	2.8	0.0	655.9	0.0	6.1	30.3	14.1	18.8	159.7	2.7	7.2	1013.7	0.6	0.0	0.0	229.2	8.9	0.4	0.0	110.6	0.1	24.3	0.0	2.9	10.5	0.0	111.7	154.6	73.5	1.2	1.5	2.4	7.2	9.6	2.9	22.4	0.0	4.7
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419328	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.2;thyroid gland: 65.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Collecting duct cells: 51.5;Gastric mucus-secreting cells: 48.4;Sertoli cells: 39.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 26.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;CACO-2: 10.4;RT4: 22.0;SK-BR-3: 9.7;T-47d: 15.9"	"Region enriched"	"Detected in many"	6	"cerebellum: 9.0"	"Low region specificity"	"Detected in many"			"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favorable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	6.7	11.5	1.3	0.7	1.3	0.0	7.4	1.5	2.5	10.4	5.5	2.2	1.4	4.8	9.6	1.1	9.5	2.1	7.7	1.6	2.7	36.1	10.7	9.0	0.6	2.1	1.3	0.3	2.5	21.1	46.2	15.5	5.6	1.9	6.5	1.4	0.8	5.9	9.5	2.1	1.3	1.8	0.9	1.5	8.2	13.9	0.6	1.8	0.2	65.4	0.6	0.3	5.3	5.7	1.6	0.0	0.6	0.0	0.1	1.1	0.2	17.7	1.1	1.4	0.6	2.0	10.4	7.4	0.0	6.5	1.3	2.6	4.6	0.0	0.0	0.1	0.0	0.0	0.1	4.2	3.3	2.7	0.0	0.0	0.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.9	1.4	0.0	0.7	2.2	6.3	22.0	1.0	5.2	0.2	9.7	3.3	3.7	15.9	0.0	0.0	3.3	0.0	2.5	0.9	0.0	0.6	1.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.3	1.5	2.5	1.6	2.7	2.1	1.3	0.3	1.9	1.5	1.8	1.6	3.1	19.2	21.0	32.3	1.1	0.1	2.1	0.4	1.8	0.3	3.3	4.6	4.6	12.8	12.4	51.5	0.0	12.9	0.0	2.2	11.7	8.6	0.0	14.8	9.6	5.8	10.3	0.0	0.5	4.2	11.9	4.1	48.4	18.4	1.3	3.1	26.0	5.8	3.0	0.0	0.6	7.7	2.0	7.4	0.3	0.2	3.7	1.5	5.4	4.7	0.0	16.9	0.0	1.5	0.5	5.7	5.3	0.4	0.6	1.4	0.0	4.6	1.7	0.6	39.5	9.9	18.7	0.6	1.7	0.0	0.0	12.0	0.2	0.8	2.4	2.0
RPS6KA2	"HU-2, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 26.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"eosinophil: 22.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	30.0	9.1	41.1	8.1	39.3	10.6	28.0	35.2	36.5	18.3	12.2	15.2	6.2	26.2	7.2	20.3	18.9	18.4	62.4	38.8	39.5	13.8	6.7	45.4	7.6	46.7	42.1	31.1	29.4	19.6	50.0	27.4	18.1	45.4	15.0	10.4	29.2	14.8	14.4	24.3	15.2	16.6	22.9	40.6	26.3	21.6	7.7	44.6	6.0	36.6	30.8	7.4	24.7	15.0	51.9	9.1	0.0	17.9	26.0	214.5	156.1	0.4	19.3	37.4	10.6	14.6	0.0	5.8	1.1	6.2	68.2	8.4	8.2	9.4	41.8	9.4	4.2	2.3	0.1	40.2	0.4	158.5	0.6	7.2	141.4	29.4	56.6	173.0	316.2	58.0	19.2	0.2	0.2	43.6	1.9	0.8	2.1	4.5	9.1	10.5	3.0	9.2	27.3	11.1	10.1	9.8	68.8	6.7	17.9	24.8	4.4	0.5	14.3	21.7	37.3	3.7	103.8	5.6	5.2	8.4	2.6	24.8	1.2	36.0	0.2	0.6	22.4	0.6	0.8	0.3	0.3	0.6	0.3	0.8	0.5	0.7	0.3	0.5	4.4	2.2	4.7	0.5	0.4	41.1	39.3	35.2	36.5	38.8	39.5	46.7	42.1	31.1	45.4	40.6	44.6	51.9	60.9	22.4	46.2	399.6	2.7	4.7	5.4	4.6	3.4	37.1	7.1	5.0	60.0	15.7	11.6	36.8	8.4	0.2	8.0	1.9	11.7	15.2	14.8	20.6	4.6	58.2	5.4	0.0	204.1	24.0	0.3	16.3	16.8	20.3	2.5	10.5	45.3	11.9	7.2	287.7	552.3	5.3	2.0	6.0	6.7	69.3	5.3	8.0	19.6	144.3	3.5	10.1	1.0	244.8	97.7	26.8	1.7	4.5	2.4	9.9	0.3	7.0	9.4	17.1	13.1	10.0	14.5	3.5	2.3	1.2	3.4	0.3	2.0	9.5	1.4	6.6
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002311	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;lung: 12.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Early spermatids: 6.6;Late spermatids: 7.3;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;EFO-21: 2.0;fHDF/TERT166: 2.4;NTERA-2: 6.3;SK-BR-3: 4.3;U-2 OS: 6.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"			HPA048887	Uncertain				"Secreted in other tissues"	NA	NA					"HPA048887: AB_2680545"	"unprognostic (2.36e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (8.93e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.68e-9)"	"unprognostic (6.65e-3)"	"unprognostic (4.41e-2)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	0.3	0.2	4.9	0.6	4.6	0.0	1.3	2.3	5.4	0.6	1.1	0.2	0.1	0.3	1.4	0.9	1.6	0.5	0.4	3.0	5.8	0.6	0.3	12.7	0.0	11.2	7.4	2.1	0.4	0.3	0.3	2.1	0.2	12.8	0.4	0.0	1.2	0.4	0.2	0.1	2.5	0.3	0.0	3.5	0.2	0.2	3.2	7.4	0.0	3.0	0.0	0.4	0.2	0.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.2	0.0	0.1	0.0	0.0	0.0	0.8	2.0	2.4	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.6	2.3	5.4	3.0	5.8	11.2	7.4	2.1	12.8	3.5	7.4	9.6	0.0	0.0	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.0	0.0	2.9	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.8	7.3	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	2.1	0.9	0.0	0.4	0.3	0.0	0.0	0.0	0.0
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	1.3	1.3	1.2	0.4	1.0	0.2	1.2	3.2	1.2	2.2	1.6	1.8	0.4	2.6	2.0	0.5	2.3	1.1	0.8	0.7	1.1	1.4	0.8	1.4	0.3	0.2	0.3	0.8	2.8	0.6	1.1	7.2	1.0	1.4	1.5	0.4	0.7	0.8	1.3	0.3	0.4	1.1	1.2	0.0	0.8	1.9	1.4	1.1	0.1	3.8	0.4	0.1	1.7	1.5	0.8	0.0	0.1	3.7	4.2	0.9	1.1	0.2	1.4	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.1	0.7	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	7.0	0.2	0.0	0.0	1.5	0.1	0.0	0.4	0.5	0.4	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	3.2	1.2	0.7	1.1	0.2	0.3	0.8	1.4	0.0	1.1	0.8	2.9	3.2	3.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	1.8	0.0	0.0	0.1	2.7	0.0	1.9	0.1	0.0	3.8	8.9	0.6	0.0	0.0	0.0	0.0	0.4	2.0	0.0	2.3	2.5	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	1.1	7.0	0.0	0.0
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.7;thyroid gland: 5.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3"	"Region enriched"	"Detected in many"	86	"olfactory bulb: 980.0"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 5.6"	HPA064184			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.2	0.1	0.3	0.1	0.2	0.8	0.2	0.8	0.8	0.3	0.1	0.2	1.5	0.6	0.2	0.9	0.5	1.0	0.1	0.2	0.3	0.9	0.0	0.5	1.5	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.1	3.7	0.3	0.0	0.2	0.4	1.2	0.1	0.3	0.7	5.3	0.1	0.4	1.1	0.3	0.4	2.2	5.7	0.0	0.0	0.6	0.4	0.4	1.0	1.3	0.7	1.4	0.6	4.2	0.0	3.7	2.1	0.4	1.7	0.1	1.0	0.9	0.5	0.0	2.7	2.6	0.2	0.4	0.0	3.5	0.0	1.1	2.7	0.8	0.5	0.5	0.0	0.7	0.2	3.0	0.2	0.5	1.3	0.2	34.3	9.7	0.0	1.8	1.1	11.9	19.9	17.3	0.0	0.2	9.0	0.8	1.5	0.0	0.5	0.4	0.1	1.3	2.6	1.7	0.0	0.9	0.0	0.5	0.7	0.4	0.0	0.7	1.4	1.2	0.1	4.6	0.5	2.6	1.3	1.8	0.3	1.4	0.6	1.2	0.0	0.4	3.0	3.9	0.7	0.3	0.2	0.8	0.8	0.2	0.3	0.3	0.2	0.1	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	3.7	0.0	0.1	0.2	0.1	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	8.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.6	3.1	0.0	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.6	6.8	0.3	0.6
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 388.6;skin 1: 305.2;vagina: 122.6"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	1.7	0.1	0.0	0.1	0.1	0.1	19.7	0.1	0.1	33.5	0.0	1.2	0.0	0.1	0.1	388.6	0.4	0.1	0.1	0.0	0.0	0.4	0.1	60.4	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	58.3	0.0	1.5	305.2	0.1	0.0	0.0	0.0	0.6	2.4	0.1	0.5	2.2	0.0	77.4	0.1	122.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118162806-118176639	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4;heart muscle: 12.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;thyroid cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	0.6	1.5	15.1	0.3	21.0	0.0	0.7	16.3	34.4	1.4	0.0	1.3	0.6	1.6	1.4	1.8	1.3	1.3	12.9	22.0	13.5	0.4	0.0	1.2	0.0	7.4	15.3	21.4	1.3	0.1	0.0	0.8	0.0	14.6	1.1	0.7	3.7	0.5	1.2	7.3	0.2	1.1	1.9	3.0	0.1	0.3	0.2	20.0	1.8	0.7	7.6	0.0	0.3	0.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.1	21.0	16.3	34.4	22.0	13.5	7.4	15.3	21.4	14.6	3.0	20.0	22.6	0.1	0.0	0.0	3.9	0.0	0.4	0.6	0.7	1.8	8.8	0.1	2.0	16.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.0	21.9	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	13.5	32.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.9	0.0	0.9	0.0	2.5	7.4	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.1	1.9	0.0	0.9	0.8	0.1	0.6	0.0	0.1	0.0	0.1	0.5	0.0	0.3
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 138.7;tongue: 54.5"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 46.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"REH: 15.0;RH-30: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	14.7	0.7	0.0	0.2	0.1	0.0	16.2	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.0	1.1	0.2	0.3	0.8	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.7	1.5	0.1	0.1	0.5	0.1	0.0	1.8	0.0	138.7	0.7	0.3	0.0	0.0	0.9	0.5	1.7	0.0	0.2	4.3	54.5	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	15.0	45.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	1.4	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	1.1	2.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.1	5.9	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35213956-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 29.2"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 10.8;Horizontal cells: 10.1;Rod photoreceptor cells: 7.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.0;ASC diff: 76.7;ASC TERT1: 102.2;HSkMC: 48.1;hTEC/SVTERT24-B: 30.1;U-138 MG: 29.1;WM-115: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	490000	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.1	2.4	0.9	0.9	1.0	0.1	0.4	1.8	0.9	0.5	2.8	3.0	0.1	0.6	0.9	0.7	0.8	0.5	2.0	0.6	0.5	2.8	0.1	0.7	0.1	0.8	0.7	0.4	0.5	0.1	0.1	1.7	0.7	0.8	2.2	0.9	1.4	0.2	4.6	0.3	0.6	0.8	0.9	0.2	0.2	1.4	1.1	0.7	0.1	29.2	0.0	0.2	5.1	0.9	0.9	0.0	0.1	26.0	0.2	76.7	102.2	0.3	6.7	3.3	0.1	0.1	0.5	0.1	0.0	0.9	15.5	0.0	0.0	5.3	0.0	0.4	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	48.1	0.0	30.1	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	1.2	0.0	0.4	0.1	0.0	0.0	0.1	2.9	0.5	0.0	0.1	0.7	1.9	10.2	0.7	0.1	1.5	29.1	1.3	0.0	0.2	0.1	0.0	0.0	4.6	0.0	25.2	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.9	1.0	1.8	0.9	0.6	0.5	0.8	0.7	0.4	0.8	0.2	0.7	0.9	0.2	0.0	0.6	0.7	0.5	0.0	0.2	0.4	0.0	2.6	0.3	0.0	3.5	0.0	2.0	1.8	2.1	1.2	0.5	0.0	0.0	0.0	2.1	1.2	0.4	0.6	10.8	0.0	2.2	0.0	2.1	1.3	0.0	0.4	1.3	0.5	0.0	0.1	0.3	10.1	3.2	0.1	0.0	0.6	0.4	3.3	0.9	0.2	1.8	0.0	0.1	3.0	0.0	4.0	3.5	0.1	0.0	3.8	0.4	0.1	0.0	0.1	0.9	7.1	0.0	0.6	3.2	0.5	2.1	0.0	0.0	0.7	0.2	0.1	0.0	0.2
SELENOV	SELV	ENSG00000186838	"Selenoprotein V"	P59797	19	39515113-39520686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 10.0"	"Cell type enhanced"	"Detected in single"		"Breast myoepithelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059274	Uncertain					NA	NA					"HPA059274: AB_2683964"				"unprognostic (1.38e-3)"	"unprognostic (2.70e-2)"				"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"		"unprognostic (8.31e-2)"		"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.43e-4)"		0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.1	0.1	2.3	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.4	0.2	0.2	0.5	0.3	0.2	0.5	0.2	0.3	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 163.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.6	6.9	21.5	7.6	20.0	1.7	21.8	18.0	28.4	22.5	15.4	51.0	35.5	10.0	24.9	55.7	17.9	23.4	6.9	23.0	28.1	15.8	53.6	12.8	5.5	27.0	23.7	17.5	4.2	23.5	31.8	16.7	24.2	30.5	26.4	48.3	26.3	163.1	11.5	4.8	11.0	35.9	15.9	24.8	6.6	69.5	2.1	26.2	4.8	59.7	10.2	10.7	12.8	19.9	28.0	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	21.5	20.0	18.0	28.4	23.0	28.1	27.0	23.7	17.5	30.5	24.8	26.2	28.0	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.2	9.8	9.3	3.4	8.6	1.2	21.1	7.7	10.7	12.0	9.2	7.4	3.4	12.2	4.4	5.1	12.6	7.0	19.7	8.1	8.1	10.5	5.9	20.8	3.9	9.0	9.0	7.0	7.7	3.0	4.9	3.8	16.6	8.7	8.2	4.3	0.6	5.4	4.2	7.1	6.3	9.0	8.1	7.8	21.5	5.5	22.3	9.6	2.7	22.3	11.4	2.3	9.8	10.0	9.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.3	8.6	7.7	10.7	8.1	8.1	9.0	9.0	7.0	8.7	7.8	9.6	9.2	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26052016	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.5;skeletal muscle: 14.4;thyroid gland: 21.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.5	0.0	1.0	0.2	2.4	0.1	12.5	1.4	2.0	1.7	1.3	0.1	0.7	0.1	7.9	0.2	0.2	0.6	0.2	1.9	1.6	4.7	0.0	4.4	0.5	1.6	1.6	0.9	0.3	0.3	0.1	1.6	0.0	1.9	0.5	0.1	0.0	2.8	0.3	14.4	0.8	0.7	0.1	2.3	0.2	2.1	1.2	1.6	2.6	21.2	1.2	0.7	0.7	0.1	5.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.4	4.2	1.4	0.0	0.0	1.7	26.7	1.0	20.8	0.0	0.0	18.7	1.2	2.3	0.5	15.5	8.4	8.2	0.0	46.3	0.3	1.7	6.5	0.4	0.0	0.4	0.0	5.4	2.6	0.7	0.2	1.6	0.1	0.7	30.4	7.0	0.0	0.0	0.0	0.0	0.0	4.1	0.8	0.1	0.5	0.1	0.2	0.2	0.1	0.4	0.1	0.0	0.2	1.0	1.6	0.4	0.2	0.3	0.1	0.2	0.1	1.0	2.4	1.4	2.0	1.9	1.6	1.6	1.6	0.9	1.9	2.3	1.6	5.6	4.7	0.0	13.1	0.0	0.4	5.4	14.6	2.3	0.6	0.0	24.1	6.2	0.5	0.0	1.5	3.7	0.0	0.3	0.3	0.1	0.0	6.0	2.6	1.0	0.5	5.1	0.0	0.0	0.0	0.2	0.3	2.8	3.1	2.5	0.0	2.4	1.1	0.0	0.8	0.0	1.0	0.1	8.2	0.3	2.3	1.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.5	10.9	1.2	0.0	0.4	0.2	3.9	0.0	0.3	1.1	0.0	0.0	7.6	1.6	0.7	5.1	0.4	1.7	0.1	1.1	0.7	0.0	19.6
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	8.2	1.8	11.1	1.9	16.9	1.2	5.4	15.3	11.1	3.3	2.1	1.7	1.2	3.6	1.6	2.8	2.3	3.0	6.1	7.0	11.6	5.3	0.9	13.4	0.9	19.4	16.6	3.9	1.3	0.9	1.9	2.0	9.0	19.0	2.2	1.4	1.3	2.0	1.8	3.7	1.7	1.5	4.1	15.9	1.0	1.3	0.6	16.3	0.6	3.3	5.0	1.0	3.5	2.3	29.8	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	6.7	0.9	0.0	0.6	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	0.0	5.5	2.5	0.1	0.0	0.0	0.8	1.5	3.6	0.1	0.1	10.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	0.2	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	16.9	15.3	11.1	7.0	11.6	19.4	16.6	3.9	19.0	15.9	16.3	29.8	45.0	25.6	18.6	3.3	0.0	3.6	2.0	1.9	2.2	0.3	1.0	1.5	4.2	0.0	2.0	5.5	0.0	0.6	0.2	1.1	3.9	0.7	0.1	2.8	5.4	46.5	3.0	0.0	1.1	0.2	3.0	3.0	0.0	2.9	3.8	2.3	30.7	0.9	0.5	0.0	1.1	2.8	0.0	2.4	2.7	0.6	1.2	0.6	0.0	51.5	0.0	3.6	0.0	126.7	463.4	2.3	1.0	1.2	0.0	1.2	0.3	3.5	2.5	0.6	0.0	2.5	2.6	0.0	1.0	2.0	3.1	0.3	0.6	3.0	3.2	1.6
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 107.6"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	13	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 500.7"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	0.5	0.1	0.2	3.0	0.3	0.5	0.7	0.3	0.3	1.6	0.1	2.2	2.2	1.5	1.0	2.5	0.3	2.5	0.4	0.2	0.1	0.1	0.1	4.4	3.8	0.2	0.1	0.2	0.1	0.3	0.1	0.0	107.6	0.3	1.0	3.1	0.4	0.5	0.8	0.5	0.5	3.3	1.4	0.0	1.7	2.6	0.3	0.1	0.7	0.0	0.6	4.3	1.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	1.2	500.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2	4.9	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.6	4.5	0.0	0.0	0.2	0.6	0.0	11.0	0.0	0.4	0.2	0.3	0.3	0.3	0.2	0.1	0.2	0.1	0.2	0.3	0.0	0.1	0.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	5.2	0.7	0.0	0.0	55.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.7	0.5	0.0	0.0	0.0
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683688	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.5;kidney: 3.2"	"Cell type enriched"	"Detected in many"	7	"Collecting duct cells: 77.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 4.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.5	1.1	0.2	0.2	0.2	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.2	4.9	0.2	0.1	0.2	0.7	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.4	6.4	9.6	5.2	0.7	0.6	0.9	0.3	0.0	1.1	0.4	0.3	0.9	0.0	1.9	77.3	2.1	0.3	0.6	0.3	0.0	0.0	1.3	0.2	0.3	0.9	0.0	0.0	8.8	0.0	0.5	2.4	0.0	0.3	3.8	0.1	1.1	0.0	0.4	1.7	10.6	0.5	0.0	0.3	2.0	1.4	0.6	0.8	1.8	2.8	0.2	0.9	1.0	6.6	1.0	0.1	1.2	0.7	0.1	0.5	4.9	0.2	1.5	2.0	0.0	0.4	0.2	0.3	0.4	0.0	0.1	0.8	1.0	0.2	0.2	0.5
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 312.8"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.3	10.6	6.0	6.5	6.2	6.8	13.9	6.2	7.1	10.8	5.9	20.6	16.6	9.5	45.0	8.5	5.4	10.5	7.7	6.6	8.2	32.2	17.7	13.3	5.4	6.6	6.9	6.1	4.0	11.7	312.8	10.0	21.9	7.4	16.9	22.3	18.4	30.5	14.8	5.5	7.2	21.2	10.7	5.9	7.0	14.5	6.2	7.3	4.6	43.9	6.3	5.6	12.7	6.4	7.3	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	6.0	6.2	6.2	7.1	6.6	8.2	6.6	6.9	6.1	7.4	5.9	7.3	7.3	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC22A31		ENSG00000259803	"Solute carrier family 22 member 31"	A6NKX4	16	89195761-89201651	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 23.3;lung: 41.0;pancreas: 33.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 130.7;Late spermatids: 33.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 26.2;thyroid cancer: 20.4"	"Group enriched"	"Detected in some"	10	"cerebellum: 23.3;pons: 11.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 33.7;Hep G2: 28.7;NB-4: 14.7;RPMI-8226: 17.7;THP-1: 9.3"															NA	NA						"unprognostic (2.71e-3)"	"unprognostic (2.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.89e-1)"	0.1	0.8	0.0	0.2	0.3	0.9	0.1	23.3	0.8	0.6	0.0	0.3	0.4	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.2	0.5	1.2	41.0	0.1	0.4	1.7	0.0	3.1	33.2	0.1	0.5	0.0	11.0	0.6	0.0	0.0	0.4	0.1	0.0	1.2	0.6	0.0	0.2	3.6	3.3	5.2	0.3	0.0	0.4	0.0	0.0	0.2	0.5	0.4	0.0	0.1	0.0	1.6	0.0	0.0	33.7	0.1	0.0	0.0	0.0	1.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	28.7	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.0	14.7	0.8	0.3	3.4	0.0	3.7	17.7	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	23.3	0.8	0.0	0.2	0.4	1.7	0.0	11.0	0.2	0.3	0.4	0.0	6.4	130.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.1	1.1	0.0	8.2	0.0	0.4	0.3	0.7	0.0	0.4	0.0	0.0	0.3	0.0	33.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.9	3.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291116-100306547	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"thyroid gland: 423.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA					"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	24.7	45.0	61.6	5.3	67.2	13.6	34.7	73.9	74.7	40.1	70.8	18.7	8.2	32.3	37.8	36.6	85.1	12.3	29.0	58.6	64.6	102.4	36.2	44.4	8.1	86.9	71.6	57.9	50.3	22.4	6.7	63.2	6.7	80.9	69.6	5.4	47.8	45.9	12.7	12.0	39.8	18.7	8.3	77.7	20.6	26.8	45.1	67.1	8.9	423.1	6.1	5.7	27.1	27.2	100.0	11.0	23.2	29.7	39.0	6.8	2.5	17.4	8.2	8.9	16.8	9.9	5.4	6.7	0.0	20.4	2.8	8.6	11.5	12.7	4.2	5.6	4.2	5.4	10.4	35.8	9.9	16.1	6.1	13.0	7.4	12.9	7.7	7.1	25.5	23.3	35.7	3.4	1.2	4.9	34.8	37.9	33.6	14.8	9.7	22.5	49.1	12.4	0.8	55.5	7.7	42.9	52.8	19.3	13.2	15.4	12.5	33.0	10.2	24.5	6.1	11.7	8.6	12.9	2.9	1.3	1.4	6.9	14.9	7.6	1.5	1.1	2.1	0.9	0.2	0.0	0.1	0.4	0.9	1.2	0.5	0.1	0.6	1.2	0.1	0.0	0.5	0.6	0.2	61.6	67.2	73.9	74.7	58.6	64.6	86.9	71.6	57.9	80.9	77.7	67.1	100.0	23.5	9.6	26.5	108.7	5.8	6.5	16.3	14.8	22.8	17.9	57.1	38.5	1.4	11.5	23.3	123.2	75.0	6.2	17.8	9.4	17.6	31.4	19.7	136.7	24.8	20.9	20.9	3.8	26.4	11.8	0.7	10.9	12.2	136.0	14.5	22.6	31.8	9.5	7.4	21.9	22.4	8.8	12.2	2.8	30.0	62.4	2.5	11.7	10.6	30.9	8.8	21.0	12.3	42.7	78.5	14.2	17.0	6.0	4.1	39.6	4.6	13.1	45.1	82.7	13.1	7.0	12.6	4.2	5.0	24.5	6.5	18.6	6.4	6.3	14.3	13.8
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046118	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 100.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 31.0;Endometrial ciliated cells: 30.5;Glandular and luminal cells: 93.7;Proximal tubular cells: 36.2;Syncytiotrophoblasts: 85.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.1;RPTEC TERT1: 4.5;WM-115: 3.5"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	1.2	0.4	0.3	0.6	0.6	1.1	1.7	1.0	0.1	0.5	0.5	0.5	0.5	0.3	0.1	0.4	6.7	4.2	0.5	0.4	19.7	0.1	0.2	0.2	0.2	0.1	0.8	0.1	100.6	2.2	0.0	4.5	0.7	0.2	0.1	0.5	1.6	2.3	3.9	1.0	0.8	0.1	0.0	0.3	0.3	0.2	1.1	0.0	20.0	0.7	0.1	0.5	0.0	0.8	0.1	0.1	0.0	0.4	0.1	0.0	2.1	0.1	0.1	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.3	0.3	4.5	0.1	0.4	0.1	0.3	0.5	0.1	0.7	0.3	0.1	0.2	0.2	0.5	0.2	0.1	0.3	0.2	0.3	0.2	0.2	3.5	0.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.4	0.6	1.7	1.0	0.5	0.4	0.2	0.1	0.8	0.7	0.0	1.1	0.8	0.2	3.2	3.0	0.0	0.6	0.4	0.7	0.0	0.0	4.5	9.1	0.4	13.9	8.6	0.0	9.2	0.0	31.0	0.1	0.5	5.9	11.5	0.0	30.5	9.7	1.0	0.0	0.0	0.0	21.1	2.8	0.5	0.0	93.7	4.5	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.9	3.6	0.0	1.0	0.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	3.9	36.2	0.0	2.3	6.6	2.1	1.0	0.2	0.4	0.0	0.9	85.1	0.9	0.1	1.1	0.7
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;epididymis: 69.1;testis: 35.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0"	"Group enriched"	"Detected in all"	4	"amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7"	"Group enriched"	"Detected in many"	6	"amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.1	2.1	15.1	0.1	12.1	0.3	0.1	0.0	17.6	0.2	0.0	0.1	0.0	0.4	69.1	0.1	0.3	0.1	6.8	22.9	2.4	0.1	0.2	0.2	0.6	1.6	0.6	15.3	0.2	0.0	0.5	0.3	0.0	9.6	0.3	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	35.4	2.0	0.0	0.2	0.0	0.1	0.0	0.2	9.8	0.4	1.3	0.1	2.0	0.2	0.2	0.3	0.0	0.0	1.3	1.4	0.5	0.5	0.0	0.1	0.0	8.8	0.3	11.2	0.0	0.3	0.0	1.2	5.9	0.5	12.0	0.2	0.2	2.3	0.0	0.0	0.6	0.0	0.2	0.9	2.9	1.7	0.1	0.2	3.9	0.1	0.4	1.8	0.4	0.0	22.8	11.0	1.4	0.0	0.3	0.0	0.7	2.8	0.0	0.0	0.1	0.0	0.8	0.1	0.3	5.1	0.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	15.1	12.1	0.0	17.6	22.9	2.4	1.6	0.6	15.3	9.6	0.0	2.0	9.8	0.3	0.0	0.0	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	17.8	0.0	0.1	0.4	0.0	0.0	15.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	42.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	15.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	16.6	10.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073578-34106260	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0;choroid plexus: 76.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 129.1;Collecting duct cells: 138.0;Granulosa cells: 148.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	5.5	5.9	10.5	4.5	9.5	1.9	6.6	5.8	28.8	3.5	76.5	4.5	2.7	6.9	5.3	3.1	4.8	2.6	2.0	15.5	34.0	29.2	6.0	4.0	4.9	9.4	9.5	5.6	3.9	1.9	3.2	4.2	10.7	9.5	2.9	5.3	5.7	2.9	3.6	2.5	5.8	3.8	2.9	10.2	2.4	3.9	6.3	15.4	4.0	25.4	2.6	4.9	3.8	3.5	17.0	10.5	9.3	19.0	13.4	15.5	12.7	9.1	11.8	35.7	7.2	10.9	15.5	22.5	16.9	9.3	24.0	13.5	5.3	23.3	6.7	12.2	17.7	6.0	17.5	9.0	5.2	4.1	7.6	7.1	6.1	17.0	19.7	7.8	22.0	4.4	13.7	17.6	3.9	18.7	7.1	8.1	6.1	9.6	4.0	9.0	8.1	3.4	7.7	28.1	14.5	9.9	4.6	24.5	6.4	5.6	11.3	3.9	8.0	4.2	14.0	10.7	27.1	4.8	20.1	18.5	12.4	28.2	10.9	9.6	0.0	0.2	0.0	0.6	0.2	0.5	0.1	0.3	0.4	0.2	0.1	0.4	0.6	0.1	0.2	0.1	0.5	0.1	0.1	10.5	9.5	5.8	28.8	15.5	34.0	9.4	9.5	5.6	9.5	10.2	15.4	17.0	18.8	16.0	10.2	0.0	33.3	0.0	46.5	0.0	129.1	33.8	37.4	34.9	11.4	10.0	13.0	138.0	20.9	27.4	43.0	39.1	21.5	4.0	9.0	38.7	59.9	16.4	49.3	17.0	0.0	5.5	19.7	42.3	18.3	42.5	41.3	148.6	5.0	20.7	15.2	37.0	0.0	69.3	0.0	14.4	0.0	7.2	6.5	41.0	0.0	0.0	23.3	6.7	16.5	0.0	0.0	7.6	49.7	20.7	54.1	88.4	16.3	9.4	8.7	20.9	13.1	15.4	33.7	14.8	18.5	39.7	0.0	28.2	48.3	14.0	36.3	69.5
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871945-17895174	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 132.1;salivary gland: 65.0;stomach 1: 59.3"	"Cell type enriched"	"Detected in some"	40	"Gastric mucus-secreting cells: 244.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 11.1"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA					"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.5	0.2	0.2	0.3	0.1	5.4	3.0	5.6	132.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	11.1	0.2	0.0	0.0	0.1	0.3	0.2	3.1	0.2	0.0	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.1	65.0	0.0	0.4	0.2	0.2	0.0	0.1	0.2	59.3	0.4	2.7	0.0	12.1	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	1.1	0.1	0.1	0.3	0.4	0.4	0.3	0.9	0.1	0.2	0.3	1.2	0.9	0.6	0.2	0.1	0.1	0.6	0.3	0.5	0.2	5.4	3.0	11.1	0.2	0.2	3.1	0.2	1.3	0.1	2.7	0.3	0.0	0.0	0.6	0.3	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.6	1.3	0.1	244.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.9	0.1	0.0	0.0	2.9	0.0	0.0	1.2	0.2	0.1	6.1	0.2	0.3	0.0	0.9	0.0	0.0	0.2
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	62.5	20.9	6.5	12.0	11.2	0.1	33.0	12.3	7.7	36.7	3.2	17.2	5.5	24.1	8.9	21.6	22.4	43.9	40.1	12.9	4.9	13.2	1.5	38.4	6.2	11.6	1.7	6.2	17.1	7.9	45.2	4.4	21.9	12.1	10.4	9.8	3.1	17.0	15.5	4.4	21.9	10.5	27.4	0.3	14.4	10.1	2.7	6.0	20.2	23.4	6.5	4.2	56.1	24.6	6.3	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	6.5	11.2	12.3	7.7	12.9	4.9	11.6	1.7	6.2	12.1	0.3	6.0	6.3	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SMIM10L2A	"LED, LINC00086, LINC0086, MGC39606, NCRNA00086"	ENSG00000178947	"Small integral membrane protein 10 like 2A"	P0DMW4	X	135421944-135428075	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 30.5;brain: 24.6;epididymis: 14.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Distal tubular cells: 7.9;Granulosa cells: 8.4;Proximal tubular cells: 12.4;Rod photoreceptor cells: 6.6;Theca cells: 16.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;CACO-2: 2.6;HAP1: 10.3;hTCEpi: 5.4"															NA	NA						"unprognostic (4.22e-2)"	"unprognostic (4.72e-2)"	"unprognostic (4.50e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (8.62e-3)"	"unprognostic (5.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.28e-2)"	0.8	30.5	16.9	0.4	19.4	0.1	1.9	9.4	24.6	1.9	4.5	0.7	0.2	1.5	14.5	1.4	2.3	0.6	3.2	20.1	21.3	5.7	0.2	2.1	0.5	15.5	17.5	21.3	4.7	3.2	4.6	4.0	0.3	17.7	2.1	0.3	5.2	2.8	1.8	0.3	2.4	0.6	0.8	9.9	3.1	1.4	5.4	17.4	0.4	3.6	0.5	0.5	0.8	1.4	16.1	0.0	0.1	0.2	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.8	0.1	1.9	0.0	10.3	1.3	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.4	0.4	5.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.5	2.4	0.0	0.0	0.0	1.5	0.1	0.3	0.9	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.4	9.4	24.6	20.1	21.3	15.5	17.5	21.3	17.7	9.9	17.4	16.1	0.9	0.0	3.3	0.0	0.0	0.0	1.0	0.0	4.6	6.5	1.6	5.7	3.8	2.8	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.7	0.4	0.8	0.6	1.8	1.2	0.0	0.0	0.4	0.0	0.7	0.0	1.0	1.3	8.4	3.3	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.4	0.1	12.4	0.0	6.6	0.0	1.2	0.6	1.1	0.4	1.3	0.0	0.3	0.3	16.3	0.1	0.7
SPRING1	"C12orf49, FLJ21415, LUR1, POST1, SPRING"	ENSG00000111412	"SREBF pathway regulator in golgi 1"	Q9H741	12	116710171-116738070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 37.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.5;Cytotrophoblasts: 11.5;dendritic cells: 9.8;Extravillous trophoblasts: 37.5;Hofbauer cells: 40.9;Syncytiotrophoblasts: 17.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026905	Uncertain				"Intracellular and membrane"	NA	NA		330000			"HPA026905: AB_10603446"	"unprognostic (2.74e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (2.56e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.91e-11)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.73e-1)"	5.5	8.2	12.9	8.0	13.3	6.3	6.0	13.5	12.5	3.5	7.2	11.3	6.6	4.3	8.6	7.9	3.5	5.8	6.6	10.6	14.9	14.7	8.8	18.6	8.6	17.3	15.5	10.4	3.5	6.9	7.1	6.9	4.4	15.3	4.6	8.4	5.7	13.8	4.2	3.1	6.3	6.5	3.9	13.3	7.2	11.4	9.3	17.5	9.9	37.8	2.4	8.8	5.4	4.2	14.4	12.6	16.7	15.2	15.2	17.4	13.8	19.0	8.6	11.5	9.5	8.2	32.9	9.3	32.3	16.6	11.9	14.1	16.0	21.3	13.2	10.6	26.0	17.1	9.2	8.5	31.6	12.2	17.8	27.3	16.8	16.3	12.4	14.0	16.1	14.5	21.3	10.0	7.3	15.3	18.9	16.2	16.5	24.4	19.2	19.4	24.0	10.3	14.0	24.1	33.7	14.0	17.4	14.0	14.0	25.9	17.1	16.9	18.3	18.9	14.1	19.4	20.0	17.1	15.0	48.7	45.6	22.9	18.2	16.9	3.1	2.4	4.1	4.5	3.3	4.6	5.6	3.5	3.7	2.2	4.9	3.0	4.1	1.7	2.9	2.3	4.3	3.9	1.7	12.9	13.3	13.5	12.5	10.6	14.9	17.3	15.5	10.4	15.3	13.3	17.5	14.4	10.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	11.5	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	37.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	17.9	1.6	0.0	0.0	0.0
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 47.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 112.8;Oligodendrocyte precursor cells: 94.0;Oligodendrocytes: 108.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 54.4;RT4: 47.0;SK-MEL-30: 40.8;U-266/84: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	13.9	47.8	16.2	4.7	25.6	2.4	8.6	15.2	19.8	5.4	7.3	4.9	1.0	9.9	0.9	2.7	10.5	8.2	4.1	14.8	18.8	2.4	9.9	14.8	9.1	23.9	22.3	11.7	10.2	3.9	0.4	12.9	17.9	27.4	6.7	2.6	31.3	7.1	0.5	12.5	6.1	6.9	3.5	20.3	20.1	5.6	10.8	21.5	5.0	28.1	3.5	4.4	21.0	6.0	41.2	0.3	27.0	2.5	54.4	22.0	11.8	8.0	5.9	18.0	5.6	5.0	0.5	19.6	0.7	0.2	10.2	2.5	1.0	3.6	6.4	7.0	0.2	3.2	0.6	1.1	1.0	17.6	0.4	7.8	6.9	0.8	2.1	0.8	10.1	13.7	7.4	0.8	30.2	18.3	1.8	1.9	3.1	0.2	9.6	0.0	3.5	17.0	11.0	2.9	47.0	3.8	3.8	0.2	0.1	40.8	5.4	0.2	1.1	4.5	0.1	2.7	0.1	0.4	30.0	42.5	0.5	4.2	5.6	27.7	0.6	0.8	0.1	0.6	3.0	0.8	1.1	0.3	0.4	0.5	0.7	0.3	0.3	0.6	0.6	2.4	0.2	0.1	0.3	16.2	25.6	15.2	19.8	14.8	18.8	23.9	22.3	11.7	27.4	20.3	21.5	41.2	8.5	86.6	112.8	37.5	29.1	5.6	27.6	20.5	1.2	56.6	3.1	2.3	1.9	40.0	33.9	3.7	58.4	0.4	48.3	0.2	3.9	12.0	12.3	9.0	27.8	8.1	6.7	0.4	46.9	16.6	1.1	21.7	6.1	8.5	34.8	35.2	29.6	21.1	35.6	72.3	60.2	0.1	12.2	45.4	18.1	12.0	8.1	24.9	32.0	45.9	20.1	56.0	12.3	94.0	108.4	6.2	0.1	1.9	19.5	6.8	0.0	3.7	10.7	45.2	0.0	21.3	5.0	8.4	16.1	0.2	3.8	0.3	28.9	6.3	0.1	8.3
SYNDIG1L	"capucin, DSPC1, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405894-74426210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	34	"brain: 378.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.7;Bipolar cells: 10.9;Inhibitory neurons: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Region enhanced"	"Detected in all"		"basal ganglia: 378.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 280.7"	"Region enriched"	"Detected in many"	7	"basal ganglia: 125.1"	"HPA042594, HPA048487"	Uncertain					NA	NA					"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.4	0.1	40.1	0.0	378.6	0.0	0.3	1.3	48.3	0.3	0.6	0.4	0.0	0.3	11.1	0.1	0.2	0.2	0.2	3.7	33.7	0.3	0.1	1.4	0.1	96.9	48.3	12.5	0.2	0.2	0.0	0.7	0.0	126.8	0.3	0.2	4.7	0.2	0.2	0.2	0.4	0.5	0.3	12.4	0.2	0.2	0.2	99.6	0.0	0.3	0.0	0.0	0.2	0.3	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	378.6	1.3	48.3	3.7	33.7	96.9	48.3	12.5	126.8	12.4	99.6	8.0	0.1	0.0	2.7	1.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0
SYT12	SRG1	ENSG00000173227	"Synaptotagmin 12"	Q8IV01	11	67006778-67050863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.4;liver: 17.8;parathyroid gland: 64.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 8.8;Basal respiratory cells: 10.9;Excitatory neurons: 39.3;Inhibitory neurons: 21.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 49.8;MCF7: 38.0;SiHa: 44.3;SK-BR-3: 20.9;T-47d: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011006, HPA074255"	Enhanced					NA	NA					"HPA011006: AB_2286996, HPA074255: "	"unprognostic (2.72e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.75e-1)"	"unprognostic (9.86e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.42e-2)"	"unprognostic (9.85e-2)"	0.6	6.9	7.8	0.2	10.9	0.0	4.6	21.4	18.7	0.1	2.6	0.0	0.7	0.1	5.1	0.4	3.8	0.6	0.4	9.8	15.7	0.3	17.8	0.1	0.1	10.2	12.0	9.5	0.1	0.3	64.3	5.7	0.8	12.3	1.7	0.0	0.4	1.6	0.8	0.3	0.8	0.3	0.0	4.7	0.0	0.3	1.4	8.2	0.0	0.4	0.0	0.1	1.2	0.2	11.3	0.0	2.0	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	8.1	1.5	3.4	1.3	0.3	1.5	0.2	4.5	0.0	0.0	0.4	0.0	49.8	0.1	0.0	0.0	0.1	0.5	0.3	0.1	0.0	4.6	0.0	0.0	0.1	0.1	0.0	38.0	0.0	0.1	0.9	0.2	1.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	44.3	20.9	0.1	0.1	19.3	0.2	0.0	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.9	21.4	18.7	9.8	15.7	10.2	12.0	9.5	12.3	4.7	8.2	11.3	0.2	0.0	0.0	8.8	0.1	1.3	3.8	10.9	0.0	2.2	6.9	6.6	1.2	1.5	3.1	1.8	0.0	0.4	0.1	0.5	0.0	2.9	0.5	0.8	0.3	0.4	0.0	0.0	39.3	0.0	1.5	1.1	0.0	0.5	0.0	0.3	0.0	5.8	0.1	0.0	21.6	0.0	0.0	0.0	1.2	0.2	0.0	0.1	0.0	4.7	0.0	0.1	0.0	3.0	2.3	0.4	0.0	0.4	0.1	1.2	0.2	0.1	1.6	1.2	0.0	1.2	1.6	0.8	1.2	0.0	1.1	1.9	0.5	0.0	0.4	1.3
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209900923-210171389	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 7.0;retina: 1.9;testis: 3.2;thyroid gland: 5.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 208.7;Inhibitory neurons: 213.9;Oligodendrocyte precursor cells: 152.8;Oligodendrocytes: 197.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Region enhanced"	"Detected in some"		"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.7;GAMG: 6.7;hTERT-HME1: 4.7;SCLC-21H: 6.5;U-138 MG: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles		NA	NA			Vesicles		"HPA036963: AB_10670378"	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.0	0.7	0.3	0.0	0.8	0.0	0.0	7.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.5	0.7	0.2	0.0	0.2	0.0	0.6	0.0	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.0	5.1	0.0	0.0	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	9.7	2.2	1.2	0.0	0.0	0.0	0.0	0.1	6.7	3.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	4.7	1.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.0	1.9	6.5	2.0	0.0	0.0	3.6	0.8	0.0	0.0	1.6	6.4	3.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	7.0	1.2	0.5	0.5	0.5	0.7	0.2	1.9	0.2	0.4	1.8	0.0	0.0	0.0	30.3	0.0	0.0	0.1	0.0	0.0	30.1	0.2	0.0	2.2	0.0	0.0	0.0	27.1	0.0	0.0	0.0	3.9	0.3	17.0	11.6	2.9	0.2	0.0	0.0	208.7	0.6	0.0	0.2	0.0	29.3	0.0	0.9	0.0	0.0	0.0	52.2	213.9	0.0	0.0	0.0	0.0	5.0	0.6	0.2	0.0	3.7	0.0	1.6	0.0	152.8	197.6	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.0	29.4	0.0	0.9	0.2	6.0	16.8	0.0	0.0	0.0	0.1	0.7	0.0	0.2
TAFA2	"FAM19A2, TAFA-2"	ENSG00000198673	"TAFA chemokine like family member 2"	Q8N3H0	12	61708259-62279150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.6;seminal vesicle: 7.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Cytotrophoblasts: 1.3;Extravillous trophoblasts: 1.4;Hofbauer cells: 1.8;Plasma cells: 1.0;Syncytiotrophoblasts: 2.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 31.6;neutrophil: 12.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 31.6"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 5.7;SCLC-21H: 2.1;WM-115: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.83e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.16e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.22e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	1.0	1.0	4.4	0.7	9.8	3.0	0.8	0.0	20.6	1.7	0.0	1.0	1.0	1.1	0.5	0.4	0.7	0.6	0.4	11.9	4.2	0.4	0.4	0.4	0.5	4.4	1.0	9.1	2.7	1.1	0.6	1.5	3.3	7.0	1.4	0.8	0.9	0.7	7.3	0.2	0.7	0.7	0.5	0.0	1.2	0.7	3.0	1.6	0.8	0.5	0.5	0.3	1.1	1.8	9.4	0.1	0.0	1.1	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.4	0.1	0.0	0.1	0.2	0.2	0.4	0.2	0.8	1.6	0.0	0.2	0.8	1.3	0.0	5.7	0.0	0.0	0.1	0.0	1.5	1.1	0.6	0.0	0.0	1.5	0.3	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.5	0.0	0.4	0.4	0.2	0.2	0.0	0.2	0.6	0.1	0.3	0.4	0.5	0.3	0.0	0.3	4.7	31.6	2.4	5.2	0.5	0.8	0.2	0.5	1.0	0.5	0.3	0.2	0.8	0.3	12.0	0.6	0.2	0.5	3.9	0.5	4.4	9.8	0.0	20.6	11.9	4.2	4.4	1.0	9.1	7.0	0.0	1.6	9.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0
TENM1	"ODZ1, ODZ3, TEN-M1, TEN1, TNM"	ENSG00000009694	"Teneurin transmembrane protein 1"	Q9UKZ4	X	124375903-124963817	"Predicted membrane proteins, Transporters"	"Stress response, Transcription, Transcription regulation"	"Neuropeptide, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.6"	"Group enriched"	"Detected in many"	11	"Excitatory neurons: 126.0;Inhibitory neurons: 463.2;Oligodendrocyte precursor cells: 434.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 23.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;MOLT-4: 5.9;RPTEC TERT1: 2.0;SCLC-21H: 1.9;U-138 MG: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002848	Uncertain					NA	NA					"HPA002848: AB_1079523"	"unprognostic (1.71e-3)"	"unprognostic (8.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.68e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.68e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.44e-2)"	1.6	1.6	4.3	0.2	4.6	2.2	1.2	23.6	2.5	0.2	0.0	1.4	0.1	1.9	1.2	0.2	1.7	0.7	0.3	4.4	5.2	1.3	8.0	1.4	0.6	2.0	4.3	3.8	0.1	0.1	0.1	4.7	0.0	7.2	4.6	0.2	2.5	1.4	1.0	1.0	1.2	1.2	0.6	1.0	0.6	0.8	0.4	3.3	8.2	1.7	0.8	0.4	0.5	0.3	2.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.6	0.0	0.0	5.9	0.0	0.3	0.0	0.8	0.0	0.0	0.0	2.0	0.0	1.9	0.0	0.0	0.4	0.0	1.2	0.4	0.0	0.0	3.2	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	4.3	4.6	23.6	2.5	4.4	5.2	2.0	4.3	3.8	7.2	1.0	3.3	2.3	0.7	0.0	0.0	29.0	0.2	3.3	0.1	0.0	1.8	10.2	0.6	0.3	1.6	1.5	0.0	1.8	0.0	0.0	3.4	0.1	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.7	126.0	0.0	0.0	6.8	0.0	0.2	7.6	2.2	0.4	22.9	0.0	6.7	463.2	0.0	0.0	1.0	0.8	0.4	5.0	0.3	3.6	5.6	0.6	0.7	2.1	434.8	7.7	0.0	0.0	0.0	3.0	13.7	0.0	4.0	0.0	0.6	0.0	0.6	1.8	0.0	3.4	0.1	1.8	0.0	2.2	0.0	0.0	0.3
TMEM132D	"KIAA1944, MOLT, PPP1R153"	ENSG00000151952	"Transmembrane protein 132D"	Q14C87	12	129071725-129904025	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.0"	"Group enriched"	"Detected in some"	60	"Excitatory neurons: 448.6;Inhibitory neurons: 523.0;Oligodendrocyte precursor cells: 573.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;MOLT-4: 4.6;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010739	Approved					NA	NA		110000			"HPA010739: AB_2204753"			"unprognostic (1.69e-1)"		"unprognostic (1.21e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.39e-1)"		"unprognostic (1.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.31e-4)"		0.0	0.1	1.1	0.1	5.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.1	0.1	0.0	1.0	0.3	4.1	0.0	0.3	0.0	0.4	0.0	1.4	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.6	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	5.0	0.0	4.8	2.5	0.9	1.0	0.3	4.1	1.4	0.0	1.8	1.8	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	1.8	0.0	448.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	523.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.4	0.0	0.2	0.0	573.0	7.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0
TRDC		ENSG00000211829	"T cell receptor delta constant"		14	22462932-22465787	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 408.1"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 746.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	87	"gdT-cell: 5873.4;NK-cell: 2243.9"	"Group enriched"	"Detected in all"	150	"NK-cells: 2243.9;T-cells: 5873.4"	"Cell line enriched"	"Detected in some"	38	"NB-4: 356.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.21e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.67e-5)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.99e-2)"	9.5	0.4	1.1	7.9	1.1	26.4	3.8	1.5	1.5	2.9	0.8	9.0	4.0	7.7	2.1	2.1	4.1	8.0	2.7	2.1	1.0	1.1	11.1	11.7	22.9	1.0	1.2	0.9	1.9	0.2	0.5	0.7	2.8	0.9	1.0	7.5	0.0	4.7	1.2	1.6	1.4	5.6	2.2	0.8	54.6	2.1	2.7	1.0	408.1	1.8	1.4	18.4	4.6	0.9	1.4	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	356.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	3.1	0.9	1.4	0.0	0.0	0.1	3.2	4.8	2.3	5873.4	7.9	3.8	5.7	16.7	31.7	9.2	1.9	16.2	46.6	27.0	2243.9	5.5	7.1	27.5	1292.0	1.1	1.1	1.5	1.5	2.1	1.0	1.0	1.2	0.9	0.9	0.8	1.0	1.4	1.1	3.2	5.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.6	0.0	0.0	0.0	165.7	0.3	0.0	0.5	0.0	0.9	0.8	0.7	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	4.2	0.5	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	746.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	123.5	0.0	0.0	0.0
TRDJ2		ENSG00000211827	"T cell receptor delta joining 2"		14	22456689-22456742	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	89	"gdT-cell: 953.4;NK-cell: 2991.2"	"Group enriched"	"Detected in all"	279	"NK-cells: 2991.2;T-cells: 953.4"	"Cell line enriched"	"Detected in some"	17	"NB-4: 104.6"															NA	NA																							3.0	0.0	0.3	3.7	0.2	4.8	0.8	0.1	0.9	0.0	0.0	3.3	0.0	4.8	0.0	0.0	1.6	0.0	0.0	0.8	0.6	1.2	0.0	7.7	6.4	0.7	0.2	0.3	1.7	0.0	0.0	0.0	1.8	0.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	26.5	1.5	0.8	0.6	37.4	0.0	0.0	2.9	0.5	0.0	1.7	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	6.3	0.4	0.0	953.4	2.0	3.3	0.8	22.0	14.7	3.9	1.7	17.6	14.4	7.0	2991.2	2.2	1.4	19.2	206.2	0.3	0.2	0.1	0.9	0.8	0.6	0.7	0.2	0.3	0.4	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857187-247880138	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.5;thyroid gland: 15.3"	"Cell type enriched"	"Detected in many"	23	"Erythroid cells: 456.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.3;HEL: 40.7;K-562: 21.8;PC-3: 37.0;U-2 OS: 29.0;WM-115: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023637	Uncertain					NA	NA					"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.5	0.6	1.4	0.6	0.8	32.5	0.5	0.2	1.4	0.4	1.3	1.2	0.1	0.2	0.1	0.1	1.3	0.3	0.2	0.6	2.8	0.2	0.2	1.3	0.2	3.0	3.2	0.7	0.0	0.2	0.1	0.2	5.8	3.6	1.5	0.9	0.6	0.3	0.2	0.2	0.9	0.3	0.6	1.1	2.4	0.4	2.7	2.7	0.3	15.3	1.6	0.1	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.7	18.3	0.0	0.0	0.0	1.3	40.7	0.0	0.0	0.0	5.5	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.4	21.8	0.1	0.0	0.0	0.2	0.3	2.7	0.0	37.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	4.7	0.0	0.0	29.0	0.0	0.0	6.3	0.0	0.0	0.0	13.0	42.1	0.7	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.6	1.4	0.8	0.2	1.4	0.6	2.8	3.0	3.2	0.7	3.6	1.1	2.7	3.3	0.6	3.2	3.0	0.3	1.7	1.0	1.4	0.0	0.6	3.4	1.1	0.3	0.5	0.0	5.6	1.8	12.5	3.3	0.4	0.8	0.0	0.1	4.3	2.5	0.7	1.7	1.2	456.4	3.7	0.0	4.6	3.0	0.0	2.1	8.2	0.4	1.8	0.1	2.4	0.0	1.8	0.4	0.0	3.2	1.4	1.2	0.9	19.4	1.8	0.0	1.0	2.7	2.1	0.5	0.3	0.2	0.7	0.7	0.3	4.0	0.0	0.2	3.7	3.7	0.0	0.9	0.7	2.8	9.7	0.1	0.9	4.9	1.7	0.3	0.8	0.8
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 115.5;choroid plexus: 300.0"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.9;Collecting duct cells: 14.7;Distal tubular cells: 11.7;Endometrial ciliated cells: 35.1;Glandular and luminal cells: 18.7;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Region enhanced"	"Detected in all"		"cerebellum: 115.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.0;BJ: 8.7;fHDF/TERT166: 11.9;RPTEC TERT1: 4.0;SCLC-21H: 4.3;U-266/84: 4.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 31.1"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	1.3	0.4	7.4	0.6	7.2	0.3	2.3	115.5	8.3	1.6	300.0	1.1	0.7	1.0	0.9	0.9	2.0	1.6	5.4	26.4	6.3	3.5	2.3	1.8	0.4	4.4	15.7	3.2	0.3	2.3	1.6	1.4	0.4	35.5	1.2	1.2	24.7	2.6	1.0	3.2	3.3	1.2	0.4	4.4	1.5	1.1	1.2	12.4	0.2	34.0	1.6	0.3	0.9	0.8	5.4	0.1	0.0	6.0	0.0	0.0	0.0	1.4	8.7	2.0	1.2	0.6	0.0	0.1	0.1	0.4	11.9	1.1	0.2	0.1	0.2	1.2	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.6	0.2	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.7	0.1	0.0	1.0	0.0	0.1	4.0	0.1	4.3	0.1	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.1	0.8	0.8	0.1	0.2	4.4	0.0	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	7.4	7.2	115.5	8.3	26.4	6.3	4.4	15.7	3.2	35.5	4.4	12.4	5.4	6.2	6.4	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	6.7	0.0	0.0	9.9	14.7	0.0	1.0	0.2	0.0	11.7	2.3	0.0	35.1	6.4	2.1	0.0	0.0	0.0	1.1	0.2	1.8	0.0	18.7	1.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	14.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448859-6496723	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.6;retina: 28.6;skeletal muscle: 54.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	1.1	1.4	12.1	0.4	16.2	0.0	1.1	18.4	24.6	1.9	4.0	3.8	0.3	0.8	1.0	0.4	0.7	0.4	12.4	20.1	12.7	3.3	1.3	0.1	0.1	13.6	10.1	14.1	2.6	0.6	0.1	3.2	0.0	15.4	3.6	0.3	28.6	0.8	5.5	54.9	1.5	1.4	0.7	7.3	0.2	3.0	0.7	11.7	0.3	1.2	14.0	0.2	0.3	1.4	19.2	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.7	0.0	5.3	0.0	0.0	0.3	0.0	24.6	0.1	0.0	11.5	0.0	0.0	23.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	54.4	52.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	16.2	18.4	24.6	20.1	12.7	13.6	10.1	14.1	15.4	7.3	11.7	19.2	0.2	0.0	0.0	5.5	0.3	1.3	0.5	0.5	0.0	30.0	0.4	1.0	27.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	5.9	0.0	0.0	0.2	0.4	1.0	5.4	0.0	47.8	0.2	0.0	3.6	1.1	0.1	0.0	45.5	0.0	1.0	0.1	45.4	35.3	0.0	0.0	0.3	0.3	0.3	4.1	0.1	0.0	2.8	0.0	9.4	0.0	12.1	5.4	0.1	0.0	6.8	1.8	0.9	0.0	0.2	0.0	63.6	0.0	3.2	1.4	0.1	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA					"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.3	8.2	3.0	7.2	0.2	6.2	11.9	6.8	7.2	6.8	7.4	1.7	6.9	5.7	4.7	9.2	6.1	3.2	5.8	15.6	3.6	1.4	5.2	3.9	29.2	15.7	4.4	11.7	13.2	4.6	1.9	4.6	15.7	6.4	2.7	6.8	3.2	4.9	1.7	6.6	5.7	8.9	13.0	6.6	5.0	6.8	19.2	6.6	27.7	5.8	3.7	8.9	7.7	15.9	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	8.2	7.2	11.9	6.8	5.8	15.6	29.2	15.7	4.4	15.7	13.0	19.2	15.9	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8
VEGFC	"VEGF-C, VRP"	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792922	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.3;Endothelial cells: 22.0;Leydig cells: 13.7;Microglial cells: 36.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 146.5;HBF TERT88: 114.4;hTEC/SVTERT24-B: 116.5;LHCN-M2: 129.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 7.0"						"Secreted to blood"	NA	NA	383000	340000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	20.6	7.0	2.6	4.2	2.3	0.2	16.9	2.8	2.9	9.5	3.1	4.7	2.4	7.4	1.8	4.1	8.6	6.9	10.7	2.3	2.4	4.9	4.3	17.0	8.1	3.1	2.7	1.8	6.0	1.8	2.8	1.5	19.5	2.7	5.1	3.4	1.3	7.5	5.0	3.1	4.7	6.9	6.6	2.6	3.9	3.3	1.4	3.4	1.1	28.0	4.1	3.4	10.4	7.7	3.5	5.9	2.8	1.8	0.0	25.5	25.3	0.0	146.5	87.3	79.2	62.5	0.0	0.7	0.0	0.0	82.7	33.1	4.4	1.3	54.8	114.4	0.1	2.8	0.0	3.8	0.0	13.9	0.0	0.0	27.0	2.5	116.5	80.5	79.3	49.7	0.0	0.0	0.0	129.9	2.1	0.0	0.0	1.3	0.0	47.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	2.3	3.3	0.1	0.7	0.7	0.2	24.2	83.6	9.2	20.8	42.1	0.2	0.0	0.0	34.9	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	2.3	2.8	2.9	2.3	2.4	3.1	2.7	1.8	2.7	2.6	3.4	3.5	39.3	3.2	0.0	10.1	0.1	2.4	1.3	3.2	0.0	1.0	3.2	1.7	1.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	3.1	8.3	10.9	22.0	0.0	0.0	2.0	0.0	0.0	9.1	0.0	11.0	0.0	8.5	10.0	0.0	0.3	1.7	2.0	0.0	4.1	0.3	2.2	1.2	13.7	0.4	3.6	36.5	0.0	3.4	0.0	1.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.2	0.0	1.9	11.7	0.2	2.0	0.3	2.0	0.0	0.2	1.9	0.0	3.6
WDR86		ENSG00000187260	"WD repeat domain 86"	Q86TI4	7	151375909-151410727	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 29.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 17.9;Endometrial ciliated cells: 13.9;Endometrial stromal cells: 22.5;Fibroblasts: 10.0;Microglial cells: 7.5;Muller glia cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 13.7;NTERA-2: 2.6;SCLC-21H: 5.8;SH-SY5Y: 4.1;SuSa: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.93e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.13e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.32e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-6)"	"unprognostic (7.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-1)"	6.5	1.3	7.4	0.3	4.6	0.1	8.2	0.6	3.4	18.3	7.2	7.8	0.8	9.2	0.2	1.4	19.3	0.9	0.6	4.7	5.4	3.0	0.8	1.4	1.2	3.7	2.3	5.4	6.3	0.9	7.7	8.0	2.9	1.1	4.1	0.1	0.4	1.3	4.8	0.5	0.7	3.2	0.4	2.6	18.7	5.9	0.8	1.0	0.2	29.3	0.0	0.1	2.3	6.7	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	4.1	0.0	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.4	4.6	0.6	3.4	4.7	5.4	3.7	2.3	5.4	1.1	2.6	1.0	1.1	3.4	0.0	0.5	2.6	1.3	0.0	0.2	1.9	1.2	0.3	3.4	17.9	1.4	0.0	1.5	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	13.9	22.5	1.5	0.0	0.0	1.8	0.0	1.4	10.0	0.5	3.1	0.0	0.7	0.4	0.2	0.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	7.5	1.2	11.5	1.0	1.5	0.2	0.0	0.0	3.0	0.4	0.0	0.0	0.0	5.4	0.8	0.0	0.2	4.6	0.1	0.5	0.0	0.3	0.8	3.1	0.1	0.0	0.3
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129288-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.4;thyroid gland: 17.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"RT4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	0.9	0.7	6.9	0.1	11.9	0.0	0.8	38.4	14.8	3.5	1.0	2.6	0.3	10.2	2.1	1.0	2.6	0.1	0.3	16.9	7.1	1.0	0.0	0.3	0.2	4.4	4.4	9.7	0.3	1.4	0.0	1.4	0.2	14.0	4.3	0.3	12.0	0.3	13.6	0.2	0.6	0.7	6.8	2.5	0.1	1.9	0.2	7.9	0.0	17.0	0.4	0.1	2.5	1.3	7.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.9	11.9	38.4	14.8	16.9	7.1	4.4	4.4	9.7	14.0	2.5	7.9	7.9	0.8	0.0	0.0	5.9	0.6	0.1	0.0	0.1	0.0	43.7	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	30.1	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.7	0.0	0.0	21.9	27.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	2.8	0.0	0.3	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 16.4;retina: 4.5;thyroid gland: 16.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 220.9;Inhibitory neurons: 507.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	86	"NK-cell: 8.6"	"Lineage enriched"	"Detected in single"	86	"NK-cells: 8.6"	"Group enriched"	"Detected in some"	5	"AF22: 22.5;U-2197: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.0	0.7	3.7	0.1	5.6	0.0	0.1	1.7	14.5	1.4	0.0	0.5	0.0	0.3	0.1	0.0	0.1	0.1	0.5	6.5	3.1	0.2	0.0	0.0	0.1	14.2	4.6	3.1	0.4	0.1	0.0	1.8	0.1	16.4	0.6	0.2	4.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.4	12.4	0.3	16.5	0.0	0.1	0.0	0.0	15.2	0.0	1.3	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.0	0.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	3.7	5.6	1.7	14.5	6.5	3.1	14.2	4.6	3.1	16.4	0.0	12.4	15.2	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	8.5	0.1	0.0	0.9	2.8	0.0	0.0	6.2	0.0	1.0	0.0	1.9	0.0	19.7	0.0	0.1	0.0	1.8	0.0	220.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	507.5	0.0	0.0	0.0	0.0	55.2	2.8	0.0	0.0	7.5	0.0	1.3	42.2	13.0	4.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.1	0.1
ZNF486	"KRBO2, MGC2396"	ENSG00000256229	"Zinc finger protein 486"	Q96H40	19	20167214-20200488	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 34.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 13.6;Theca cells: 14.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 19.9;HBF TERT88: 21.5;SuSa: 19.8"															NA	NA						"unprognostic (9.94e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-2)"	2.5	2.4	1.6	4.1	2.3	2.9	8.5	3.4	2.1	8.4	1.5	2.6	1.3	6.3	3.8	3.0	5.8	5.0	3.3	1.5	1.8	6.4	1.1	3.5	7.2	2.4	2.2	1.2	7.9	3.0	6.5	0.8	8.0	2.4	3.5	3.0	1.8	2.0	4.6	0.8	5.1	1.5	3.2	1.4	5.0	3.5	2.1	2.0	5.7	34.3	3.1	6.8	12.3	1.8	3.4	0.1	0.1	5.9	0.4	4.3	4.6	0.5	8.1	6.4	15.3	14.5	0.7	3.6	7.2	19.9	6.9	10.8	3.4	0.0	0.7	21.5	0.1	2.4	0.1	0.1	2.1	5.4	0.0	0.1	8.5	2.2	9.0	0.9	5.3	1.0	0.2	3.3	0.1	3.6	0.2	1.5	6.6	10.5	0.0	2.3	4.9	8.1	3.0	18.0	5.7	3.3	9.7	0.0	9.7	1.4	19.8	4.3	0.0	2.2	1.5	0.6	10.5	6.4	0.8	9.4	6.6	0.2	0.1	2.9	2.5	0.7	0.7	0.8	1.2	1.0	1.6	1.1	1.1	0.8	2.1	1.5	2.2	9.5	1.0	1.0	0.9	1.5	0.6	1.6	2.3	3.4	2.1	1.5	1.8	2.4	2.2	1.2	2.4	1.4	2.0	3.4	4.7	6.4	6.7	1.3	4.9	0.1	1.9	0.2	0.0	1.1	4.8	4.7	2.3	0.0	4.0	3.7	0.0	4.5	2.0	1.1	3.9	8.4	0.5	13.0	6.4	4.3	1.2	4.4	1.2	7.1	13.6	4.0	3.1	12.5	5.1	5.7	1.4	0.0	2.2	0.0	1.6	1.8	0.0	1.3	2.0	0.5	4.4	1.5	0.0	2.8	1.4	2.1	4.1	2.0	3.8	2.7	0.9	2.6	1.9	1.1	0.1	1.0	10.5	0.4	6.6	4.4	2.5	2.6	2.7	1.4	1.1	1.5	3.1	14.1	1.6	2.7
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 26.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Excitatory neurons: 47.7;Inhibitory neurons: 56.5;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 27.7;Rod photoreceptor cells: 22.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0"									HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	1.5	5.0	9.9	2.3	10.8	0.6	3.2	14.6	11.6	4.9	7.3	3.6	2.2	3.3	4.8	1.7	3.9	1.9	5.3	9.7	11.8	4.4	2.2	2.6	3.8	8.9	9.4	10.1	8.5	2.5	5.3	14.8	1.2	10.0	5.6	1.8	26.0	3.5	4.6	2.0	3.2	4.2	1.8	7.4	4.7	3.3	2.9	11.1	2.1	7.9	1.6	3.4	3.7	3.5	10.6	0.1	0.0	1.1	1.3	3.0	1.8	0.1	0.4	0.4	0.5	0.9	0.1	0.0	0.5	0.1	1.1	0.3	0.4	0.8	0.4	0.4	1.7	1.2	0.4	0.8	0.0	0.8	0.5	0.9	0.9	1.1	0.3	0.0	0.2	0.0	2.4	0.2	0.0	0.7	0.0	0.8	0.3	0.4	0.1	0.2	0.7	0.7	0.4	0.2	0.1	1.2	1.4	0.4	0.1	0.1	0.8	0.6	0.5	0.0	0.4	1.4	0.5	0.4	1.6	1.0	1.3	0.0	0.2	0.2	0.0	0.0	0.8	2.7	0.0	2.6	1.9	2.7	3.0	0.1	2.2	4.4	4.8	0.1	2.4	0.0	0.2	3.1	1.2	9.9	10.8	14.6	11.6	9.7	11.8	8.9	9.4	10.1	10.0	7.4	11.1	10.6	2.3	3.2	2.6	15.3	6.3	1.7	1.3	0.8	3.4	23.3	2.4	2.2	10.4	0.0	1.7	1.8	6.2	0.3	3.3	0.2	7.9	0.3	18.6	1.1	1.0	2.2	0.0	0.0	47.7	0.4	0.4	2.8	1.5	0.6	3.8	1.7	2.2	1.1	0.8	18.5	56.5	0.3	0.0	0.8	1.0	5.5	2.5	1.0	3.6	11.2	0.5	5.5	8.2	23.1	27.7	0.2	1.1	5.7	2.5	0.4	2.3	2.7	0.4	22.3	6.6	3.1	2.9	5.7	3.3	1.8	1.3	0.1	3.9	1.2	0.3	0.2
